Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/Poland/2142377304_gx1/2021	EPI_ISL_1007954	2021-02-03	Europe / Poland / Wielkopolska / Jarocin	Human	Original	Oropharyngeal and nasopharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142385010_gx1/2021	EPI_ISL_1007960	2021-02-03	Europe / Poland / Dolnośląskie / Ząbkowice Śląskie	Human	Original	Oropharyngeal and nasopharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Netherlands/NH-RIVM-12055/2021	EPI_ISL_1013965	2021-01-29	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Netherlands/NH-RIVM-12056/2021	EPI_ISL_1013966	2021-01-29	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/USA/NY-Wadsworth-21017468-01/2021	EPI_ISL_1016101	2021-02-01	North America / USA / New York / Monroe County	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/USA/AZ-CDC-LC0000906/2020	EPI_ISL_1029344	2020-12-24	North America / USA / Arizona	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.231	GR
hCoV-19/Netherlands/ZH-RIVM-12947/2021	EPI_ISL_1035200	2021-02-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.177.73	GR
hCoV-19/Netherlands/ZH-RIVM-12962/2021	EPI_ISL_1035208	2021-01-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.31	GR
hCoV-19/Netherlands/ZH-RIVM-12958/2021	EPI_ISL_1035209	2021-02-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.177.50	GR
hCoV-19/Poland/Pomorskie_MWB_93/2021	EPI_ISL_1041010	2021-01-28	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/USA/CA-IGI-1135/2020	EPI_ISL_1041082	2020-09-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.3.1 reference aligned			B.1.1.174	GR
hCoV-19/Poland/0006WSN/2021	EPI_ISL_1048407	2021-02-03	Europe / Poland / Warminsko-Mazurskie / Olsztynski	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/0024WSN/2021	EPI_ISL_1048425	2021-02-02	Europe / Poland / Warminsko-Mazurskie / Olsztynski	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Canada/NS-NML-5508/2020	EPI_ISL_1055677	2020-08-26	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-5509/2020	EPI_ISL_1055678	2020-08-26	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.291	GR
hCoV-19/Canada/NS-NML-5510/2020	EPI_ISL_1055679	2020-08-24	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-5514/2020	EPI_ISL_1055680	2020-08-22	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-5515/2020	EPI_ISL_1055681	2020-08-21	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-5516/2020	EPI_ISL_1055682	2020-08-20	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.291	GR
hCoV-19/Canada/NS-NML-5517/2020	EPI_ISL_1055683	2020-08-18	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.291	GR
hCoV-19/Canada/NS-NML-5518/2020	EPI_ISL_1055684	2020-08-17	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-5519/2020	EPI_ISL_1055685	2020-08-15	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.291	GR
hCoV-19/Canada/NS-NML-5520/2020	EPI_ISL_1055686	2020-08-13	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.291	GR
hCoV-19/Canada/NS-NML-16234/2021	EPI_ISL_1055747	2021-01-20	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Canada/NS-NML-16240/2021	EPI_ISL_1055751	2021-01-27	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/USA/MI-UM-S544519/2021	EPI_ISL_1059197	2021-02-04	North America / USA / Michigan	Human	Original			Illumina MiSeq	BWA-MEM, iVar			B.1.1.231	GR
hCoV-19/Denmark/DCGC-45625/2021	EPI_ISL_1065135	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-46793/2020	EPI_ISL_1066303	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-46955/2021	EPI_ISL_1066466	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Israel/CVL-3308/2021	EPI_ISL_1073451	2021-01-21	Asia / Israel / Haifa	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-3210/2021	EPI_ISL_1073453	2021-01-20	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-3211/2021	EPI_ISL_1073454	2021-01-20	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 21 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-3350/2021	EPI_ISL_1073457	2021-01-21	Asia / Israel / Tel Aviv	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 19 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-824/2020	EPI_ISL_1073473	2020-12-29	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-3311/2021	EPI_ISL_1073474	2021-01-21	Asia / Israel / Central	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-3314/2021	EPI_ISL_1073475	2021-01-21	Asia / Israel / Central	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-3317/2021	EPI_ISL_1073476	2021-01-21	Asia / Israel / Central	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-2689/2021	EPI_ISL_1073484	2021-01-04	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/Sweden/SUS0000070/2021	EPI_ISL_1081912	2021-02-11	Europe / Sweden / Skane	Human	Original			Illumina NextSeq	bwa + iVar trim + iVar consensus			B.1.1	GR
hCoV-19/England/20109099106/2020	EPI_ISL_417298	2020-03-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109099206/2020	EPI_ISL_417299	2020-03-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Australia/VIC128/2020	EPI_ISL_419730	2020-03-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC123/2020	EPI_ISL_419731	2020-03-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	O
hCoV-19/Australia/VIC163/2020	EPI_ISL_419860	2020-03-18	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/England/20134004904/2020	EPI_ISL_423065	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134016902/2020	EPI_ISL_423092	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Sweden/20-08149/2020	EPI_ISL_429120	2020-03-11	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08155/2020	EPI_ISL_429122	2020-03-11	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08173/2020	EPI_ISL_429125	2020-03-12	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50361/2020	EPI_ISL_429163	2020-03-16	Europe / Sweden / Gavleborgs lan	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Spain/VC-FISABIO-170/2020	EPI_ISL_436265	2020-03-20	Europe / Spain / Comunitat Valenciana / Valencia / Valencia	Human	Original			Illumina MiSeq	BWA/IVAR	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Spain/VC-FISABIO-171/2020	EPI_ISL_436266	2020-03-20	Europe / Spain / Comunitat Valenciana / Valencia / Valencia	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/VC-FISABIO-247/2020	EPI_ISL_436342	2020-03-25	Europe / Spain / Comunitat Valenciana / Valencia / Valencia	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Ireland/un-NVRL-20W268/2020	EPI_ISL_437686	2020-04	Europe / Ireland	Human	Original			Nanopore MinION	Artic Network protocol			B.1.1	GR
hCoV-19/Ireland/un-NVRL-20W270/2020	EPI_ISL_437688	2020-04	Europe / Ireland	Human	Original			Nanopore MinION	Artic Network protocol			B.1.1	GR
hCoV-19/England/CAMB-7BC0C/2020	EPI_ISL_442089	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7BC84/2020	EPI_ISL_442146	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7E0B2/2020	EPI_ISL_442201	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D38D/2020	EPI_ISL_442252	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7B6FF/2020	EPI_ISL_442259	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-7C430/2020	EPI_ISL_442277	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-8422C/2020	EPI_ISL_443454	2020-04-15	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-1AA4B0/2020	EPI_ISL_443502	2020-04-17	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-83111/2020	EPI_ISL_443548	2020-04-15	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/NY-NYUMC601/2020	EPI_ISL_444718	2020-04-03	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/England/NORW-E88F7/2020	EPI_ISL_448249	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E898B/2020	EPI_ISL_448256	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9401/2020	EPI_ISL_448311	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E95A4/2020	EPI_ISL_448321	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9CEB/2020	EPI_ISL_448360	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-D3B50/2020	EPI_ISL_449631	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3DC3/2020	EPI_ISL_449654	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.254	GR
hCoV-19/England/LOND-D4BF5/2020	EPI_ISL_449662	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Switzerland/VD-ETHZ-110466/2020	EPI_ISL_451884	2020-04-06	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Russia/SCPM-O-08/2020	EPI_ISL_451970	2020-03-22	Europe / Russia / Moscow	Human	Original			BGISEQ-500	Unicycler v0.4.7	Insertion of 2 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Portugal/PT0304/2020	EPI_ISL_454020	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0307/2020	EPI_ISL_454023	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0316/2020	EPI_ISL_454032	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0331/2020	EPI_ISL_454047	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0345/2020	EPI_ISL_454061	2020-03-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0364/2020	EPI_ISL_454080	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0378/2020	EPI_ISL_454094	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/England/CAMB-1B2BA1/2020	EPI_ISL_456708	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2BCF/2020	EPI_ISL_456709	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2C08/2020	EPI_ISL_456713	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2C71/2020	EPI_ISL_456716	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/BRIS-125F9E/2020	EPI_ISL_459020	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125FAD/2020	EPI_ISL_459058	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Italy/LOM-INMI-BG-7158/2020	EPI_ISL_460081	2020-02-24	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA 0.7.12 + Samtools 1.3.1 + Geneious 2019.2.3			B.1.1	GR
hCoV-19/Netherlands/NoordHolland_23/2020	EPI_ISL_461213	2020-05-06	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/ZuidHolland_126/2020	EPI_ISL_461299	2020-04-24	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/20146016004/2020	EPI_ISL_466034	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20148035204/2020	EPI_ISL_466061	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	O
hCoV-19/England/20149003004/2020	EPI_ISL_466089	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149003104/2020	EPI_ISL_466090	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149005204/2020	EPI_ISL_466107	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149006104/2020	EPI_ISL_466115	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149054404/2020	EPI_ISL_466216	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Canada/BC_16588829/2020	EPI_ISL_468683	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Chile/RM-CMM-05426/2020	EPI_ISL_468750	2020-04-30	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/Spain/PV-IBV-2117/2020	EPI_ISL_468861	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2141/2020	EPI_ISL_468866	2020-04-12	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2116/2020	EPI_ISL_468869	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2108/2020	EPI_ISL_468873	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2110/2020	EPI_ISL_468874	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2111/2020	EPI_ISL_468880	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2113/2020	EPI_ISL_468881	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2137/2020	EPI_ISL_468885	2020-04-12	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Spain/PV-IBV-2119/2020	EPI_ISL_468887	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2103/2020	EPI_ISL_468890	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2114/2020	EPI_ISL_468892	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2118/2020	EPI_ISL_468897	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/BIRM-5F0E4/2020	EPI_ISL_473311	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5F187/2020	EPI_ISL_473318	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5F73A/2020	EPI_ISL_473324	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5FA22/2020	EPI_ISL_473363	2020-05-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Austria/CeMM0367/2020	EPI_ISL_475814	2020-03-17	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.5	GR
hCoV-19/Austria/CeMM0371/2020	EPI_ISL_475816	2020-03-25	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0377/2020	EPI_ISL_475821	2020-03-30	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.5	GR
hCoV-19/Austria/CeMM0379/2020	EPI_ISL_475822	2020-03-31	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.5	GR
hCoV-19/Austria/CeMM0380/2020	EPI_ISL_475823	2020-03-31	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.5	GR
hCoV-19/Austria/CeMM0409/2020	EPI_ISL_475841	2020-03-26	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0414/2020	EPI_ISL_475844	2020-03-09	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0427/2020	EPI_ISL_475855	2020-03-13	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0461/2020	EPI_ISL_475872	2020-03-07	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0473/2020	EPI_ISL_475878	2020-03-07	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0484/2020	EPI_ISL_475886	2020-03-06	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Singapore/437/2020	EPI_ISL_475968	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.5	GR
hCoV-19/Wales/PHWC-164C7E/2020	EPI_ISL_479365	2020-06-11	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BRIS-12CBDF/2020	EPI_ISL_481818	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12D048/2020	EPI_ISL_481853	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/GSTT-265D703/2020	EPI_ISL_484002	2020-03-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DC5F/2020	EPI_ISL_484085	2020-03-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB3052/2020	EPI_ISL_487851	2020-04-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2699/2020	EPI_ISL_487933	2020-03-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB6429/2020	EPI_ISL_487953	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2848/2020	EPI_ISL_487991	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185315B/2020	EPI_ISL_492309	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-299AA2/2020	EPI_ISL_492478	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D7BD4/2020	EPI_ISL_492503	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/SHEF-C17D9/2020	EPI_ISL_493669	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C43A5/2020	EPI_ISL_493678	2020-05-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C6051/2020	EPI_ISL_493684	2020-07-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CA275/2020	EPI_ISL_493693	2020-07-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CA9F8/2020	EPI_ISL_493696	2020-06-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CB6F0/2020	EPI_ISL_493702	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD069/2020	EPI_ISL_493709	2020-06-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CDC83/2020	EPI_ISL_493716	2020-07-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/WA-S1660/2020	EPI_ISL_496086	2020-05-29	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/WA-S2574/2020	EPI_ISL_497206	2020-06-17	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/England/LCST-24D71C9/2020	EPI_ISL_499974	2020-06-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Northern Ireland/NIRE-106BBD/2020	EPI_ISL_501035	2020-05-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106CF6/2020	EPI_ISL_501064	2020-05-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29BA0A/2020	EPI_ISL_507121	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C433C/2020	EPI_ISL_507163	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.5	GR
hCoV-19/Russia/Novy_Urengoy-RII24774S/2020	EPI_ISL_507217	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	O
hCoV-19/Russia/Novy_Urengoy-RII24775S/2020	EPI_ISL_507218	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24776S/2020	EPI_ISL_507219	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24786S/2020	EPI_ISL_507222	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/Novy_Urengoy-RII24787S/2020	EPI_ISL_507223	2020-05	Europe / Russia / Yamalo-Nenets	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33	NS6_E54stop results in 13.1% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Russia/StPetersburg-RII10261S/2020	EPI_ISL_507229	2020-04-25	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Sweden/20-51946/2020	EPI_ISL_510860	2020-06-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51948/2020	EPI_ISL_510862	2020-06-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH869/2020	EPI_ISL_513023	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.1	GR
hCoV-19/South Africa/KRISP-K002226/2020	EPI_ISL_515622	2020-07-21	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002243/2020	EPI_ISL_515634	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/England/LOND-12609D1/2020	EPI_ISL_516858	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B5B35/2020	EPI_ISL_516995	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B5B44/2020	EPI_ISL_516996	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/VA-DCLS-0913/2020	EPI_ISL_522785	2020-05-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0918/2020	EPI_ISL_522789	2020-05-12	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0920/2020	EPI_ISL_522791	2020-05-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0930/2020	EPI_ISL_522797	2020-05-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/ALDP-97CC99/2020	EPI_ISL_526312	2020-07-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-980BB3/2020	EPI_ISL_526351	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-98150F/2020	EPI_ISL_526353	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9826CF/2020	EPI_ISL_526366	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Italy/ABR-IZSGC-TE5040/2020	EPI_ISL_528922	2020-03-17	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE10002/2020	EPI_ISL_528990	2020-04-01	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE34742/2020	EPI_ISL_528993	2020-05-04	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-960F44/2020	EPI_ISL_532004	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-960797/2020	EPI_ISL_532005	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96109B/2020	EPI_ISL_532018	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96106E/2020	EPI_ISL_532042	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-960542/2020	EPI_ISL_532049	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960515/2020	EPI_ISL_532053	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961347/2020	EPI_ISL_532057	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9606F4/2020	EPI_ISL_532062	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96122C/2020	EPI_ISL_532076	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960CF2/2020	EPI_ISL_532078	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9611B6/2020	EPI_ISL_532081	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960C01/2020	EPI_ISL_532093	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9611C5/2020	EPI_ISL_532094	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9611D4/2020	EPI_ISL_532102	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96073D/2020	EPI_ISL_532123	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96116B/2020	EPI_ISL_532125	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960928/2020	EPI_ISL_532126	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96112F/2020	EPI_ISL_532129	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-9604AF/2020	EPI_ISL_532130	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96120E/2020	EPI_ISL_532138	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-554C9B/2020	EPI_ISL_532143	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-55336A/2020	EPI_ISL_532157	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53D17B/2020	EPI_ISL_532158	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53DABC/2020	EPI_ISL_532160	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-550DC9/2020	EPI_ISL_532162	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-554CB9/2020	EPI_ISL_532164	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-541EB9/2020	EPI_ISL_532165	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-554D98/2020	EPI_ISL_532188	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5E62AB/2020	EPI_ISL_533300	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5EB58F/2020	EPI_ISL_533320	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-5EA5EA/2020	EPI_ISL_533337	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/QEUH-5458A8/2020	EPI_ISL_533357	2020-05-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5477A9/2020	EPI_ISL_533377	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54AA34/2020	EPI_ISL_533385	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5476CA/2020	EPI_ISL_533390	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54A445/2020	EPI_ISL_533400	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/QEUH-54C9CC/2020	EPI_ISL_533413	2020-05-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-548052/2020	EPI_ISL_533414	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/QEUH-54CB20/2020	EPI_ISL_533418	2020-05-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54D4BB/2020	EPI_ISL_533422	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54AE65/2020	EPI_ISL_533425	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96CF0C/2020	EPI_ISL_534602	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D75E/2020	EPI_ISL_534605	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D730/2020	EPI_ISL_534606	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D509/2020	EPI_ISL_534607	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C7AA/2020	EPI_ISL_534608	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D4EE/2020	EPI_ISL_534609	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D76D/2020	EPI_ISL_534610	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D527/2020	EPI_ISL_534611	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D5CD/2020	EPI_ISL_534613	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0F9/2020	EPI_ISL_534614	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF57/2020	EPI_ISL_534616	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D7B8/2020	EPI_ISL_534619	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D518/2020	EPI_ISL_534620	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF2A/2020	EPI_ISL_534623	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDC6/2020	EPI_ISL_534624	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D4FD/2020	EPI_ISL_534625	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6BB/2020	EPI_ISL_534627	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D67F/2020	EPI_ISL_534628	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD20/2020	EPI_ISL_534629	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D572/2020	EPI_ISL_534630	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D23F/2020	EPI_ISL_534632	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CC05/2020	EPI_ISL_534633	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D32D/2020	EPI_ISL_534637	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CF66/2020	EPI_ISL_534638	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0BD/2020	EPI_ISL_534640	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6F7/2020	EPI_ISL_534641	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF39/2020	EPI_ISL_534642	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-964B3D/2020	EPI_ISL_534643	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B741/2020	EPI_ISL_534648	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96BBFA/2020	EPI_ISL_534653	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B3C5/2020	EPI_ISL_534656	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B547/2020	EPI_ISL_534657	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B495/2020	EPI_ISL_534659	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B77E/2020	EPI_ISL_534662	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B51A/2020	EPI_ISL_534663	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B0DD/2020	EPI_ISL_534664	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B0EC/2020	EPI_ISL_534668	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96AAD0/2020	EPI_ISL_534672	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96BF49/2020	EPI_ISL_534673	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96AAC1/2020	EPI_ISL_534674	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B76F/2020	EPI_ISL_534675	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B6DB/2020	EPI_ISL_534677	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96B635/2020	EPI_ISL_534679	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A9E2/2020	EPI_ISL_534680	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B9A5/2020	EPI_ISL_534681	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96ADE6/2020	EPI_ISL_534685	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B538/2020	EPI_ISL_534690	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/203690348/2020	EPI_ISL_534723	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690351/2020	EPI_ISL_534724	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690354/2020	EPI_ISL_534725	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690358/2020	EPI_ISL_534726	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690360/2020	EPI_ISL_534727	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690361/2020	EPI_ISL_534728	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203690368/2020	EPI_ISL_534729	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/OXON-B2F5B/2020	EPI_ISL_534829	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-95E529/2020	EPI_ISL_537011	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95DFE0/2020	EPI_ISL_537015	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9614EA/2020	EPI_ISL_537018	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9615E7/2020	EPI_ISL_537055	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-961B21/2020	EPI_ISL_537080	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-961CF1/2020	EPI_ISL_537083	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95E2C8/2020	EPI_ISL_537091	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Canada/ON-OICR-SLB2817/2020	EPI_ISL_538345	2020-04-02	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/England/MILK-9921E9/2020	EPI_ISL_540658	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-992213/2020	EPI_ISL_540659	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-992222/2020	EPI_ISL_540660	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-99232F/2020	EPI_ISL_540672	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9923B6/2020	EPI_ISL_540676	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9924A4/2020	EPI_ISL_540685	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-99908B/2020	EPI_ISL_541803	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/USA/TX-HMH-3143/2020	EPI_ISL_544022	2020-06-11	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-3145/2020	EPI_ISL_544024	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-3171/2020	EPI_ISL_544047	2020-06-11	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-3190/2020	EPI_ISL_544064	2020-06-13	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-3292/2020	EPI_ISL_544109	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3322/2020	EPI_ISL_544131	2020-06-12	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3374/2020	EPI_ISL_544158	2020-06-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3422/2020	EPI_ISL_544180	2020-06-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-3444/2020	EPI_ISL_544199	2020-06-13	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2422/2020	EPI_ISL_545303	2020-05-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2444/2020	EPI_ISL_545311	2020-05-31	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2506/2020	EPI_ISL_545344	2020-05-12	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2525/2020	EPI_ISL_545361	2020-06-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2527/2020	EPI_ISL_545363	2020-06-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2561/2020	EPI_ISL_545387	2020-06-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-2568/2020	EPI_ISL_545393	2020-06-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2576/2020	EPI_ISL_545399	2020-06-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2589/2020	EPI_ISL_545412	2020-06-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2631/2020	EPI_ISL_545438	2020-06-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7272/2020	EPI_ISL_546641	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7277/2020	EPI_ISL_546645	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	GR
hCoV-19/USA/TX-HMH-7283/2020	EPI_ISL_546647	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7323/2020	EPI_ISL_546675	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7361/2020	EPI_ISL_546707	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7384/2020	EPI_ISL_546723	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-7409/2020	EPI_ISL_546746	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-7433/2020	EPI_ISL_546765	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-7435/2020	EPI_ISL_546766	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-7452/2020	EPI_ISL_546778	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-7454/2020	EPI_ISL_546779	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-7481/2020	EPI_ISL_546792	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/Singapore/993/2020	EPI_ISL_549001	2020-03-14	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/MILK-9A5435/2020	EPI_ISL_550013	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A66A7/2020	EPI_ISL_550018	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A507D/2020	EPI_ISL_550032	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6689/2020	EPI_ISL_550039	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A6DC0/2020	EPI_ISL_550056	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB129/2020	EPI_ISL_551194	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9AD5/2020	EPI_ISL_551225	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AAF8A/2020	EPI_ISL_551230	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A964A/2020	EPI_ISL_551231	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9B3C/2020	EPI_ISL_551232	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9A9738/2020	EPI_ISL_551233	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9AB03B/2020	EPI_ISL_551241	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9C1B/2020	EPI_ISL_551244	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB29F/2020	EPI_ISL_551245	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4A8/2020	EPI_ISL_551260	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A8E43/2020	EPI_ISL_551263	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9E24/2020	EPI_ISL_551274	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-951F19/2020	EPI_ISL_551307	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951FCE/2020	EPI_ISL_551309	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-951D97/2020	EPI_ISL_551314	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.370	GR
hCoV-19/England/ALDP-951F28/2020	EPI_ISL_551322	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951EEF/2020	EPI_ISL_551326	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951D88/2020	EPI_ISL_551330	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-951F37/2020	EPI_ISL_551351	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-936615/2020	EPI_ISL_551354	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-937B60/2020	EPI_ISL_551395	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-932813/2020	EPI_ISL_551397	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-975173/2020	EPI_ISL_552563	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-974AD3/2020	EPI_ISL_552581	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-982A2D/2020	EPI_ISL_552639	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982832/2020	EPI_ISL_552642	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982B84/2020	EPI_ISL_552669	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-982823/2020	EPI_ISL_552681	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9758F6/2020	EPI_ISL_552685	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-957502/2020	EPI_ISL_553889	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9560E4/2020	EPI_ISL_553892	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9578FA/2020	EPI_ISL_553896	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957854/2020	EPI_ISL_553897	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955F9D/2020	EPI_ISL_553919	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-952789/2020	EPI_ISL_553950	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95269B/2020	EPI_ISL_553962	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95658B/2020	EPI_ISL_553966	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9527A7/2020	EPI_ISL_553975	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95273E/2020	EPI_ISL_553977	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95283B/2020	EPI_ISL_553978	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/MILK-9573F9/2020	EPI_ISL_553983	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-957C2B/2020	EPI_ISL_553987	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-956433/2020	EPI_ISL_553991	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-955CC3/2020	EPI_ISL_553995	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C9D7/2020	EPI_ISL_556002	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C597/2020	EPI_ISL_556004	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CF99/2020	EPI_ISL_556008	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D420/2020	EPI_ISL_556065	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CA497/2020	EPI_ISL_556107	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-6422BB/2020	EPI_ISL_556109	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-95C066/2020	EPI_ISL_556110	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CA109/2020	EPI_ISL_556122	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EF2E/2020	EPI_ISL_556136	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-632412/2020	EPI_ISL_556138	2020-07-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-6D6489/2020	EPI_ISL_556147	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D6665/2020	EPI_ISL_556153	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CA3A9/2020	EPI_ISL_556174	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-6412E9/2020	EPI_ISL_556197	2020-07-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-632922/2020	EPI_ISL_556198	2020-07-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-84F8BA/2020	EPI_ISL_557311	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-817C37/2020	EPI_ISL_557326	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Wales/MILK-848FF8/2020	EPI_ISL_557337	2020-07-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-813E9F/2020	EPI_ISL_557339	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-828608/2020	EPI_ISL_557348	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-745C22/2020	EPI_ISL_557354	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-8579E9/2020	EPI_ISL_557391	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-874069/2020	EPI_ISL_557394	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-873B4B/2020	EPI_ISL_557400	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-744986/2020	EPI_ISL_557404	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-74592B/2020	EPI_ISL_557405	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-747C3F/2020	EPI_ISL_557411	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-850D7B/2020	EPI_ISL_557431	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-870CD2/2020	EPI_ISL_557441	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-6F9D67/2020	EPI_ISL_557445	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-854F26/2020	EPI_ISL_557451	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-8664D7/2020	EPI_ISL_557455	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-870777/2020	EPI_ISL_557459	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-6F100C/2020	EPI_ISL_557461	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CD34D/2020	EPI_ISL_558610	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A3A0C/2020	EPI_ISL_558620	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A6A63/2020	EPI_ISL_558650	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A3B63/2020	EPI_ISL_558654	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5B76C5/2020	EPI_ISL_558659	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5ADE51/2020	EPI_ISL_558670	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-5A67E4/2020	EPI_ISL_558678	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AAF06/2020	EPI_ISL_558689	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5B4042/2020	EPI_ISL_558711	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AB336/2020	EPI_ISL_558744	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5AC292/2020	EPI_ISL_558750	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-59FDCE/2020	EPI_ISL_558754	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5A3B90/2020	EPI_ISL_558761	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AC942/2020	EPI_ISL_558768	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A4C23/2020	EPI_ISL_558797	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/SHEF-CC1EF/2020	EPI_ISL_559931	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CC5B6/2020	EPI_ISL_559932	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Sweden/20-52426/2020	EPI_ISL_560987	2020-07-17	Europe / Sweden / Norrbotten	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Gambia/3671/2020	EPI_ISL_560994	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/3673/2020	EPI_ISL_560995	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/England/ALDP-9BC84E/2020	EPI_ISL_568034	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC811/2020	EPI_ISL_568035	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE25D/2020	EPI_ISL_568049	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE9EF/2020	EPI_ISL_568109	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE5BE/2020	EPI_ISL_568127	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BDD11/2020	EPI_ISL_568135	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BDA74/2020	EPI_ISL_568147	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BEA19/2020	EPI_ISL_568164	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC7D8/2020	EPI_ISL_568174	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC7E7/2020	EPI_ISL_568175	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC8A8/2020	EPI_ISL_568183	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BECF5/2020	EPI_ISL_568185	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BE7F4/2020	EPI_ISL_568190	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9BDD7B/2020	EPI_ISL_568196	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/France/PAC-IHU-0316/2020	EPI_ISL_569449	2020-04-01	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.254	GR
hCoV-19/USA/WA-UW-10471/2020	EPI_ISL_570317	2020-06-07	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.231	GR
hCoV-19/USA/WA-UW-11519/2020	EPI_ISL_570427	2020-06-20	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.258	GR
hCoV-19/USA/WA-UW-11562/2020	EPI_ISL_570437	2020-06-22	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/England/ALDP-9B5DFB/2020	EPI_ISL_572967	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B5EAD/2020	EPI_ISL_572971	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9B61EF/2020	EPI_ISL_572992	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B62CE/2020	EPI_ISL_572996	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B62FB/2020	EPI_ISL_572998	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B6325/2020	EPI_ISL_572999	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16C12C/2020	EPI_ISL_574013	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9DA877/2020	EPI_ISL_575373	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/OR-UW-23549/2020	EPI_ISL_576474	2020-08-10	North America / USA / Oregon	Human	Original			Illumina	custom			B.1.1.258	GR
hCoV-19/USA/WA-UW-23597/2020	EPI_ISL_576482	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.337	GR
hCoV-19/USA/CA-IGI-0333/2020	EPI_ISL_576524	2020-06-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0339/2020	EPI_ISL_576528	2020-07-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0341/2020	EPI_ISL_576530	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0344/2020	EPI_ISL_576532	2020-07-15	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0356/2020	EPI_ISL_576541	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.1.174	GR
hCoV-19/England/ALDP-9D783E/2020	EPI_ISL_576589	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D785C/2020	EPI_ISL_576591	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D78B6/2020	EPI_ISL_576595	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/ALDP-9D7DE4/2020	EPI_ISL_576631	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D7DF3/2020	EPI_ISL_576632	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D7FA2/2020	EPI_ISL_576636	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Netherlands/ZH-EMC-488/2020	EPI_ISL_577918	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/QEUH-9DC787/2020	EPI_ISL_581001	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DAE75/2020	EPI_ISL_581003	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC21D/2020	EPI_ISL_581005	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E1F0F/2020	EPI_ISL_581169	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E2171/2020	EPI_ISL_581179	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E2047/2020	EPI_ISL_581198	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/MB-NML-1041/2020	EPI_ISL_582401	2020-04-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Austria/CeMM0646/2020	EPI_ISL_583620	2020-03-29	Europe / Austria / Kappl	Human	Original			Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0853/2020	EPI_ISL_583728	2020-04-04	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0867/2020	EPI_ISL_583732	2020-04-26	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0868/2020	EPI_ISL_583733	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0872/2020	EPI_ISL_583736	2020-04-30	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0874/2020	EPI_ISL_583737	2020-04-30	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0877/2020	EPI_ISL_583739	2020-05-06	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0878/2020	EPI_ISL_583740	2020-05-06	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0885/2020	EPI_ISL_583741	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0886/2020	EPI_ISL_583742	2020-04-28	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0887/2020	EPI_ISL_583743	2020-04-29	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/Austria/CeMM0934/2020	EPI_ISL_583786	2020-03-26	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/QEUH-A029AF/2020	EPI_ISL_584939	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A2E758/2020	EPI_ISL_587121	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F0D4/2020	EPI_ISL_587167	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2EFD8/2020	EPI_ISL_587172	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F61E/2020	EPI_ISL_587180	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F5E4/2020	EPI_ISL_587269	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1EE1A/2020	EPI_ISL_587346	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1EE0B/2020	EPI_ISL_587354	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F474D/2020	EPI_ISL_588472	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F34B0/2020	EPI_ISL_588483	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F409D/2020	EPI_ISL_588490	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3A54/2020	EPI_ISL_588492	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F36F6/2020	EPI_ISL_588499	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F374E/2020	EPI_ISL_588506	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4121/2020	EPI_ISL_588553	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F36E7/2020	EPI_ISL_588569	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F373F/2020	EPI_ISL_588570	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F3104/2020	EPI_ISL_588600	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3C8B/2020	EPI_ISL_588635	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3A45/2020	EPI_ISL_588641	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4358/2020	EPI_ISL_588661	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E2214/2020	EPI_ISL_589796	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D09F6/2020	EPI_ISL_589811	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0835/2020	EPI_ISL_589816	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFDC1/2020	EPI_ISL_589820	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D01D0/2020	EPI_ISL_589825	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0B5A/2020	EPI_ISL_589834	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0361/2020	EPI_ISL_589836	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9CFF70/2020	EPI_ISL_589839	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02CE/2020	EPI_ISL_589878	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D07ED/2020	EPI_ISL_589882	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D08DB/2020	EPI_ISL_589884	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFDB2/2020	EPI_ISL_589885	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0194/2020	EPI_ISL_589886	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D06E0/2020	EPI_ISL_589899	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D01C1/2020	EPI_ISL_589901	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D05D4/2020	EPI_ISL_589903	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D1236/2020	EPI_ISL_589914	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFF61/2020	EPI_ISL_589916	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9D0F8B/2020	EPI_ISL_589943	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9D08BD/2020	EPI_ISL_589956	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02FB/2020	EPI_ISL_589959	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFF52/2020	EPI_ISL_589984	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0668/2020	EPI_ISL_589985	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0A20/2020	EPI_ISL_589988	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFE82/2020	EPI_ISL_589990	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/TG-UZH-IMV10/2020	EPI_ISL_590832	2020-04-14	Europe / Switzerland / Thurgau	Human	Vero P2	Oropharyngeal swab		Illumina MiSeq	SMALT, 50% ambiguity threshold			B.1.1	GR
hCoV-19/USA/UT-UPHL-201007233/2020	EPI_ISL_594444	2020-06-22	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2.2			B.1.1	GR
hCoV-19/England/ALDP-9E75BC/2020	EPI_ISL_594479	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9F6BB8/2020	EPI_ISL_595618	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9F6FBC/2020	EPI_ISL_595650	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-9F774A/2020	EPI_ISL_595700	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7980/2020	EPI_ISL_595714	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7EEB/2020	EPI_ISL_595721	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F7F15/2020	EPI_ISL_595723	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F8099/2020	EPI_ISL_595725	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F80E4/2020	EPI_ISL_595729	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F8390/2020	EPI_ISL_595734	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F92A1/2020	EPI_ISL_595739	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-9F9BE2/2020	EPI_ISL_595753	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F9DDD/2020	EPI_ISL_595767	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-A585A6/2020	EPI_ISL_596956	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51FBE/2020	EPI_ISL_598005	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B083/2020	EPI_ISL_599150	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0BA58/2020	EPI_ISL_599188	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B153/2020	EPI_ISL_599242	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0C88A/2020	EPI_ISL_599250	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A0ADD8/2020	EPI_ISL_599256	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0BF77/2020	EPI_ISL_599288	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B0ED/2020	EPI_ISL_599300	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A0B0B0/2020	EPI_ISL_599319	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F6B12/2020	EPI_ISL_600704	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F6945/2020	EPI_ISL_600724	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4CA8/2020	EPI_ISL_600730	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F4CE4/2020	EPI_ISL_600738	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/QEUH-9F38F0/2020	EPI_ISL_600770	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F2C7D/2020	EPI_ISL_600795	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7A720/2020	EPI_ISL_606831	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A79CF5/2020	EPI_ISL_606834	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A40B/2020	EPI_ISL_606869	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A122/2020	EPI_ISL_606896	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CE56/2020	EPI_ISL_606915	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E130/2020	EPI_ISL_606934	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E5AD/2020	EPI_ISL_606956	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E4DD/2020	EPI_ISL_606961	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-A6E622/2020	EPI_ISL_606991	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64A7B/2020	EPI_ISL_609054	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	G
hCoV-19/England/ALDP-A68B29/2020	EPI_ISL_609070	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A646D1/2020	EPI_ISL_609091	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A646FF/2020	EPI_ISL_609099	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/CAMC-A58E9C/2020	EPI_ISL_609166	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5E1BB/2020	EPI_ISL_609197	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F38B/2020	EPI_ISL_611390	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A9F52B/2020	EPI_ISL_611395	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F6FB/2020	EPI_ISL_611408	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EA4B/2020	EPI_ISL_611417	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F628/2020	EPI_ISL_611422	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AA02B7/2020	EPI_ISL_611435	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F02A/2020	EPI_ISL_611436	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F127/2020	EPI_ISL_611440	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9E8AB/2020	EPI_ISL_611472	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-47EFA2/2020	EPI_ISL_612611	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47F75E/2020	EPI_ISL_612720	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Denmark/DCGC-3423/2020	EPI_ISL_616185	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3445/2020	EPI_ISL_616207	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3452/2020	EPI_ISL_616216	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3588/2020	EPI_ISL_616231	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3538/2020	EPI_ISL_616331	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3560/2020	EPI_ISL_616355	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3561/2020	EPI_ISL_616356	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3608/2020	EPI_ISL_616374	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2208/2020	EPI_ISL_617511	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2214/2020	EPI_ISL_617517	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2227/2020	EPI_ISL_617532	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2228/2020	EPI_ISL_617533	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2236/2020	EPI_ISL_617541	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2246/2020	EPI_ISL_617551	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2249/2020	EPI_ISL_617554	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2403/2020	EPI_ISL_617585	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2421/2020	EPI_ISL_617603	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2263/2020	EPI_ISL_617620	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2267/2020	EPI_ISL_617624	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.163	GR
hCoV-19/Denmark/DCGC-2282/2020	EPI_ISL_617640	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2283/2020	EPI_ISL_617641	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2287/2020	EPI_ISL_617645	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2334/2020	EPI_ISL_617672	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2355/2020	EPI_ISL_617693	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-7899/2020	EPI_ISL_618814	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7905/2020	EPI_ISL_618815	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7908/2020	EPI_ISL_618850	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7868/2020	EPI_ISL_618853	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7880/2020	EPI_ISL_618860	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7870/2020	EPI_ISL_618867	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7959/2020	EPI_ISL_618895	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-4096/2020	EPI_ISL_622052	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT). Submitter Note: Submitter had confirmed frameshift to be correct.	info	B.1.1	GR
hCoV-19/Denmark/DCGC-4103/2020	EPI_ISL_622059	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4190/2020	EPI_ISL_622083	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4211/2020	EPI_ISL_622104	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4214/2020	EPI_ISL_622107	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4224/2020	EPI_ISL_622117	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4225/2020	EPI_ISL_622118	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4236/2020	EPI_ISL_622129	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4237/2020	EPI_ISL_622130	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4711/2020	EPI_ISL_622150	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4731/2020	EPI_ISL_622170	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4738/2020	EPI_ISL_622177	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4739/2020	EPI_ISL_622178	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4741/2020	EPI_ISL_622180	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4742/2020	EPI_ISL_622181	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4746/2020	EPI_ISL_622185	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4748/2020	EPI_ISL_622187	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4754/2020	EPI_ISL_622193	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/England/MILK-AB746C/2020	EPI_ISL_623381	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB8717/2020	EPI_ISL_623401	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAFB62/2020	EPI_ISL_623444	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB8340/2020	EPI_ISL_623464	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AB8665/2020	EPI_ISL_623466	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-AB76EE/2020	EPI_ISL_623478	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A955AD/2020	EPI_ISL_624691	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A95A53/2020	EPI_ISL_624717	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A96032/2020	EPI_ISL_624748	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-485324/2020	EPI_ISL_628169	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4855C4/2020	EPI_ISL_628196	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-485922/2020	EPI_ISL_628235	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A322D8/2020	EPI_ISL_628343	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-A32302/2020	EPI_ISL_628345	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A326AF/2020	EPI_ISL_628358	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A326BE/2020	EPI_ISL_628359	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-ACEA06/2020	EPI_ISL_629467	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC89F0/2020	EPI_ISL_629469	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8170/2020	EPI_ISL_629518	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEE46/2020	EPI_ISL_629523	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACF3BF/2020	EPI_ISL_629537	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-ACF3A0/2020	EPI_ISL_629539	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8DD6/2020	EPI_ISL_629543	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEBB8/2020	EPI_ISL_629545	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/MILK-ACE769/2020	EPI_ISL_629555	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE6F3/2020	EPI_ISL_629565	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/MILK-ACF48F/2020	EPI_ISL_629566	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE74B/2020	EPI_ISL_629569	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC828C/2020	EPI_ISL_629582	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEEFB/2020	EPI_ISL_629601	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE70F/2020	EPI_ISL_629617	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC81CB/2020	EPI_ISL_629622	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC800A/2020	EPI_ISL_629626	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACEEEC/2020	EPI_ISL_629634	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7CAD/2020	EPI_ISL_629664	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE9BE/2020	EPI_ISL_629673	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A670C1/2020	EPI_ISL_630505	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68D7E/2020	EPI_ISL_630531	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6737D/2020	EPI_ISL_630548	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A66AC4/2020	EPI_ISL_630553	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68664/2020	EPI_ISL_630556	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67C27/2020	EPI_ISL_630560	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A67119/2020	EPI_ISL_630567	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A673B9/2020	EPI_ISL_630573	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67999/2020	EPI_ISL_630586	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67717/2020	EPI_ISL_630616	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD07BF/2020	EPI_ISL_634008	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD30A2/2020	EPI_ISL_634015	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD04E5/2020	EPI_ISL_634028	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3743/2020	EPI_ISL_634039	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD493D/2020	EPI_ISL_634045	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3C71/2020	EPI_ISL_634142	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD4A1C/2020	EPI_ISL_634152	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD37CB/2020	EPI_ISL_634173	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/C200024017/2020	EPI_ISL_636688	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/QEUH-B11B00/2020	EPI_ISL_642457	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B12343/2020	EPI_ISL_642492	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1443F/2020	EPI_ISL_642534	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14402/2020	EPI_ISL_642536	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B12668/2020	EPI_ISL_642547	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B1254D/2020	EPI_ISL_642562	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B129E7/2020	EPI_ISL_642581	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F24C/2020	EPI_ISL_642587	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B11DCE/2020	EPI_ISL_642610	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1005D/2020	EPI_ISL_642613	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B12677/2020	EPI_ISL_642621	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B10B3E/2020	EPI_ISL_642624	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0ECE5/2020	EPI_ISL_642629	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EE2B/2020	EPI_ISL_642631	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08911/2020	EPI_ISL_643796	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08CEB/2020	EPI_ISL_643886	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B073AB/2020	EPI_ISL_643888	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08920/2020	EPI_ISL_643906	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08753/2020	EPI_ISL_643949	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0737E/2020	EPI_ISL_643975	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B1DBAA/2020	EPI_ISL_646106	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1D603/2020	EPI_ISL_646113	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31B64/2020	EPI_ISL_646147	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B3195B/2020	EPI_ISL_646171	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B31C16/2020	EPI_ISL_646194	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B23F96/2020	EPI_ISL_646198	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2288D/2020	EPI_ISL_647314	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22D60/2020	EPI_ISL_647319	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21D70/2020	EPI_ISL_647365	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B21F89/2020	EPI_ISL_647390	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22D06/2020	EPI_ISL_647418	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2147B/2020	EPI_ISL_647432	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B22C09/2020	EPI_ISL_647450	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5BEF2/2020	EPI_ISL_655908	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5CCE8/2020	EPI_ISL_655916	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51D2C/2020	EPI_ISL_658010	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B553F9/2020	EPI_ISL_658018	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51D1D/2020	EPI_ISL_658019	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54BA7/2020	EPI_ISL_658023	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B54EDB/2020	EPI_ISL_658040	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54CE0/2020	EPI_ISL_658057	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51AF8/2020	EPI_ISL_658119	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B546E2/2020	EPI_ISL_658187	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B54776/2020	EPI_ISL_658199	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3387A/2020	EPI_ISL_659303	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32E3D/2020	EPI_ISL_659347	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B335CE/2020	EPI_ISL_659359	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B330AF/2020	EPI_ISL_659369	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B33528/2020	EPI_ISL_659381	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B33E4B/2020	EPI_ISL_659394	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32FA3/2020	EPI_ISL_659401	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32486/2020	EPI_ISL_659406	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Sweden/20-52652/2020	EPI_ISL_660416	2020-05-25	Europe / Sweden / Orebro	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/QEUH-B7ECA4/2020	EPI_ISL_661760	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B78563/2020	EPI_ISL_661761	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7EF6F/2020	EPI_ISL_661786	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF49DD/2020	EPI_ISL_662930	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52E0/2020	EPI_ISL_662932	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF3E75/2020	EPI_ISL_662945	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AF6777/2020	EPI_ISL_662946	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF667A/2020	EPI_ISL_662960	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF672C/2020	EPI_ISL_662970	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF665C/2020	EPI_ISL_662971	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52FF/2020	EPI_ISL_662976	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF6786/2020	EPI_ISL_662994	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/LOND-1250761/2020	EPI_ISL_665231	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48CBF8/2020	EPI_ISL_666519	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48CFFC/2020	EPI_ISL_666565	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48D122/2020	EPI_ISL_666583	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Japan/IC-0328/2020	EPI_ISL_667757	2020-09-13	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/England/QEUH-B7EA22/2020	EPI_ISL_667887	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-11669/2020	EPI_ISL_671057	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-11722/2020	EPI_ISL_671094	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-11760/2020	EPI_ISL_671116	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-11763/2020	EPI_ISL_671119	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/USA/CA-CZB-13038/2020	EPI_ISL_672318	2020-05-14	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-5687/2020	EPI_ISL_672391	2020-07-17	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-5684/2020	EPI_ISL_672392	2020-07-17	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13362/2020	EPI_ISL_672449	2020-05-21	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13392/2020	EPI_ISL_672456	2020-09-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13397/2020	EPI_ISL_672458	2020-09-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13424/2020	EPI_ISL_672468	2020-09-03	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13449/2020	EPI_ISL_672472	2020-09-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13454/2020	EPI_ISL_672474	2020-09-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13544/2020	EPI_ISL_672495	2020-06-11	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/CAMC-B9873A/2020	EPI_ISL_673604	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B988CE/2020	EPI_ISL_673651	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-B9AEBB/2020	EPI_ISL_673656	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-B9870D/2020	EPI_ISL_673685	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9871C/2020	EPI_ISL_673689	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B989DA/2020	EPI_ISL_673731	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-B95515/2020	EPI_ISL_673785	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B98794/2020	EPI_ISL_673788	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/NY-Wadsworth-220230-01/2020	EPI_ISL_677102	2020-09-17	North America / USA / New York / Warren County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/France/ARA-29004/2020	EPI_ISL_678535	2020-04-22	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/England/MILK-B3ACB3/2020	EPI_ISL_679722	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3B2ED/2020	EPI_ISL_679750	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.274	GR
hCoV-19/England/MILK-B3B46F/2020	EPI_ISL_679759	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3BCA3/2020	EPI_ISL_679802	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.274	GR
hCoV-19/England/MILK-B3BDA0/2020	EPI_ISL_679810	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3BDFB/2020	EPI_ISL_679812	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48DC21/2020	EPI_ISL_680739	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48DCC7/2020	EPI_ISL_680745	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/United Arab Emirates/0772/2020	EPI_ISL_698915	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0816/2020	EPI_ISL_698955	2020-05-19	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0818/2020	EPI_ISL_698957	2020-05-19	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/England/CAMC-BC1F03/2020	EPI_ISL_705068	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC03CC/2020	EPI_ISL_705167	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BC1C1B/2020	EPI_ISL_705188	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/NORT-1B71321/2020	EPI_ISL_706308	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B71A95/2020	EPI_ISL_706313	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B71AA4/2020	EPI_ISL_706314	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B71AC2/2020	EPI_ISL_706316	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B71B92/2020	EPI_ISL_706318	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B71DAB/2020	EPI_ISL_706321	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B71E3F/2020	EPI_ISL_706324	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B71F5A/2020	EPI_ISL_706327	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B71F96/2020	EPI_ISL_706328	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-28D27C/2020	EPI_ISL_706332	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D2D6/2020	EPI_ISL_706336	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D31F/2020	EPI_ISL_706338	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D35B/2020	EPI_ISL_706339	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D546/2020	EPI_ISL_706345	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Belgium/ULG-10977/2020	EPI_ISL_707751	2020-09-08	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.1	GR
hCoV-19/Wales/ALDP-B24B91/2020	EPI_ISL_711022	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-B1A7E5/2020	EPI_ISL_711027	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-14952/2020	EPI_ISL_713543	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16502/2020	EPI_ISL_714804	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16563/2020	EPI_ISL_714839	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-16571/2020	EPI_ISL_714844	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/CAMC-C44286/2020	EPI_ISL_718415	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/QEUH-BA016E/2020	EPI_ISL_719621	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BA1710/2020	EPI_ISL_719661	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BA0113/2020	EPI_ISL_719731	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-BA019B/2020	EPI_ISL_719733	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA1983/2020	EPI_ISL_719736	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA1042/2020	EPI_ISL_719739	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9EC35/2020	EPI_ISL_719756	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA175C/2020	EPI_ISL_719758	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B9EBED/2020	EPI_ISL_719783	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-BB0040/2020	EPI_ISL_720606	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BB1B8A/2020	EPI_ISL_720611	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-BB215A/2020	EPI_ISL_720626	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAC84F/2020	EPI_ISL_720660	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-BFCE99/2020	EPI_ISL_720681	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-BFDEA7/2020	EPI_ISL_720751	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/MILK-BFD593/2020	EPI_ISL_720795	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BBCB70/2020	EPI_ISL_724191	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NOTT-11F7EA/2020	EPI_ISL_725571	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Switzerland/BE-ETHZ-350336/2020	EPI_ISL_729196	2020-11-03	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Nigeria/FC-CV355/2020	EPI_ISL_730020	2020-06-26	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.0	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.484	GR
hCoV-19/Nigeria/FC-CV360/2020	EPI_ISL_730024	2020-07-01	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1.484	GR
hCoV-19/Nigeria/LA-CV374/2020	EPI_ISL_730033	2020-05-16	Africa / Nigeria / Lagos State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1	GR
hCoV-19/Nigeria/LA-CV379/2020	EPI_ISL_730035	2020-05-30	Africa / Nigeria / Lagos State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1	GR
hCoV-19/England/QEUH-C35FAF/2020	EPI_ISL_731321	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-C35F81/2020	EPI_ISL_731458	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Russia/MOS-CRIE-13381937/2020	EPI_ISL_732665	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13363841/2020	EPI_ISL_732666	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.349	GR
hCoV-19/Russia/MOS-CRIE-13385401/2020	EPI_ISL_732670	2020-11-07	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/MOS-CRIE-13384448/2020	EPI_ISL_732674	2020-11-07	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.336	GR
hCoV-19/Russia/MOS-CRIE-13298544/2020	EPI_ISL_732676	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.349	GR
hCoV-19/England/QEUH-C3317E/2020	EPI_ISL_733951	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C331BA/2020	EPI_ISL_733964	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-C57CCE/2020	EPI_ISL_736193	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C57B2B/2020	EPI_ISL_736221	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C57B85/2020	EPI_ISL_736223	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C5402F/2020	EPI_ISL_736242	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/AG-ETHZ-410268/2020	EPI_ISL_737658	2020-12-14	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/USA/CA-CZB-13895/2020	EPI_ISL_738800	2020-08-10	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14323/2020	EPI_ISL_738819	2020-07-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14111/2020	EPI_ISL_738843	2020-05-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/SHEF-10D3012/2020	EPI_ISL_742053	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-10D62A0/2020	EPI_ISL_742084	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D6A99/2020	EPI_ISL_742091	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/UT-UPHL-2012768090/2020	EPI_ISL_745949	2020-08-11	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1.230	GR
hCoV-19/Germany/BE-ChVir-W1727-8260/2020	EPI_ISL_754014	2020-08-19	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BW-ChVir-W1441-8265/2020	EPI_ISL_754023	2020-06-19	Europe / Germany / Baden-Wurttemberg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/HE-ChVir-W1287-2006/2020	EPI_ISL_754040	2020-04-07	Europe / Germany / Hesse	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/NI-ChVir-W1707-6795/2020	EPI_ISL_754045	2020-08-07	Europe / Germany / Lower Saxony	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/England/MILK-C7B3B0/2020	EPI_ISL_756799	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/QEUH-CAD977/2020	EPI_ISL_761176	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-CB4DBD/2020	EPI_ISL_761242	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/NY-Wadsworth-224452-01/2020	EPI_ISL_767425	2020-09-22	North America / USA / New York / Warren County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/Singapore/1506/2020	EPI_ISL_768622	2020-12-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.398	GR
hCoV-19/Singapore/1507/2020	EPI_ISL_768623	2020-12-26	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.398	GR
hCoV-19/Japan/IC-0511/2020	EPI_ISL_768720	2020-12-24	Asia / Japan	Human	Original		COVID-19 positive case who entered from Mexico.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Luxembourg/LNS0432074/2020	EPI_ISL_770941	2020-11-30	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiSeq DX, (2x250bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/England/CAMC-CB728E/2020	EPI_ISL_778030	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Slovakia/UKBA-401/2020	EPI_ISL_779403	2020-11-22	Europe / Slovakia / Bratislava	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 2000bp, manual inspection of 2bp frameshift insertion	Insertion of 2 nucleotides found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.1.163	GR
hCoV-19/USA/TX-HMH-MCoV-9858/2020	EPI_ISL_780308	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9877/2020	EPI_ISL_780317	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-9924/2020	EPI_ISL_780343	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9943/2020	EPI_ISL_780350	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/Italy/LOM-UniMI17/2020	EPI_ISL_780413	2020-03-04	Europe / Italy / Lombardy	Human	Original	Sputum		Illumina Miseq				B.1.1	GR
hCoV-19/England/MILK-D09134/2020	EPI_ISL_781749	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-C2F3E8/2020	EPI_ISL_782968	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/USA/TX-HMH-MCoV-18806/2020	EPI_ISL_785133	2020-11-23	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-19012/2020	EPI_ISL_785282	2020-11-24	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14932/2020	EPI_ISL_786416	2020-10-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-14944/2020	EPI_ISL_786428	2020-10-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-14974/2020	EPI_ISL_786458	2020-10-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-14975/2020	EPI_ISL_786459	2020-10-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	G
hCoV-19/USA/TX-HMH-MCoV-14997/2020	EPI_ISL_786481	2020-10-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-14998/2020	EPI_ISL_786482	2020-10-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-15107/2020	EPI_ISL_786591	2020-10-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/Denmark/DCGC-25314/2020	EPI_ISL_794948	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/MILK-DB0406/2020	EPI_ISL_797149	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/MILK-DB0390/2020	EPI_ISL_797266	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/MILK-D67D21/2020	EPI_ISL_798545	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-D1A042/2020	EPI_ISL_799743	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-D1AFEB/2020	EPI_ISL_799880	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-BC28F8/2020	EPI_ISL_801004	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC2A01/2020	EPI_ISL_801008	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-MSHSPSP-PV15317/2020	EPI_ISL_802120	2020-07-04	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/USA/NY-MSHSPSP-PV15711/2020	EPI_ISL_802151	2020-08-04	North America / USA / New York / Bronx	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV15713/2020	EPI_ISL_802153	2020-08-05	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/USA/NY-MSHSPSP-PV17166/2020	EPI_ISL_802192	2020-08-21	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV17626/2020	EPI_ISL_802196	2020-08-21	North America / USA / New York / Nassau County	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/USA/NY-MSHSPSP-PV17518/2020	EPI_ISL_802201	2020-08-25	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/USA/NY-MSHSPSP-PV17533/2020	EPI_ISL_802205	2020-08-28	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV18763/2020	EPI_ISL_802255	2020-09-17	North America / USA / New York / Brooklyn	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV19350/2020	EPI_ISL_802310	2020-09-30	North America / USA / New York / Bronx	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/USA/MI-MDHHS-SC22910/2020	EPI_ISL_804796	2020-11-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/USA/MI-MDHHS-SC22919/2020	EPI_ISL_804805	2020-11-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/Israel/CVL-128-ngs/2020	EPI_ISL_814247	2020-12-27	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/England/TFCI-26FA182/2020	EPI_ISL_816760	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/TFCI-26FA1EC/2020	EPI_ISL_816766	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/TFCI-26FA304/2020	EPI_ISL_816784	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/TFCI-26FA340/2020	EPI_ISL_816788	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/TFCI-26FA35F/2020	EPI_ISL_816789	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/TFCI-26FA401/2020	EPI_ISL_816800	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/TFCI-26FA4C5/2020	EPI_ISL_816812	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/TFCI-26FAA1E/2020	EPI_ISL_816845	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Iceland/3790/2020	EPI_ISL_827487	2020-12-17	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS8_E110stop results in 9.9% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Iceland/3877/2020	EPI_ISL_827573	2020-10-18	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	MPileup			B.1.1	GR
hCoV-19/France/GE-IPP10938/2020	EPI_ISL_832132	2020-12-17	Europe / France / Grand Est / Reims	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Indonesia/BGR-LIPI010/2020	EPI_ISL_833493	2020-07-17	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.1.398	GR
hCoV-19/England/MILK-EC1771/2021	EPI_ISL_835902	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-B5AC17/2020	EPI_ISL_839460	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-29983/2020	EPI_ISL_844030	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-29544/2021	EPI_ISL_844129	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT confirmed by submitter).	info	B.1.1.294	GR
hCoV-19/Switzerland/GE-32845358/2020	EPI_ISL_847953	2020-12-31	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Wales/ALDP-D448ED/2020	EPI_ISL_858753	2020-12-28	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/United Arab Emirates/3941/2020	EPI_ISL_859908	2020-11-23	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/4159/2020	EPI_ISL_859940	2020-05-01	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/4173/2020	EPI_ISL_859954	2020-05-02	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/4207/2020	EPI_ISL_859987	2020-05-06	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/4214/2020	EPI_ISL_859994	2020-05-04	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/Denmark/DCGC-32356/2021	EPI_ISL_869360	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-32444/2021	EPI_ISL_869448	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-34756/2020	EPI_ISL_871767	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Russia/IVA-RII-MH11761S/2020	EPI_ISL_872905	2020-12-06	Europe / Russia / Ivanovo / Kineshma	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/IVA-RII-MH11885S/2020	EPI_ISL_872941	2020-12-15	Europe / Russia / Ivanovo / Ivanovo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/KAM-RII-MH12143S/2020	EPI_ISL_872954	2020-12-17	Europe / Russia / Kamchatka / Petropavlovsk-Kamchatsky	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/KAM-RII-MH12144S/2020	EPI_ISL_872955	2020-12-16	Europe / Russia / Kamchatka / Petropavlovsk-Kamchatsky	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/SPE-RII-MH13216S/2020	EPI_ISL_872986	2020-12-24	Europe / Russia / Saint Petersburg / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH13219S/2020	EPI_ISL_872987	2020-12-24	Europe / Russia / Saint Petersburg / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.336	GR
hCoV-19/USA/NC-UNC-LCCC0155/2020	EPI_ISL_877736	2020-08-24	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/USA/NC-UNC-LCCC0172/2020	EPI_ISL_877753	2020-08-26	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/England/ALDP-F7434B/2020	EPI_ISL_882323	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Germany/SN-DcGC-L56902/2020	EPI_ISL_887107	2020-04-06	Europe / Germany / Saxony / Dresden	Human	Original			Illumina NextSeq 500	Nfcore viralrecon, ivar			B.1.1	GR
hCoV-19/USA/MT-BHDH-5296/2020	EPI_ISL_900740	2020-08-04	North America / USA / Montana / West Yellowstone	Human	Original	Oro-pharyngeal swab	unknown	Nanopore MinION	ARTIC			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-28/2021	EPI_ISL_904123	2021-01-12	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-41/2021	EPI_ISL_904124	2021-01-13	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-55/2021	EPI_ISL_904126	2021-01-24	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/Pomorskie_MWB_15/2021	EPI_ISL_906723	2021-01-10	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Pomorskie_MWB_35/2021	EPI_ISL_906735	2021-01-10	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Pomorskie_MWB_66/2021	EPI_ISL_906756	2021-01-10	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/TX-HHD-2101214910/2020	EPI_ISL_911478	2020-12-11	North America / USA / Texas	Human	Original			Illumina MiSeq	Staph-B Monroe			B.1.1.337	GR
hCoV-19/Mexico/MOR-InDRE_113/2020	EPI_ISL_913917	2020-07-18	North America / Mexico / Morelos	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Mexico/MOR-InDRE_155/2020	EPI_ISL_913957	2020-10-20	North America / Mexico / Morelos	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Denmark/DCGC-37070/2020	EPI_ISL_928211	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-37135/2021	EPI_ISL_928276	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-38354/2021	EPI_ISL_929495	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-39420/2020	EPI_ISL_930562	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/ALDP-11860B3/2021	EPI_ISL_931787	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Lithuania/ID3779/2020	EPI_ISL_934108	2020-12-14	Europe / Lithuania / Vilniaus apskritis	Human	Original			Illumina Miseq	covid-19-signal			AD.2.1	GR
hCoV-19/USA/FL-BPHL-2905/2020	EPI_ISL_935426	2020-11-16	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/Spain/VC-IBV-98014524/2021	EPI_ISL_941226	2021-01-04	Europe / Spain / Comunitat Valenciana / Elda	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/VC-IBV-98014525/2021	EPI_ISL_941227	2021-01-04	Europe / Spain / Comunitat Valenciana / Elda	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Indonesia/BT-EIJK73/2020	EPI_ISL_947265	2020-11-16	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JK-EIJK85/2020	EPI_ISL_947278	2020-12-02	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JB-EIJK86/2020	EPI_ISL_947281	2020-12-02	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/BT-EIJK92/2020	EPI_ISL_947284	2020-12-03	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1	GR
hCoV-19/Indonesia/BT-EIJK94/2020	EPI_ISL_947290	2020-12-02	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JK-EIJK96/2020	EPI_ISL_947293	2020-12-07	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JB-EIJK101/2020	EPI_ISL_947301	2020-12-10	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JK-EIJK102/2020	EPI_ISL_947304	2020-12-11	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1	GR
hCoV-19/Indonesia/JB-EIJK105/2020	EPI_ISL_947307	2020-12-14	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JB-EIJK106/2020	EPI_ISL_947309	2020-12-15	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JB-EIJK109/2020	EPI_ISL_947312	2020-12-18	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/Indonesia/JK-EIJK111/2020	EPI_ISL_947315	2020-12-18	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/England/OXON-F4652E/2020	EPI_ISL_950899	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/MI-UM-S480782/2021	EPI_ISL_955857	2021-01-21	North America / USA / Michigan	Human	Original			Illumina MiSeq	BWA-MEM, iVar			B.1.1.231	GR
hCoV-19/England/ALDP-1196117/2021	EPI_ISL_959263	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/OK-CDC-STM-000003151/2021	EPI_ISL_967827	2021-01-15	North America / USA / Oklahoma	Human	Original	Nasal swab		Illumina	COVIDSEQ	Gap of 11 nucleotides when compared to the reference sequence.	info	B.1.1.337	GR
hCoV-19/Denmark/DCGC-41847/2021	EPI_ISL_973574	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-41893/2021	EPI_ISL_973664	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Canada/BC-BCCDC-7035/2020	EPI_ISL_974999	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.1.315	GR
hCoV-19/USA/CA-IGI-3092/2021	EPI_ISL_980841	2021-01-26	North America / USA / California / Contra Costa County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.3.1 reference aligned	Gap of 4 nucleotide(s) found at refpos 26158 (FRAMESHIFT confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.1	GR
hCoV-19/USA/WI-WSLH-210950/2021	EPI_ISL_984202	2021-01-27	North America / USA / Wisconsin / Burnett County	Human	Original			Illumina				B.1.1.453	GR
hCoV-19/Brazil/SP-1118/2020	EPI_ISL_984244	2020-08-24	South America / Brazil / Sao Paulo / Taruma	Human	Original	Nasopharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Belgium/UZA-UA-2202/2021	EPI_ISL_984284	2021-01-30	Europe / Belgium / Stabroek	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Belgium/UZA-UA-3842/2021	EPI_ISL_984285	2021-01-29	Europe / Belgium / Zoersel	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Belgium/UZA-UA-7275/2021	EPI_ISL_984287	2021-01-26	Europe / Belgium / Brasschaat	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/mink/Poland/210209_3596/2021	EPI_ISL_984305	2021-01-27	Europe / Poland / Pomorskie	Neovison vison	Original			Illumina MiSeq		NS7b_L22stop results in 51.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/mink/Poland/210209_3597/2021	EPI_ISL_984307	2021-01-27	Europe / Poland / Pomorskie	Neovison vison	Original			Illumina MiSeq		NS7b_L22stop results in 51.2% truncation of the protein sequence.	info	B.1.1	O
hCoV-19/USA/NY-PRL-2021_0210_01H06/2021	EPI_ISL_995055	2021-02-07	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina Miseq/NextSeq	bwa mem			B.1.1.231	GR
hCoV-19/USA/OR-PROV-367/2020	EPI_ISL_1017244	2020-07-08	North America / USA / Oregon	Human	Original			Illumina NovaSeq 6000	BWA mem, Freebayes, vcffilter, bcftools consensus (AF >=50%, min DP > 100)			B.1.1	GR
hCoV-19/Denmark/DCGC-43830/2021	EPI_ISL_1024208	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-43877/2021	EPI_ISL_1024255	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/TX-CDC-LC0000122/2020	EPI_ISL_1029110	2020-12-26	North America / USA / Texas	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.231	GR
hCoV-19/USA/AZ-CDC-LC0000181/2020	EPI_ISL_1029128	2020-12-26	North America / USA / Arizona	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.231	GR
hCoV-19/USA/WA-CDC-LC0000770/2020	EPI_ISL_1029290	2020-12-24	North America / USA / Washington	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.337	GR
hCoV-19/USA/FL-BPHL-0318/2021	EPI_ISL_1030074	2021-01-22	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/Netherlands/ZH-RIVM-12818/2021	EPI_ISL_1035264	2021-01-22	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1.315	GR
hCoV-19/Netherlands/ZH-RIVM-12435/2021	EPI_ISL_1035268	2021-02-05	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1.315	GR
hCoV-19/Italy/CAM-TIGEM-2092/2021	EPI_ISL_1056821	2021	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1.372	GR
hCoV-19/Italy/CAM-TIGEM-2164/2021	EPI_ISL_1056872	2021	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1	GR
hCoV-19/USA/MI-UM-S535489/2021	EPI_ISL_1059218	2021-02-02	North America / USA / Michigan	Human	Original			Illumina MiSeq	BWA-MEM, iVar			B.1.1.231	GR
hCoV-19/USA/WY-WPHL-21011580/2021	EPI_ISL_1060021	2021-02-02	North America / USA / Wyoming	Human	Original	Nasal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-46886/2021	EPI_ISL_1066397	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-47829/2020	EPI_ISL_1067364	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT confirmed by submitter). Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-20453/2021	EPI_ISL_1074895	2021-01-04	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-24730/2021	EPI_ISL_1079312	2021-01-19	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/Colombia/DC-INS-78390/2020	EPI_ISL_418262	2020-03-06	South America / Colombia / Bogota	Human	Original	Swab		Nanopore MinION	BWA, Nanopolish	Stretches of NNNs (2.88% of overall sequence).		B.1.1	GR
hCoV-19/Canada/ON-PHL-3458/2020	EPI_ISL_418368	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Canada/ON-PHL-8539/2020	EPI_ISL_418369	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Canada/ON-PHL-0654/2020	EPI_ISL_418370	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Canada/ON-PHL-8458/2020	EPI_ISL_418372	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3			B.1.1	GR
hCoV-19/Luxembourg/LNS7866283/2020	EPI_ISL_419596	2020-03-12	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1	GR
hCoV-19/Australia/VIC134/2020	EPI_ISL_419827	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-6193/2020	EPI_ISL_420568	2020-03-23	Europe / Italy / Abruzzo	Human	Original							B.1.1	GR
hCoV-19/England/20136097204/2020	EPI_ISL_420652	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380037/2020	EPI_ISL_421801	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139024004/2020	EPI_ISL_421890	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139027004/2020	EPI_ISL_421900	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/20139027604/2020	EPI_ISL_421905	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.5	GR
hCoV-19/England/20139033404/2020	EPI_ISL_421921	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144037304/2020	EPI_ISL_421946	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134006504/2020	EPI_ISL_423070	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20129035304/2020	EPI_ISL_424028	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20129036404/2020	EPI_ISL_424034	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/USA/WA-UW-1917/2020	EPI_ISL_424332	2020-03-22	North America / USA / Washington	Human	Original			unknown				B.1.1	GR
hCoV-19/Australia/VIC361/2020	EPI_ISL_426669	2020-03-22	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC394/2020	EPI_ISL_426697	2020-03-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC651/2020	EPI_ISL_426947	2020-03-28	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC672/2020	EPI_ISL_426968	2020-03-27	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1.89	GR
hCoV-19/Australia/VIC696/2020	EPI_ISL_426988	2020-03-28	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/USA/CA-CZB0713/2020	EPI_ISL_429022	2020-03-23	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB0714/2020	EPI_ISL_429052	2020-03-23	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/England/CAMB-7AA8B/2020	EPI_ISL_433833	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AAB8/2020	EPI_ISL_433835	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AB2E/2020	EPI_ISL_433842	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AD46/2020	EPI_ISL_433870	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7ADDD/2020	EPI_ISL_433877	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AEDA/2020	EPI_ISL_433890	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.208	GR
hCoV-19/England/CAMB-7AF5F/2020	EPI_ISL_433898	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.89	GR
hCoV-19/England/CAMB-7AFAA/2020	EPI_ISL_433902	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B52F/2020	EPI_ISL_433971	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-8214F/2020	EPI_ISL_438623	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-8217C/2020	EPI_ISL_438625	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-821C7/2020	EPI_ISL_438630	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/CAMB-83D77/2020	EPI_ISL_438688	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83DB3/2020	EPI_ISL_438692	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.274	GR
hCoV-19/England/CAMB-83E0B/2020	EPI_ISL_438696	2020-04-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LIVE-9BC06/2020	EPI_ISL_440904	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9C959/2020	EPI_ISL_440924	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D37F2/2020	EPI_ISL_440990	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-7BC57/2020	EPI_ISL_442176	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Singapore/113/2020	EPI_ISL_443205	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/118/2020	EPI_ISL_443210	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.89	GR
hCoV-19/USA/NY-NYUMC514/2020	EPI_ISL_444631	2020-03-30	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/USA/NY-NYUMC556/2020	EPI_ISL_444673	2020-03-31	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/England/CAMB-1AD72D/2020	EPI_ISL_448001	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADB6D/2020	EPI_ISL_448038	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADBC7/2020	EPI_ISL_448044	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AEBC6/2020	EPI_ISL_448057	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.274	GR
hCoV-19/England/CAMB-1AECE1/2020	EPI_ISL_448072	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AECF0/2020	EPI_ISL_448073	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B001D/2020	EPI_ISL_448098	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-E98BA/2020	EPI_ISL_448341	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100098/2020	EPI_ISL_451690	2020-03-13	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100838/2020	EPI_ISL_451786	2020-03-25	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-101130/2020	EPI_ISL_451797	2020-03-30	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/un-ETHZ-110503/2020	EPI_ISL_451909	2020-04-07	Europe / Switzerland	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/un-ETHZ-110510/2020	EPI_ISL_451916	2020-04-07	Europe / Switzerland	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/CAMB-1B0675/2020	EPI_ISL_452904	2020-05-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0B58/2020	EPI_ISL_452944	2020-05-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0BD0/2020	EPI_ISL_452950	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B193F/2020	EPI_ISL_452983	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B1999/2020	EPI_ISL_452989	2020-05-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Portugal/PT0286a/2020	EPI_ISL_454001	2020-03-09	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0291/2020	EPI_ISL_454007	2020-03-11	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0425/2020	EPI_ISL_454149	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0426/2020	EPI_ISL_454150	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Netherlands/NA_375/2020	EPI_ISL_455178	2020-04-08	Europe / Netherlands	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Spain/CN-ISCIII-201939/2020	EPI_ISL_455326	2020-02-29	Africa / Canary Islands	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1	GR
hCoV-19/England/BIRM-5F327/2020	EPI_ISL_456671	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BRIS-126470/2020	EPI_ISL_459014	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/WA-S1209/2020	EPI_ISL_463699	2020-05-07	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/England/20118051204/2020	EPI_ISL_464925	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20118111104/2020	EPI_ISL_464954	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20118123004/2020	EPI_ISL_464958	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Canada/BC_11135150/2020	EPI_ISL_467318	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/USA/CA-CZB-1488/2020	EPI_ISL_468438	2020-03-19	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1678/2020	EPI_ISL_468618	2020-03-30	North America / USA / California / Contra Costa County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/England/BRIS-127442/2020	EPI_ISL_469750	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1277B2/2020	EPI_ISL_469771	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127381/2020	EPI_ISL_469779	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127E17/2020	EPI_ISL_469803	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-162B37/2020	EPI_ISL_473166	2020-05-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-162C70/2020	EPI_ISL_473183	2020-05-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-CSMC66/2020	EPI_ISL_475680	2020-03-28	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Belgium/rega-0409431/2020	EPI_ISL_476941	2020-04-09	Europe / Belgium / Houthalen-Helchteren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0409433/2020	EPI_ISL_476942	2020-04-09	Europe / Belgium / Landen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0409436/2020	EPI_ISL_476945	2020-04-09	Europe / Belgium / Molenbeek-Saint-Jean	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0409438/2020	EPI_ISL_476947	2020-04-09	Europe / Belgium / Linter	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/rega-0409439/2020	EPI_ISL_476948	2020-04-09	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/rega-0411447/2020	EPI_ISL_476957	2020-04-11	Europe / Belgium / Haasrode	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/rega-0411454/2020	EPI_ISL_476964	2020-04-11	Europe / Belgium / Peer	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0411459/2020	EPI_ISL_476969	2020-04-11	Europe / Belgium / Sint-Truiden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/rega-0411469/2020	EPI_ISL_476979	2020-04-11	Europe / Belgium / Paal	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/England/OXON-B236E/2020	EPI_ISL_479138	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B26FC/2020	EPI_ISL_479168	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Egypt/MASRI-027/2020	EPI_ISL_482773	2020-05-08	Africa / Egypt	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Scotland/EDB2692/2020	EPI_ISL_487652	2020-03-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB6418/2020	EPI_ISL_487729	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.5	GR
hCoV-19/Scotland/EDB2846/2020	EPI_ISL_488909	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB3024/2020	EPI_ISL_488948	2020-04-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2711/2020	EPI_ISL_488988	2020-03-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B451A/2020	EPI_ISL_492190	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B45DE/2020	EPI_ISL_492191	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B4565/2020	EPI_ISL_492194	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B4626/2020	EPI_ISL_492196	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/NORT-29950B/2020	EPI_ISL_492450	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BIRM-61674/2020	EPI_ISL_493449	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-298821/2020	EPI_ISL_493468	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2993E3/2020	EPI_ISL_493487	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CF5FF/2020	EPI_ISL_493724	2020-07-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D285A/2020	EPI_ISL_493735	2020-07-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Italy/CAM-INTPas-7/2020	EPI_ISL_494761	2020	Europe / Italy / Campania	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/England/LIVE-A5FA6/2020	EPI_ISL_499670	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-299F3A/2020	EPI_ISL_507110	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Spain/PV-IBV-004288/2020	EPI_ISL_510404	2020-04-08	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004289/2020	EPI_ISL_510405	2020-04-08	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004290/2020	EPI_ISL_510406	2020-04-08	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004296/2020	EPI_ISL_510411	2020-04-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004307/2020	EPI_ISL_510422	2020-04-09	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004180/2020	EPI_ISL_510467	2020-04-02	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004187/2020	EPI_ISL_510474	2020-04-02	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004195/2020	EPI_ISL_510481	2020-04-02	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004198/2020	EPI_ISL_510483	2020-04-03	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Mexico/COA-InDRE_40/2020	EPI_ISL_516620	2020-06-19	North America / Mexico / Coahuila	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Estonia/ChVir4307/2020	EPI_ISL_516627	2020-03	Europe / Estonia	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/USA/VA-DCLS-0840/2020	EPI_ISL_516707	2020-05-05	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/LOND-125F814/2020	EPI_ISL_516873	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Germany/BY-UHR-2O/2020	EPI_ISL_522407	2020-03-20	Europe / Germany / Bavaria	Human	Original	Swab		Illumina	DRAGEN RNA Pathogen Detection v. 3.5.13			B.1.1	GR
hCoV-19/South Korea/KCDC2671/2020	EPI_ISL_522453	2020-06-06	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2710/2020	EPI_ISL_522489	2020-07-08	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/Switzerland/BL-ETHZ-240001/2020	EPI_ISL_523856	2020-08-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240010/2020	EPI_ISL_523865	2020-08-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240022/2020	EPI_ISL_523873	2020-08-10	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-240045/2020	EPI_ISL_523887	2020-08-12	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/QEUH-96C124/2020	EPI_ISL_530901	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-785C71/2020	EPI_ISL_533157	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-7858C8/2020	EPI_ISL_533168	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-5FFCCF/2020	EPI_ISL_533245	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5EF47F/2020	EPI_ISL_533249	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-5DEBD8/2020	EPI_ISL_533293	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-5ECFF9/2020	EPI_ISL_533297	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Scotland/QEUH-964010/2020	EPI_ISL_534401	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A1BD/2020	EPI_ISL_534404	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963AE6/2020	EPI_ISL_534405	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E152/2020	EPI_ISL_534407	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E082/2020	EPI_ISL_534409	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E459/2020	EPI_ISL_534410	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E44A/2020	EPI_ISL_534411	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E35C/2020	EPI_ISL_534412	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E468/2020	EPI_ISL_534414	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E19E/2020	EPI_ISL_534415	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E161/2020	EPI_ISL_534418	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E1AD/2020	EPI_ISL_534420	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95DFA4/2020	EPI_ISL_534421	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E477/2020	EPI_ISL_534423	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E27D/2020	EPI_ISL_534425	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95DF95/2020	EPI_ISL_534426	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E4C2/2020	EPI_ISL_534429	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E8A5/2020	EPI_ISL_534456	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EA54/2020	EPI_ISL_534459	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E553/2020	EPI_ISL_534461	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EA63/2020	EPI_ISL_534462	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EBE8/2020	EPI_ISL_534465	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E8B4/2020	EPI_ISL_534468	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1C8/2020	EPI_ISL_534469	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E975/2020	EPI_ISL_534470	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB15/2020	EPI_ISL_534472	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB8E/2020	EPI_ISL_534473	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E984/2020	EPI_ISL_534474	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E26B/2020	EPI_ISL_534476	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F024/2020	EPI_ISL_534478	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EF28/2020	EPI_ISL_534480	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E32C/2020	EPI_ISL_534481	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E939/2020	EPI_ISL_534482	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EF64/2020	EPI_ISL_534486	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E957/2020	EPI_ISL_534488	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EDE2/2020	EPI_ISL_534490	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96EBBB/2020	EPI_ISL_534491	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EF73/2020	EPI_ISL_534496	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E84B/2020	EPI_ISL_534497	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E91B/2020	EPI_ISL_534503	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1B9/2020	EPI_ISL_534505	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E8E1/2020	EPI_ISL_534506	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E1F5/2020	EPI_ISL_534507	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96E948/2020	EPI_ISL_534508	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB24/2020	EPI_ISL_534509	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96EB51/2020	EPI_ISL_534511	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D93A/2020	EPI_ISL_534515	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D448/2020	EPI_ISL_534516	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEC3/2020	EPI_ISL_534517	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0CC/2020	EPI_ISL_534520	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D949/2020	EPI_ISL_534521	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D967/2020	EPI_ISL_534522	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEF0/2020	EPI_ISL_534524	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF48/2020	EPI_ISL_534526	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CF1B/2020	EPI_ISL_534527	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CCD8/2020	EPI_ISL_534528	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD7B/2020	EPI_ISL_534529	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D78B/2020	EPI_ISL_534530	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CCE7/2020	EPI_ISL_534531	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D536/2020	EPI_ISL_534534	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D484/2020	EPI_ISL_534536	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D6E8/2020	EPI_ISL_534537	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D91C/2020	EPI_ISL_534538	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D642/2020	EPI_ISL_534541	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D712/2020	EPI_ISL_534542	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96DBBC/2020	EPI_ISL_534544	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D42A/2020	EPI_ISL_534545	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D5BE/2020	EPI_ISL_534548	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D475/2020	EPI_ISL_534551	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D31E/2020	EPI_ISL_534552	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CD6C/2020	EPI_ISL_534553	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D493/2020	EPI_ISL_534554	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D114/2020	EPI_ISL_534555	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D615/2020	EPI_ISL_534556	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D74F/2020	EPI_ISL_534557	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C810/2020	EPI_ISL_534559	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CF75/2020	EPI_ISL_534560	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D8E2/2020	EPI_ISL_534562	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D68E/2020	EPI_ISL_534563	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C8A7/2020	EPI_ISL_534564	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D81F/2020	EPI_ISL_534565	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D69D/2020	EPI_ISL_534567	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D0AE/2020	EPI_ISL_534568	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD8A/2020	EPI_ISL_534573	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CFEE/2020	EPI_ISL_534575	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CD4E/2020	EPI_ISL_534576	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CEB4/2020	EPI_ISL_534577	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D800/2020	EPI_ISL_534578	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D92B/2020	EPI_ISL_534579	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D105/2020	EPI_ISL_534580	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D958/2020	EPI_ISL_534581	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDF3/2020	EPI_ISL_534582	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D28A/2020	EPI_ISL_534584	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D457/2020	EPI_ISL_534585	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CDD5/2020	EPI_ISL_534586	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CE0F/2020	EPI_ISL_534587	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96CCBA/2020	EPI_ISL_534589	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CDA8/2020	EPI_ISL_534590	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D879/2020	EPI_ISL_534591	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D7F4/2020	EPI_ISL_534596	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D721/2020	EPI_ISL_534597	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96D85B/2020	EPI_ISL_534598	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96DE1D/2020	EPI_ISL_534599	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/USA/MD-MDH-0174/2020	EPI_ISL_534711	2020-06-03	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.231	GR
hCoV-19/Canada/QC-LSPQ-L00214023/2020	EPI_ISL_535723	2020-03-10	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00214050/2020	EPI_ISL_535724	2020-03-10	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00214488/2020	EPI_ISL_535727	2020-03-11	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00215977/2020	EPI_ISL_535742	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00215981/2020	EPI_ISL_535743	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217032/2020	EPI_ISL_535757	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217534/2020	EPI_ISL_535763	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00219618/2020	EPI_ISL_535794	2020-03-14	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00230351/2020	EPI_ISL_535916	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Spain/CT-ISCIII-2012572/2020	EPI_ISL_539539	2020-05-21	Europe / Spain / Catalunya	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1	GR
hCoV-19/Spain/CT-ISCIII-2012573/2020	EPI_ISL_539540	2020-05-21	Europe / Spain / Catalunya	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1	GR
hCoV-19/England/QEUH-96FF90/2020	EPI_ISL_540294	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98EEDA/2020	EPI_ISL_540408	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98EF04/2020	EPI_ISL_540416	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/BHRT-24B3E17/2020	EPI_ISL_541773	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/LOND-1286D7F/2020	EPI_ISL_541782	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-99906D/2020	EPI_ISL_541836	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998F52/2020	EPI_ISL_541837	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-3229/2020	EPI_ISL_544096	2020-06-13	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2098/2020	EPI_ISL_545119	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2101/2020	EPI_ISL_545121	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2102/2020	EPI_ISL_545122	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2107/2020	EPI_ISL_545125	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2109/2020	EPI_ISL_545126	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2115/2020	EPI_ISL_545128	2020-05-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2121/2020	EPI_ISL_545131	2020-05-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2193/2020	EPI_ISL_545172	2020-05-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2200/2020	EPI_ISL_545177	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2243/2020	EPI_ISL_545200	2020-05-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-2267/2020	EPI_ISL_545216	2020-05-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-2352/2020	EPI_ISL_545260	2020-05-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2401/2020	EPI_ISL_545288	2020-05-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2415/2020	EPI_ISL_545297	2020-05-11	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-6987/2020	EPI_ISL_546411	2020-06-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7013/2020	EPI_ISL_546432	2020-06-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-7081/2020	EPI_ISL_546488	2020-06-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-7093/2020	EPI_ISL_546498	2020-06-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7107/2020	EPI_ISL_546509	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7108/2020	EPI_ISL_546510	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7153/2020	EPI_ISL_546550	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7157/2020	EPI_ISL_546552	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-7169/2020	EPI_ISL_546564	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7170/2020	EPI_ISL_546566	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7192/2020	EPI_ISL_546586	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/England/MILK-9AB341/2020	EPI_ISL_551059	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4B7/2020	EPI_ISL_551062	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9C48/2020	EPI_ISL_551070	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9EE8/2020	EPI_ISL_551074	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9176/2020	EPI_ISL_551080	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9BA5/2020	EPI_ISL_551082	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB314/2020	EPI_ISL_551093	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4D5/2020	EPI_ISL_551099	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB0C2/2020	EPI_ISL_551103	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A9AE4/2020	EPI_ISL_551117	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9A903D/2020	EPI_ISL_551149	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A912B/2020	EPI_ISL_551150	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9194/2020	EPI_ISL_551155	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4C6/2020	EPI_ISL_551162	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A956B/2020	EPI_ISL_551165	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9255/2020	EPI_ISL_551166	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9C2A/2020	EPI_ISL_551169	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/MILK-993CC9/2020	EPI_ISL_552394	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993968/2020	EPI_ISL_552401	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995517/2020	EPI_ISL_552433	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-974AB5/2020	EPI_ISL_552461	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-97535F/2020	EPI_ISL_552502	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-93A875/2020	EPI_ISL_553707	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9067DF/2020	EPI_ISL_553725	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-953973/2020	EPI_ISL_553764	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953955/2020	EPI_ISL_553765	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9542D1/2020	EPI_ISL_553767	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95412F/2020	EPI_ISL_553781	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953964/2020	EPI_ISL_553783	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954462/2020	EPI_ISL_553788	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954444/2020	EPI_ISL_553793	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9540E6/2020	EPI_ISL_553807	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-953533/2020	EPI_ISL_553824	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-9540F5/2020	EPI_ISL_553828	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-954101/2020	EPI_ISL_553830	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953F17/2020	EPI_ISL_553836	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95381C/2020	EPI_ISL_553837	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95371F/2020	EPI_ISL_553838	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95407D/2020	EPI_ISL_553853	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-954453/2020	EPI_ISL_553859	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95372E/2020	EPI_ISL_553860	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-95DA67/2020	EPI_ISL_556075	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D5DE9/2020	EPI_ISL_556078	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6CAC62/2020	EPI_ISL_556089	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8BA43E/2020	EPI_ISL_557101	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8FF9A7/2020	EPI_ISL_557104	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8BA0A3/2020	EPI_ISL_557122	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-90DAA2/2020	EPI_ISL_557137	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8CF1A8/2020	EPI_ISL_557139	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-90FB70/2020	EPI_ISL_557152	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-8B65F3/2020	EPI_ISL_557153	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-84812F/2020	EPI_ISL_557218	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-804F61/2020	EPI_ISL_557226	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-820C4A/2020	EPI_ISL_557242	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-84AE35/2020	EPI_ISL_557252	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-819066/2020	EPI_ISL_557258	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-8461E5/2020	EPI_ISL_557261	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-817B76/2020	EPI_ISL_557264	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-81D8E2/2020	EPI_ISL_557281	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-800BDA/2020	EPI_ISL_557282	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-84490D/2020	EPI_ISL_557297	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-5D3818/2020	EPI_ISL_558413	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D0514/2020	EPI_ISL_558420	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1829/2020	EPI_ISL_558421	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D05D8/2020	EPI_ISL_558433	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D3933/2020	EPI_ISL_558463	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5CDC9D/2020	EPI_ISL_558464	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-5D067B/2020	EPI_ISL_558470	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D149E/2020	EPI_ISL_558475	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5C789F/2020	EPI_ISL_558478	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1461/2020	EPI_ISL_558480	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D1CA5/2020	EPI_ISL_558489	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D0BB8/2020	EPI_ISL_558505	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D58DA/2020	EPI_ISL_558510	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D4E9D/2020	EPI_ISL_558522	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D0189/2020	EPI_ISL_558534	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D19BD/2020	EPI_ISL_558539	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D3960/2020	EPI_ISL_558541	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5D5360/2020	EPI_ISL_558549	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-5D4D72/2020	EPI_ISL_558575	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5CC8B8/2020	EPI_ISL_558584	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4858F8/2020	EPI_ISL_559701	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-45F7FA/2020	EPI_ISL_559743	2020-05-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides found at refpos 686.	info	B.1.1	GR
hCoV-19/England/QEUH-99B14A/2020	EPI_ISL_559765	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-99BE16/2020	EPI_ISL_559773	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9ACB93/2020	EPI_ISL_559799	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9ACBEE/2020	EPI_ISL_559801	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9ACE8B/2020	EPI_ISL_559813	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9AD1BE/2020	EPI_ISL_559820	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AD224/2020	EPI_ISL_559821	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AD27F/2020	EPI_ISL_559823	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF222/2020	EPI_ISL_559829	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF29B/2020	EPI_ISL_559830	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF2E6/2020	EPI_ISL_559834	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF5DE/2020	EPI_ISL_559851	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_G38stop results in 69.4% truncation of the protein sequence.	info	B.1.532	GR
hCoV-19/England/QEUH-9AF644/2020	EPI_ISL_559854	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.294	GR
hCoV-19/England/QEUH-9B0C5D/2020	EPI_ISL_559856	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0C7B/2020	EPI_ISL_559858	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0D0F/2020	EPI_ISL_559861	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0D5A/2020	EPI_ISL_559865	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0DF0/2020	EPI_ISL_559866	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0E39/2020	EPI_ISL_559867	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F36/2020	EPI_ISL_559868	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F54/2020	EPI_ISL_559870	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F63/2020	EPI_ISL_559871	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B4406/2020	EPI_ISL_559891	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/GSTT-5777/2020	EPI_ISL_560712	2020-03-23	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.59	GR
hCoV-19/England/GSTT-6731/2020	EPI_ISL_560722	2020-03-29	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-6742/2020	EPI_ISL_560724	2020-03-30	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-6746/2020	EPI_ISL_560726	2020-03-29	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/ALDP-9BE81F/2020	EPI_ISL_568050	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9BDCAB/2020	EPI_ISL_568090	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE9D0/2020	EPI_ISL_568093	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/France/PAC-IHU-0012/2020	EPI_ISL_569243	2020-03-06	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0018/2020	EPI_ISL_569247	2020-03-08	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0024/2020	EPI_ISL_569252	2020-03-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0222/2020	EPI_ISL_569386	2020-03-28	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/WA-UW-11072/2020	EPI_ISL_570370	2020-06-17	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/England/QEUH-9BA0DF/2020	EPI_ISL_572726	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/Egypt/CUNCI-HGC7I010/2020	EPI_ISL_576371	2020-07-19	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Indonesia/JT-UGM-47906/2020	EPI_ISL_576383	2020-09-01	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.1	GR
hCoV-19/USA/un-UW-12782/2020	EPI_ISL_576404	2020-06-29	North America / USA	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/England/ALDP-9D75CE/2020	EPI_ISL_576570	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Slovakia/UKBA-203/2020	EPI_ISL_577735	2020-04-06	Europe / Slovakia / Zehra	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1	GR
hCoV-19/Slovakia/UKBA-205/2020	EPI_ISL_577737	2020-04-13	Europe / Slovakia / Zehra	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1	GR
hCoV-19/USA/LA-EVTL495/2020	EPI_ISL_578899	2020-06-24	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/England/QEUH-9DADC3/2020	EPI_ISL_581015	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC6C6/2020	EPI_ISL_581022	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DCC79/2020	EPI_ISL_581027	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/Wales/MILK-9E0FC4/2020	EPI_ISL_581029	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DCDFE/2020	EPI_ISL_581033	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC66C/2020	EPI_ISL_581070	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DABE7/2020	EPI_ISL_581077	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DADE1/2020	EPI_ISL_581081	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAFDC/2020	EPI_ISL_581096	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/MB-NML-561/2020	EPI_ISL_582262	2020-04-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Canada/MB-NML-565/2020	EPI_ISL_582263	2020-05-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/MB-NML-598/2020	EPI_ISL_582283	2020-05-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Austria/CeMM0512/2020	EPI_ISL_583597	2020-03-11	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1.271	GR
hCoV-19/England/NORW-F06E3/2020	EPI_ISL_584737	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NOTT-1147C7/2020	EPI_ISL_584753	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DED1A/2020	EPI_ISL_584825	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DED29/2020	EPI_ISL_584826	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DEF7E/2020	EPI_ISL_584835	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DEF9C/2020	EPI_ISL_584836	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DF03E/2020	EPI_ISL_584843	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E36EA/2020	EPI_ISL_584866	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E378D/2020	EPI_ISL_584870	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E387B/2020	EPI_ISL_584876	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A005F8/2020	EPI_ISL_584892	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-A2EAF5/2020	EPI_ISL_587001	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F4C9/2020	EPI_ISL_587003	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A2EC59/2020	EPI_ISL_587063	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F890/2020	EPI_ISL_587108	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-A2F71B/2020	EPI_ISL_587202	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A2F3CC/2020	EPI_ISL_587230	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAF03/2020	EPI_ISL_588206	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAEE8/2020	EPI_ISL_588208	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA738/2020	EPI_ISL_588213	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB078/2020	EPI_ISL_588216	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB0E1/2020	EPI_ISL_588221	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA589/2020	EPI_ISL_588248	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAF30/2020	EPI_ISL_588253	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FB588/2020	EPI_ISL_588257	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAE9D/2020	EPI_ISL_588270	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5A9E/2020	EPI_ISL_588326	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F523C/2020	EPI_ISL_588331	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ABC/2020	EPI_ISL_588332	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ACB/2020	EPI_ISL_588341	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5BD7/2020	EPI_ISL_588356	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4877/2020	EPI_ISL_588357	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F484A/2020	EPI_ISL_588367	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F58FE/2020	EPI_ISL_588371	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5A61/2020	EPI_ISL_588377	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F51D5/2020	EPI_ISL_588378	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ADA/2020	EPI_ISL_588382	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F49A1/2020	EPI_ISL_588397	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5D86/2020	EPI_ISL_588398	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F4A80/2020	EPI_ISL_588407	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5C10/2020	EPI_ISL_588418	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5A52/2020	EPI_ISL_588432	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F34A1/2020	EPI_ISL_588531	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F3DA6/2020	EPI_ISL_588534	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F40D9/2020	EPI_ISL_588535	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F332C/2020	EPI_ISL_588543	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F33FF/2020	EPI_ISL_588557	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3E3A/2020	EPI_ISL_588567	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F08A8/2020	EPI_ISL_589574	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F135B/2020	EPI_ISL_589586	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F13C4/2020	EPI_ISL_589589	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F133D/2020	EPI_ISL_589673	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1EC3/2020	EPI_ISL_589674	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F134C/2020	EPI_ISL_589739	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1027/2020	EPI_ISL_589745	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9E53E1/2020	EPI_ISL_589775	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E492C/2020	EPI_ISL_589777	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D4C26/2020	EPI_ISL_589800	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-9CBBAD/2020	EPI_ISL_589802	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D1193/2020	EPI_ISL_589863	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0756/2020	EPI_ISL_589874	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02EC/2020	EPI_ISL_589888	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0B0F/2020	EPI_ISL_589893	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFD94/2020	EPI_ISL_589897	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0E7F/2020	EPI_ISL_589898	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B79AA/2020	EPI_ISL_590524	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B744F/2020	EPI_ISL_590528	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7FC6/2020	EPI_ISL_590534	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7AF2/2020	EPI_ISL_590548	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B79C8/2020	EPI_ISL_590566	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7193/2020	EPI_ISL_590568	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B6ED9/2020	EPI_ISL_590583	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7272/2020	EPI_ISL_590589	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7870/2020	EPI_ISL_590591	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B795F/2020	EPI_ISL_590648	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B804A/2020	EPI_ISL_590650	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B788F/2020	EPI_ISL_590651	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B78BC/2020	EPI_ISL_590652	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7DF9/2020	EPI_ISL_590656	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B74D6/2020	EPI_ISL_590668	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7A3E/2020	EPI_ISL_590681	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/FL-BPHL-1648/2020	EPI_ISL_594337	2020-07-03	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/FL-BPHL-1685/2020	EPI_ISL_594374	2020-08-12	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.192	GR
hCoV-19/Scotland/QEUH-9F7100/2020	EPI_ISL_595662	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7276/2020	EPI_ISL_595673	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F73FB/2020	EPI_ISL_595685	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9F756E/2020	EPI_ISL_595686	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F76D4/2020	EPI_ISL_595694	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F772C/2020	EPI_ISL_595698	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/CAMC-A58D80/2020	EPI_ISL_596983	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A585D3/2020	EPI_ISL_596994	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B584/2020	EPI_ISL_599207	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFFE0/2020	EPI_ISL_600493	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9FB3E8/2020	EPI_ISL_600580	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4419/2020	EPI_ISL_600636	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4516/2020	EPI_ISL_600657	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F5FBD/2020	EPI_ISL_600684	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4A71/2020	EPI_ISL_600695	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.315	GR
hCoV-19/USA/UT-UPHL-2009728/2020	EPI_ISL_605400	2020-07-26	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.1	GR
hCoV-19/England/MILK-A7CF9F/2020	EPI_ISL_606611	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A79FA1/2020	EPI_ISL_606614	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A79FB0/2020	EPI_ISL_606672	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-A7CFAE/2020	EPI_ISL_606689	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A061/2020	EPI_ISL_606704	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7CFCC/2020	EPI_ISL_606727	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7CF17/2020	EPI_ISL_606751	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D887/2020	EPI_ISL_607920	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6EA35/2020	EPI_ISL_607942	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6DB15/2020	EPI_ISL_607957	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E437/2020	EPI_ISL_607961	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F409/2020	EPI_ISL_607962	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A6463B/2020	EPI_ISL_609014	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-A6802A/2020	EPI_ISL_609031	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A69108/2020	EPI_ISL_609034	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92740/2020	EPI_ISL_611139	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A929A4/2020	EPI_ISL_611145	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A9282F/2020	EPI_ISL_611162	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92731/2020	EPI_ISL_611169	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A936F7/2020	EPI_ISL_611183	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92643/2020	EPI_ISL_611192	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92ED2/2020	EPI_ISL_611194	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A9250A/2020	EPI_ISL_611220	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A927C8/2020	EPI_ISL_611228	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A929B3/2020	EPI_ISL_611251	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92EA5/2020	EPI_ISL_611286	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9AE16/2020	EPI_ISL_611302	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EDD9/2020	EPI_ISL_611325	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EE9A/2020	EPI_ISL_611341	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AA0545/2020	EPI_ISL_611350	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-A9F01B/2020	EPI_ISL_611356	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F2CA/2020	EPI_ISL_611364	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A18DE6/2020	EPI_ISL_612462	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-A192F5/2020	EPI_ISL_612500	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A1937A/2020	EPI_ISL_612507	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A1942C/2020	EPI_ISL_612510	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A194FF/2020	EPI_ISL_612513	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A19556/2020	EPI_ISL_612517	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-1B6BEDE/2020	EPI_ISL_612551	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C040/2020	EPI_ISL_612557	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C08C/2020	EPI_ISL_612559	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C0B9/2020	EPI_ISL_612560	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C0C8/2020	EPI_ISL_612561	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C101/2020	EPI_ISL_612564	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C14D/2020	EPI_ISL_612566	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A7FEE/2020	EPI_ISL_612569	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-47F23F/2020	EPI_ISL_612648	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47F2B7/2020	EPI_ISL_612656	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	G
hCoV-19/Denmark/DCGC-3180/2020	EPI_ISL_616002	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3189/2020	EPI_ISL_616012	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3299/2020	EPI_ISL_616051	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3314/2020	EPI_ISL_616068	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3319/2020	EPI_ISL_616073	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3325/2020	EPI_ISL_616079	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.177	GV
hCoV-19/Denmark/DCGC-3364/2020	EPI_ISL_616121	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3369/2020	EPI_ISL_616126	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3395/2020	EPI_ISL_616154	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Denmark/DCGC-3406/2020	EPI_ISL_616165	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-8346/2020	EPI_ISL_617331	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-2465/2020	EPI_ISL_617426	2020-08-03	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2258/2020	EPI_ISL_617438	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2259/2020	EPI_ISL_617439	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2145/2020	EPI_ISL_617443	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2148/2020	EPI_ISL_617446	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.1.288	GR
hCoV-19/Denmark/DCGC-2153/2020	EPI_ISL_617451	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2183/2020	EPI_ISL_617482	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.288	GR
hCoV-19/Denmark/DCGC-2185/2020	EPI_ISL_617485	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-7777/2020	EPI_ISL_618696	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-7785/2020	EPI_ISL_618714	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7775/2020	EPI_ISL_618734	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5665/2020	EPI_ISL_619952	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5668/2020	EPI_ISL_619955	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-6226/2020	EPI_ISL_619986	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6231/2020	EPI_ISL_619991	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6233/2020	EPI_ISL_619993	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6234/2020	EPI_ISL_619994	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6236/2020	EPI_ISL_619996	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6237/2020	EPI_ISL_619997	2020-10-05	Europe / Denmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6239/2020	EPI_ISL_619999	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5581/2020	EPI_ISL_620906	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5592/2020	EPI_ISL_620917	2020-09-28	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5596/2020	EPI_ISL_620921	2020-09-21	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5617/2020	EPI_ISL_620942	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5626/2020	EPI_ISL_620951	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5769/2020	EPI_ISL_620956	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5772/2020	EPI_ISL_620959	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT). Gap of 2 nucleotides when compared to the reference sequence.Submitter Note: Submitter had confirmed the frameshift to be correct.	info	B.1.1.346	GR
hCoV-19/England/MILK-AB7A88/2020	EPI_ISL_623244	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAFC23/2020	EPI_ISL_623268	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAF959/2020	EPI_ISL_623273	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB83F5/2020	EPI_ISL_623303	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAFC32/2020	EPI_ISL_623333	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3BC8/2020	EPI_ISL_624450	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2868/2020	EPI_ISL_624482	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-AA48A2/2020	EPI_ISL_624492	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA277A/2020	EPI_ISL_624532	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94CE5/2020	EPI_ISL_624567	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A94ABE/2020	EPI_ISL_624635	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A961D5/2020	EPI_ISL_624678	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-8913/2020	EPI_ISL_625872	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-8565/2020	EPI_ISL_625940	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-8651/2020	EPI_ISL_625994	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Wales/PHWC-4845C5/2020	EPI_ISL_628020	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-AC8608/2020	EPI_ISL_629310	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACBE94/2020	EPI_ISL_629341	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8477/2020	EPI_ISL_629344	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-AC95FB/2020	EPI_ISL_629351	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE945/2020	EPI_ISL_629370	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC7D9B/2020	EPI_ISL_629372	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACBD4C/2020	EPI_ISL_629376	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8592/2020	EPI_ISL_629378	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8662/2020	EPI_ISL_629387	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE8A2/2020	EPI_ISL_629414	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC8617/2020	EPI_ISL_629426	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACEFBC/2020	EPI_ISL_629471	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC9133/2020	EPI_ISL_629472	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8FFE/2020	EPI_ISL_629477	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC81E9/2020	EPI_ISL_629486	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-ACDC01/2020	EPI_ISL_630330	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACCFDC/2020	EPI_ISL_630337	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A675FF/2020	EPI_ISL_630383	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6698B/2020	EPI_ISL_630419	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Norway/4276/2020	EPI_ISL_635143	2020-10-10	Europe / Norway / Agder	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Norway/4235/2020	EPI_ISL_635166	2020-10-09	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/4282/2020	EPI_ISL_635189	2020-10-11	Europe / Norway / Agder	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Italy/VEN-IZSVe-1-1/2020	EPI_ISL_636464	2020-03-21	Europe / Italy / Veneto / Padova	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Aruba/AW-RIVM-10391/2020	EPI_ISL_636517	2020-08-07	South America / Aruba	Human	Original			Nanopore MinION				B.1.1.231	GR
hCoV-19/Netherlands/GE-RIVM-10374/2020	EPI_ISL_636533	2020-09-23	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Netherlands/NB-RIVM-10290/2020	EPI_ISL_636547	2020-04-14	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.1.5	GR
hCoV-19/Netherlands/UT-RIVM-10349/2020	EPI_ISL_636573	2020-05-08	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1	GR
hCoV-19/Netherlands/UT-RIVM-10351/2020	EPI_ISL_636575	2020-05-22	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1	GR
hCoV-19/Netherlands/UT-RIVM-10377/2020	EPI_ISL_636579	2020-09-29	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/England/QEUH-9F51B7/2020	EPI_ISL_637856	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B1155D/2020	EPI_ISL_642301	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B117B1/2020	EPI_ISL_642330	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13694/2020	EPI_ISL_642336	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B115F3/2020	EPI_ISL_642346	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B122A0/2020	EPI_ISL_642357	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B118BE/2020	EPI_ISL_642370	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10EF9/2020	EPI_ISL_642403	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B13676/2020	EPI_ISL_642406	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-B0AEE3/2020	EPI_ISL_643613	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B080D0/2020	EPI_ISL_643623	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B0B6F9/2020	EPI_ISL_643633	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B083E6/2020	EPI_ISL_643638	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B073BA/2020	EPI_ISL_643657	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B077DC/2020	EPI_ISL_643727	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2ED28/2020	EPI_ISL_647110	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B245FD/2020	EPI_ISL_647116	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2252C/2020	EPI_ISL_647233	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21077/2020	EPI_ISL_647241	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21341/2020	EPI_ISL_647249	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22E8B/2020	EPI_ISL_647257	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B22DAC/2020	EPI_ISL_647267	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B21AE2/2020	EPI_ISL_647281	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/CA-CZB-12810/2020	EPI_ISL_648461	2020-09-05	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-12812/2020	EPI_ISL_648463	2020-09-10	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/204321411/2020	EPI_ISL_649824	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Italy/APU-IZSPB-193APT/2020	EPI_ISL_649940	2020-08-28	Europe / Italy / Apulia / Foggia	Human	Vero	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/England/QEUH-AAED21/2020	EPI_ISL_653001	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAED7C/2020	EPI_ISL_653003	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAF42B/2020	EPI_ISL_653022	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF55F6/2020	EPI_ISL_653029	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF5F16/2020	EPI_ISL_653031	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF5F43/2020	EPI_ISL_653034	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/QEUH-AF62B2/2020	EPI_ISL_653049	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF62EF/2020	EPI_ISL_653051	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF62FE/2020	EPI_ISL_653052	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF630A/2020	EPI_ISL_653053	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF63A0/2020	EPI_ISL_653055	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-C334C/2020	EPI_ISL_653062	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CDA01/2020	EPI_ISL_653083	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF1BF/2020	EPI_ISL_653091	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-D3200/2020	EPI_ISL_653097	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-B5CC8E/2020	EPI_ISL_655638	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B677F8/2020	EPI_ISL_655660	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B65E6E/2020	EPI_ISL_655695	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B5C626/2020	EPI_ISL_655700	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5697E/2020	EPI_ISL_656997	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B325FC/2020	EPI_ISL_659175	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B324B3/2020	EPI_ISL_659181	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3244A/2020	EPI_ISL_659205	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B338F2/2020	EPI_ISL_659267	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K004315/2020	EPI_ISL_660192	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004325/2020	EPI_ISL_660201	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004330/2020	EPI_ISL_660206	2020-10-24	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004534-CS1/2020	EPI_ISL_660232	2020-11-17	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004536/2020	EPI_ISL_660234	2020-10-18	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004552/2020	EPI_ISL_660249	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004553/2020	EPI_ISL_660250	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004723-CS1/2020	EPI_ISL_660256	2020-11-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/England/QEUH-B679F2/2020	EPI_ISL_661404	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6894C/2020	EPI_ISL_661408	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B676CE/2020	EPI_ISL_661416	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B665B3/2020	EPI_ISL_661439	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6837B/2020	EPI_ISL_661472	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6992D/2020	EPI_ISL_661484	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B699A5/2020	EPI_ISL_661496	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B682AB/2020	EPI_ISL_661497	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B662E9/2020	EPI_ISL_661510	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B67A86/2020	EPI_ISL_661512	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6895B/2020	EPI_ISL_661517	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66586/2020	EPI_ISL_661530	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B677DA/2020	EPI_ISL_661539	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6643E/2020	EPI_ISL_661541	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C535/2020	EPI_ISL_661558	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B662DA/2020	EPI_ISL_661566	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68E4D/2020	EPI_ISL_661579	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6702A/2020	EPI_ISL_661585	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6636E/2020	EPI_ISL_661597	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AF00BE/2020	EPI_ISL_662749	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-AEFFD3/2020	EPI_ISL_662766	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF476A/2020	EPI_ISL_662800	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF480D/2020	EPI_ISL_662833	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF46E5/2020	EPI_ISL_662837	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AEFA69/2020	EPI_ISL_662844	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF48D0/2020	EPI_ISL_662890	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4D68/2020	EPI_ISL_662892	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AF5ECE/2020	EPI_ISL_662920	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF4A43/2020	EPI_ISL_662927	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1BAECE/2020	EPI_ISL_665000	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-B2337C/2020	EPI_ISL_665034	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMC-B2343D/2020	EPI_ISL_665036	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMC-B2344C/2020	EPI_ISL_665037	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-138F3E/2020	EPI_ISL_665050	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-48C7E5/2020	EPI_ISL_666470	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Japan/IC-0177/2020	EPI_ISL_667606	2020-09-15	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0182/2020	EPI_ISL_667611	2020-10-03	Asia / Japan	Human	Original		COVID-19 positive case who entered from USA.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0225/2020	EPI_ISL_667654	2020-08-04	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Denmark/DCGC-9384/2020	EPI_ISL_668943	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/CA-CZB-9773/2020	EPI_ISL_672172	2020-03-31	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-10149/2020	EPI_ISL_672232	2020-06-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-12988/2020	EPI_ISL_672295	2020-10-21	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/CAMC-B9AE06/2020	EPI_ISL_673441	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9C578/2020	EPI_ISL_673476	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B98FE7/2020	EPI_ISL_673533	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8F88E/2020	EPI_ISL_674702	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8ECB0/2020	EPI_ISL_674709	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EBE0/2020	EPI_ISL_674730	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7D65C/2020	EPI_ISL_674746	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EBA4/2020	EPI_ISL_674787	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8DBF0/2020	EPI_ISL_674789	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B982B1/2020	EPI_ISL_674845	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-Wadsworth-226966-01/2020	EPI_ISL_677130	2020-09-24	North America / USA / New York / Washington County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/Russia/SAR-RARI-2272/2020	EPI_ISL_678284	2020-07-28	Europe / Russia / Saratov	Human	Original	Bronchi		IonTorrent	SPAdes v. 3.12			B.1.1	GR
hCoV-19/Australia/NSW2939/2020	EPI_ISL_678371	2020-10-16	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.1.315	GR
hCoV-19/England/MILK-B3A099/2020	EPI_ISL_679676	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3AB98/2020	EPI_ISL_679710	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3BBA6/2020	EPI_ISL_679789	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48D535/2020	EPI_ISL_680640	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48D553/2020	EPI_ISL_680642	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Ireland/WW-NVRL-20Z06427/2020	EPI_ISL_681901	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/PA-MGEL-00255/2020	EPI_ISL_681988	2020-05-19	North America / USA / Pennsylvania / Allegheny County / Pittsburgh	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34; gdtools			B.1.1.231	GR
hCoV-19/France/ARA-29628/2020	EPI_ISL_684107	2020-04-23	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original			Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Japan/PG-3152/2020	EPI_ISL_691272	2020-06-01	Asia / Japan / Ibaraki	Human	Original	Nasopharyngeal swab		Illumina iSeq	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.1.370	GR
hCoV-19/USA/AZ-TG666103/2020	EPI_ISL_696193	2020-04-30	North America / USA / Arizona	Human	Original			Illumina				B.1.1	GR
hCoV-19/United Arab Emirates/0629/2020	EPI_ISL_698785	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0677/2020	EPI_ISL_698830	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0731/2020	EPI_ISL_698882	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0735/2020	EPI_ISL_698885	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/South Africa/NHLS-UCT-GP-5792/2020	EPI_ISL_700547	2020-05-19	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/England/ALDP-BB3D46/2020	EPI_ISL_701811	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCC09C/2020	EPI_ISL_704047	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCBA35/2020	EPI_ISL_704067	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC4A0F/2020	EPI_ISL_704080	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-490FAA/2020	EPI_ISL_706594	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49105B/2020	EPI_ISL_706603	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/ALDP-B1AB16/2020	EPI_ISL_711032	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-15262/2020	EPI_ISL_713730	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15330/2020	EPI_ISL_713766	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15379/2020	EPI_ISL_713792	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-B9EA2C/2020	EPI_ISL_719814	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA17C5/2020	EPI_ISL_719847	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F083/2020	EPI_ISL_719861	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA27D3/2020	EPI_ISL_719894	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B9EA68/2020	EPI_ISL_719900	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B9E85F/2020	EPI_ISL_719910	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9E743/2020	EPI_ISL_719913	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9EB83/2020	EPI_ISL_719920	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA27F1/2020	EPI_ISL_719924	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA1C7B/2020	EPI_ISL_719966	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9E725/2020	EPI_ISL_719985	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9E42E/2020	EPI_ISL_720915	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B9F95B/2020	EPI_ISL_720955	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F4F0/2020	EPI_ISL_720965	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9FB91/2020	EPI_ISL_720975	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F2E7/2020	EPI_ISL_720998	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/MN-MDH-2169/2020	EPI_ISL_723120	2020-11-13	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2170/2020	EPI_ISL_723121	2020-11-15	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2171/2020	EPI_ISL_723122	2020-11-15	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2172/2020	EPI_ISL_723123	2020-11-18	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2173/2020	EPI_ISL_723124	2020-11-23	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2174/2020	EPI_ISL_723125	2020-11-23	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2175/2020	EPI_ISL_723126	2020-11-21	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2176/2020	EPI_ISL_723127	2020-11-24	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2177/2020	EPI_ISL_723128	2020-11-24	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2181/2020	EPI_ISL_723132	2020-11-27	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2182/2020	EPI_ISL_723133	2020-11-27	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2183/2020	EPI_ISL_723134	2020-11-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2184/2020	EPI_ISL_723135	2020-11-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2185/2020	EPI_ISL_723136	2020-11-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2187/2020	EPI_ISL_723138	2020-12-04	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/England/LIVE-DCA506/2020	EPI_ISL_724366	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DCA603/2020	EPI_ISL_724370	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DCA76A/2020	EPI_ISL_724382	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DCC021/2020	EPI_ISL_724481	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-C3AAB8/2020	EPI_ISL_731640	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C3B2DD/2020	EPI_ISL_731691	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-C3B316/2020	EPI_ISL_731697	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Poland/77061/2020	EPI_ISL_732859	2020-11	Europe / Poland	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/78566/2020	EPI_ISL_732884	2020-11	Europe / Poland	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/79297/2020	EPI_ISL_732896	2020-11	Europe / Poland	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Belgium/rega-09231008/2020	EPI_ISL_735031	2020-09-23	Europe / Belgium / Winksele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-10031030/2020	EPI_ISL_735047	2020-10-03	Europe / Belgium / Bost	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-10061194/2020	EPI_ISL_735068	2020-10-06	Europe / Belgium / Bost	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/England/QEUH-C53DFC/2020	EPI_ISL_736416	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/AG-ETHZ-410960/2020	EPI_ISL_737660	2020-11-27	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-321085/2020	EPI_ISL_737698	2020-10-14	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.294	GR
hCoV-19/Switzerland/GE-ETHZ-410908/2020	EPI_ISL_737758	2020-11-30	Europe / Switzerland / Geneva	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.336	GR
hCoV-19/Switzerland/SO-ETHZ-410060/2020	EPI_ISL_737789	2020-12-17	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/SO-ETHZ-410957/2020	EPI_ISL_737812	2020-11-27	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/England/CAMC-B79F73/2020	EPI_ISL_741068	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-B7A033/2020	EPI_ISL_741077	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49B2E2/2020	EPI_ISL_742318	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A0A2E/2020	EPI_ISL_743530	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A12DA/2020	EPI_ISL_743651	2020-12-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Luxembourg/LNS9338692/2020	EPI_ISL_744886	2020-08-06	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/USA/MT-CDC-2-3693754/2020	EPI_ISL_747033	2020-10-30	North America / USA / Montana	Human	Original			unknown				B.1.1.337	GR
hCoV-19/USA/NY-CDC-2-3693757/2020	EPI_ISL_747039	2020-10-01	North America / USA / New York	Human	Original	Nasopharyngeal and oropharyngeal		unknown				B.1.1.231	GR
hCoV-19/USA/NC-CDC-2-4693563/2020	EPI_ISL_747176	2020-11-10	North America / USA / North Carolina	Human	Original	Nasopharyngeal and oropharyngeal		unknown				B.1.1.231	GR
hCoV-19/Denmark/DCGC-18077/2020	EPI_ISL_749742	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16927/2020	EPI_ISL_750647	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17101/2020	EPI_ISL_750759	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Russia/MOS-CRIE-13650805/2020	EPI_ISL_754202	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.274	GR
hCoV-19/Russia/MOS-CRIE-13674490/2020	EPI_ISL_754214	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/England/205260465/2020	EPI_ISL_754320	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/MILK-C789FD/2020	EPI_ISL_756978	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-20505/2020	EPI_ISL_759192	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/South Korea/KDCA0339/2020	EPI_ISL_760125	2020-07-14	Asia / South Korea	Human	Original		Imported case from Uzbekistan	Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KDCA0348/2020	EPI_ISL_760133	2020-08-25	Asia / South Korea	Human	Original		Imported case from Uzbekistan	Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KDCA0349/2020	EPI_ISL_760134	2020-08-25	Asia / South Korea	Human	Original		Imported case from Uzbekistan	Illumina MiSeq				B.1.1.294	GR
hCoV-19/England/ALDP-CB463A/2020	EPI_ISL_761336	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/205140697/2020	EPI_ISL_766229	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/NY-Wadsworth-292289-01/2020	EPI_ISL_767645	2020-12-03	North America / USA / New York / Kings County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-292385-01/2020	EPI_ISL_767671	2020-12-19	North America / USA / New York / Monroe County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/England/205090731/2020	EPI_ISL_768812	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Germany/HH-hpi-p1809/2020	EPI_ISL_775931	2020-03-19	Europe / Germany / Hamburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p1478/2020	EPI_ISL_775989	2020-03-14	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p1486/2020	EPI_ISL_775996	2020-03-10	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMC-CB6DE8/2020	EPI_ISL_778285	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-9237/2020	EPI_ISL_780503	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Insertion of 5 nucleotides when compared to the reference sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-9500/2020	EPI_ISL_780526	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Insertion of 2 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-8456/2020	EPI_ISL_780569	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-8461/2020	EPI_ISL_780573	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8467/2020	EPI_ISL_780578	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8479/2020	EPI_ISL_780584	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	O
hCoV-19/USA/TX-HMH-MCoV-8495/2020	EPI_ISL_780592	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-MCoV-8611/2020	EPI_ISL_780650	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-8626/2020	EPI_ISL_780660	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/England/MILK-D0D67D/2020	EPI_ISL_781950	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/USA/TX-HMH-MCoV-19758/2020	EPI_ISL_784101	2020-11-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-19848/2020	EPI_ISL_784170	2020-11-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-8083/2020	EPI_ISL_784186	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-15657/2020	EPI_ISL_785341	2020-07-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-15702/2020	EPI_ISL_785386	2020-07-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-15750/2020	EPI_ISL_785434	2020-07-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.426	GR
hCoV-19/USA/TX-HMH-MCoV-15761/2020	EPI_ISL_785445	2020-07-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14710/2020	EPI_ISL_787995	2020-10-12	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/Denmark/DCGC-23517/2020	EPI_ISL_793803	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-23617/2020	EPI_ISL_793852	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-23838/2020	EPI_ISL_793959	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Germany/NW-IOV-K-5694/2020	EPI_ISL_796061	2020-10-09	Europe / Germany / North Rhine-Westphalia / Cologne	Human	Original	Oropharyngeal swab		Illumina Miseq + Nanopore MinION	ARTIC Protocol V3			B.1.1	GR
hCoV-19/Spain/VC-IBV-98006946/2020	EPI_ISL_796137	2020-03-20	Europe / Spain / Comunitat Valenciana / Castellon de la Plana	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/MILK-DB0363/2020	EPI_ISL_797349	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-CE2150/2020	EPI_ISL_799902	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-BC3226/2020	EPI_ISL_801160	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-MSHSPSP-PV19680/2020	EPI_ISL_802371	2020-10-08	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV21173/2020	EPI_ISL_802399	2020-10-10	North America / USA / New York / Manhattan	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.337	GR
hCoV-19/USA/NY-MSHSPSP-PV21184/2020	EPI_ISL_802420	2020-10-13	North America / USA / New York / Bronx	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.231	GR
hCoV-19/Denmark/DCGC-27526/2020	EPI_ISL_815725	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-27557/2020	EPI_ISL_815750	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-27625/2020	EPI_ISL_815789	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-27721/2020	EPI_ISL_815850	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-27317/2020	EPI_ISL_818064	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/MILK-E7F314/2021	EPI_ISL_821410	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Singapore/26/2021	EPI_ISL_825064	2021-01-09	Asia / Singapore	Human	Original			Illumina Miseq				B.1.1.398	GR
hCoV-19/Singapore/39/2021	EPI_ISL_825077	2021-01-09	Asia / Singapore	Human	Original			Illumina Miseq				B.1.1.398	GR
hCoV-19/Iceland/3994/2021	EPI_ISL_827690	2021-01-05	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/Indonesia/BGR-LIPI024/2020	EPI_ISL_833506	2020-07-17	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.1.398	GR
hCoV-19/Scotland/EDB12078/2021	EPI_ISL_838295	2021-01-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/LOND-1288135/2020	EPI_ISL_843058	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-28834/2021	EPI_ISL_845516	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-28887/2021	EPI_ISL_845519	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-29144/2021	EPI_ISL_845542	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-31962/2021	EPI_ISL_856378	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Wales/ALDP-CF1473/2020	EPI_ISL_858955	2020-12-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-CC91C8/2020	EPI_ISL_858958	2020-12-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Indonesia/YO-UGM-10010/2020	EPI_ISL_862041	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.1.398	GR
hCoV-19/Finland/30SS7D7/2020	EPI_ISL_862070	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.1.163	GR
hCoV-19/Iran/Tehran-02/2020	EPI_ISL_862076	2020-11-24	Asia / Iran / Tehran	Human	Original	Throat swab		Illumina NextSeq				B.1.1	GR
hCoV-19/England/SHEF-10C5EA0/2021	EPI_ISL_868366	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Denmark/DCGC-32543/2021	EPI_ISL_869547	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-33543/2021	EPI_ISL_870553	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-33654/2021	EPI_ISL_870664	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-33664/2021	EPI_ISL_870674	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Spain/CT-IBV-98013073/2020	EPI_ISL_871922	2020-12-18	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/USA/AL-Madison-JEHX/2020	EPI_ISL_876504	2020-11-04	North America / USA / Alabama / Madison County	Human	Original			Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			B.1.1.337	GR
hCoV-19/Canada/ON-SC0252/2020	EPI_ISL_876604	2020-08-23	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1	GR
hCoV-19/Canada/ON-SC0232/2020	EPI_ISL_876612	2020-08-16	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Canada/ON-SC0229/2020	EPI_ISL_876613	2020-08-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/ALDP-1092291/2021	EPI_ISL_877885	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-10921D0/2021	EPI_ISL_877918	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Indonesia/BT-SHSIU-01-6368/2021	EPI_ISL_882645	2021-01-04	Asia / Indonesia / Banten	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.1.398	GR
hCoV-19/USA/AL-HGSC-JGBS/2020	EPI_ISL_883808	2020-12-04	North America / USA / Alabama / Shelby County	Human	Original	Nasal		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			B.1.1.467	GR
hCoV-19/England/ALDP-109E16B/2021	EPI_ISL_886045	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Germany/BAV-PL-virotum_rx6q/2020	EPI_ISL_887351	2020-04-03	Europe / Germany / Bavaria / Munich	Human	Original			Illumina				B.1.1	GR
hCoV-19/Romania/Bucuresti-FV5166/2020	EPI_ISL_888677	2020-12-14	Europe / Romania / Bucuresti	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Belgium/rega-1448/2020	EPI_ISL_888699	2020-12-14	Europe / Belgium / Leopoldsburg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Czech Republic/FNHK-15901/2020	EPI_ISL_895827	2020-04-07	Europe / Czech Republic	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Reference based bowtie2			B.1.1	O
hCoV-19/Belgium/rega-1909/2021	EPI_ISL_898030	2021-01-08	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1911/2021	EPI_ISL_898031	2021-01-08	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/USA/WA-S3788/2021	EPI_ISL_903074	2021-01-06	North America / USA / Washington / King County	Human	Original			Illumina Nextseq	Seattle Flu Assembly Pipeline			B.1.1.231	GR
hCoV-19/Netherlands/GE-RIVM-10219/2021	EPI_ISL_905666	2021-01-06	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Norway/0734/2021	EPI_ISL_906801	2021-01-05	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1	GR
hCoV-19/Indonesia/KB-TUH-C2132860/2020	EPI_ISL_911675	2020-10-30	Asia / Indonesia / West Kalimantan	Human	Original	Nasopharyngeal Swab		Oxford Nanopore				B.1.1.398	GR
hCoV-19/Denmark/DCGC-35891/2021	EPI_ISL_927032	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-37354/2021	EPI_ISL_928495	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/IL-NM-4834/2020	EPI_ISL_936685	2020-12-18	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC			B.1.1	GR
hCoV-19/USA/MN-GMF-41789/2020	EPI_ISL_942689	2020-12-13	North America / USA / Minnesota / Winona County	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Indonesia/JB-EIJK140/2021	EPI_ISL_947328	2021-01-08	Asia / Indonesia / West Java / Depok	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.1.398	GR
hCoV-19/England/TFCI-2704685/2020	EPI_ISL_953303	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/TFCI-2704694/2020	EPI_ISL_953304	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/TFCI-2704807/2020	EPI_ISL_953327	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/TFCI-2704825/2020	EPI_ISL_953329	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/TFCI-2704A01/2020	EPI_ISL_953358	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Singapore/134-2/2021	EPI_ISL_953397	2021-02-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.315	GR
hCoV-19/Canada/QC-JUS-V6050728/2020	EPI_ISL_954636	2020-04-04	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/USA/OH-PLMI-J6GLK-5254/2020	EPI_ISL_955986	2020-03	North America / USA / Ohio	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Megahit			B.1.1	GR
hCoV-19/Poland/2142267130-gx1/2021	EPI_ISL_959395	2021-01-26	Europe / Poland / Wielkopolska / Poznan	Human	Original	Oropharyngeal and nasopharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Canada/NB-NML-6345/2021	EPI_ISL_961631	2021-01-16	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Canada/NB-NML-6344/2021	EPI_ISL_961633	2021-01-15	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Canada/NB-NML-6347/2021	EPI_ISL_961640	2021-01-14	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Canada/NB-NML-6333/2021	EPI_ISL_961648	2021-01-08	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Canada/NB-NML-6332/2021	EPI_ISL_961651	2021-01-05	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			AL.1	GR
hCoV-19/Denmark/DCGC-39697/2021	EPI_ISL_971241	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-40724/2021	EPI_ISL_972401	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-40811/2021	EPI_ISL_972488	2021-02-01	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-40887/2021	EPI_ISL_972564	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-40927/2021	EPI_ISL_972604	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Canada/BC-BCCDC-5172/2020	EPI_ISL_973771	2020-09-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.1.453	GR
hCoV-19/Zambia/ZMB-33670/2020	EPI_ISL_977410	2020-07-10	Africa / Zambia / Lusaka	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Field Workflow			B.1.1	GR
hCoV-19/USA/CA-CDPH-UC1538/2020	EPI_ISL_984552	2020-09-12	North America / USA / California / Los Angeles County	Human	Original	Nasopharyngeal swab		Illumina NovaSeq with tiling multiplex PCR (artic-ncov2019 protocol)	in-house scripts, Geneious			B.1.1.174	GR
hCoV-19/Montenegro/ChVir23239/2021	EPI_ISL_1013613	2021-01-18	Europe / Montenegro	Human	Original			NextSeq	bowtie2			AD.2	GR
hCoV-19/USA/NY-Wadsworth-21007544-01/2021	EPI_ISL_1020533	2021-01-02	North America / USA / New York / New York County	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/Denmark/DCGC-43653/2021	EPI_ISL_1024031	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-43682/2021	EPI_ISL_1024060	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-43684/2021	EPI_ISL_1024062	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-43980/2021	EPI_ISL_1024358	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-43997/2021	EPI_ISL_1024375	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Spain/CL-IBV-98017548/2021	EPI_ISL_1036038	2021-01-22	Europe / Spain / Castilla y Leon / Leon	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Poland/Pomorskie_MWB_115/2021	EPI_ISL_1040941	2021-01-16	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Pomorskie_MWB_165/2021	EPI_ISL_1040988	2021-01-29	Europe / Poland / Pomorskie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/South Korea/KDCA1486/2021	EPI_ISL_1063617	2021-01-04	Asia / South Korea	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.166	GR
hCoV-19/South Korea/KDCA1487/2021	EPI_ISL_1063618	2021-01-04	Asia / South Korea	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.166	GR
hCoV-19/South Korea/KDCA1381/2020	EPI_ISL_1063664	2020-10-16	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KDCA1426/2020	EPI_ISL_1063680	2020-11-30	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.163	GR
hCoV-19/Turkey/HSGM-2302/2021	EPI_ISL_1063982	2021-01-28	Europe / Turkey	Human	Original	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-24553/2021	EPI_ISL_1079128	2021-01-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/CA-ALSR-7031/2021	EPI_ISL_1081779	2021-01-14	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.3.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/MO-CDC-QDX21566575/2021	EPI_ISL_1086460	2021-01-29	North America / USA / Missouri	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12			B.1.1.337	GR
hCoV-19/USA/CA-CDC-STM-000010525/2021	EPI_ISL_1088904	2021-02-08	North America / USA / California	Human	Original	Nasal swab		Illumina	COVIDSEQ	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/GE-SNRCI-29933895/2020	EPI_ISL_413997	2020-02-26	Europe / Switzerland / Geneve	Human	Original	Nasopharyngeal swab		unknown				B.1.1	GR
hCoV-19/Iceland/187/2020	EPI_ISL_417551	2020-03-16	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Wales/PHWC-2649F/2020	EPI_ISL_422032	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/England/20129174804/2020	EPI_ISL_424152	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/CAMB-77031/2020	EPI_ISL_425453	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/CAMB-770B9/2020	EPI_ISL_425460	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/EDB396/2020	EPI_ISL_425996	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Australia/VIC427/2020	EPI_ISL_426727	2020-03-25	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/USA/WI-UW-156/2020	EPI_ISL_428252	2020-03-25	North America / USA / Wisconsin / Milwaukee County	Human	Original	Nasopharyngeal swab		unknown				B.1.1	GR
hCoV-19/England/CAMB-7B2EC/2020	EPI_ISL_433939	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7C2AF/2020	EPI_ISL_434021	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/USA/WI-UW-336/2020	EPI_ISL_436630	2020-03-25	North America / USA / Wisconsin / Milwaukee County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/Austria/CeMM0078/2020	EPI_ISL_437946	2020-03-24	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0103/2020	EPI_ISL_437964	2020-03-19	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0137/2020	EPI_ISL_437990	2020-03-13	Europe / Austria / Ischgl	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/CAMB-7A818/2020	EPI_ISL_441249	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A0E3/2020	EPI_ISL_441290	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/SHEF-D21D7/2020	EPI_ISL_442506	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.5	GR
hCoV-19/England/CAMB-806AC/2020	EPI_ISL_442562	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-81B15/2020	EPI_ISL_442570	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/France/BRE-5325/2020	EPI_ISL_443267	2020-03-18	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1.254	GR
hCoV-19/France/BRE-5355/2020	EPI_ISL_443271	2020-03-24	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/France/BRE-5397/2020	EPI_ISL_443275	2020-03-27	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/France/BRE-5415/2020	EPI_ISL_443278	2020-03-29	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/France/BRE-5447/2020	EPI_ISL_443280	2020-04-01	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/France/BRE-5458/2020	EPI_ISL_443282	2020-03-22	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/England/BRIS-125392/2020	EPI_ISL_443879	2020-03-27	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1258B1/2020	EPI_ISL_443888	2020-03-29	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B05D2/2020	EPI_ISL_448114	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/OXON-ADD59/2020	EPI_ISL_448633	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE4F9/2020	EPI_ISL_448698	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Switzerland/BS-ETHZ-100132/2020	EPI_ISL_451716	2020-03-16	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100138/2020	EPI_ISL_451722	2020-03-15	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100147/2020	EPI_ISL_451731	2020-03-16	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-100815/2020	EPI_ISL_451765	2020-03-26	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Sweden/20-50238/2020	EPI_ISL_455880	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50242/2020	EPI_ISL_455883	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50244/2020	EPI_ISL_455884	2020-03-08	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50245/2020	EPI_ISL_455885	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50246/2020	EPI_ISL_455886	2020-03-07	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/CAMB-1AF63D/2020	EPI_ISL_459317	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FA801/2020	EPI_ISL_459382	2020-04-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Singapore/292/2020	EPI_ISL_462410	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/311/2020	EPI_ISL_462429	2020-03-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/20169001704/2020	EPI_ISL_465167	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169001804/2020	EPI_ISL_465168	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169030304/2020	EPI_ISL_465225	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166016004/2020	EPI_ISL_466539	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.254	GR
hCoV-19/England/20166069104/2020	EPI_ISL_466573	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168002704/2020	EPI_ISL_466593	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Spain/GA-IBV-002745/2020	EPI_ISL_467265	2020-04-13	Europe / Spain / Galicia / Teo	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/CAMB-1B1F1F/2020	EPI_ISL_469896	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B1EF4/2020	EPI_ISL_469899	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/NORW-EBF86/2020	EPI_ISL_472326	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-283F60/2020	EPI_ISL_478528	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-295C19/2020	EPI_ISL_478658	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C2116/2020	EPI_ISL_479201	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C580F/2020	EPI_ISL_479216	2020-06-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C6CB7/2020	EPI_ISL_479223	2020-05-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D1509/2020	EPI_ISL_479276	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Turkey/IST-GLAB-092/2020	EPI_ISL_480244	2020-04-23	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM			B.1.1	GR
hCoV-19/USA/FL-BPHL-0176/2020	EPI_ISL_480827	2020-04-03	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/FL-BPHL-0220/2020	EPI_ISL_480871	2020-04-19	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.231	GR
hCoV-19/Senegal/68458/2020	EPI_ISL_482878	2020-06-18	Africa / Senegal / Dakar	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/cat/France/Env-Ba/2020	EPI_ISL_483063	2020-05-14	Europe / France	Felis catus	Original	Home environment		Oxford Nanopore Technologies	Bcftools mpileup v. 1.6			B.1.1.254	GR
hCoV-19/cat/France/Env-Di/2020	EPI_ISL_483064	2020-05-14	Europe / France	Felis catus	Original	Home environment		Oxford Nanopore Technologies	Bcftools mpileup v. 1.6			B.1.1.254	GR
hCoV-19/England/NOTT-11232F/2020	EPI_ISL_484371	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B3E89/2020	EPI_ISL_492200	2020-05-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B44D1/2020	EPI_ISL_492206	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/BRIS-18539DB/2020	EPI_ISL_492243	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185414B/2020	EPI_ISL_492250	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185413C/2020	EPI_ISL_492265	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185362F/2020	EPI_ISL_492290	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/WSFT-25C13CB/2020	EPI_ISL_492849	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28AD14/2020	EPI_ISL_492962	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E366/2020	EPI_ISL_493512	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E490/2020	EPI_ISL_493517	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E5AC/2020	EPI_ISL_493519	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29E72E/2020	EPI_ISL_493526	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EE56/2020	EPI_ISL_493540	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EEB07/2020	EPI_ISL_493543	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.115	GR
hCoV-19/England/NORW-EEB34/2020	EPI_ISL_493544	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.115	GR
hCoV-19/India/GJ-GBRC290b/2020	EPI_ISL_495028	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12	Spike_Q493stop results in 61.4% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/France/ARA-16251/2020	EPI_ISL_508907	2020-03-29	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/ARA-22592/2020	EPI_ISL_508918	2020-04-09	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Spain/PV-IBV-004213/2020	EPI_ISL_510498	2020-04-04	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004214/2020	EPI_ISL_510499	2020-04-04	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/USA/CA-IGI-0068/2020	EPI_ISL_511822	2020-05-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.1.174	GR
hCoV-19/USA/un-CDC-7467/2020	EPI_ISL_514072	2020-04-21	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/Russia/MOW-PMU-0417/2020	EPI_ISL_514750	2020-04-17	Europe / Russia / Moscow	Human	Original			Illumina	Bowtie2 v. 2.3.4			B.1.1	GR
hCoV-19/USA/VA-DCLS-0369/2020	EPI_ISL_516692	2020-05-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0370/2020	EPI_ISL_516693	2020-05-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/England/LIVE-A73C6/2020	EPI_ISL_517014	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.366	GR
hCoV-19/United Arab Emirates/L3290162047/2020	EPI_ISL_520682	2020-05-13	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/L3290166145/2020	EPI_ISL_520685	2020-05-14	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/OR-OHSU-1739/2020	EPI_ISL_526018	2020-07-24	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-1903/2020	EPI_ISL_526064	2020-07-28	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/VA-DCLS-1067/2020	EPI_ISL_528669	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1072/2020	EPI_ISL_528671	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1080/2020	EPI_ISL_528676	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.231	GR
hCoV-19/United Arab Emirates/313/2020	EPI_ISL_528696	2020-06-02	Asia / United Arab Emirates / Dubai	Human	Original			Illumina NextSeq 500				B.1.1.366	GR
hCoV-19/Italy/ABR-IZSGC-TE77497/2020	EPI_ISL_529006	2020-06-09	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE27016/2020	EPI_ISL_529019	2020-04-27	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/England/QEUH-96C670/2020	EPI_ISL_530938	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9698D7/2020	EPI_ISL_530952	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-969637/2020	EPI_ISL_530953	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-964DEC/2020	EPI_ISL_530955	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-964D28/2020	EPI_ISL_530962	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9657CF/2020	EPI_ISL_530968	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965774/2020	EPI_ISL_530973	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965792/2020	EPI_ISL_530979	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964D91/2020	EPI_ISL_530981	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969646/2020	EPI_ISL_530983	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964AC7/2020	EPI_ISL_530986	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-9659BA/2020	EPI_ISL_530997	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96538F/2020	EPI_ISL_531181	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969743/2020	EPI_ISL_531189	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9695EF/2020	EPI_ISL_531215	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96B143/2020	EPI_ISL_531229	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/QEUH-96BE00/2020	EPI_ISL_531250	2020-08-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96BCF7/2020	EPI_ISL_531254	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96AEE3/2020	EPI_ISL_531258	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96BE97/2020	EPI_ISL_531260	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96AF68/2020	EPI_ISL_531268	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96BD5E/2020	EPI_ISL_531270	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-96B996/2020	EPI_ISL_531271	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96B556/2020	EPI_ISL_531281	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96B2F5/2020	EPI_ISL_531282	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-96B29B/2020	EPI_ISL_531305	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96AFB3/2020	EPI_ISL_531308	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96BA66/2020	EPI_ISL_531311	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BEB5/2020	EPI_ISL_531313	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-943633/2020	EPI_ISL_532584	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9435AF/2020	EPI_ISL_532587	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9437E5/2020	EPI_ISL_532589	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-9439C1/2020	EPI_ISL_532594	2020-07-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-943581/2020	EPI_ISL_532610	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-943B70/2020	EPI_ISL_532617	2020-07-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9435EB/2020	EPI_ISL_532619	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-943439/2020	EPI_ISL_532621	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-943ABF/2020	EPI_ISL_532626	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-941125/2020	EPI_ISL_532632	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95E26E/2020	EPI_ISL_534434	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E1F8/2020	EPI_ISL_534436	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E091/2020	EPI_ISL_534437	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/Qc-LSPQ-L00235639/2020	EPI_ISL_536104	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00236367/2020	EPI_ISL_536124	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/England/QEUH-98F2CE/2020	EPI_ISL_540346	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F2EC/2020	EPI_ISL_540380	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F097/2020	EPI_ISL_540392	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98EEF8/2020	EPI_ISL_540393	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-3754/2020	EPI_ISL_543165	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-3840/2020	EPI_ISL_543243	2020-06-12	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-3921/2020	EPI_ISL_543281	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-3923/2020	EPI_ISL_543282	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-4010/2020	EPI_ISL_543293	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-4011/2020	EPI_ISL_543294	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5112/2020	EPI_ISL_544533	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5157/2020	EPI_ISL_544566	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-5230/2020	EPI_ISL_544609	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5261/2020	EPI_ISL_544634	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2211/2020	EPI_ISL_545184	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-2236/2020	EPI_ISL_545196	2020-05-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/Switzerland/GE-SNRCI-2956/2020	EPI_ISL_548162	2020-03	Europe / Switzerland / Geneve	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Switzerland/GE-SNRCI-7347/2020	EPI_ISL_548190	2020-03	Europe / Switzerland / Geneve	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMC-9B2004/2020	EPI_ISL_549405	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9B2462/2020	EPI_ISL_549410	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9B24F9/2020	EPI_ISL_549411	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-9A8757/2020	EPI_ISL_549417	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9A8793/2020	EPI_ISL_549420	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9A899D/2020	EPI_ISL_549437	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB578/2020	EPI_ISL_549443	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9AB675/2020	EPI_ISL_549453	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB6DF/2020	EPI_ISL_549454	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB709/2020	EPI_ISL_549455	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9C4676/2020	EPI_ISL_549460	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C4834/2020	EPI_ISL_549468	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORW-EE651/2020	EPI_ISL_549477	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EF869/2020	EPI_ISL_549480	2020-09-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/NOTT-1132E5/2020	EPI_ISL_549494	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11335B/2020	EPI_ISL_549499	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/MILK-99A679/2020	EPI_ISL_550400	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99B4F6/2020	EPI_ISL_550402	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99A688/2020	EPI_ISL_550406	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A8CE/2020	EPI_ISL_550409	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9780CE/2020	EPI_ISL_550432	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9781AD/2020	EPI_ISL_550445	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-977469/2020	EPI_ISL_550447	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9780DD/2020	EPI_ISL_550450	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9780FB/2020	EPI_ISL_550465	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9779A6/2020	EPI_ISL_550471	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-978046/2020	EPI_ISL_550481	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9A8DFB/2020	EPI_ISL_551004	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9A970B/2020	EPI_ISL_551005	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9291/2020	EPI_ISL_551008	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB0D1/2020	EPI_ISL_551009	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9A8EF8/2020	EPI_ISL_551022	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A962C/2020	EPI_ISL_551027	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9AB48A/2020	EPI_ISL_551032	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9B78/2020	EPI_ISL_551038	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-9A8F6E/2020	EPI_ISL_551041	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9D90/2020	EPI_ISL_551044	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9AF3/2020	EPI_ISL_551052	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A94AA/2020	EPI_ISL_551057	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994202/2020	EPI_ISL_551700	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993DE4/2020	EPI_ISL_551704	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9941F6/2020	EPI_ISL_551730	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99386B/2020	EPI_ISL_552323	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995359/2020	EPI_ISL_552324	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99394A/2020	EPI_ISL_552325	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993C9C/2020	EPI_ISL_552326	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993A0B/2020	EPI_ISL_552332	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-993A29/2020	EPI_ISL_552334	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993D6C/2020	EPI_ISL_552337	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993D7B/2020	EPI_ISL_552344	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9954FC/2020	EPI_ISL_552347	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-993B62/2020	EPI_ISL_552355	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994897/2020	EPI_ISL_552363	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994A91/2020	EPI_ISL_552365	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994F0B/2020	EPI_ISL_552380	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-993D5D/2020	EPI_ISL_552383	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-95CBFC/2020	EPI_ISL_553604	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-954A06/2020	EPI_ISL_553607	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954FF8/2020	EPI_ISL_553630	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9520AC/2020	EPI_ISL_553631	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953919/2020	EPI_ISL_553635	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952E39/2020	EPI_ISL_553638	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9520D9/2020	EPI_ISL_553651	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-9520CA/2020	EPI_ISL_553683	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95309C/2020	EPI_ISL_553685	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-952E48/2020	EPI_ISL_553686	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95A0B3/2020	EPI_ISL_554901	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95ABB2/2020	EPI_ISL_554903	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94D5A5/2020	EPI_ISL_554911	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CFE1/2020	EPI_ISL_554917	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A61B/2020	EPI_ISL_554918	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C1EB/2020	EPI_ISL_554934	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CF69/2020	EPI_ISL_554942	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95C109/2020	EPI_ISL_554945	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C637/2020	EPI_ISL_554951	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C646/2020	EPI_ISL_554985	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C682/2020	EPI_ISL_554998	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F95C/2020	EPI_ISL_555254	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9504EE/2020	EPI_ISL_555256	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F85F/2020	EPI_ISL_555260	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95041B/2020	EPI_ISL_555281	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FC44/2020	EPI_ISL_555285	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F840/2020	EPI_ISL_555286	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FB65/2020	EPI_ISL_555297	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-948829/2020	EPI_ISL_556524	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-947AF7/2020	EPI_ISL_556534	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94822B/2020	EPI_ISL_556542	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94870E/2020	EPI_ISL_556549	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8F766C/2020	EPI_ISL_556580	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8C12B2/2020	EPI_ISL_556598	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8E63A5/2020	EPI_ISL_556604	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-81BEA6/2020	EPI_ISL_557167	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-6B2DD3/2020	EPI_ISL_557839	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6118B3/2020	EPI_ISL_557848	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6C3786/2020	EPI_ISL_557860	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6B556F/2020	EPI_ISL_557863	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6238FA/2020	EPI_ISL_557867	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/England/MILK-628F78/2020	EPI_ISL_557879	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-63A025/2020	EPI_ISL_557890	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-622381/2020	EPI_ISL_557894	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-60EB38/2020	EPI_ISL_557926	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6BB226/2020	EPI_ISL_557929	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-6BBD9E/2020	EPI_ISL_557931	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6BB5D2/2020	EPI_ISL_557939	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-623809/2020	EPI_ISL_557949	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-5D1838/2020	EPI_ISL_558493	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Gambia/GC19-3846/2020	EPI_ISL_561100	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3854/2020	EPI_ISL_561102	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2427/2020	EPI_ISL_561105	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2459/2020	EPI_ISL_561108	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2525/2020	EPI_ISL_561113	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192602/2020	EPI_ISL_561120	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192610/2020	EPI_ISL_561121	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2663/2020	EPI_ISL_561133	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2707/2020	EPI_ISL_561134	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-2731/2020	EPI_ISL_561137	2020-07-21	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC192772/2020	EPI_ISL_561140	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC192778/2020	EPI_ISL_561141	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC192786/2020	EPI_ISL_561144	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC192812/2020	EPI_ISL_561148	2020-07-22	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2842/2020	EPI_ISL_561151	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2904/2020	EPI_ISL_561154	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-2973/2020	EPI_ISL_561156	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2977/2020	EPI_ISL_561157	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-2991/2020	EPI_ISL_561159	2020-07-24	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3064/2020	EPI_ISL_561160	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3081/2020	EPI_ISL_561162	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3085/2020	EPI_ISL_561163	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3110/2020	EPI_ISL_561165	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3113/2020	EPI_ISL_561167	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3114/2020	EPI_ISL_561168	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3145/2020	EPI_ISL_561170	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3399/2020	EPI_ISL_561172	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3533/2020	EPI_ISL_561193	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.466	GR
hCoV-19/England/MILK-9C3422/2020	EPI_ISL_566933	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9C3CB1/2020	EPI_ISL_566949	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C45A6/2020	EPI_ISL_566987	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8180/2020	EPI_ISL_566998	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C84F0/2020	EPI_ISL_567129	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C8FC2/2020	EPI_ISL_567206	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9C7DBA/2020	EPI_ISL_567212	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8B19/2020	EPI_ISL_567219	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9C9143/2020	EPI_ISL_567222	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C91E9/2020	EPI_ISL_567226	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C835D/2020	EPI_ISL_567239	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C81AE/2020	EPI_ISL_567243	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C891F/2020	EPI_ISL_567245	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C80A1/2020	EPI_ISL_567246	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C8654/2020	EPI_ISL_567248	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C81CC/2020	EPI_ISL_567254	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9C87AC/2020	EPI_ISL_567255	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C895B/2020	EPI_ISL_567262	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8A67/2020	EPI_ISL_567264	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA31F/2020	EPI_ISL_567282	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Russia/OMS-ORINFI-8583S/2020	EPI_ISL_569790	2020-07-22	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4791S/2020	EPI_ISL_569820	2020-07-10	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5195S/2020	EPI_ISL_569823	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-1631S/2020	EPI_ISL_569827	2020-06-29	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-4814S/2020	EPI_ISL_569829	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-3961S/2020	EPI_ISL_569834	2020-07-08	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5204S/2020	EPI_ISL_569838	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8474S/2020	EPI_ISL_569839	2020-07-22	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-9661S/2020	EPI_ISL_569843	2020-06-22	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-7593S/2020	EPI_ISL_569844	2020-07-20	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4818S/2020	EPI_ISL_569845	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5208S/2020	EPI_ISL_569846	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8499S/2020	EPI_ISL_569847	2020-07-22	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-7598S/2020	EPI_ISL_569851	2020-06-12	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-9975S/2020	EPI_ISL_569852	2020-06-22	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4890S/2020	EPI_ISL_569854	2020-05-03	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-9060S/2020	EPI_ISL_569856	2020-05-19	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/USA/CA-IGI-0202/2020	EPI_ISL_569887	2020-07-02	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0211/2020	EPI_ISL_569892	2020-07-02	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0228/2020	EPI_ISL_569900	2020-07-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0204/2020	EPI_ISL_569932	2020-07-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.1.174	GR
hCoV-19/USA/WA-UW-26858/2020	EPI_ISL_570780	2020-09-01	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.453	GR
hCoV-19/England/ALDP-9CC447/2020	EPI_ISL_573107	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9CC456/2020	EPI_ISL_573108	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9BFF0A/2020	EPI_ISL_573161	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9BFFFB/2020	EPI_ISL_573165	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/CAMC-9C006D/2020	EPI_ISL_573168	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9C0258/2020	EPI_ISL_573176	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0364/2020	EPI_ISL_573180	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/CAMC-9C03DD/2020	EPI_ISL_573184	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0425/2020	EPI_ISL_573185	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0452/2020	EPI_ISL_573186	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C048F/2020	EPI_ISL_573187	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0540/2020	EPI_ISL_573188	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Switzerland/VD-ETHZ-100332/2020	EPI_ISL_575010	2020-03-18	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/ALDP-9CB32D/2020	EPI_ISL_575706	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9CB5FA/2020	EPI_ISL_575711	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAE4B/2020	EPI_ISL_575717	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAD11/2020	EPI_ISL_575722	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAF93/2020	EPI_ISL_575739	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAEB4/2020	EPI_ISL_575748	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-973139/2020	EPI_ISL_575763	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-973588/2020	EPI_ISL_575771	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-974842/2020	EPI_ISL_575785	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9745E1/2020	EPI_ISL_575786	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-976716/2020	EPI_ISL_575792	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/USA/LA-EVTL501/2020	EPI_ISL_578905	2020-07-30	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL502/2020	EPI_ISL_578906	2020-07-30	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/New Zealand/20VR2549/2020	EPI_ISL_579292	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/England/ALDP-9E9BC7/2020	EPI_ISL_580202	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EADFD/2020	EPI_ISL_580223	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA07C/2020	EPI_ISL_580227	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA962/2020	EPI_ISL_580265	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC283/2020	EPI_ISL_580299	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-5ED462/2020	EPI_ISL_581437	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/USA/VA-DCLS-1540/2020	EPI_ISL_581535	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1432/2020	EPI_ISL_581554	2020-07-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/Italy/TUS-DBM-1/2020	EPI_ISL_582123	2020-03-01	Europe / Italy / Tuscany	Human	Vero			Nanopore MinION	Medaka v 0.12.1			B.1.1	GR
hCoV-19/USA/CA-CZB-6928/2020	EPI_ISL_582888	2020-08-19	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6929/2020	EPI_ISL_582889	2020-08-19	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6932/2020	EPI_ISL_582890	2020-08-22	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/SHEF-CE6A2/2020	EPI_ISL_585069	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF28F/2020	EPI_ISL_585074	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-D131E/2020	EPI_ISL_585079	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Northern Ireland/NIRE-10709F/2020	EPI_ISL_585103	2020-03-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-10825C/2020	EPI_ISL_585178	2020-04-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Canada/ON-S750/2020	EPI_ISL_586437	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S855/2020	EPI_ISL_586460	2020-04-11	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S889/2020	EPI_ISL_586471	2020-04-12	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/England/QEUH-A20774/2020	EPI_ISL_587701	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCEF5/2020	EPI_ISL_587727	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FD058/2020	EPI_ISL_587749	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCEAA/2020	EPI_ISL_587753	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD243/2020	EPI_ISL_587757	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD261/2020	EPI_ISL_587780	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCAC4/2020	EPI_ISL_587782	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAC2A/2020	EPI_ISL_588261	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA6E0/2020	EPI_ISL_588263	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAE60/2020	EPI_ISL_588268	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4EA2/2020	EPI_ISL_588308	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4C3F/2020	EPI_ISL_588322	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F1801/2020	EPI_ISL_589592	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9F0A75/2020	EPI_ISL_589615	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F0A1B/2020	EPI_ISL_589624	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F0D30/2020	EPI_ISL_589638	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7719/2020	EPI_ISL_590569	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7DEA/2020	EPI_ISL_590572	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9B78E9/2020	EPI_ISL_590609	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B77A0/2020	EPI_ISL_590614	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7E23/2020	EPI_ISL_590625	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B702D/2020	EPI_ISL_590636	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7649/2020	EPI_ISL_590639	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57E33/2020	EPI_ISL_597050	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A585E2/2020	EPI_ISL_597094	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A59235/2020	EPI_ISL_597098	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57CC0/2020	EPI_ISL_597105	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585F1/2020	EPI_ISL_597110	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A593BA/2020	EPI_ISL_597111	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5860D/2020	EPI_ISL_597122	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5898C/2020	EPI_ISL_597157	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46D58/2020	EPI_ISL_598414	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46CE2/2020	EPI_ISL_598434	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-A46E37/2020	EPI_ISL_598459	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A471B5/2020	EPI_ISL_598463	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47BC6/2020	EPI_ISL_598476	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-A47391/2020	EPI_ISL_598481	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD8DE/2020	EPI_ISL_599705	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE13C/2020	EPI_ISL_599710	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB8A/2020	EPI_ISL_599717	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE4BB/2020	EPI_ISL_599727	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DD7A4/2020	EPI_ISL_599737	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE187/2020	EPI_ISL_599752	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD892/2020	EPI_ISL_599768	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD0F4/2020	EPI_ISL_599774	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE21B/2020	EPI_ISL_599778	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD416/2020	EPI_ISL_599780	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDC3C/2020	EPI_ISL_599789	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD0E5/2020	EPI_ISL_599792	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDA23/2020	EPI_ISL_599794	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDDC0/2020	EPI_ISL_599795	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FFF3B/2020	EPI_ISL_600402	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A008FF/2020	EPI_ISL_600417	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/MILK-9D4CDB/2020	EPI_ISL_601705	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4716/2020	EPI_ISL_601708	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D47AD/2020	EPI_ISL_601723	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D2068/2020	EPI_ISL_601730	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4BCF/2020	EPI_ISL_601744	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D1D9F/2020	EPI_ISL_601747	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D1DAE/2020	EPI_ISL_601771	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D45EF/2020	EPI_ISL_601774	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D22CC/2020	EPI_ISL_601778	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3E8B/2020	EPI_ISL_601784	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A6908/2020	EPI_ISL_602145	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99DD9F/2020	EPI_ISL_602149	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86C40/2020	EPI_ISL_605978	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C3FD/2020	EPI_ISL_606580	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A939/2020	EPI_ISL_606592	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D1E6/2020	EPI_ISL_608253	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D377/2020	EPI_ISL_608277	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C7F4/2020	EPI_ISL_608291	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A420CC/2020	EPI_ISL_609515	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A419D1/2020	EPI_ISL_609520	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A40E4C/2020	EPI_ISL_609530	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E62B/2020	EPI_ISL_609543	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3ECB0/2020	EPI_ISL_609585	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A3EC47/2020	EPI_ISL_609594	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A85A1A/2020	EPI_ISL_610534	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A84D9A/2020	EPI_ISL_610542	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85AB0/2020	EPI_ISL_610547	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858C5/2020	EPI_ISL_610561	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A850EB/2020	EPI_ISL_610578	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85CAB/2020	EPI_ISL_610583	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85C41/2020	EPI_ISL_610584	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85B08/2020	EPI_ISL_610597	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/LIVE-1D2AAE/2020	EPI_ISL_612405	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-D9B69/2020	EPI_ISL_612452	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/VA-DCLS-1838/2020	EPI_ISL_614130	2020-09-17	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1839/2020	EPI_ISL_614131	2020-09-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Denmark/DCGC-4403/2020	EPI_ISL_615401	2020-09-07	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3639/2020	EPI_ISL_615410	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3650/2020	EPI_ISL_615422	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3695/2020	EPI_ISL_615472	2020-09-07	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3708/2020	EPI_ISL_615486	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3710/2020	EPI_ISL_615488	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3718/2020	EPI_ISL_615496	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2786/2020	EPI_ISL_616621	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2940/2020	EPI_ISL_616701	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2947/2020	EPI_ISL_616708	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2959/2020	EPI_ISL_616721	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2974/2020	EPI_ISL_616736	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2992/2020	EPI_ISL_616756	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2994/2020	EPI_ISL_616758	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2995/2020	EPI_ISL_616759	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3214/2020	EPI_ISL_616770	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3012/2020	EPI_ISL_616790	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-7699/2020	EPI_ISL_618563	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7045/2020	EPI_ISL_619893	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7046/2020	EPI_ISL_619894	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5560/2020	EPI_ISL_620885	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5562/2020	EPI_ISL_620887	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5565/2020	EPI_ISL_620890	2020-09-28	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-5569/2020	EPI_ISL_620894	2020-09-28	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5607/2020	EPI_ISL_620932	2020-09-28	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5695/2020	EPI_ISL_621200	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5705/2020	EPI_ISL_621210	2020-09-21	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5729/2020	EPI_ISL_621234	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5732/2020	EPI_ISL_621237	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5733/2020	EPI_ISL_621238	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4594/2020	EPI_ISL_621263	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-4598/2020	EPI_ISL_621267	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4599/2020	EPI_ISL_621268	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-4612/2020	EPI_ISL_621281	2020-09-21	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-1947/2020	EPI_ISL_622529	2020-04-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1828/2020	EPI_ISL_622565	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.359	GR
hCoV-19/Denmark/DCGC-1844/2020	EPI_ISL_622567	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.359	GR
hCoV-19/Denmark/DCGC-1850/2020	EPI_ISL_622568	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.359	GR
hCoV-19/Denmark/DCGC-1856/2020	EPI_ISL_622569	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.359	GR
hCoV-19/England/CAMC-AB1EFB/2020	EPI_ISL_623846	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA07A9/2020	EPI_ISL_623889	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA34CD/2020	EPI_ISL_623890	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1D3D/2020	EPI_ISL_624422	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3BAA/2020	EPI_ISL_624425	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/EXET-13860C/2020	EPI_ISL_627424	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138790/2020	EPI_ISL_627427	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-1388E8/2020	EPI_ISL_627430	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138A6A/2020	EPI_ISL_627433	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/LOND-126C9A/2020	EPI_ISL_627464	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A18A67/2020	EPI_ISL_627475	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A6A2B9/2020	EPI_ISL_627497	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A6A32F/2020	EPI_ISL_627499	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A4DB2A/2020	EPI_ISL_628616	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4DB66/2020	EPI_ISL_628617	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-AC842C/2020	EPI_ISL_629211	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACED3A/2020	EPI_ISL_629213	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7CCB/2020	EPI_ISL_629237	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACC8C2/2020	EPI_ISL_629263	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC297/2020	EPI_ISL_629282	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACC3B2/2020	EPI_ISL_629285	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACBFCE/2020	EPI_ISL_629286	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-AD2FF1/2020	EPI_ISL_629946	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0F5D/2020	EPI_ISL_629947	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACCD4B/2020	EPI_ISL_630246	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/MILK-ACCE93/2020	EPI_ISL_630275	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/MILK-ACDB22/2020	EPI_ISL_630291	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AC7760/2020	EPI_ISL_630293	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACDECF/2020	EPI_ISL_630294	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AAE7AB/2020	EPI_ISL_630923	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AEAFF6/2020	EPI_ISL_633211	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEACFF/2020	EPI_ISL_633215	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/CAMC-AEB02F/2020	EPI_ISL_633220	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEA785/2020	EPI_ISL_633265	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AEACE0/2020	EPI_ISL_633267	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC4EC/2020	EPI_ISL_634506	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD524/2020	EPI_ISL_634514	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/QEUH-AD1F2F/2020	EPI_ISL_634526	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19C7/2020	EPI_ISL_634562	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD4399/2020	EPI_ISL_634566	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD16B1/2020	EPI_ISL_634584	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AD5E6A/2020	EPI_ISL_634585	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-ALSR-3050/2020	EPI_ISL_635814	2020-09-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.277	GR
hCoV-19/USA/CA-ALSR-3068/2020	EPI_ISL_635827	2020-09-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.277	GR
hCoV-19/Wales/PHWC-488BCF/2020	EPI_ISL_639477	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B13B1D/2020	EPI_ISL_641697	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B14226/2020	EPI_ISL_641708	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14569/2020	EPI_ISL_641729	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1396E/2020	EPI_ISL_641748	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14217/2020	EPI_ISL_641752	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B137CE/2020	EPI_ISL_641753	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13904/2020	EPI_ISL_641768	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13843/2020	EPI_ISL_641770	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14068/2020	EPI_ISL_641793	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13069/2020	EPI_ISL_641796	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F0E8/2020	EPI_ISL_641798	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10D83/2020	EPI_ISL_642216	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10F05/2020	EPI_ISL_642231	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B11845/2020	EPI_ISL_642238	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B11960/2020	EPI_ISL_642293	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B0280B/2020	EPI_ISL_642924	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0A8F4/2020	EPI_ISL_643512	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B705/2020	EPI_ISL_643533	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B714/2020	EPI_ISL_643553	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0AB0A/2020	EPI_ISL_643574	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B084E3/2020	EPI_ISL_643579	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0C83E/2020	EPI_ISL_643583	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B360CA/2020	EPI_ISL_645223	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B36A26/2020	EPI_ISL_645238	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B26072/2020	EPI_ISL_646572	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-B0639D/2020	EPI_ISL_647820	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-B06236/2020	EPI_ISL_647823	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AE1D13/2020	EPI_ISL_647874	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AE1C34/2020	EPI_ISL_647881	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AE2091/2020	EPI_ISL_647889	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-286D45/2020	EPI_ISL_652337	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286D72/2020	EPI_ISL_652338	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286D90/2020	EPI_ISL_652339	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286E33/2020	EPI_ISL_652340	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CEA6/2020	EPI_ISL_652343	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CF3A/2020	EPI_ISL_652344	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11B7DF/2020	EPI_ISL_652379	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B62BA6/2020	EPI_ISL_655580	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5448E/2020	EPI_ISL_656822	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B522A4/2020	EPI_ISL_656859	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B56A7B/2020	EPI_ISL_656865	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4367D/2020	EPI_ISL_657200	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B43428/2020	EPI_ISL_657203	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40027/2020	EPI_ISL_657220	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4332B/2020	EPI_ISL_657251	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B4017F/2020	EPI_ISL_657268	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B416AC/2020	EPI_ISL_658522	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B41949/2020	EPI_ISL_658555	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F46B/2020	EPI_ISL_658556	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F735/2020	EPI_ISL_658586	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E906/2020	EPI_ISL_659819	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D239/2020	EPI_ISL_659823	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EBD3/2020	EPI_ISL_659830	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D266/2020	EPI_ISL_659836	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F941/2020	EPI_ISL_659851	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D284/2020	EPI_ISL_659875	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF2957/2020	EPI_ISL_662784	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF53FC/2020	EPI_ISL_663007	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF3E84/2020	EPI_ISL_663009	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AF4120/2020	EPI_ISL_663015	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5E28/2020	EPI_ISL_663018	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF567B/2020	EPI_ISL_663022	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF61B5/2020	EPI_ISL_663041	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5DEF/2020	EPI_ISL_663045	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5848/2020	EPI_ISL_663090	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52A4/2020	EPI_ISL_663095	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/PHWC-48B18E/2020	EPI_ISL_666200	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Japan/IC-0131/2020	EPI_ISL_667560	2020-09-09	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0134/2020	EPI_ISL_667563	2020-07-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina iSeq	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0166/2020	EPI_ISL_667595	2020-09-24	Asia / Japan	Human	Original		COVID-19 positive case who entered from Ukraine.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Denmark/DCGC-9275/2020	EPI_ISL_668882	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-9820/2020	EPI_ISL_669202	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10785/2020	EPI_ISL_670205	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10836/2020	EPI_ISL_670242	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10898/2020	EPI_ISL_670273	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/QEUH-BA13A3/2020	EPI_ISL_672805	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-BA3392/2020	EPI_ISL_672837	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B9620E/2020	EPI_ISL_675000	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B95B40/2020	EPI_ISL_675051	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B974F8/2020	EPI_ISL_675057	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B9612F/2020	EPI_ISL_676302	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B675A3/2020	EPI_ISL_676338	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B6A661/2020	EPI_ISL_676340	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/VAN4169/2020	EPI_ISL_677687	2020-05-11	North America / USA / New York / New York	Human	Original			Illumina MiSeq				B.1.1.231	GR
hCoV-19/England/LOND-12D4BA5/2020	EPI_ISL_679551	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-12D4BE1/2020	EPI_ISL_679555	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/QEUH-A9D2EA/2020	EPI_ISL_680564	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Ireland/D-NVRL-20Z06394/2020	EPI_ISL_681899	2020-04-17	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Japan/PG-2527/2020	EPI_ISL_690662	2020-05-05	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/PG-2528/2020	EPI_ISL_690663	2020-05-05	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/PG-2533/2020	EPI_ISL_690668	2020-05-07	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/PG-2542/2020	EPI_ISL_690677	2020-05-12	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/PG-2543/2020	EPI_ISL_690678	2020-05-13	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/PG-2546/2020	EPI_ISL_690681	2020-05-17	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/United Arab Emirates/0521/2020	EPI_ISL_698684	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0523/2020	EPI_ISL_698686	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0908/2020	EPI_ISL_699046	2020-06-26	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	G
hCoV-19/South Africa/NHLS-UCT-GS-2058/2020	EPI_ISL_700559	2020-09-18	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/South Africa/NHLS-UCT-GP-5790/2020	EPI_ISL_700570	2020-05-19	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/South Africa/NHLS-UCT-GS-2980/2020	EPI_ISL_700574	2020-05-10	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/England/ALDP-BBA0EC/2020	EPI_ISL_701882	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/ALDP-BB4E51/2020	EPI_ISL_702422	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BBB397/2020	EPI_ISL_702425	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BB9C34/2020	EPI_ISL_702460	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-BB9B73/2020	EPI_ISL_702482	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-BE715C/2020	EPI_ISL_709815	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BE4061/2020	EPI_ISL_709834	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BE4113/2020	EPI_ISL_709835	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BE415F/2020	EPI_ISL_709845	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B027B3/2020	EPI_ISL_709907	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B0272C/2020	EPI_ISL_709908	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/CAMC-BC09E8/2020	EPI_ISL_710827	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/CAMC-BC0951/2020	EPI_ISL_710828	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-B6C140/2020	EPI_ISL_710872	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-13058/2020	EPI_ISL_712557	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13108/2020	EPI_ISL_712586	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/ALDP-C47FD7/2020	EPI_ISL_718735	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C3E586/2020	EPI_ISL_719205	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-C17C9D/2020	EPI_ISL_721519	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C17C60/2020	EPI_ISL_721521	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Japan/IC-0343/2020	EPI_ISL_721588	2020-11-23	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.337	GR
hCoV-19/Italy/BAS-IZSPB-194PT/2020	EPI_ISL_722892	2020-08-24	Europe / Italy / Basilicata / Potenza	Human	Vero			Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/Netherlands/NH-RIVM-20021/2020	EPI_ISL_723220	2020-11-23	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/NH-RIVM-20108/2020	EPI_ISL_723285	2020-11-15	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/LIVE-DCC5AA/2020	EPI_ISL_724517	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F19E9/2020	EPI_ISL_725129	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-F1A9B/2020	EPI_ISL_725134	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-4956BF/2020	EPI_ISL_726381	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49585F/2020	EPI_ISL_726405	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49597A/2020	EPI_ISL_726419	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-495AFF/2020	EPI_ISL_726439	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-495BA1/2020	EPI_ISL_726450	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-495BED/2020	EPI_ISL_726454	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A9D666/2020	EPI_ISL_727781	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9D693/2020	EPI_ISL_727782	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9D781/2020	EPI_ISL_727787	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Portugal/PT2050/2020	EPI_ISL_732264	2020-11-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			AD.2	GR
hCoV-19/Belgium/rega-0801770/2020	EPI_ISL_734847	2020-08-01	Europe / Belgium / Evere	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0801773/2020	EPI_ISL_734850	2020-08-01	Europe / Belgium / Deurne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0801924/2020	EPI_ISL_734866	2020-08-01	Europe / Belgium / Lubbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/England/ALDP-C489AB/2020	EPI_ISL_736575	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				AD.2	GR
hCoV-19/Czech Republic/NRL_11016/2020	EPI_ISL_737026	2020-11-08	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1	GR
hCoV-19/Finland/S1B4/2020	EPI_ISL_737035	2020-08-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.1	GR
hCoV-19/Belgium/rega-12091307/2020	EPI_ISL_738361	2020-12-09	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111308/2020	EPI_ISL_738362	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141309/2020	EPI_ISL_738363	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111310/2020	EPI_ISL_738364	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141311/2020	EPI_ISL_738365	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111312/2020	EPI_ISL_738366	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111313/2020	EPI_ISL_738367	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111314/2020	EPI_ISL_738368	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141315/2020	EPI_ISL_738369	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111316/2020	EPI_ISL_738370	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12081318/2020	EPI_ISL_738371	2020-12-08	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111319/2020	EPI_ISL_738372	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111320/2020	EPI_ISL_738373	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141321/2020	EPI_ISL_738374	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111322/2020	EPI_ISL_738375	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141323/2020	EPI_ISL_738376	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111324/2020	EPI_ISL_738377	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Belgium/rega-12111325/2020	EPI_ISL_738378	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111326/2020	EPI_ISL_738379	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141327/2020	EPI_ISL_738380	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Belgium/rega-12141328/2020	EPI_ISL_738381	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141329/2020	EPI_ISL_738382	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111330/2020	EPI_ISL_738383	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111331/2020	EPI_ISL_738384	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111332/2020	EPI_ISL_738385	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-14121333/2020	EPI_ISL_738386	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141334/2020	EPI_ISL_738387	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141335/2020	EPI_ISL_738388	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12091336/2020	EPI_ISL_738389	2020-12-09	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111337/2020	EPI_ISL_738390	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111338/2020	EPI_ISL_738391	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141339/2020	EPI_ISL_738392	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111340/2020	EPI_ISL_738393	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141341/2020	EPI_ISL_738394	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111342/2020	EPI_ISL_738395	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111343/2020	EPI_ISL_738396	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111344/2020	EPI_ISL_738397	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141345/2020	EPI_ISL_738398	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111346/2020	EPI_ISL_738399	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141347/2020	EPI_ISL_738400	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111348/2020	EPI_ISL_738401	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111349/2020	EPI_ISL_738402	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111350/2020	EPI_ISL_738403	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111351/2020	EPI_ISL_738404	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111352/2020	EPI_ISL_738405	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141353/2020	EPI_ISL_738406	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111354/2020	EPI_ISL_738407	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111355/2020	EPI_ISL_738408	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141356/2020	EPI_ISL_738409	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111357/2020	EPI_ISL_738410	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111358/2020	EPI_ISL_738411	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141359/2020	EPI_ISL_738412	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12081361/2020	EPI_ISL_738414	2020-12-08	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141362/2020	EPI_ISL_738415	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111363/2020	EPI_ISL_738416	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141364/2020	EPI_ISL_738417	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111365/2020	EPI_ISL_738418	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141367/2020	EPI_ISL_738420	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111368/2020	EPI_ISL_738421	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111369/2020	EPI_ISL_738422	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111370/2020	EPI_ISL_738423	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141371/2020	EPI_ISL_738424	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111373/2020	EPI_ISL_738426	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141374/2020	EPI_ISL_738427	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111375/2020	EPI_ISL_738428	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111376/2020	EPI_ISL_738429	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141377/2020	EPI_ISL_738430	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12091379/2020	EPI_ISL_738431	2020-12-09	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141380/2020	EPI_ISL_738432	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111381/2020	EPI_ISL_738433	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111382/2020	EPI_ISL_738434	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141383/2020	EPI_ISL_738435	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12091385/2020	EPI_ISL_738437	2020-12-09	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111386/2020	EPI_ISL_738438	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141387/2020	EPI_ISL_738439	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111388/2020	EPI_ISL_738440	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141389/2020	EPI_ISL_738441	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111391/2020	EPI_ISL_738443	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111392/2020	EPI_ISL_738444	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111393/2020	EPI_ISL_738445	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111394/2020	EPI_ISL_738446	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111397/2020	EPI_ISL_738449	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141398/2020	EPI_ISL_738450	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111399/2020	EPI_ISL_738451	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141400/2020	EPI_ISL_738452	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141402/2020	EPI_ISL_738454	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111404/2020	EPI_ISL_738456	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111405/2020	EPI_ISL_738457	2020-12-11	Europe / Belgium / Meerhout	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141406/2020	EPI_ISL_738458	2020-12-14	Europe / Belgium / Laakdal	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141407/2020	EPI_ISL_738459	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141408/2020	EPI_ISL_738460	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Belgium/rega-12111410/2020	EPI_ISL_738462	2020-12-11	Europe / Belgium / Balen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111411/2020	EPI_ISL_738463	2020-12-11	Europe / Belgium / Dessel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141412/2020	EPI_ISL_738464	2020-12-14	Europe / Belgium / Geel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12121413/2020	EPI_ISL_738465	2020-12-12	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141414/2020	EPI_ISL_738466	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111416/2020	EPI_ISL_738468	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12061417/2020	EPI_ISL_738469	2020-12-06	Europe / Belgium / Olmen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111438/2020	EPI_ISL_738490	2020-12-11	Europe / Belgium / Balen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/England/CAMC-B7A0D9/2020	EPI_ISL_741081	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Chile/RM-85457/2020	EPI_ISL_746813	2020-05-31	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Indonesia/JK-NIHRD-PME1264/2020	EPI_ISL_747234	2020-06-05	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen			B.1.1.398	GR
hCoV-19/Indonesia/JB-WJHL-ITB-A03267/2020	EPI_ISL_747236	2020-10-23	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	DRAGEN RNA Pathogen Detection Ilumina			B.1.1.398	GR
hCoV-19/Denmark/DCGC-18825/2020	EPI_ISL_748580	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-18834/2020	EPI_ISL_748585	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19662/2020	EPI_ISL_749094	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-18259/2020	EPI_ISL_749847	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-18552/2020	EPI_ISL_750038	2020-12-07	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17228/2020	EPI_ISL_750841	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17246/2020	EPI_ISL_750853	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Italy/VEN-UniVR-151/2020	EPI_ISL_751322	2020-04-13	Europe / Italy / Veneto / Verona	Human	Original			Illumina NovaSeq 5998	Artic amplicon V3; BWA 0.7.17; Ivar v1.2.2	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Italy/VEN-UniVR-122/2020	EPI_ISL_751422	2020-03-30	Europe / Italy / Veneto / Verona	Human	Original			Illumina NovaSeq 5969	Artic amplicon V3; BWA 0.7.17; Ivar v1.2.2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1649-7416/2020	EPI_ISL_753981	2020-07-16	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1688-4369/2020	EPI_ISL_753984	2020-07-16	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1695-8202/2020	EPI_ISL_753990	2020-07-01	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1696-8291/2020	EPI_ISL_753991	2020-07-23	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/England/204920919/2020	EPI_ISL_754341	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Denmark/DCGC-22468/2020	EPI_ISL_757577	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/South Korea/KDCA0421/2020	EPI_ISL_760205	2020-10-04	Asia / South Korea	Human	Original		Imported case from UK	Illumina MiSeq				AD.2	GR
hCoV-19/England/QEUH-CC5DF5/2020	EPI_ISL_760251	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-CA6B96/2020	EPI_ISL_761547	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/QEUH-C9332B/2020	EPI_ISL_762003	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-C997ED/2020	EPI_ISL_762015	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C934BF/2020	EPI_ISL_762039	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C838E3/2020	EPI_ISL_762840	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C7C74A/2020	EPI_ISL_762877	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4A4037/2020	EPI_ISL_764653	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/205140691/2020	EPI_ISL_766396	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/QEUH-C4B814/2020	EPI_ISL_769556	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Norway/5385/2020	EPI_ISL_775323	2020-10-27	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/6268/2020	EPI_ISL_775372	2020-10-23	Europe / Norway	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/USA/WA-UW-11591/2020	EPI_ISL_776677	2020-06-23	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.231	GR
hCoV-19/USA/WA-UW-14608/2020	EPI_ISL_776681	2020-07-12	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-8527/2020	EPI_ISL_780609	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8643/2020	EPI_ISL_780673	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/England/QEUH-C32BAE/2020	EPI_ISL_782581	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-8131/2020	EPI_ISL_784221	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-16338/2020	EPI_ISL_786022	2020-11-01	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14019/2020	EPI_ISL_787308	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14020/2020	EPI_ISL_787309	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14031/2020	EPI_ISL_787320	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14032/2020	EPI_ISL_787321	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14035/2020	EPI_ISL_787324	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14043/2020	EPI_ISL_787331	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-14078/2020	EPI_ISL_787364	2020-08-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-13572/2020	EPI_ISL_788683	2020-08-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-13589/2020	EPI_ISL_788699	2020-08-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12585/2020	EPI_ISL_789922	2020-08-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3	NSP6_Q160stop results in 45.2% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/TX-HMH-MCoV-12021/2020	EPI_ISL_789949	2020-09-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Insertion of 5 nucleotides when compared to the reference sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-11784/2020	EPI_ISL_789973	2020-09-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.337	O
hCoV-19/USA/TX-HMH-MCoV-11947/2020	EPI_ISL_789974	2020-09-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-12143/2020	EPI_ISL_789975	2020-09-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-11688/2020	EPI_ISL_789981	2020-09-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-11438/2020	EPI_ISL_790021	2020-09-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-11476/2020	EPI_ISL_790028	2020-09-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-11692/2020	EPI_ISL_790087	2020-09-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-11726/2020	EPI_ISL_790095	2020-09-13	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/Czech Republic/NRL_11159/2020	EPI_ISL_792692	2020-11-13	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1.294	GR
hCoV-19/Denmark/DCGC-23878/2020	EPI_ISL_793982	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22777/2020	EPI_ISL_794506	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22791/2020	EPI_ISL_794510	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22798/2020	EPI_ISL_794513	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22845/2020	EPI_ISL_794540	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22848/2020	EPI_ISL_794541	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22852/2020	EPI_ISL_794544	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22882/2020	EPI_ISL_794559	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.44	GR
hCoV-19/England/CAMC-BC2FD5/2020	EPI_ISL_800888	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-BC2D62/2020	EPI_ISL_800972	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC295F/2020	EPI_ISL_800975	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BC2E6F/2020	EPI_ISL_801153	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Italy/TUS-UniSi01/2020	EPI_ISL_803881	2020-03-26	Europe / Italy / Tuscany	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Italy/TUS-UniSi03/2020	EPI_ISL_803882	2020-03-29	Europe / Italy / Tuscany	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Italy/TUS-UniSi12/2020	EPI_ISL_803893	2020-03-01	Europe / Italy / Tuscany	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/France/OCC-190/2020	EPI_ISL_804374	2020-12	Europe / France / Occitanie / Toulouse	Human	Vero P3	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1.254	GR
hCoV-19/Canada/AB-45504/2020	EPI_ISL_805639	2020-04-25	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-19219/2020	EPI_ISL_805641	2020-04-20	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-44495/2020	EPI_ISL_805646	2020-05-09	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-84064/2020	EPI_ISL_805673	2020-05-09	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-52715/2020	EPI_ISL_805681	2020-04-30	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-13690/2020	EPI_ISL_805685	2020-04-13	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-42519/2020	EPI_ISL_806040	2020-04-05	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-90954/2020	EPI_ISL_806064	2020-04-11	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Egypt/CCHE57357-A-45/2020	EPI_ISL_812818	2020-06-20	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1.1	GR
hCoV-19/Egypt/CCHE57357-P-24/2020	EPI_ISL_812858	2020-06-21	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1.1	GR
hCoV-19/Egypt/CCHE57357-P-38/2020	EPI_ISL_812868	2020-06-30	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1.1	GR
hCoV-19/Turkey/HSGM-17956/2020	EPI_ISL_812875	2020-12-29	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188	Insertion of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Turkey/HSGM-IST1/2020	EPI_ISL_812898	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.1	GR
hCoV-19/England/CAMB-1B6017/2020	EPI_ISL_813154	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-10CB745/2020	EPI_ISL_816374	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Denmark/DCGC-26590/2021	EPI_ISL_817647	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/ALDP-C695BF/2020	EPI_ISL_820313	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-DCBA15/2020	EPI_ISL_822232	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/PHWC-4ABF51/2020	EPI_ISL_823502	2020-12-20	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4AC3CD/2020	EPI_ISL_823549	2020-12-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/WA-UW-48197/2020	EPI_ISL_824869	2020-12-20	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/Iceland/6003/2020	EPI_ISL_829682	2020-09-08	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			AD.2	GR
hCoV-19/Iceland/6004/2020	EPI_ISL_829683	2020-09-08	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			AD.2	GR
hCoV-19/England/C200058893/2020	EPI_ISL_837198	2020-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/South Korea/KDCA0470/2020	EPI_ISL_850186	2020-04-29	Asia / South Korea	Human	Original			Illumina Miseq				B.1.1.231	GR
hCoV-19/Scotland/QEUH-EFB9A5/2021	EPI_ISL_858186	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-EF11A7/2021	EPI_ISL_858209	2021-01-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-EF11D4/2021	EPI_ISL_858211	2021-01-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-EF1198/2021	EPI_ISL_858215	2021-01-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/CAMC-BC296E/2020	EPI_ISL_859558	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/GE-32928612/2021	EPI_ISL_864703	2021-01-11	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.1.384	GR
hCoV-19/Denmark/DCGC-34198/2021	EPI_ISL_871208	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/ALDP-FC128E/2021	EPI_ISL_874123	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/D-NVRL-82IRL80568/2021	EPI_ISL_875489	2021-01-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Poland/6859615223_diag1_gx1/2020	EPI_ISL_876009	2020-12-22	Europe / Poland / warminsko-mazurskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/340601021_diag1_gx1/2020	EPI_ISL_876012	2020-12-22	Europe / Poland / dolnoslaskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/USA/OH-CDC-STM-A100394/2021	EPI_ISL_876718	2021-01-06	North America / USA / Ohio	Human	Original	Nasal swab	screened by S dropout	Illumina	COVIDSEQ			B.1.1.337	GR
hCoV-19/USA/TX-QDX-3287/2020	EPI_ISL_884422	2020-11-10	North America / USA / Texas	Human	Original	Patient specimen		Illumina	Bwa v. 0.7.17-r1188; iVar v. 1.2.2			B.1.1.258	GR
hCoV-19/Belgium/rega-1464/2020	EPI_ISL_888714	2020-10-13	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1525/2020	EPI_ISL_888771	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Israel/CVL-999ngs/2020	EPI_ISL_889306	2020-12-31	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Czech Republic/IAB20_016_045/2020	EPI_ISL_889367	2020-08-06	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, reference mapping			B.1.1	GR
hCoV-19/Belgium/rega-1657/2021	EPI_ISL_890305	2021-01-03	Europe / Belgium / Schaarbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/USA/LA-EVTL1567/2020	EPI_ISL_890362	2020-12-31	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	Breseq v0.34.1; genome diff, mapping to EPI_ISL_402124	Gap of 4 nucleotide(s) found at refpos 26158 (FRAMESHIFT confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.1	GR
hCoV-19/Switzerland/GE-32955724/2021	EPI_ISL_897735	2021-01-13	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Switzerland/GE-32980765/2021	EPI_ISL_897802	2021-01-15	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B	G
hCoV-19/Switzerland/GE-32989095/2021	EPI_ISL_897834	2021-01-17	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Switzerland/GE-32990319/2021	EPI_ISL_897839	2021-01-17	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Switzerland/GE-32990557/2021	EPI_ISL_897840	2021-01-17	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Poland/NIPH-NIH-21/2021	EPI_ISL_905737	2021-01-05	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-22/2021	EPI_ISL_905738	2021-01-05	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-35/2021	EPI_ISL_905746	2021-01-11	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-36/2021	EPI_ISL_905747	2021-01-11	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Poland/NIPH-NIH-54/2021	EPI_ISL_905760	2021-01-24	Europe / Poland / Mazowieckie / Warsaw	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/USA/VA-DCLS-0950/2020	EPI_ISL_914841	2020-05-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	Minimap2 / ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0976/2020	EPI_ISL_914854	2020-05-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	Minimap2 / ivar			B.1.1.231	GR
hCoV-19/USA/KS-KHEL-0071/2021	EPI_ISL_914868	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0073/2021	EPI_ISL_914869	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0076/2021	EPI_ISL_914870	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0086/2021	EPI_ISL_914871	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0087/2021	EPI_ISL_914872	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/England/QEUH-1014D96/2021	EPI_ISL_917009	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Spain/CT-HUVH-12045/2021	EPI_ISL_918314	2021-01-19	Europe / Spain / Catalunya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Miseq				B.1.1	GR
hCoV-19/Germany/BW-FR0429/2020	EPI_ISL_918339	2020-12-21	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0431/2020	EPI_ISL_918341	2020-12-21	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0433/2020	EPI_ISL_918343	2020-12-21	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0434/2020	EPI_ISL_918344	2020-12-22	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0435/2020	EPI_ISL_918345	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0436/2020	EPI_ISL_918346	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0437/2020	EPI_ISL_918347	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0440/2021	EPI_ISL_918348	2021-01-04	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0441/2020	EPI_ISL_918349	2020-12-28	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0442/2020	EPI_ISL_918350	2020-12-28	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0443/2020	EPI_ISL_918351	2020-12-29	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0444/2020	EPI_ISL_918352	2020-12-20	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0446/2020	EPI_ISL_918353	2020-12-21	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0448/2020	EPI_ISL_918354	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0450/2020	EPI_ISL_918355	2020-12-25	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0452/2020	EPI_ISL_918357	2020-12-20	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Belgium/ULG-11479/2020	EPI_ISL_925434	2020-09-15	Europe / Belgium / Luxembourg	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Denmark/DCGC-36002/2021	EPI_ISL_927143	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Mexico/CMX-INMEGEN-11-01/2020	EPI_ISL_930783	2020-11-26	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Switzerland/BL-UHB-42514718/2020	EPI_ISL_931337	2020-10-31	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.1	GV
hCoV-19/USA/NY-Wadsworth-21013977-01/2020	EPI_ISL_936177	2020-12-24	North America / USA / New York / Kings County	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1.467	GR
hCoV-19/England/MILK-118DDB5/2021	EPI_ISL_958226	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Italy/CAM-TIGEM-1740/2020	EPI_ISL_960580	2020-11-19	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			AD.2	GR
hCoV-19/Italy/CAM-TIGEM-1734/2020	EPI_ISL_960581	2020-11-20	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			AD.2	GR
hCoV-19/Ecuador/UEES-9841/2021	EPI_ISL_962498	2021	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80372/2020	EPI_ISL_966147	2020-03	North America / Canada / Ontario	Human	Original			unknown	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80356/2020	EPI_ISL_966152	2020-03	North America / Canada / Ontario	Human	Original			unknown	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/USA/OH-CDC-STM-000004231/2021	EPI_ISL_966649	2021-01-21	North America / USA / Ohio	Human	Original	Nasal swab		Illumina	COVIDSEQ			B.1.1.337	GR
hCoV-19/USA/NY-NYULH69/2021	EPI_ISL_966682	2021-01-02	North America / USA / New York / Manhattan	Human	Original			Amplicon (Swift), Illumina Novaseq	BWA v0.7.17, bases below 1000x coverage masked			B.1.1.467	GR
hCoV-19/USA/MD-CDC-STM-000008228/2021	EPI_ISL_978678	2021-01-09	North America / USA / Maryland	Human	Original	Nasal swab		Illumina	COVIDSEQ			B.1.1.467	GR
hCoV-19/USA/TX-HHD-2102094514/2021	EPI_ISL_979395	2021-01-09	North America / USA / Texas	Human	Original			Illumina MiSeq	Staph-B Monroe			B.1.1.337	GR
hCoV-19/USA/AL-HGSC-JHKF/2021	EPI_ISL_979496	2021-01-26	North America / USA / Alabama / Marshall County	Human	Original	NASAL		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3	Gap of 18 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/Switzerland/GE-33127425/2021	EPI_ISL_981715	2021-01-31	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/GE-33114869/2021	EPI_ISL_981739	2021-01-29	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Switzerland/GE-33115801/2021	EPI_ISL_981742	2021-01-29	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Switzerland/GE-33123620/2021	EPI_ISL_981766	2021-01-30	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.1.384	GR
hCoV-19/Switzerland/GE-33124779/2021	EPI_ISL_981774	2021-01-30	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.1.384	GR
hCoV-19/England/CAMC-11B5983/2021	EPI_ISL_987857	2021-01-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-115CB6A/2021	EPI_ISL_991684	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-10EEDB3/2021	EPI_ISL_992926	2021-01-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/BL-ETHZ-451006/2021	EPI_ISL_1002793	2021-01-11	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GE-ETHZ-451035/2021	EPI_ISL_1002811	2021-01-11	Europe / Switzerland / Geneva	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Norway/0157/2021	EPI_ISL_1013462	2021-01-04	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1.451	GR
hCoV-19/Hong Kong/HKPU-05330/2020	EPI_ISL_1019650	2020-11-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.1.174	GR
hCoV-19/Denmark/DCGC-42649/2021	EPI_ISL_1022927	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-42704/2021	EPI_ISL_1022982	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-43761/2021	EPI_ISL_1024139	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-43775/2021	EPI_ISL_1024153	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/IL-IDPH-DUP-C-001499/2020	EPI_ISL_1032697	2020-06-26	North America / USA / Illinois / DuPage County	Human	Original			Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/USA/IL-IDPH-MSC-C-001503/2020	EPI_ISL_1032698	2020-06-26	North America / USA / Illinois / Massac County	Human	Original			Nanopore MinION	Medaka			B.1.1.426	GR
hCoV-19/Germany/ST-MD752/2021	EPI_ISL_1034909	2021-02-15	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Germany/ST-MD766/2021	EPI_ISL_1034912	2021-02-16	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Germany/ST-MD768/2021	EPI_ISL_1034913	2021-02-16	Europe / Germany / Saxony-Anhalt	Human	Original			Nanopore MinION				B.1.1.117	GR
hCoV-19/USA/KS-CDC-LC0011956/2021	EPI_ISL_1038475	2021-01-29	North America / USA / Kansas	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.337	GR
hCoV-19/USA/KS-CDC-LC0011457/2021	EPI_ISL_1038717	2021-01-28	North America / USA / Kansas	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.337	GR
hCoV-19/South Africa/NHLS-UCT-GS-0974/2020	EPI_ISL_1040786	2020-10-26	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/England/ARCH-REACT0000899/2020	EPI_ISL_1046907	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ARCH-REACT0002052/2020	EPI_ISL_1046923	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ARCH-REACT0003994/2020	EPI_ISL_1046945	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/South Korea/KDCA1560/2021	EPI_ISL_1063736	2021-01-26	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KDCA1561/2021	EPI_ISL_1063737	2021-01-27	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/South Korea/KDCA1562/2021	EPI_ISL_1063738	2021-01-29	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-22233/2021	EPI_ISL_1076761	2021-01-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-22269/2021	EPI_ISL_1076797	2021-01-09	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/CA-ALSR-6762/2021	EPI_ISL_1081595	2021-01-15	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.3.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Wales/PHW04/2020	EPI_ISL_415041	2020-03-07	Europe / United Kingdom / Wales	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Belgium/BG-030955/2020	EPI_ISL_418984	2020-03-09	Europe / Belgium / Kaulile	Human	Original	Oropharyngeal swab		Nanopore MinION	qcat, Porechop, CLC Genomics Workbench 20, Medaka	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Australia/VIC297/2020	EPI_ISL_419988	2020-03-23	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Wales/PHWC-26C00/2020	EPI_ISL_422103	2020-03-29	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26927/2020	EPI_ISL_422166	2020-03-28	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/England/20140070304/2020	EPI_ISL_423406	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140071404/2020	EPI_ISL_423412	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142002704/2020	EPI_ISL_423424	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144002904/2020	EPI_ISL_423479	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Australia/VIC742/2020	EPI_ISL_427020	2020-03-29	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/NJ-NYUMC344/2020	EPI_ISL_430371	2020-04-08	North America / USA / New Jersey / Hudson County	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/England/NOTT-10F000/2020	EPI_ISL_432955	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Hungary/SRC-00175/2020	EPI_ISL_435406	2020-03-22	Europe / Hungary / Baranya	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Artic network protocol			B.1.1.5	GR
hCoV-19/Italy/ABR-IZSGC-TE27020/2020	EPI_ISL_436725	2020-04-27	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE26423/2020	EPI_ISL_436731	2020-04-26	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/USA/MI-MDHHS-SC20162/2020	EPI_ISL_436803	2020-03-10	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1	GR
hCoV-19/England/CAMB-72D11/2020	EPI_ISL_440072	2020-03-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/LOND-D39A1/2020	EPI_ISL_441017	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D3A44/2020	EPI_ISL_441026	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D3A53/2020	EPI_ISL_441027	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D3A80/2020	EPI_ISL_441030	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/CAMB-79794/2020	EPI_ISL_441053	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A195/2020	EPI_ISL_441338	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A0A7/2020	EPI_ISL_441346	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-8173F/2020	EPI_ISL_442613	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/BRIS-1235DA/2020	EPI_ISL_442655	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AA2B6/2020	EPI_ISL_443629	2020-04-17	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-84392/2020	EPI_ISL_443667	2020-04-16	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-8268C/2020	EPI_ISL_443674	2020-04-13	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124973/2020	EPI_ISL_443911	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125B4F/2020	EPI_ISL_443916	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124BC8/2020	EPI_ISL_443988	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/OXON-AE6F3/2020	EPI_ISL_448713	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE990/2020	EPI_ISL_448740	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEBA9/2020	EPI_ISL_448764	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEEA0/2020	EPI_ISL_448792	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMB-1B1B48/2020	EPI_ISL_453000	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2048/2020	EPI_ISL_453001	2020-05-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Portugal/PT0614/2020	EPI_ISL_454337	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0615/2020	EPI_ISL_454338	2020-03-17	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0616/2020	EPI_ISL_454339	2020-03-17	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0619/2020	EPI_ISL_454342	2020-03-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0628/2020	EPI_ISL_454351	2020-04-06	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Zhejiang/OS4/2020	EPI_ISL_455693	2020-03-24	Asia / China / Zhejiang	Human	unknown			Illumina	Geneious v. 11.1.5			B.1.1	GR
hCoV-19/Vietnam/VNHN_1492/2020	EPI_ISL_455699	2020-03-21	Asia / Vietnam / Hanoi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20.0.3			B.1.1	GR
hCoV-19/Belgium/Rega-0328186/2020	EPI_ISL_458156	2020-03-28	Europe / Belgium / Kaggevinne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/Rega-0328188/2020	EPI_ISL_458158	2020-03-28	Europe / Belgium / Geetbets	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/England/LOND-D6A50/2020	EPI_ISL_461764	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6A7E/2020	EPI_ISL_461766	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Canada/ON-UHTC_0050/2020	EPI_ISL_464036	2020-04-08	North America / Canada / Ontario	Human	unknown			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/England/20119000404/2020	EPI_ISL_465002	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170036904/2020	EPI_ISL_465287	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172002504/2020	EPI_ISL_465320	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169000804/2020	EPI_ISL_466625	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Spain/PV-IBV-2104/2020	EPI_ISL_468917	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2095/2020	EPI_ISL_468919	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2106/2020	EPI_ISL_468944	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2105/2020	EPI_ISL_468945	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2115/2020	EPI_ISL_468950	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/IB-IBV-h2551/2020	EPI_ISL_468999	2020-03-20	Europe / Spain / Balear Islands / Palma de Mallorca	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Gambia/0214/2020	EPI_ISL_471158	2020-03-29	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/Gambia/0536/2020	EPI_ISL_471163	2020-04-30	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/0547/2020	EPI_ISL_471164	2020-04-30	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/1094/2020	EPI_ISL_471167	2020-05-04	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/1277/2020	EPI_ISL_471171	2020-05-07	Africa / Gambia / Kombo	Human	Original			Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/England/LIVE-A0600/2020	EPI_ISL_472121	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-111F2C/2020	EPI_ISL_472425	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B4125/2020	EPI_ISL_473459	2020-06-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B426E/2020	EPI_ISL_473464	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B42C8/2020	EPI_ISL_473466	2020-06-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4A57/2020	EPI_ISL_473491	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Belgium/rega-0505428/2020	EPI_ISL_477001	2020-05-05	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0505485/2020	EPI_ISL_477002	2020-05-05	Europe / Belgium / Sint-Truiden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/rega-0507488/2020	EPI_ISL_477005	2020-05-07	Europe / Belgium / Lummen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/England/NORT-294F7B/2020	EPI_ISL_478623	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Australia/NSW563/2020	EPI_ISL_478675	2020-03-23	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Canada/NB-234/2020	EPI_ISL_479647	2020-03-25	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/England/BRIS-12CC27/2020	EPI_ISL_481924	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Australia/SA0350/2020	EPI_ISL_483125	2020-03-23	Oceania / Australia / South Australia	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/England/SHEF-C1038/2020	EPI_ISL_484435	2020-06-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C3E2D/2020	EPI_ISL_484446	2020-06-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C5D1F/2020	EPI_ISL_484460	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C8D1C/2020	EPI_ISL_484476	2020-05-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C913D/2020	EPI_ISL_484478	2020-06-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9847/2020	EPI_ISL_484482	2020-06-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9A8D/2020	EPI_ISL_484484	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CAB7A/2020	EPI_ISL_484489	2020-06-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CB53F/2020	EPI_ISL_484494	2020-06-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Senegal/66458/2020	EPI_ISL_485710	2020-06-15	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Scotland/EDB1926/2020	EPI_ISL_491566	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB6447/2020	EPI_ISL_491577	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130A80/2020	EPI_ISL_492604	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130A08/2020	EPI_ISL_492623	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C373/2020	EPI_ISL_492885	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C3A0/2020	EPI_ISL_492905	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/NORT-28B108/2020	EPI_ISL_492937	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28C459/2020	EPI_ISL_492954	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-032/2020	EPI_ISL_497799	2020-03-17	Asia / Hong Kong	Human	Original	Nasopharyngeal and throat swab		Nanopore MinION				B.1.1.254	GR
hCoV-19/England/LIVE-A3C92/2020	EPI_ISL_500020	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4736/2020	EPI_ISL_500037	2020-03-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A48CA/2020	EPI_ISL_500052	2020-03-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4D70/2020	EPI_ISL_500086	2020-03-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Ireland/LH-NVRL-20IRL22956/2020	EPI_ISL_501259	2020-05-27	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.399	GR
hCoV-19/Germany/BY-UHR-9ZK/2020	EPI_ISL_513306	2020-03-29	Europe / Germany / Bavaria	Human	Viral culture			Illumina	DRAGEN RNA Pathogen Detection v.: 3.5.14			B.1.1	GR
hCoV-19/Scotland/EDB7075/2020	EPI_ISL_514516	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7076/2020	EPI_ISL_514517	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7079/2020	EPI_ISL_514518	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7080/2020	EPI_ISL_514519	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7081/2020	EPI_ISL_514520	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7084/2020	EPI_ISL_514521	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7086/2020	EPI_ISL_514522	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7088/2020	EPI_ISL_514523	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7092/2020	EPI_ISL_514524	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7094/2020	EPI_ISL_514526	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7102/2020	EPI_ISL_514528	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7103/2020	EPI_ISL_514529	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7104/2020	EPI_ISL_514530	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7105/2020	EPI_ISL_514531	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7109/2020	EPI_ISL_514533	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7110/2020	EPI_ISL_514534	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7111/2020	EPI_ISL_514535	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7116/2020	EPI_ISL_514536	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7118/2020	EPI_ISL_514537	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7121/2020	EPI_ISL_514539	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7123/2020	EPI_ISL_514540	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7126/2020	EPI_ISL_514542	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7132/2020	EPI_ISL_514544	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7133/2020	EPI_ISL_514545	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7135/2020	EPI_ISL_514546	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7136/2020	EPI_ISL_514547	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7139/2020	EPI_ISL_514548	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7140/2020	EPI_ISL_514549	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7142/2020	EPI_ISL_514550	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7145/2020	EPI_ISL_514551	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7146/2020	EPI_ISL_514552	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7147/2020	EPI_ISL_514553	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7148/2020	EPI_ISL_514554	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7149/2020	EPI_ISL_514555	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7151/2020	EPI_ISL_514557	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7152/2020	EPI_ISL_514558	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7153/2020	EPI_ISL_514559	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7154/2020	EPI_ISL_514560	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7155/2020	EPI_ISL_514561	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7156/2020	EPI_ISL_514562	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/South Africa/KRISP-K001326/2020	EPI_ISL_515811	2020-07-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001328/2020	EPI_ISL_515813	2020-07-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001344/2020	EPI_ISL_515829	2020-07-13	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K001356/2020	EPI_ISL_515841	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001369/2020	EPI_ISL_515854	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001371/2020	EPI_ISL_515856	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001376/2020	EPI_ISL_515861	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/Russia/SPE-RII-13179V/2020	EPI_ISL_524003	2020-05-12	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-13247V/2020	EPI_ISL_524004	2020-05-12	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-15911V/2020	EPI_ISL_524010	2020-05-18	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-21357V/2020	EPI_ISL_524033	2020-06-05	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-22086V/2020	EPI_ISL_524038	2020-06-08	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-7388V/2020	EPI_ISL_524049	2020-04-20	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Scotland/EDB7185/2020	EPI_ISL_526521	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7275/2020	EPI_ISL_526526	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7358/2020	EPI_ISL_526532	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7359/2020	EPI_ISL_526533	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7360/2020	EPI_ISL_526534	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/FL-BPHL-1159/2020	EPI_ISL_526645	2020-08-18	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.180	GR
hCoV-19/Switzerland/BL-UHB-42167842/2020	EPI_ISL_527917	2020-02-26	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/BL-UHB-42185206/2020	EPI_ISL_527984	2020-03-10	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/England/QEUH-9697AD/2020	EPI_ISL_531000	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964A5E/2020	EPI_ISL_531004	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96978F/2020	EPI_ISL_531014	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964CB2/2020	EPI_ISL_531017	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965765/2020	EPI_ISL_531020	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9697E9/2020	EPI_ISL_531032	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96986E/2020	EPI_ISL_531033	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964C1C/2020	EPI_ISL_531036	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Scotland/QEUH-964AB8/2020	EPI_ISL_531038	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9653AD/2020	EPI_ISL_531039	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-964BF1/2020	EPI_ISL_531064	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964D46/2020	EPI_ISL_531079	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96589F/2020	EPI_ISL_531081	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9697CB/2020	EPI_ISL_531085	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969752/2020	EPI_ISL_531087	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969549/2020	EPI_ISL_531091	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964B1F/2020	EPI_ISL_531096	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9698C8/2020	EPI_ISL_531100	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965589/2020	EPI_ISL_531104	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9652EC/2020	EPI_ISL_531109	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9695FE/2020	EPI_ISL_531113	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9655E3/2020	EPI_ISL_531116	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969822/2020	EPI_ISL_531118	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-964D73/2020	EPI_ISL_531125	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-969691/2020	EPI_ISL_531129	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9648FA/2020	EPI_ISL_531141	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9654E6/2020	EPI_ISL_531147	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-964906/2020	EPI_ISL_531151	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96506A/2020	EPI_ISL_531154	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9657A1/2020	EPI_ISL_531155	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964F8C/2020	EPI_ISL_531156	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964AF4/2020	EPI_ISL_531157	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964B88/2020	EPI_ISL_531167	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9698B9/2020	EPI_ISL_531175	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964C3A/2020	EPI_ISL_531201	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-965307/2020	EPI_ISL_531203	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-964A4F/2020	EPI_ISL_531207	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F528/2020	EPI_ISL_532310	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95E8F3/2020	EPI_ISL_532311	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9B3/2020	EPI_ISL_532316	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E86C/2020	EPI_ISL_532317	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA48/2020	EPI_ISL_532321	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95EE6A/2020	EPI_ISL_532331	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95F27C/2020	EPI_ISL_532334	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9A4/2020	EPI_ISL_532335	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9E0/2020	EPI_ISL_532340	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EF3A/2020	EPI_ISL_532347	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E90F/2020	EPI_ISL_532349	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FA92/2020	EPI_ISL_532351	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9FF/2020	EPI_ISL_532353	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FB71/2020	EPI_ISL_532355	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EE97/2020	EPI_ISL_532356	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95EFD0/2020	EPI_ISL_532357	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95E617/2020	EPI_ISL_532363	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FA47/2020	EPI_ISL_532390	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F25E/2020	EPI_ISL_532398	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-95F90E/2020	EPI_ISL_532399	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F564/2020	EPI_ISL_532425	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F212/2020	EPI_ISL_532429	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95EDA9/2020	EPI_ISL_532430	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F230/2020	EPI_ISL_532436	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-95E8A8/2020	EPI_ISL_532440	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F41C/2020	EPI_ISL_532444	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F731/2020	EPI_ISL_532446	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95ED03/2020	EPI_ISL_532452	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E653/2020	EPI_ISL_532454	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F713/2020	EPI_ISL_532456	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95ECD9/2020	EPI_ISL_532457	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95F26D/2020	EPI_ISL_532458	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95F616/2020	EPI_ISL_532463	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F33D/2020	EPI_ISL_532464	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F6AD/2020	EPI_ISL_532472	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961EDD/2020	EPI_ISL_532473	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-95ED6D/2020	EPI_ISL_532480	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E8B7/2020	EPI_ISL_532484	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FBCC/2020	EPI_ISL_532492	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E88A/2020	EPI_ISL_532493	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F009/2020	EPI_ISL_532499	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95EA2A/2020	EPI_ISL_532510	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E85D/2020	EPI_ISL_532512	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA0C/2020	EPI_ISL_532514	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F4FE/2020	EPI_ISL_532515	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E662/2020	EPI_ISL_532518	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F106/2020	EPI_ISL_532523	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F4EF/2020	EPI_ISL_532531	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9436BB/2020	EPI_ISL_532541	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/OXON-B46FA/2020	EPI_ISL_534967	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B47CA/2020	EPI_ISL_534973	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4A58/2020	EPI_ISL_534988	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4AC1/2020	EPI_ISL_534993	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00234333/2020	EPI_ISL_536051	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Wales/PHWC-16A522/2020	EPI_ISL_540901	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A57D/2020	EPI_ISL_540906	2020-09-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Peru/CAL-UPCH-0080/2020	EPI_ISL_540958	2020-06-17	South America / Peru / Callao / Callao	Human	Original	Oropharyngeal swab		Illumina MiSeq	MEGAHIT			B.1.1	GR
hCoV-19/USA/TX-HMH-3544/2020	EPI_ISL_543007	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3598/2020	EPI_ISL_543054	2020-06-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3729/2020	EPI_ISL_543141	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-3762/2020	EPI_ISL_543173	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3765/2020	EPI_ISL_543176	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-3769/2020	EPI_ISL_543178	2020-06-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4808/2020	EPI_ISL_544344	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-4884/2020	EPI_ISL_544403	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4939/2020	EPI_ISL_544414	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4940/2020	EPI_ISL_544416	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5096/2020	EPI_ISL_544522	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-7873/2020	EPI_ISL_545675	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7953/2020	EPI_ISL_545736	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7990/2020	EPI_ISL_545771	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-7991/2020	EPI_ISL_545772	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-8010/2020	EPI_ISL_545789	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-8069/2020	EPI_ISL_545834	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-8071/2020	EPI_ISL_545837	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5709/2020	EPI_ISL_546958	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5762/2020	EPI_ISL_546996	2020-06-18	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/England/MILK-99A7D0/2020	EPI_ISL_550301	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99A882/2020	EPI_ISL_550317	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99A6A6/2020	EPI_ISL_550328	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.315	G
hCoV-19/England/MILK-99A9DA/2020	EPI_ISL_550329	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-999D57/2020	EPI_ISL_550343	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999C3C/2020	EPI_ISL_550347	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A0C6/2020	EPI_ISL_550350	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999C5A/2020	EPI_ISL_550354	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CC3/2020	EPI_ISL_550357	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CD2/2020	EPI_ISL_550373	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999D84/2020	EPI_ISL_550380	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A04E/2020	EPI_ISL_550382	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A61F/2020	EPI_ISL_550383	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CF0/2020	EPI_ISL_550396	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99A697/2020	EPI_ISL_550397	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A5A9/2020	EPI_ISL_550399	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995ADC/2020	EPI_ISL_551607	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9959A2/2020	EPI_ISL_551617	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995984/2020	EPI_ISL_551621	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995AFA/2020	EPI_ISL_551622	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-993DD5/2020	EPI_ISL_551637	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99423F/2020	EPI_ISL_551638	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993FC0/2020	EPI_ISL_551670	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-995993/2020	EPI_ISL_551680	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993FEE/2020	EPI_ISL_551691	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-993F66/2020	EPI_ISL_551692	2020-08-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-939CC5/2020	EPI_ISL_552928	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-931FC4/2020	EPI_ISL_552951	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-939ECF/2020	EPI_ISL_552957	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-933BBF/2020	EPI_ISL_552964	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-933A76/2020	EPI_ISL_552988	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-959EE7/2020	EPI_ISL_555029	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95C206/2020	EPI_ISL_555033	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-959D35/2020	EPI_ISL_555043	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D5D2/2020	EPI_ISL_555044	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94E780/2020	EPI_ISL_555060	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C8AA/2020	EPI_ISL_555065	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-95A639/2020	EPI_ISL_555072	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-95C628/2020	EPI_ISL_555075	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C3A9/2020	EPI_ISL_555076	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C145/2020	EPI_ISL_555107	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C619/2020	EPI_ISL_555110	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CAC2/2020	EPI_ISL_555113	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F87D/2020	EPI_ISL_555132	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FA0E/2020	EPI_ISL_555135	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94FC53/2020	EPI_ISL_555158	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D9B8/2020	EPI_ISL_555168	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94E322/2020	EPI_ISL_555172	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950493/2020	EPI_ISL_555174	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950581/2020	EPI_ISL_555177	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9504A2/2020	EPI_ISL_555199	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D305/2020	EPI_ISL_556312	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D3AB/2020	EPI_ISL_556319	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-949B2F/2020	EPI_ISL_556331	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EE03/2020	EPI_ISL_556337	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9498A0/2020	EPI_ISL_556352	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94EDE8/2020	EPI_ISL_556387	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A04D/2020	EPI_ISL_556395	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A56C/2020	EPI_ISL_556400	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EE5E/2020	EPI_ISL_556413	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B8F9/2020	EPI_ISL_556415	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A450/2020	EPI_ISL_556421	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D1ED/2020	EPI_ISL_556422	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94AA8B/2020	EPI_ISL_556424	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94D39C/2020	EPI_ISL_556441	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-94A6D2/2020	EPI_ISL_556450	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94ABC4/2020	EPI_ISL_556456	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B8DB/2020	EPI_ISL_556462	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EBB1/2020	EPI_ISL_556484	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94D0B3/2020	EPI_ISL_556485	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D38D/2020	EPI_ISL_556498	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94EEB8/2020	EPI_ISL_556502	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-703534/2020	EPI_ISL_557616	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71C019/2020	EPI_ISL_557652	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7259C7/2020	EPI_ISL_557666	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-722A6D/2020	EPI_ISL_557684	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-723598/2020	EPI_ISL_557688	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7000BE/2020	EPI_ISL_557717	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71CBAF/2020	EPI_ISL_557722	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6DF918/2020	EPI_ISL_557723	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-724FB7/2020	EPI_ISL_557735	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6285D0/2020	EPI_ISL_557742	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-6C176A/2020	EPI_ISL_557747	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6BBC28/2020	EPI_ISL_557763	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6C3A41/2020	EPI_ISL_557790	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-61CB28/2020	EPI_ISL_557795	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Wales/MILK-610878/2020	EPI_ISL_557796	2020-07-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-625A10/2020	EPI_ISL_557802	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 514.	info	B.1.1	GR
hCoV-19/England/ALDP-6BBE5F/2020	EPI_ISL_557813	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-628FB4/2020	EPI_ISL_557821	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-526421/2020	EPI_ISL_558927	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50ED60/2020	EPI_ISL_558928	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-51D751/2020	EPI_ISL_558930	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50C227/2020	EPI_ISL_558934	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-52C40D/2020	EPI_ISL_558958	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-526C56/2020	EPI_ISL_558963	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526FC6/2020	EPI_ISL_558964	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-50E38C/2020	EPI_ISL_558965	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5217D2/2020	EPI_ISL_558972	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-524C76/2020	EPI_ISL_558979	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-50EF97/2020	EPI_ISL_558980	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Gambia/3725/2020	EPI_ISL_561004	2020-07-30	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-1527/2020	EPI_ISL_561022	2020-05-16	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3165/2020	EPI_ISL_561043	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3192/2020	EPI_ISL_561046	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3214/2020	EPI_ISL_561051	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3255/2020	EPI_ISL_561054	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/GC19-3317/2020	EPI_ISL_561060	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/Gambia/GC19-3358/2020	EPI_ISL_561062	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3776/2020	EPI_ISL_561076	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3792/2020	EPI_ISL_561077	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3806/2020	EPI_ISL_561084	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3807/2020	EPI_ISL_561085	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3812/2020	EPI_ISL_561086	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3813/2020	EPI_ISL_561087	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3816/2020	EPI_ISL_561089	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/GC19-3818/2020	EPI_ISL_561090	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3820/2020	EPI_ISL_561091	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3831/2020	EPI_ISL_561095	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3835/2020	EPI_ISL_561096	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/GC19-3842/2020	EPI_ISL_561099	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/England/QEUH-9C7B1A/2020	EPI_ISL_567010	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C8566/2020	EPI_ISL_567013	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7DD8/2020	EPI_ISL_567015	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C80B0/2020	EPI_ISL_567022	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8900/2020	EPI_ISL_567039	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9C896A/2020	EPI_ISL_567042	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C919E/2020	EPI_ISL_567053	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C7FE1/2020	EPI_ISL_567058	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C86DC/2020	EPI_ISL_567076	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C7DAB/2020	EPI_ISL_567109	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C86BE/2020	EPI_ISL_567116	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C8C43/2020	EPI_ISL_567141	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9C7AD1/2020	EPI_ISL_567151	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8478/2020	EPI_ISL_567152	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C7F69/2020	EPI_ISL_567168	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C889A/2020	EPI_ISL_567171	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C8C8F/2020	EPI_ISL_567186	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C8117/2020	EPI_ISL_567194	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C7E4E/2020	EPI_ISL_567198	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998E37/2020	EPI_ISL_568302	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998D0D/2020	EPI_ISL_568319	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998A7F/2020	EPI_ISL_568331	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98F9D8/2020	EPI_ISL_568345	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998D58/2020	EPI_ISL_568347	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998A8E/2020	EPI_ISL_568352	2020-08-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998347/2020	EPI_ISL_568353	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-9900EE/2020	EPI_ISL_568362	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-997F80/2020	EPI_ISL_568391	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9700F3/2020	EPI_ISL_568403	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96F6B9/2020	EPI_ISL_568404	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FB7E/2020	EPI_ISL_568406	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F69B/2020	EPI_ISL_568408	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FEEE/2020	EPI_ISL_568411	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FE66/2020	EPI_ISL_568413	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FD78/2020	EPI_ISL_568416	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FBC9/2020	EPI_ISL_568417	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96F6AA/2020	EPI_ISL_568418	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FB05/2020	EPI_ISL_568426	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FE48/2020	EPI_ISL_568427	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FC99/2020	EPI_ISL_568429	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96FF45/2020	EPI_ISL_568430	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98F03D/2020	EPI_ISL_568455	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F57A/2020	EPI_ISL_568457	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/CAMC-990FE1/2020	EPI_ISL_568458	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Russia/OMS-ORINFI-6675S/2020	EPI_ISL_569740	2020-05-12	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-9064S/2020	EPI_ISL_569750	2020-05-19	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-1296S/2020	EPI_ISL_569758	2020-05-24	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-3811S/2020	EPI_ISL_569764	2020-06-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5948S/2020	EPI_ISL_569773	2020-06-07	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-3012S/2020	EPI_ISL_569779	2020-07-06	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-3868S/2020	EPI_ISL_569781	2020-07-08	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4761S/2020	EPI_ISL_569783	2020-06-30	Europe / Russia / Omsk / Sedelnikovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	O
hCoV-19/Russia/OMS-ORINFI-5042S/2020	EPI_ISL_569785	2020-07-11	Europe / Russia / Omsk / Muromtsevo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-5207S/2020	EPI_ISL_569786	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4822S/2020	EPI_ISL_569800	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4882S/2020	EPI_ISL_569804	2020-07-10	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-3019S/2020	EPI_ISL_569805	2020-07-06	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4827S/2020	EPI_ISL_569806	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/USA/OR-UW-22871/2020	EPI_ISL_570618	2020-08-04	North America / USA / Oregon	Human	Original			Illumina	custom			B.1.1.258	GR
hCoV-19/England/ALDP-9B6431/2020	EPI_ISL_573005	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B645F/2020	EPI_ISL_573007	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B646E/2020	EPI_ISL_573008	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B66D1/2020	EPI_ISL_573028	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9BCBBE/2020	EPI_ISL_573059	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9BCC24/2020	EPI_ISL_573066	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9CB74F/2020	EPI_ISL_575612	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB1AB/2020	EPI_ISL_575622	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBAEC/2020	EPI_ISL_575628	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAFC0/2020	EPI_ISL_575639	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CC034/2020	EPI_ISL_575656	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBD98/2020	EPI_ISL_575665	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1B634B/2020	EPI_ISL_576900	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9DFBD3/2020	EPI_ISL_576926	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9DFCA3/2020	EPI_ISL_576930	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/CAMC-9DFDCE/2020	EPI_ISL_576938	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9DFE34/2020	EPI_ISL_576939	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/New Zealand/20CV0356/2020	EPI_ISL_579102	2020-09-15	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20VR1964/2020	EPI_ISL_579183	2020-04-06	Oceania / New Zealand / Southern	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR1982/2020	EPI_ISL_579189	2020-04-07	Oceania / New Zealand / Southern	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR1991/2020	EPI_ISL_579192	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1.89	GR
hCoV-19/England/ALDP-9E9C97/2020	EPI_ISL_580014	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA1A6/2020	EPI_ISL_580018	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EAB5D/2020	EPI_ISL_580026	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA9EA/2020	EPI_ISL_580028	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA81A/2020	EPI_ISL_580033	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E7622/2020	EPI_ISL_580037	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA14C/2020	EPI_ISL_580113	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA0C7/2020	EPI_ISL_580130	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EAF7F/2020	EPI_ISL_580161	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EABF3/2020	EPI_ISL_580170	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA452/2020	EPI_ISL_580178	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9E2E98/2020	EPI_ISL_581302	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E2AA3/2020	EPI_ISL_581306	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-8D1B96/2020	EPI_ISL_581426	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-4F3619/2020	EPI_ISL_581448	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/United Arab Emirates/skmc-3124949/2020	EPI_ISL_582657	2020-08-29	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/United Arab Emirates/skmc-3358771/2020	EPI_ISL_582659	2020-09-03	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/United Arab Emirates/skmc-3890161/2020	EPI_ISL_582681	2020-09-23	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/England/SHEF-C5720/2020	EPI_ISL_585023	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CBF13/2020	EPI_ISL_585046	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Canada/ON-S1283/2020	EPI_ISL_586332	2020-04-28	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.1	GR
hCoV-19/Canada/ON-S1286/2020	EPI_ISL_586334	2020-04-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.1	GR
hCoV-19/England/QEUH-A2045F/2020	EPI_ISL_587603	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A209E7/2020	EPI_ISL_587604	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1FCE2/2020	EPI_ISL_587633	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2101E/2020	EPI_ISL_587634	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-A202BF/2020	EPI_ISL_587649	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2055C/2020	EPI_ISL_587651	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A202EC/2020	EPI_ISL_587669	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F9BE/2020	EPI_ISL_587696	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2100F/2020	EPI_ISL_587697	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F6347/2020	EPI_ISL_588918	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F93F9/2020	EPI_ISL_588943	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F87EF/2020	EPI_ISL_588998	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC9BB/2020	EPI_ISL_594633	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9ECA21/2020	EPI_ISL_594635	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/CVR4851/2020	EPI_ISL_594651	2020-10-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.294	GR
hCoV-19/Scotland/CVR4905/2020	EPI_ISL_594672	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A317AD/2020	EPI_ISL_595910	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A48EBD/2020	EPI_ISL_595936	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A4C5D2/2020	EPI_ISL_595983	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4C6A2/2020	EPI_ISL_595989	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-A5899B/2020	EPI_ISL_597003	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A516D7/2020	EPI_ISL_598128	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5184A/2020	EPI_ISL_598141	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51DD2/2020	EPI_ISL_598146	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51FFA/2020	EPI_ISL_598156	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A5213F/2020	EPI_ISL_598166	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A523DF/2020	EPI_ISL_598192	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51516/2020	EPI_ISL_598198	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46D85/2020	EPI_ISL_598272	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47B8A/2020	EPI_ISL_598280	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47FAC/2020	EPI_ISL_598291	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47F51/2020	EPI_ISL_598298	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A469FA/2020	EPI_ISL_598327	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46B03/2020	EPI_ISL_598354	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A0BA3A/2020	EPI_ISL_599459	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE66A/2020	EPI_ISL_599493	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE239/2020	EPI_ISL_599494	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE0D5/2020	EPI_ISL_599498	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DE2B1/2020	EPI_ISL_599582	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDEAF/2020	EPI_ISL_599583	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB5D/2020	EPI_ISL_599585	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD980/2020	EPI_ISL_599586	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDA9C/2020	EPI_ISL_599606	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDCA5/2020	EPI_ISL_599610	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9DE65B/2020	EPI_ISL_599614	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDE09/2020	EPI_ISL_599631	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DCC97/2020	EPI_ISL_599635	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD6A7/2020	EPI_ISL_599639	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB7B/2020	EPI_ISL_599652	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDAC9/2020	EPI_ISL_599654	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD64D/2020	EPI_ISL_599660	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9DD15B/2020	EPI_ISL_599677	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD58C/2020	EPI_ISL_599679	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DE257/2020	EPI_ISL_599686	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDFE8/2020	EPI_ISL_599687	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DDD0C/2020	EPI_ISL_599689	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DDA41/2020	EPI_ISL_599693	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9CE2F0/2020	EPI_ISL_602011	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B5089/2020	EPI_ISL_602052	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B4CE0/2020	EPI_ISL_602084	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Singapore/1109/2020	EPI_ISL_605818	2020-10-19	Asia / Singapore	Human	Original			Illumina MiSeq				AD.2	GR
hCoV-19/England/ALDP-A871C8/2020	EPI_ISL_605968	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D74E/2020	EPI_ISL_608101	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D702/2020	EPI_ISL_608106	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C40C/2020	EPI_ISL_608108	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6CF0B/2020	EPI_ISL_608128	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CF56/2020	EPI_ISL_608153	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CB16/2020	EPI_ISL_608156	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C3D2/2020	EPI_ISL_608180	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A4194A/2020	EPI_ISL_609412	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A4231E/2020	EPI_ISL_609420	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.532	GR
hCoV-19/England/CAMC-A41C8D/2020	EPI_ISL_609449	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41801/2020	EPI_ISL_609455	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41704/2020	EPI_ISL_609488	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85BF9/2020	EPI_ISL_610409	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85E78/2020	EPI_ISL_610421	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A85C14/2020	EPI_ISL_610427	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858D4/2020	EPI_ISL_610437	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A84D12/2020	EPI_ISL_610496	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Denmark/DCGC-5297/2020	EPI_ISL_615228	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5298/2020	EPI_ISL_615229	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5299/2020	EPI_ISL_615230	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5302/2020	EPI_ISL_615233	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5362/2020	EPI_ISL_615293	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5364/2020	EPI_ISL_615295	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5371/2020	EPI_ISL_615302	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5375/2020	EPI_ISL_615306	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5382/2020	EPI_ISL_615313	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5384/2020	EPI_ISL_615315	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5388/2020	EPI_ISL_615320	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5393/2020	EPI_ISL_615325	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5400/2020	EPI_ISL_615332	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5405/2020	EPI_ISL_615337	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5407/2020	EPI_ISL_615339	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5408/2020	EPI_ISL_615340	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5412/2020	EPI_ISL_615344	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5417/2020	EPI_ISL_615349	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5420/2020	EPI_ISL_615352	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5423/2020	EPI_ISL_615355	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-5426/2020	EPI_ISL_615358	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4512/2020	EPI_ISL_615373	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4379/2020	EPI_ISL_615377	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4386/2020	EPI_ISL_615384	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2623/2020	EPI_ISL_616502	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2625/2020	EPI_ISL_616504	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2545/2020	EPI_ISL_616521	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2900/2020	EPI_ISL_616534	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2901/2020	EPI_ISL_616535	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2906/2020	EPI_ISL_616540	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2923/2020	EPI_ISL_616558	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2871/2020	EPI_ISL_616565	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2775/2020	EPI_ISL_616610	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2782/2020	EPI_ISL_616617	2020-08-24	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Denmark/DCGC-2804/2020	EPI_ISL_616640	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2833/2020	EPI_ISL_616659	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2845/2020	EPI_ISL_616672	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2933/2020	EPI_ISL_616694	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2560/2020	EPI_ISL_617818	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2562/2020	EPI_ISL_617820	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2563/2020	EPI_ISL_617821	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2564/2020	EPI_ISL_617822	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.191	GR
hCoV-19/Denmark/DCGC-2595/2020	EPI_ISL_617831	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2598/2020	EPI_ISL_617834	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2574/2020	EPI_ISL_617905	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5864/2020	EPI_ISL_621051	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-5865/2020	EPI_ISL_621052	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5879/2020	EPI_ISL_621066	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5880/2020	EPI_ISL_621067	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5963/2020	EPI_ISL_621072	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5966/2020	EPI_ISL_621075	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5972/2020	EPI_ISL_621081	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	G
hCoV-19/Denmark/DCGC-5973/2020	EPI_ISL_621082	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5974/2020	EPI_ISL_621083	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5983/2020	EPI_ISL_621092	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5984/2020	EPI_ISL_621093	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5985/2020	EPI_ISL_621094	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5987/2020	EPI_ISL_621096	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5992/2020	EPI_ISL_621101	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5995/2020	EPI_ISL_621104	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5999/2020	EPI_ISL_621108	2020-09-28	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6016/2020	EPI_ISL_621125	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.224	GR
hCoV-19/Denmark/DCGC-6017/2020	EPI_ISL_621126	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-6020/2020	EPI_ISL_621129	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-6025/2020	EPI_ISL_621134	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-6029/2020	EPI_ISL_621138	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.224	GR
hCoV-19/Denmark/DCGC-6113/2020	EPI_ISL_621147	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-6130/2020	EPI_ISL_621164	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6149/2020	EPI_ISL_621183	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6335/2020	EPI_ISL_621192	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1415/2020	EPI_ISL_622432	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1393/2020	EPI_ISL_622456	2020-04-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/MILK-AB8735/2020	EPI_ISL_623718	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AB1408/2020	EPI_ISL_623794	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/CVR4762/2020	EPI_ISL_627342	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5106/2020	EPI_ISL_627375	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A4BE41/2020	EPI_ISL_628530	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4D37D/2020	EPI_ISL_628597	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A615C8/2020	EPI_ISL_628620	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A6162F/2020	EPI_ISL_628624	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A616F2/2020	EPI_ISL_628628	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61777/2020	EPI_ISL_628632	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61953/2020	EPI_ISL_628644	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61E81/2020	EPI_ISL_628656	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A61E90/2020	EPI_ISL_628657	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A63AB8/2020	EPI_ISL_628663	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A643BC/2020	EPI_ISL_628693	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A643CB/2020	EPI_ISL_628694	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AD1806/2020	EPI_ISL_629832	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1EF5/2020	EPI_ISL_629834	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD25C2/2020	EPI_ISL_629835	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0F11/2020	EPI_ISL_629838	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD25B3/2020	EPI_ISL_629844	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD045E/2020	EPI_ISL_629869	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1C46/2020	EPI_ISL_629892	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2AE1/2020	EPI_ISL_629908	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD22BC/2020	EPI_ISL_629918	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1CCE/2020	EPI_ISL_629921	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-AD2674/2020	EPI_ISL_629929	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2726/2020	EPI_ISL_629965	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD29B7/2020	EPI_ISL_629988	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4E46/2020	EPI_ISL_630812	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DB2/2020	EPI_ISL_630816	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4E55/2020	EPI_ISL_630845	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE028/2020	EPI_ISL_630851	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A53/2020	EPI_ISL_630878	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4EBF/2020	EPI_ISL_630899	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE7E7/2020	EPI_ISL_630900	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAF27C/2020	EPI_ISL_630915	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1BD9/2020	EPI_ISL_630935	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-AA4D58/2020	EPI_ISL_630945	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3FBD/2020	EPI_ISL_630946	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AADFFF/2020	EPI_ISL_630949	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DFE/2020	EPI_ISL_630950	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE055/2020	EPI_ISL_630959	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3955/2020	EPI_ISL_630969	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ABBFEF/2020	EPI_ISL_630978	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-NYCPHL-001071/2020	EPI_ISL_633072	2020-10-15	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001079/2020	EPI_ISL_633080	2020-10-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/England/QEUH-AE4FB0/2020	EPI_ISL_633113	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE53C2/2020	EPI_ISL_633168	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE5438/2020	EPI_ISL_633179	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4F92/2020	EPI_ISL_633181	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4E2C/2020	EPI_ISL_633190	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8143/2020	EPI_ISL_634375	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC877/2020	EPI_ISL_634417	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC4DD/2020	EPI_ISL_634425	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7988/2020	EPI_ISL_634448	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC613/2020	EPI_ISL_634459	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD1A8/2020	EPI_ISL_634473	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4876ED/2020	EPI_ISL_639228	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	G
hCoV-19/Germany/BW-MVZ-LS-21/2020	EPI_ISL_640239	2020-04-15	Europe / Germany / Baden-Wurttemberg / Villingen-Schwenningen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/BW-MVZ-LS-42/2020	EPI_ISL_640259	2020-04-14	Europe / Germany / Baden-Wurttemberg / Villingen-Schwenningen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/France/PAC-SC246/2020	EPI_ISL_641531	2020-04-24	Europe / France / Provence-Alpes-Cote d'Azur / Nice	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/PAC-SC248/2020	EPI_ISL_641533	2020-04-29	Europe / France / Provence-Alpes-Cote d'Azur / Nice	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/OCC-SC417/2020	EPI_ISL_641552	2020-03-14	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/France/OCC-SC465/2020	EPI_ISL_641556	2020-03-03	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Belgium/ULG-10717/2020	EPI_ISL_641559	2020-09-14	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/QEUH-B14596/2020	EPI_ISL_641636	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B141ED/2020	EPI_ISL_641673	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B031C3/2020	EPI_ISL_642926	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02917/2020	EPI_ISL_642946	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02197/2020	EPI_ISL_642948	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B02865/2020	EPI_ISL_642950	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B0601E/2020	EPI_ISL_642989	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B2DDED/2020	EPI_ISL_646344	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23F1E/2020	EPI_ISL_646363	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E265/2020	EPI_ISL_646387	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B240ED/2020	EPI_ISL_646418	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23C35/2020	EPI_ISL_646429	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32143/2020	EPI_ISL_646433	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31CAD/2020	EPI_ISL_646438	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2BAD9/2020	EPI_ISL_646456	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2BA9D/2020	EPI_ISL_646460	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2C9DB/2020	EPI_ISL_646470	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B1FCB4/2020	EPI_ISL_647670	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B20EAB/2020	EPI_ISL_647676	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B20A4D/2020	EPI_ISL_647763	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B206EF/2020	EPI_ISL_647772	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B1FE09/2020	EPI_ISL_647779	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B06597/2020	EPI_ISL_652239	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.274	GR
hCoV-19/Northern Ireland/NIRE-109561/2020	EPI_ISL_652334	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/LA-EVTL847/2020	EPI_ISL_653538	2020-07-28	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL848/2020	EPI_ISL_653539	2020-07-28	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL849/2020	EPI_ISL_653540	2020-07-28	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL853/2020	EPI_ISL_653544	2020-07-29	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL857/2020	EPI_ISL_653548	2020-07-01	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL883/2020	EPI_ISL_653574	2020-07-07	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/Sweden/20-23086/2020	EPI_ISL_654953	2020-03-20	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/England/QEUH-B695CF/2020	EPI_ISL_654960	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B56DDC/2020	EPI_ISL_657023	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3FFE2/2020	EPI_ISL_657027	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4241A/2020	EPI_ISL_657033	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B42474/2020	EPI_ISL_657077	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B432E2/2020	EPI_ISL_657107	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B42395/2020	EPI_ISL_657119	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B402A9/2020	EPI_ISL_657122	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40106/2020	EPI_ISL_657154	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40160/2020	EPI_ISL_657187	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A770/2020	EPI_ISL_658336	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B549AD/2020	EPI_ISL_658356	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A78F/2020	EPI_ISL_658373	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A2E8/2020	EPI_ISL_658379	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F225/2020	EPI_ISL_658448	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B40FC0/2020	EPI_ISL_658450	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F29E/2020	EPI_ISL_658472	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B4142A/2020	EPI_ISL_658484	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32AA2/2020	EPI_ISL_659671	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B340BD/2020	EPI_ISL_659673	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3279C/2020	EPI_ISL_659695	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32B18/2020	EPI_ISL_659718	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2DF8D/2020	EPI_ISL_659752	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F316/2020	EPI_ISL_659758	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30B1A/2020	EPI_ISL_659766	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B302E8/2020	EPI_ISL_659776	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC58/2020	EPI_ISL_659779	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D5C7/2020	EPI_ISL_659790	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D59A/2020	EPI_ISL_659792	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K004610/2020	EPI_ISL_660635	2020-11-04	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/France/OCC-SC429/2020	EPI_ISL_660668	2020-04-14	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/France/OCC-SC433/2020	EPI_ISL_660670	2020-05-25	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/France/OCC-SC464/2020	EPI_ISL_660672	2020-03-03	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/OCC-SC521/2020	EPI_ISL_660708	2020-05-11	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/England/ALDP-B74CCC/2020	EPI_ISL_661968	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-9671/2020	EPI_ISL_669100	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-9809/2020	EPI_ISL_669197	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-10553/2020	EPI_ISL_670049	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-10584/2020	EPI_ISL_670069	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Ireland/D-NVRL-MPA24205/2020	EPI_ISL_671337	2020-05-01	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/CE-NVRL-MPW96382/2020	EPI_ISL_671352	2020-05-13	Europe / Ireland / Clare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06456/2020	EPI_ISL_671389	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06457/2020	EPI_ISL_671392	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06466/2020	EPI_ISL_671393	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Hungary/UD-55426/2020	EPI_ISL_671419	2020-08-31	Europe / Hungary / Szabolcs-Szatmar-Bereg County	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Geneious 10.2.4			B.1.1.163	GR
hCoV-19/England/QEUH-BA3426/2020	EPI_ISL_672770	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D2FB/2020	EPI_ISL_673953	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8E6C1/2020	EPI_ISL_673997	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B968EE/2020	EPI_ISL_676281	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/IL-UW-2119/2020	EPI_ISL_677524	2020-10-02	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.1.453	GR
hCoV-19/England/ALDP-B5D17F/2020	EPI_ISL_678863	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-B5D591/2020	EPI_ISL_678915	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-B745C1/2020	EPI_ISL_678932	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-B748AA/2020	EPI_ISL_678952	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/ALDP-BBB519/2020	EPI_ISL_702559	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC3D34/2020	EPI_ISL_703889	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A91AC0/2020	EPI_ISL_706009	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3B177/2020	EPI_ISL_706052	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3B55D/2020	EPI_ISL_706063	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3BA21/2020	EPI_ISL_706093	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3BB1F/2020	EPI_ISL_706095	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3BE61/2020	EPI_ISL_706101	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3C422/2020	EPI_ISL_706143	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3C880/2020	EPI_ISL_706163	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3CD72/2020	EPI_ISL_706197	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-AC9300/2020	EPI_ISL_709922	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-16017/2020	EPI_ISL_714537	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-16022/2020	EPI_ISL_714542	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-16118/2020	EPI_ISL_714592	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/CAMC-C3FC53/2020	EPI_ISL_719360	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C45883/2020	EPI_ISL_719377	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-BB265B/2020	EPI_ISL_720325	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAC86D/2020	EPI_ISL_720384	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-BB105E/2020	EPI_ISL_720425	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Japan/IC-0368/2020	EPI_ISL_721610	2020-11-27	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.37	GR
hCoV-19/Japan/IC-0384/2020	EPI_ISL_721623	2020-12-06	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.277	GR
hCoV-19/Switzerland/AG-ETHZ-380292/2020	EPI_ISL_721719	2020-11-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-380296/2020	EPI_ISL_721721	2020-11-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/England/NORW-F5183/2020	EPI_ISL_725226	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A9E182/2020	EPI_ISL_727801	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9E60B/2020	EPI_ISL_727804	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9E629/2020	EPI_ISL_727805	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B7C63F/2020	EPI_ISL_727807	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7C6B7/2020	EPI_ISL_727812	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7C71E/2020	EPI_ISL_727814	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-B7D9EA/2020	EPI_ISL_727840	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-B7DC2D/2020	EPI_ISL_727844	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-10C5DEF/2020	EPI_ISL_727866	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-C230A1/2020	EPI_ISL_733712	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-C2FC56/2020	EPI_ISL_733735	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/rega-0804735/2020	EPI_ISL_734911	2020-08-04	Europe / Belgium / Deurne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0908933/2020	EPI_ISL_734917	2020-09-08	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0915949/2020	EPI_ISL_734939	2020-09-15	Europe / Belgium / Oud-Heverlee	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0916981/2020	EPI_ISL_734971	2020-09-16	Europe / Belgium / Oud-Heverlee	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-09171048/2020	EPI_ISL_734973	2020-09-17	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-09171052/2020	EPI_ISL_734974	2020-09-17	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0917987/2020	EPI_ISL_734979	2020-09-17	Europe / Belgium / Deurne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0917989/2020	EPI_ISL_734981	2020-09-17	Europe / Belgium / Oud-Heverlee	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0917999/2020	EPI_ISL_734990	2020-09-17	Europe / Belgium / Etterbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141419/2020	EPI_ISL_738471	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111421/2020	EPI_ISL_738473	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141422/2020	EPI_ISL_738474	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111426/2020	EPI_ISL_738478	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141427/2020	EPI_ISL_738479	2020-12-14	Europe / Belgium / Halen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111429/2020	EPI_ISL_738481	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111432/2020	EPI_ISL_738484	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141433/2020	EPI_ISL_738485	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111435/2020	EPI_ISL_738487	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141439/2020	EPI_ISL_738491	2020-12-14	Europe / Belgium / Overpelt	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141441/2020	EPI_ISL_738493	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111443/2020	EPI_ISL_738495	2020-12-11	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12111444/2020	EPI_ISL_738496	2020-12-11	Europe / Belgium / Arendonk	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141445/2020	EPI_ISL_738497	2020-12-14	Europe / Belgium / Arendonk	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-12141447/2020	EPI_ISL_738499	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Luxembourg/LNS0726804/2020	EPI_ISL_739822	2020-10-31	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/Luxembourg/LNS1057454/2020	EPI_ISL_739882	2020-10-26	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			AD.2	GR
hCoV-19/Wales/PHWC-49E4CB/2020	EPI_ISL_743009	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Italy/VEN-UniVR-139/2020	EPI_ISL_751436	2020-04-04	Europe / Italy / Veneto / Verona	Human	Original			Illumina NovaSeq 5986	Artic amplicon V3; BWA 0.7.17; Ivar v1.2.2			B.1.1	GR
hCoV-19/USA/CA-CDPH167/2020	EPI_ISL_755061	2020-06-24	North America / USA / California / Marin County	Human	Original			Illumina Miseq				B.1.1.174	GR
hCoV-19/Denmark/DCGC-22543/2020	EPI_ISL_757628	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-C92E76/2020	EPI_ISL_762150	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/DE-DHSS-F986750/2020	EPI_ISL_767001	2020-11-17	North America / USA / Delaware / Sussex	Human	Original		Not screened by S dropout	Illumina MiSeq	DRAGEN			B.1.1.337	GR
hCoV-19/England/MILK-C53B10/2020	EPI_ISL_769729	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Russia/SVE-RII-MH8684S/2020	EPI_ISL_770671	2020-09-29	Europe / Russia / Sverdlovsk / Verkhnyaya Pyshma	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH8695S/2020	EPI_ISL_770672	2020-09-28	Europe / Russia / Sverdlovsk / Baltym	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/KAM-RII-MH10627S/2020	EPI_ISL_770679	2020-12	Europe / Russia / Kamchatka / Petropavlovsk-Kamchatsky	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Norway/6703/2020	EPI_ISL_775406	2020-12-07	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Israel/CVL-128-ngs/2020	EPI_ISL_776841	2020-12-27	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/England/MILK-D0652C/2020	EPI_ISL_781321	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-CF8F7B/2020	EPI_ISL_781360	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/USA/TX-HMH-MCoV-14733/2020	EPI_ISL_786218	2020-10-12	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14748/2020	EPI_ISL_786233	2020-10-12	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-14190/2020	EPI_ISL_787475	2020-10-02	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14220/2020	EPI_ISL_787505	2020-10-05	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13601/2020	EPI_ISL_788711	2020-08-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13612/2020	EPI_ISL_788721	2020-08-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13651/2020	EPI_ISL_788753	2020-08-20	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13768/2020	EPI_ISL_788861	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/Denmark/DCGC-23609/2020	EPI_ISL_793304	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	AD.1	GR
hCoV-19/Australia/WA524/2020	EPI_ISL_794696	2020-03-23	Oceania / Australia / Western Australia	Human	Original			Illumina MiSeq				B.1.1.5	GR
hCoV-19/Denmark/DCGC-25188/2020	EPI_ISL_795985	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-D514CB/2020	EPI_ISL_798144	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC2A10/2020	EPI_ISL_800931	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-BC248B/2020	EPI_ISL_800988	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Netherlands/NH-RIVM-10280/2020	EPI_ISL_804430	2020-04-16	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/NH-RIVM-10214/2020	EPI_ISL_804449	2020-03-27	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/France/PAC-IHUCOVID-2586/2020	EPI_ISL_804523	2020-10-21	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Canada/AB-69742/2020	EPI_ISL_805780	2020-04-28	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-53531/2020	EPI_ISL_805801	2020-03-18	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-88693/2020	EPI_ISL_805836	2020-03-20	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-68907/2020	EPI_ISL_805859	2020-03-18	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/England/BIRM-681A9/2020	EPI_ISL_812995	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-10CFCCA/2020	EPI_ISL_816464	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D0534/2020	EPI_ISL_816476	2020-12-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D19CE/2021	EPI_ISL_816506	2021-01-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D1AF8/2021	EPI_ISL_816509	2021-01-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Denmark/DCGC-26830/2020	EPI_ISL_817786	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	G
hCoV-19/England/QEUH-E50601/2021	EPI_ISL_821160	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/WA-UW-48234/2020	EPI_ISL_824905	2020-12-20	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-48247/2020	EPI_ISL_824916	2020-12-20	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-48257/2020	EPI_ISL_824917	2020-12-20	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/MD-MDH-0596/2021	EPI_ISL_824978	2021-01-05	North America / USA / Maryland	Human	Original	Throat swab		Illumina MiSeq	p			B.1.1.231	GR
hCoV-19/Iceland/6134/2020	EPI_ISL_829812	2020-10-26	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			M.2	GR
hCoV-19/Wales/PHWC-4B6005/2021	EPI_ISL_841445	2021-01-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-28251/2021	EPI_ISL_845035	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-28260/2021	EPI_ISL_845037	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-28492/2021	EPI_ISL_845110	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002298/2021	EPI_ISL_857127	2021-01-07	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/United Arab Emirates/1811/2020	EPI_ISL_859596	2020-06-28	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/1842/2020	EPI_ISL_859613	2020-06-24	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/2028/2020	EPI_ISL_859652	2020-07-06	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/2366/2020	EPI_ISL_859656	2020-08-26	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/2370/2020	EPI_ISL_859659	2020-08-26	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/2890/2020	EPI_ISL_859676	2020-08-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3152/2020	EPI_ISL_859686	2020-09-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3153/2020	EPI_ISL_859687	2020-09-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3173/2020	EPI_ISL_859690	2020-09-28	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3399/2020	EPI_ISL_859764	2020-09-04	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3408/2020	EPI_ISL_859767	2020-09-06	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3539/2020	EPI_ISL_859772	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3542/2020	EPI_ISL_859775	2020-10-26	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3544/2020	EPI_ISL_859776	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3618/2020	EPI_ISL_859789	2020-10-17	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3632/2020	EPI_ISL_859794	2020-10-11	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Brazil/PE-HIAE-ID47/2020	EPI_ISL_861911	2020-04-14	South America / Brazil / Pernambuco	Human	Original			Illumina NextSeq				B.1.1	GR
hCoV-19/England/MILK-FAFCE2/2021	EPI_ISL_864268	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ireland/MH-NVRL-MPA29100/2020	EPI_ISL_869147	2020-04-23	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1.399	GR
hCoV-19/Denmark/DCGC-34238/2021	EPI_ISL_871248	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-34250/2021	EPI_ISL_871260	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Russia/Moscow_PMVL-21/2020	EPI_ISL_872635	2020-06-05	Europe / Russia / Moscow	Human	Vero E6	Nasopharyngeal swab		Ion Torrent S5XL	BWA v0.7.17, FreeBayes v1.3.2, bcftools v1.9, bedtools v2.29.2	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Russia/Moscow_PMVL-22/2020	EPI_ISL_872636	2020-06-05	Europe / Russia / Moscow	Human	Vero E6	Nasopharyngeal swab		Ion Torrent S5XL	BWA v0.7.17, FreeBayes v1.3.2, bcftools v1.9, bedtools v2.29.2			B.1.1.294	GR
hCoV-19/Russia/Moscow_PMVL-25/2020	EPI_ISL_872639	2020-06-06	Europe / Russia / Moscow	Human	Vero E6	Nasopharyngeal swab		Ion Torrent S5XL	BWA v0.7.17, FreeBayes v1.3.2, bcftools v1.9, bedtools v2.29.2			B.1.1.294	GR
hCoV-19/Russia/Moscow_PMVL-28/2020	EPI_ISL_872642	2020-08-20	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Ion Torrent S5XL	BWA v0.7.17, FreeBayes v1.3.2, bcftools v1.9, bedtools v2.29.2			B.1.1.294	GR
hCoV-19/Australia/VIC18126/2021	EPI_ISL_877571	2021-01-17	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.3, samtools v1.11			B.1.1.163	GR
hCoV-19/USA/CA-ALSR-5982/2020	EPI_ISL_878789	2020-12-29	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.2.2	NS7a_E95stop results in 22.3% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/PA-CDC-STM-0000013-E09/2021	EPI_ISL_884775	2021-01-11	North America / USA / Pennsylvania	Human	Original	Nasal swab		Illumina	COVIDSeq v. V1			B.1.1.337	GR
hCoV-19/Canada/QC-JUS-V5192105/2020	EPI_ISL_890432	2020-03-18	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Myanmar/DMR-MM05/2020	EPI_ISL_896576	2020-05	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Switzerland/un-32999153/2021	EPI_ISL_897927	2021-01-18	Europe / Switzerland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Indonesia/KB-TUH-C2111237/2020	EPI_ISL_902917	2020-08-31	Asia / Indonesia / West Kalimantan	Human	Original			Oxford Nanopore				B.1.1.398	GR
hCoV-19/Indonesia/KB-TUH-C2134850/2020	EPI_ISL_902922	2020-11-04	Asia / Indonesia / West Kalimantan	Human	Original	nasopharyngeal swab		Oxford Nanopore				B.1.1.398	GR
hCoV-19/Netherlands/NB-RIVM-10499/2021	EPI_ISL_905292	2021-01-15	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Luxembourg/LNS5780432/2021	EPI_ISL_911133	2021-01-11	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/USA/MN-MDH-2330/2021	EPI_ISL_913719	2021-01-04	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/Belgium/rega-1985/2021	EPI_ISL_913767	2021-01-15	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1996/2020	EPI_ISL_913781	2020-12-17	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Italy/CAM-CRGS-64/2020	EPI_ISL_918417	2020-04-02	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80458/2020	EPI_ISL_925572	2020-04	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80796/2020	EPI_ISL_925748	2020-03	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80774/2020	EPI_ISL_925749	2020-03	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Denmark/DCGC-38140/2020	EPI_ISL_929281	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-39028/2020	EPI_ISL_930170	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-39070/2020	EPI_ISL_930212	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-39145/2021	EPI_ISL_930287	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Singapore/134/2021	EPI_ISL_937524	2021-01-31	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.315	GR
hCoV-19/England/CAMC-11645F8/2021	EPI_ISL_948200	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/CA-CZB-18476/2021	EPI_ISL_955453	2021-01-05	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.174	GR
hCoV-19/Shandong/2020C1240535/2020	EPI_ISL_962536	2020-03-19	Asia / China / Shandong	Human	Original			Illumina MiSeq				B.1.1.254	GR
hCoV-19/USA/GA-CDC-STM-000002905/2021	EPI_ISL_967382	2021-01-16	North America / USA / Georgia	Human	Original	Nasal swab		Illumina	COVIDSEQ			B.1.1.337	GR
hCoV-19/Canada/BC-BCCDC-3094/2020	EPI_ISL_968659	2020-08-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.1	GR
hCoV-19/Denmark/DCGC-39583/2021	EPI_ISL_970985	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-41506/2021	EPI_ISL_973183	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	G
hCoV-19/Canada/MB-NML-1057/2020	EPI_ISL_979291	2020-04-22	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Mexico/CMX-INMEGEN-01-02-08/2020	EPI_ISL_985166	2020-12-29	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Nanopore MinION	MEDAKA	Gap of 11 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Scotland/EDB14802/2021	EPI_ISL_997148	2021-01-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.163	GR
hCoV-19/Ireland/L-NVRL-79IRL93317/2020	EPI_ISL_1001236	2020-12-14	Europe / Ireland / Leinster	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/L-NVRL-80IRL07745/2020	EPI_ISL_1001257	2020-12-17	Europe / Ireland / Leinster	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/L-NVRL-80IRL07757/2020	EPI_ISL_1001259	2020-12-17	Europe / Ireland / Leinster	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-480845/2021	EPI_ISL_1002401	2021-01-05	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-471044/2021	EPI_ISL_1003759	2021-01-26	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Poland/2081274015_gx1/2021	EPI_ISL_1008720	2021-01-30	Europe / Poland / Wielkopolska / Murowana Goslina	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Poland/2120831577_gx1/2021	EPI_ISL_1008725	2021-01-29	Europe / Poland / Wielkopolska / Nowy Tomysl	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2120952069_gx1/2021	EPI_ISL_1008729	2021-01-30	Europe / Poland / Wielkopolska / Poznan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142266308_gx1/2021	EPI_ISL_1008730	2021-01-29	Europe / Poland / Wielkopolska / Poznan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142268577_gx1/2021	EPI_ISL_1008732	2021-01-29	Europe / Poland / Wielkopolska / Duszniki	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142272172_gx1/2021	EPI_ISL_1008734	2021-01-29	Europe / Poland / Wielkopolska / Jeziorki	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142826447_gx1/2021	EPI_ISL_1008756	2021-01-29	Europe / Poland / Wielkopolska / Komorniki	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/2142909123_gx1/2021	EPI_ISL_1008760	2021-01-30	Europe / Poland / Wielkopolska / Debienko	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Curacao/CW-RIVM-11653/2021	EPI_ISL_1014582	2021-01-25	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Ghana/NMIMR-NTRA-15338/2020	EPI_ISL_1018096	2020-12-27	Africa / Ghana	Human	Original	Nasopharyngeal and oropharyngeal		Illumina	Bwa v. 0.7.17-r1188			B.1.1.359	GR
hCoV-19/Ghana/NMIMR-NTRA-9793/2020	EPI_ISL_1018101	2020-11-13	Africa / Ghana	Human	Original	Nasopharyngeal and oropharyngeal		Illumina	Bwa v. 0.7.17-r1188	Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/UT-CDC-LC0011432/2021	EPI_ISL_1038453	2021-01-28	North America / USA / Utah	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1	GR
hCoV-19/USA/LA-EVTL1936/2020	EPI_ISL_1039595	2020-11-17	North America / USA / Louisiana / Bossier Parish	Human	Original	Anterior turbinate nasal swab		Illumina NextSeq	Broad viral-ngs			B.1.1.337	GR
hCoV-19/USA/LA-EVTL1940/2020	EPI_ISL_1039599	2020-11-17	North America / USA / Louisiana / Bossier Parish	Human	Original	Anterior turbinate nasal swab		Illumina NextSeq	Broad viral-ngs			B.1.1.337	GR
hCoV-19/South Africa/NHLS-UCT-GS-1104/2020	EPI_ISL_1040773	2020-11-04	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-1093/2020	EPI_ISL_1040774	2020-11-02	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3510/2020	EPI_ISL_1040800	2020-10-06	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-2088/2020	EPI_ISL_1040804	2020-09-23	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-2024/2020	EPI_ISL_1040805	2020-09-14	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.34	GR
hCoV-19/South Africa/NHLS-UCT-GS-1849/2020	EPI_ISL_1040808	2020-09-07	Africa / South Africa / Western Cape	Human	Original			Illumina Miseq				B.1.1.507	GR
hCoV-19/Wales/ALDP-119BCE4/2021	EPI_ISL_1057733	2021-01-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-46376/2020	EPI_ISL_1065886	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-21049/2020	EPI_ISL_1075493	2020-12-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-22334/2021	EPI_ISL_1076862	2021-01-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-25477/2021	EPI_ISL_1080096	2021-01-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.485	GR
hCoV-19/Australia/VIC249/2020	EPI_ISL_419944	2020-03-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1.254	GR
hCoV-19/Australia/VIC252/2020	EPI_ISL_419947	2020-03-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1.89	GR
hCoV-19/Belgium/ULG-10027/2020	EPI_ISL_421201	2020-03-31	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.5	GR
hCoV-19/England/20134025904/2020	EPI_ISL_423132	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/201360037/2020	EPI_ISL_423199	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/201360051/2020	EPI_ISL_423201	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360206/2020	EPI_ISL_423241	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360211/2020	EPI_ISL_423243	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/201360213/2020	EPI_ISL_423244	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/201360224/2020	EPI_ISL_423254	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20138010904/2020	EPI_ISL_423277	2020-03-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20138019104/2020	EPI_ISL_423292	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132104104/2020	EPI_ISL_423837	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132104404/2020	EPI_ISL_423838	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Iceland/396/2020	EPI_ISL_424420	2020-03-19	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/504/2020	EPI_ISL_424526	2020-03-21	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/507/2020	EPI_ISL_424529	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Iceland/508/2020	EPI_ISL_424530	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/509/2020	EPI_ISL_424531	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/513/2020	EPI_ISL_424535	2020-03-21	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Iceland/515/2020	EPI_ISL_424537	2020-03	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Iceland/542/2020	EPI_ISL_424562	2020-03-26	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/550/2020	EPI_ISL_424570	2020-03-28	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Iceland/577/2020	EPI_ISL_424597	2020-03-27	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Scotland/CVR41/2020	EPI_ISL_425769	2020-03-13	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Denmark/ALAB-SSI390/2020	EPI_ISL_429486	2020-03-24	Europe / Denmark	Human	Original			Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/United Arab Emirates/L0879/2020	EPI_ISL_435124	2020-03-16	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/Saudi Arabia/KAUST-Jeddah68/2020	EPI_ISL_437756	2020-03-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.1	GR
hCoV-19/USA/CT-UW-6565/2020	EPI_ISL_437866	2020-04-02	North America / USA / Connecticut	Human	Original			Illumina				B.1.1	GR
hCoV-19/Greece/152_33705/2020	EPI_ISL_437875	2020-03-14	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/Greece/218_35009/2020	EPI_ISL_437886	2020-03-17	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/Greece/153_33892/2020	EPI_ISL_437902	2020-03-14	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/England/CAMB-7558F/2020	EPI_ISL_440399	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-79916/2020	EPI_ISL_441076	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-797EF/2020	EPI_ISL_441093	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A863/2020	EPI_ISL_441132	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-78CB4/2020	EPI_ISL_441170	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7B5D4/2020	EPI_ISL_441188	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-834FA/2020	EPI_ISL_443608	2020-04-15	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-84356/2020	EPI_ISL_443614	2020-04-16	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/BRIS-124F08/2020	EPI_ISL_443768	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/OXON-AC507/2020	EPI_ISL_448457	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC91A/2020	EPI_ISL_448494	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACD69/2020	EPI_ISL_448534	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AD08D/2020	EPI_ISL_448557	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-D5848/2020	EPI_ISL_449729	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/Sweden/20-08085/2020	EPI_ISL_454459	2020-03-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08086/2020	EPI_ISL_454460	2020-03-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08096/2020	EPI_ISL_454468	2020-03-06	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08123/2020	EPI_ISL_454493	2020-03-09	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Vietnam/VNHN_4806/2020	EPI_ISL_455711	2020-04-08	Asia / Vietnam / Vinhphuc	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20.0.3			B.1.1	GR
hCoV-19/England/CAMB-1AF65B/2020	EPI_ISL_459269	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AF679/2020	EPI_ISL_459287	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B3B73/2020	EPI_ISL_461580	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B3C61/2020	EPI_ISL_461582	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B3CE9/2020	EPI_ISL_461583	2020-05-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B3E7A/2020	EPI_ISL_461587	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/20119029504/2020	EPI_ISL_465039	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119031604/2020	EPI_ISL_465044	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119032004/2020	EPI_ISL_465045	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119032104/2020	EPI_ISL_465046	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119034404/2020	EPI_ISL_465050	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20206139504/2020	EPI_ISL_465665	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.294	GR
hCoV-19/England/20154082104/2020	EPI_ISL_466267	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154083604/2020	EPI_ISL_466272	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20154083704/2020	EPI_ISL_466273	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620041/2020	EPI_ISL_466391	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620042/2020	EPI_ISL_466392	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201620047/2020	EPI_ISL_466393	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20162009704/2020	EPI_ISL_466408	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20162010504/2020	EPI_ISL_466409	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20164065904/2020	EPI_ISL_466460	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/NM-UNM-00007/2020	EPI_ISL_467590	2020-03-14	North America / USA / New Mexico	Human	Original			Nanopore	ARTIC/bwa			B.1.1	GR
hCoV-19/Romania/ChVir7245/2020	EPI_ISL_467779	2020-04-27	Europe / Romania / Bucuresti	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Romania/ChVir7246/2020	EPI_ISL_467780	2020-04-26	Europe / Romania / Teleorman	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Spain/PV-IBV-2112/2020	EPI_ISL_468904	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2107/2020	EPI_ISL_468905	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-2109/2020	EPI_ISL_468907	2020-04-11	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/NORT-283DEE/2020	EPI_ISL_472255	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-603E7/2020	EPI_ISL_473406	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-60411/2020	EPI_ISL_473408	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-61164/2020	EPI_ISL_473434	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-61182/2020	EPI_ISL_473436	2020-06-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B43E3/2020	EPI_ISL_473471	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B442C/2020	EPI_ISL_473472	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B45A1/2020	EPI_ISL_473477	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4671/2020	EPI_ISL_473479	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4D03/2020	EPI_ISL_473507	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/Hungary/UD-10333/2020	EPI_ISL_477009	2020-04-22	Europe / Hungary / Borsod-Abauj-Zemplen County	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Canada/BC_23246810/2020	EPI_ISL_477035	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/BC_23252816/2020	EPI_ISL_477036	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/BC_23279341/2020	EPI_ISL_477037	2020-04	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/England/LOND-D6BB7/2020	EPI_ISL_478412	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6DB1/2020	EPI_ISL_478433	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D6EBE/2020	EPI_ISL_478443	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.5	GR
hCoV-19/England/LOND-D705D/2020	EPI_ISL_478456	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I003/2020	EPI_ISL_479699	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I004/2020	EPI_ISL_479700	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC5I001/2020	EPI_ISL_479710	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC5I011/2020	EPI_ISL_479712	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I015/2020	EPI_ISL_479728	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.1	GR
hCoV-19/Egypt/CUNCI-HGC4I023/2020	EPI_ISL_479729	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/P1/2020	EPI_ISL_479785	2020	Europe / United Kingdom / England	Human	unknown			Illumina				B.1.1	GR
hCoV-19/England/BRIS-12D4C4/2020	EPI_ISL_481899	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2968C9/2020	EPI_ISL_484270	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-296920/2020	EPI_ISL_484271	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-296AB4/2020	EPI_ISL_484273	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-296C45/2020	EPI_ISL_484275	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-296C81/2020	EPI_ISL_484276	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-297190/2020	EPI_ISL_484283	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29CACD/2020	EPI_ISL_484289	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Russia/CRIE162398/2020	EPI_ISL_486821	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE164980/2020	EPI_ISL_486824	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE175960/2020	EPI_ISL_486827	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE187963/2020	EPI_ISL_486829	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.163	GR
hCoV-19/Senegal/6751/2020	EPI_ISL_486859	2020-04-21	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Senegal/9392/2020	EPI_ISL_486862	2020-04-25	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Senegal/6430/2020	EPI_ISL_486872	2020-04-11	Africa / Senegal / Dakar	Human	Original	Oropharyngeal swab		Illumina MiSeq	Bowtie2			B.1.1	GR
hCoV-19/Portugal/IGC3857/2020	EPI_ISL_491209	2020-05-28	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC3996/2020	EPI_ISL_491217	2020-06-01	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4016/2020	EPI_ISL_491222	2020-06-01	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4096/2020	EPI_ISL_491229	2020-06-02	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4106/2020	EPI_ISL_491232	2020-06-01	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4245/2020	EPI_ISL_491240	2020-06-03	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4260/2020	EPI_ISL_491243	2020-06-03	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Portugal/IGC4392/2020	EPI_ISL_491245	2020-06-07	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.421	GR
hCoV-19/Ecuador/52255/2020	EPI_ISL_491952	2020-05-29	South America / Ecuador / Guayas / San Jacinto de Yaguachi	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/BRIS-12FE4C/2020	EPI_ISL_492513	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1301C7/2020	EPI_ISL_492527	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130525/2020	EPI_ISL_492693	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130ADB/2020	EPI_ISL_492726	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130AEA/2020	EPI_ISL_492730	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130B9C/2020	EPI_ISL_492735	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-13068C/2020	EPI_ISL_492737	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-166359/2020	EPI_ISL_493985	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663A4/2020	EPI_ISL_493990	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663C2/2020	EPI_ISL_493992	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1663D1/2020	EPI_ISL_493993	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/WA-S1848/2020	EPI_ISL_496274	2020-05-27	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/FL-QDX-228/2020	EPI_ISL_498709	2020-04-18	North America / USA / Florida	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.1.1.231	GR
hCoV-19/USA/NY-UW-MAYO26/2020	EPI_ISL_500505	2020-03-21	North America / USA / New York	Human	Original			NextSeq 500				B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11184S/2020	EPI_ISL_507243	2020-05-02	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11311S/2020	EPI_ISL_507255	2020-05-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15221S/2020	EPI_ISL_507261	2020-05-12	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15817S/2020	EPI_ISL_507273	2020-05-18	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII16106S/2020	EPI_ISL_507277	2020-05-19	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII17940S/2020	EPI_ISL_507280	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17941S/2020	EPI_ISL_507281	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17948S/2020	EPI_ISL_507282	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17949S/2020	EPI_ISL_507283	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII18089S/2020	EPI_ISL_507285	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII18090S/2020	EPI_ISL_507286	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII21802S/2020	EPI_ISL_507290	2020-06-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/YAR-RII-24773S/2020	EPI_ISL_507300	2020-05	Europe / Russia / Yaroslavl	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Portugal/PT1521/2020	EPI_ISL_510889	2020-06-19	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq550	INSaFLU			B.1	GR
hCoV-19/Portugal/PT1522/2020	EPI_ISL_510890	2020-06-22	Europe / Portugal	Human	Original	Feces		Illumina MiSeq	INSaFLU			B.1	GR
hCoV-19/Portugal/PT0694/2020	EPI_ISL_510953	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0699/2020	EPI_ISL_510958	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0713/2020	EPI_ISL_510972	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/USA/PR-AGN5/2020	EPI_ISL_513292	2020-06-29	North America / USA / Puerto Rico / Ponce	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.1	GR
hCoV-19/Germany/BY-UHR-2ZK/2020	EPI_ISL_513299	2020-03-20	Europe / Germany / Bavaria	Human	Viral culture			Illumina	DRAGEN RNA Pathogen Detection v.: 3.5.14			B.1.1	GR
hCoV-19/USA/CA-CZB-2395/2020	EPI_ISL_513824	2020-05-19	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2397/2020	EPI_ISL_513826	2020-05-19	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2400/2020	EPI_ISL_513828	2020-05-20	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2416/2020	EPI_ISL_513837	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2417/2020	EPI_ISL_513838	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2450/2020	EPI_ISL_513858	2020-05-22	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2454/2020	EPI_ISL_513862	2020-05-22	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/England/NOTT-112EB5/2020	EPI_ISL_514452	2020-08-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112ED3/2020	EPI_ISL_514453	2020-08-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112EF1/2020	EPI_ISL_514454	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/PORT-2D1965/2020	EPI_ISL_514474	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D1A53/2020	EPI_ISL_514484	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/South Africa/KRISP-K002350/2020	EPI_ISL_515722	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002351/2020	EPI_ISL_515723	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002387/2020	EPI_ISL_515753	2020-07-22	Africa / South Africa / KwaZulu-Natal / uThukela	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/Scotland/GCVR-171E2D/2020	EPI_ISL_524513	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NOTT-112F1C/2020	EPI_ISL_526425	2020-08-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/PORT-2D1FCD/2020	EPI_ISL_526436	2020-03-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/Scotland/QEUH-969707/2020	EPI_ISL_531040	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9697DA/2020	EPI_ISL_531048	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964AD6/2020	EPI_ISL_531052	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-969840/2020	EPI_ISL_531054	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964C2B/2020	EPI_ISL_531059	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-541A3D/2020	EPI_ISL_532226	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-540C83/2020	EPI_ISL_532227	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53DA8F/2020	EPI_ISL_532233	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-53F2EF/2020	EPI_ISL_532238	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5574FA/2020	EPI_ISL_532245	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-541FF2/2020	EPI_ISL_532247	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-52E78A/2020	EPI_ISL_532255	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54E599/2020	EPI_ISL_532256	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95F740/2020	EPI_ISL_532283	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F0DC/2020	EPI_ISL_532288	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9D1/2020	EPI_ISL_532384	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FA38/2020	EPI_ISL_532386	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95EA1B/2020	EPI_ISL_532388	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA57/2020	EPI_ISL_532402	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9C2/2020	EPI_ISL_532404	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F485/2020	EPI_ISL_532409	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-95ECF7/2020	EPI_ISL_532414	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/OXON-B32BB/2020	EPI_ISL_534848	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3CAE/2020	EPI_ISL_534909	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4038/2020	EPI_ISL_534925	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16A1E2/2020	EPI_ISL_535214	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Peru/LIM-INS-138/2020	EPI_ISL_536533	2020-03-17	South America / Peru / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/England/QEUH-95DCE9/2020	EPI_ISL_537138	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-997F17/2020	EPI_ISL_537154	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997CE3/2020	EPI_ISL_537156	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9981A7/2020	EPI_ISL_537158	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997EDE/2020	EPI_ISL_537161	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997F44/2020	EPI_ISL_537164	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997F35/2020	EPI_ISL_537177	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9981B6/2020	EPI_ISL_537181	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997F08/2020	EPI_ISL_537198	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997D59/2020	EPI_ISL_537202	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/SHEF-10B2D5E/2020	EPI_ISL_537214	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-10B2E3D/2020	EPI_ISL_537215	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E1F/2020	EPI_ISL_537216	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E2E/2020	EPI_ISL_537220	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E4C/2020	EPI_ISL_537221	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D8B/2020	EPI_ISL_537225	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DC7/2020	EPI_ISL_537237	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D12/2020	EPI_ISL_537238	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2E5B/2020	EPI_ISL_537239	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DD6/2020	EPI_ISL_537251	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B3081/2020	EPI_ISL_537252	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/SHEF-10B2DF4/2020	EPI_ISL_537253	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D9A/2020	EPI_ISL_537255	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2D7C/2020	EPI_ISL_537261	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DE5/2020	EPI_ISL_537264	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2DA9/2020	EPI_ISL_537265	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-10B2A84/2020	EPI_ISL_537273	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Singapore/113nan/2020	EPI_ISL_538448	2020-03-17	Asia / Singapore	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Singapore/920/2020	EPI_ISL_538451	2020-03-22	Asia / Singapore	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Czech Republic/NRL-5886-1/2020	EPI_ISL_539778	2020-04-08	Europe / Czech Republic / Moravian-Silesian Region / Cesky Tesin	Human	Original	Nasopharyngeal swab		Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/Czech Republic/NRL-5886-2/2020	EPI_ISL_539779	2020-04-08	Europe / Czech Republic / Moravian-Silesian Region / Cesky Tesin	Human	Original	Nasopharyngeal swab		Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/England/NOTT-11317F/2020	EPI_ISL_540705	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C6E75/2020	EPI_ISL_540735	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF243/2020	EPI_ISL_540760	2020-08-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4162/2020	EPI_ISL_540843	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4169/2020	EPI_ISL_540849	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4205/2020	EPI_ISL_540870	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/TX-HMH-3555/2020	EPI_ISL_543017	2020-06-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-3503/2020	EPI_ISL_544206	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3536/2020	EPI_ISL_544232	2020-06-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-4667/2020	EPI_ISL_544240	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-4684/2020	EPI_ISL_544255	2020-06-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4699/2020	EPI_ISL_544267	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-4709/2020	EPI_ISL_544277	2020-06-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2720/2020	EPI_ISL_545503	2020-06-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2737/2020	EPI_ISL_545516	2020-06-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2745/2020	EPI_ISL_545522	2020-06-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2747/2020	EPI_ISL_545524	2020-06-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2757/2020	EPI_ISL_545532	2020-06-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-7719/2020	EPI_ISL_545600	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7742/2020	EPI_ISL_545612	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-7945/2020	EPI_ISL_545728	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6064/2020	EPI_ISL_547206	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/England/MILK-99CE24/2020	EPI_ISL_549835	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CCDF/2020	EPI_ISL_549839	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CD36/2020	EPI_ISL_549842	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CC48/2020	EPI_ISL_549848	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CFF4/2020	EPI_ISL_549854	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D272/2020	EPI_ISL_549855	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6A9C/2020	EPI_ISL_550102	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8C67/2020	EPI_ISL_550108	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A855D/2020	EPI_ISL_550118	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8B3D/2020	EPI_ISL_550120	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A53FC/2020	EPI_ISL_550142	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A6CC3/2020	EPI_ISL_550145	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6EBE/2020	EPI_ISL_550148	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A846F/2020	EPI_ISL_550158	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6B20/2020	EPI_ISL_550160	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5541/2020	EPI_ISL_550172	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8669/2020	EPI_ISL_550190	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5408/2020	EPI_ISL_550199	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9A6BF3/2020	EPI_ISL_550213	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8DA0/2020	EPI_ISL_550225	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A69AE/2020	EPI_ISL_550234	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/MILK-9A53ED/2020	EPI_ISL_550244	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A69BD/2020	EPI_ISL_550246	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A15A/2020	EPI_ISL_550265	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999FD9/2020	EPI_ISL_550270	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-99A73A/2020	EPI_ISL_550272	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99A7A3/2020	EPI_ISL_550281	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A0E4/2020	EPI_ISL_550285	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999D66/2020	EPI_ISL_550287	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A600/2020	EPI_ISL_550291	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A372/2020	EPI_ISL_550293	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A749/2020	EPI_ISL_550294	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AA281/2020	EPI_ISL_550803	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AA6C1/2020	EPI_ISL_550811	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AACA1/2020	EPI_ISL_550812	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA0A5/2020	EPI_ISL_550813	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA087/2020	EPI_ISL_550835	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAB1D/2020	EPI_ISL_550843	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-93AA24/2020	EPI_ISL_551403	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9364FD/2020	EPI_ISL_551438	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-938B32/2020	EPI_ISL_551457	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-917A78/2020	EPI_ISL_551458	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-917A5A/2020	EPI_ISL_551474	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-92CF44/2020	EPI_ISL_551486	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92D022/2020	EPI_ISL_551498	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-91DA72/2020	EPI_ISL_551529	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-90080F/2020	EPI_ISL_551562	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-993FFD/2020	EPI_ISL_551587	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-981CEC/2020	EPI_ISL_552723	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-975CBE/2020	EPI_ISL_552752	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-97689B/2020	EPI_ISL_552765	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9768F5/2020	EPI_ISL_552795	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-91D650/2020	EPI_ISL_552839	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9214C8/2020	EPI_ISL_552891	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-91D68D/2020	EPI_ISL_552894	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CE92B/2020	EPI_ISL_556215	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D67DB/2020	EPI_ISL_556217	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6D68D8/2020	EPI_ISL_556230	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94ECAF/2020	EPI_ISL_556234	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-6425A3/2020	EPI_ISL_556237	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-6C6E9D/2020	EPI_ISL_556254	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-63CBF5/2020	EPI_ISL_556265	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-63B7A7/2020	EPI_ISL_556279	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-63C6D6/2020	EPI_ISL_556281	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6CE879/2020	EPI_ISL_556295	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A05C/2020	EPI_ISL_556327	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6EBBD7/2020	EPI_ISL_557554	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7004EF/2020	EPI_ISL_557569	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-700072/2020	EPI_ISL_557573	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-7016BB/2020	EPI_ISL_557589	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-71D072/2020	EPI_ISL_557593	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A48C5/2020	EPI_ISL_558805	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A219F/2020	EPI_ISL_558816	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5AC1FF/2020	EPI_ISL_558829	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-5B63FC/2020	EPI_ISL_558853	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5A4494/2020	EPI_ISL_558854	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5B0D8B/2020	EPI_ISL_558856	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5A392D/2020	EPI_ISL_558858	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A0BB1/2020	EPI_ISL_558863	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5BA01F/2020	EPI_ISL_558878	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C191A/2020	EPI_ISL_558881	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-5A4528/2020	EPI_ISL_558884	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5B1959/2020	EPI_ISL_558890	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-59F63C/2020	EPI_ISL_558899	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5A39E1/2020	EPI_ISL_558900	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-519D53/2020	EPI_ISL_558901	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-52A3E4/2020	EPI_ISL_558906	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-526CB0/2020	EPI_ISL_558991	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9CDCE4/2020	EPI_ISL_566392	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CCF73/2020	EPI_ISL_566396	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8B28/2020	EPI_ISL_567093	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-9B8657/2020	EPI_ISL_568227	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B82BD/2020	EPI_ISL_568235	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B9AA5/2020	EPI_ISL_568259	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B8736/2020	EPI_ISL_568268	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B8305/2020	EPI_ISL_568272	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F9BA/2020	EPI_ISL_568294	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9903F4/2020	EPI_ISL_568296	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F6D1/2020	EPI_ISL_568298	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998DB2/2020	EPI_ISL_568310	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-998B7C/2020	EPI_ISL_568313	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-98FFC7/2020	EPI_ISL_568324	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-16CAD6/2020	EPI_ISL_574133	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16CD28/2020	EPI_ISL_574160	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16D4E6/2020	EPI_ISL_574245	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Switzerland/BE-UNIBE-178-2905/2020	EPI_ISL_574817	2020-03-20	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1.1	GR
hCoV-19/Scotland/QEUH-9DA80E/2020	EPI_ISL_575385	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9DA9DE/2020	EPI_ISL_575388	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-9CBE77/2020	EPI_ISL_575407	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CAE5A/2020	EPI_ISL_575414	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBF65/2020	EPI_ISL_575435	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB7C7/2020	EPI_ISL_575501	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-9CBB34/2020	EPI_ISL_575502	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9CB123/2020	EPI_ISL_575503	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAEA5/2020	EPI_ISL_575513	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBD4D/2020	EPI_ISL_575515	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CB30F/2020	EPI_ISL_575518	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CC0BC/2020	EPI_ISL_575524	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB985/2020	EPI_ISL_575560	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9CAA65/2020	EPI_ISL_575584	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAF57/2020	EPI_ISL_575593	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CB5EB/2020	EPI_ISL_575596	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CBCF5/2020	EPI_ISL_575597	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9D923E/2020	EPI_ISL_576710	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9298/2020	EPI_ISL_576714	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9517/2020	EPI_ISL_576735	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D95AE/2020	EPI_ISL_576742	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D97F3/2020	EPI_ISL_576762	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D99FD/2020	EPI_ISL_576784	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9D9A81/2020	EPI_ISL_576789	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9B15/2020	EPI_ISL_576794	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9D9BD9/2020	EPI_ISL_576800	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9DE2/2020	EPI_ISL_576818	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9F46/2020	EPI_ISL_576828	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-9DA17C/2020	EPI_ISL_576854	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9DA2D3/2020	EPI_ISL_576861	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/BIRM-63C9E/2020	EPI_ISL_576877	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D04/2020	EPI_ISL_576880	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D31/2020	EPI_ISL_576881	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D7D/2020	EPI_ISL_576882	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63D9B/2020	EPI_ISL_576883	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63DAA/2020	EPI_ISL_576884	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63DD7/2020	EPI_ISL_576885	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E10/2020	EPI_ISL_576887	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E2F/2020	EPI_ISL_576888	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E3E/2020	EPI_ISL_576889	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E4D/2020	EPI_ISL_576890	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E89/2020	EPI_ISL_576892	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63E98/2020	EPI_ISL_576893	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-63EA7/2020	EPI_ISL_576894	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9E1628/2020	EPI_ISL_577078	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/ALDP-9EAB6C/2020	EPI_ISL_580046	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA407/2020	EPI_ISL_580063	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA9DB/2020	EPI_ISL_580074	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E76B9/2020	EPI_ISL_580081	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA847/2020	EPI_ISL_580085	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E9C5B/2020	EPI_ISL_580093	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9E2038/2020	EPI_ISL_581243	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4CB0/2020	EPI_ISL_581378	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DE9C/2020	EPI_ISL_581386	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-97786D/2020	EPI_ISL_581389	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Canada/MB-NML-1195/2020	EPI_ISL_582507	2020-04-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Portugal/PT1003/2020	EPI_ISL_582517	2020-03-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Submitter Note: Submitter confirmed the indel. It was inspected and detected with high coverage. Gap of 5 nucleotide(s) found at refpos 21886 (FRAMESHIFT).	info	B.1.1	GR
hCoV-19/Austria/CeMM0973/2020	EPI_ISL_583819	2020-04-01	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Wales/PHWC-47CDF5/2020	EPI_ISL_586052	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47D2D7/2020	EPI_ISL_586124	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47D86C/2020	EPI_ISL_586201	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A22341/2020	EPI_ISL_587391	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1DB14/2020	EPI_ISL_587400	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2239C/2020	EPI_ISL_587403	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1EE83/2020	EPI_ISL_587439	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1E454/2020	EPI_ISL_587442	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-A1DE48/2020	EPI_ISL_587460	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/QEUH-A22332/2020	EPI_ISL_587500	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F480/2020	EPI_ISL_587526	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-A223BA/2020	EPI_ISL_587529	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-A1DFEB/2020	EPI_ISL_587549	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F4F9/2020	EPI_ISL_587567	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1E894/2020	EPI_ISL_587573	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A212AF/2020	EPI_ISL_587579	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A20905/2020	EPI_ISL_587597	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3896/2020	EPI_ISL_588701	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3C6D/2020	EPI_ISL_588718	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5EDE/2020	EPI_ISL_588741	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F6426/2020	EPI_ISL_588765	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8916/2020	EPI_ISL_588778	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F898F/2020	EPI_ISL_588788	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9362/2020	EPI_ISL_588789	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F89AD/2020	EPI_ISL_588801	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F803F/2020	EPI_ISL_588807	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F873A/2020	EPI_ISL_588816	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8BD4/2020	EPI_ISL_588825	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F82EE/2020	EPI_ISL_588859	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5630/2020	EPI_ISL_588875	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F92FC/2020	EPI_ISL_588876	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8336/2020	EPI_ISL_588878	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F903E/2020	EPI_ISL_588880	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F8925/2020	EPI_ISL_588885	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F921A/2020	EPI_ISL_588894	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9890/2020	EPI_ISL_589032	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F95C6/2020	EPI_ISL_589044	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7908/2020	EPI_ISL_589049	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F283D/2020	EPI_ISL_589057	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D112A/2020	EPI_ISL_590010	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE4BE/2020	EPI_ISL_590016	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE1F3/2020	EPI_ISL_590024	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE472/2020	EPI_ISL_590028	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF0C8/2020	EPI_ISL_590033	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE5AC/2020	EPI_ISL_590037	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF7F0/2020	EPI_ISL_590038	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE454/2020	EPI_ISL_590064	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9CF2B3/2020	EPI_ISL_590065	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Japan/IC-0003/2020	EPI_ISL_591349	2020-03-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Great Britain (United Kingdom).	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1.89	GR
hCoV-19/Japan/IC-0004/2020	EPI_ISL_591350	2020-03-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Great Britain (United Kingdom).	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1.89	GR
hCoV-19/England/BIRM-6477E/2020	EPI_ISL_594512	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-64F3A/2020	EPI_ISL_594533	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-655FB/2020	EPI_ISL_594570	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A013FD/2020	EPI_ISL_595811	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/QEUH-A01C10/2020	EPI_ISL_595829	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A01C7A/2020	EPI_ISL_595833	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A3152B/2020	EPI_ISL_595899	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A31770/2020	EPI_ISL_595908	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A52463/2020	EPI_ISL_598029	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A514A0/2020	EPI_ISL_598043	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A511F4/2020	EPI_ISL_598046	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A517B6/2020	EPI_ISL_598067	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51200/2020	EPI_ISL_598080	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51E93/2020	EPI_ISL_598088	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A511E5/2020	EPI_ISL_598185	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51525/2020	EPI_ISL_598209	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A51BE7/2020	EPI_ISL_598217	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A517A7/2020	EPI_ISL_598223	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/QEUH-A0AF1E/2020	EPI_ISL_599346	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B171/2020	EPI_ISL_599368	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A0BD9B/2020	EPI_ISL_599385	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0AEF3/2020	EPI_ISL_599441	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0AED5/2020	EPI_ISL_599451	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0C398/2020	EPI_ISL_599455	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD012/2020	EPI_ISL_599520	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD908/2020	EPI_ISL_599523	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDFAC/2020	EPI_ISL_599533	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDA14/2020	EPI_ISL_599549	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E4F0C/2020	EPI_ISL_600945	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9E51BA/2020	EPI_ISL_600978	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E52A8/2020	EPI_ISL_600993	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E4A74/2020	EPI_ISL_600996	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEA6E/2020	EPI_ISL_601208	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEA7D/2020	EPI_ISL_601210	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DE6E2/2020	EPI_ISL_601216	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E02DA/2020	EPI_ISL_601280	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C5AF/2020	EPI_ISL_608001	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D0CB/2020	EPI_ISL_608007	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D33B/2020	EPI_ISL_608013	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D2D4/2020	EPI_ISL_608029	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C8D3/2020	EPI_ISL_608051	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D140/2020	EPI_ISL_608071	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6D0DA/2020	EPI_ISL_608076	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/ALDP-A4FF2C/2020	EPI_ISL_609210	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A51B9C/2020	EPI_ISL_609217	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A47B99/2020	EPI_ISL_609253	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A47B5D/2020	EPI_ISL_609265	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A47C1E/2020	EPI_ISL_609266	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/MILK-A477B3/2020	EPI_ISL_609275	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A45C01/2020	EPI_ISL_609303	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41494/2020	EPI_ISL_609308	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41713/2020	EPI_ISL_609338	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A42071/2020	EPI_ISL_609348	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-A422A8/2020	EPI_ISL_609360	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41BF9/2020	EPI_ISL_609391	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Russia/CRIE5047165/2020	EPI_ISL_610236	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE7158978/2020	EPI_ISL_610239	2020-08-24	Europe / Russia / Moscow	Human	Original	Autopsy material		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE7159118/2020	EPI_ISL_610240	2020-08-24	Europe / Russia / Moscow	Human	Original	Autopsy material		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE7158368/2020	EPI_ISL_610243	2020-08-24	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.349	GR
hCoV-19/Russia/CRIE7249896/2020	EPI_ISL_610244	2020-08-25	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/England/ALDP-A84FFE/2020	EPI_ISL_610299	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A8495A/2020	EPI_ISL_610302	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A849C3/2020	EPI_ISL_610326	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A84DF4/2020	EPI_ISL_610328	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85CE7/2020	EPI_ISL_610329	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85A92/2020	EPI_ISL_610336	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A8583E/2020	EPI_ISL_610350	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85995/2020	EPI_ISL_610363	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858B6/2020	EPI_ISL_610387	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A84FA3/2020	EPI_ISL_610394	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-480839/2020	EPI_ISL_612938	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-480A7F/2020	EPI_ISL_612964	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/Wales/PHWC-480ACA/2020	EPI_ISL_612968	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48212D/2020	EPI_ISL_613200	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Sweden/20-52702/2020	EPI_ISL_615100	2020-05-28	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Denmark/DCGC-5237/2020	EPI_ISL_615168	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5301/2020	EPI_ISL_615232	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5318/2020	EPI_ISL_615249	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3944/2020	EPI_ISL_615855	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3977/2020	EPI_ISL_615890	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-6299/2020	EPI_ISL_616380	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2576/2020	EPI_ISL_616407	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2578/2020	EPI_ISL_616409	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2896/2020	EPI_ISL_616412	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2897/2020	EPI_ISL_616413	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2898/2020	EPI_ISL_616414	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2572/2020	EPI_ISL_616430	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2712/2020	EPI_ISL_616445	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2816/2020	EPI_ISL_616452	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2820/2020	EPI_ISL_616456	2020-08-17	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2822/2020	EPI_ISL_616458	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2739/2020	EPI_ISL_616484	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2746/2020	EPI_ISL_616491	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2752/2020	EPI_ISL_616497	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2884/2020	EPI_ISL_616579	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2300/2020	EPI_ISL_617725	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.1.288	GR
hCoV-19/Denmark/DCGC-2304/2020	EPI_ISL_617729	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2308/2020	EPI_ISL_617733	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2474/2020	EPI_ISL_617742	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2476/2020	EPI_ISL_617744	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2480/2020	EPI_ISL_617748	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2518/2020	EPI_ISL_617754	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2493/2020	EPI_ISL_617764	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2511/2020	EPI_ISL_617783	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-5829/2020	EPI_ISL_621016	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5835/2020	EPI_ISL_621022	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5847/2020	EPI_ISL_621034	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5848/2020	EPI_ISL_621035	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4586/2020	EPI_ISL_622255	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4589/2020	EPI_ISL_622258	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-4590/2020	EPI_ISL_622259	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6358/2020	EPI_ISL_622305	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-6377/2020	EPI_ISL_622313	2020-09-28	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-6723/2020	EPI_ISL_622361	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/MILK-AB7F3E/2020	EPI_ISL_623564	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB753C/2020	EPI_ISL_623636	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AB15E7/2020	EPI_ISL_623654	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB87DB/2020	EPI_ISL_623670	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A958A4/2020	EPI_ISL_624820	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A94B15/2020	EPI_ISL_624829	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A96445/2020	EPI_ISL_624878	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A94571/2020	EPI_ISL_624890	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A94E76/2020	EPI_ISL_624906	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA0D2F/2020	EPI_ISL_624961	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-AA3797/2020	EPI_ISL_624978	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0BF8/2020	EPI_ISL_624988	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA563E/2020	EPI_ISL_625237	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA38B2/2020	EPI_ISL_625248	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Chile/AT-CMM-ATAC05/2020	EPI_ISL_626551	2020-07-25	South America / Chile / Atacama / Domeyko	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/Chile/AT-CMM-ATAC14/2020	EPI_ISL_626560	2020-08-07	South America / Chile / Atacama / Chañaral / El Salvador	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/England/QEUH-A3287C/2020	EPI_ISL_628362	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A3335C/2020	EPI_ISL_628372	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A33529/2020	EPI_ISL_628390	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-A33547/2020	EPI_ISL_628392	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A336CC/2020	EPI_ISL_628403	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A49A8B/2020	EPI_ISL_628449	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A49AC7/2020	EPI_ISL_628452	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A4B825/2020	EPI_ISL_628483	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-AC90CD/2020	EPI_ISL_629694	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8E5B/2020	EPI_ISL_629698	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACF2B2/2020	EPI_ISL_629713	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEE0A/2020	EPI_ISL_629737	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3D7E/2020	EPI_ISL_629757	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD260B/2020	EPI_ISL_629761	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD09C8/2020	EPI_ISL_629762	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2F4C/2020	EPI_ISL_629770	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2E4F/2020	EPI_ISL_629798	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2DE8/2020	EPI_ISL_629880	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1CEC/2020	EPI_ISL_629889	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE77E/2020	EPI_ISL_630703	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA26AA/2020	EPI_ISL_630713	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence. NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/QEUH-AAE644/2020	EPI_ISL_630718	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3991/2020	EPI_ISL_630726	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AAE073/2020	EPI_ISL_630761	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A44/2020	EPI_ISL_630772	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE107/2020	EPI_ISL_630778	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A17/2020	EPI_ISL_630783	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE0CE/2020	EPI_ISL_630787	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA38EF/2020	EPI_ISL_630796	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE6F9/2020	EPI_ISL_630853	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-NYCPHL-000989/2020	EPI_ISL_633015	2020-08-27	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001004/2020	EPI_ISL_633027	2020-10-05	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001008/2020	EPI_ISL_633029	2020-10-06	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/England/QEUH-AD491F/2020	EPI_ISL_634210	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD247A/2020	EPI_ISL_634227	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD3D23/2020	EPI_ISL_634236	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD2CEB/2020	EPI_ISL_634246	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC570/2020	EPI_ISL_634269	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7E4D/2020	EPI_ISL_634276	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC80BF/2020	EPI_ISL_634284	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD427/2020	EPI_ISL_634294	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-AD002D/2020	EPI_ISL_634305	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD6B8/2020	EPI_ISL_634315	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC67D/2020	EPI_ISL_634321	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8125/2020	EPI_ISL_634336	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC79C4/2020	EPI_ISL_634346	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-ALSR-2668/2020	EPI_ISL_635619	2020-07-12	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-2803/2020	EPI_ISL_635686	2020-07-22	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.356	GR
hCoV-19/Mozambique/KRISP-MZ158905/2020	EPI_ISL_636980	2020-07-14	Africa / Mozambique / Gaza / Xai Xai	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/England/MILK-A9150B/2020	EPI_ISL_638528	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4864A8/2020	EPI_ISL_639050	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-486D16/2020	EPI_ISL_639126	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-487085/2020	EPI_ISL_639162	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/South Africa/NHLS-UCT-GS-1433/2020	EPI_ISL_640072	2020-08-11	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/South Africa/NHLS-UCT-GS-2092/2020	EPI_ISL_640084	2020-09-25	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-2085/2020	EPI_ISL_640128	2020-09-23	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3468/2020	EPI_ISL_640133	2020-10-01	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3469/2020	EPI_ISL_640134	2020-10-01	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3522/2020	EPI_ISL_640141	2020-10-11	Africa / South Africa / Western Cape / Southern	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/England/QEUH-B1437E/2020	EPI_ISL_642659	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B126B3/2020	EPI_ISL_642675	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B10020/2020	EPI_ISL_642683	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1262C/2020	EPI_ISL_642689	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B0F22E/2020	EPI_ISL_642713	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B123E9/2020	EPI_ISL_642717	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1438D/2020	EPI_ISL_642722	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B12A3F/2020	EPI_ISL_642729	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10C3B/2020	EPI_ISL_642757	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1447B/2020	EPI_ISL_642760	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B01E0A/2020	EPI_ISL_642799	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B0600F/2020	EPI_ISL_642823	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8C6B5/2020	EPI_ISL_643093	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E089/2020	EPI_ISL_646200	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32170/2020	EPI_ISL_646205	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31C9E/2020	EPI_ISL_646219	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E10E/2020	EPI_ISL_646222	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E098/2020	EPI_ISL_646241	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B318B8/2020	EPI_ISL_646267	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31BEC/2020	EPI_ISL_646275	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31C61/2020	EPI_ISL_646288	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E274/2020	EPI_ISL_646295	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32055/2020	EPI_ISL_646304	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23BB0/2020	EPI_ISL_646307	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B321AD/2020	EPI_ISL_646315	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32116/2020	EPI_ISL_646339	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B20A7A/2020	EPI_ISL_647547	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B20DDB/2020	EPI_ISL_647581	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B20F99/2020	EPI_ISL_647595	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1A93A/2020	EPI_ISL_647630	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/Scotland/EDB8814/2020	EPI_ISL_652002	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-ACFE81/2020	EPI_ISL_652141	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-ACFEBE/2020	EPI_ISL_652143	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-ACFEFA/2020	EPI_ISL_652145	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC136/2020	EPI_ISL_652845	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/LA-EVTL684/2020	EPI_ISL_653376	2020-07-15	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL736/2020	EPI_ISL_653427	2020-07-17	North America / USA / Louisiana / Lincoln Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL750/2020	EPI_ISL_653441	2020-07-20	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.134	GR
hCoV-19/USA/LA-EVTL752/2020	EPI_ISL_653443	2020-07-20	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL753/2020	EPI_ISL_653444	2020-07-20	North America / USA / Louisiana / Bossier Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1.426	GR
hCoV-19/USA/LA-EVTL763/2020	EPI_ISL_653454	2020-07-21	North America / USA / Louisiana / Lincoln Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/MN-MDH-2019/2020	EPI_ISL_654700	2020-10-30	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2020/2020	EPI_ISL_654701	2020-10-30	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2021/2020	EPI_ISL_654702	2020-11-01	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2026/2020	EPI_ISL_654707	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2027/2020	EPI_ISL_654708	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2028/2020	EPI_ISL_654709	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2029/2020	EPI_ISL_654710	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2030/2020	EPI_ISL_654711	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2031/2020	EPI_ISL_654712	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2033/2020	EPI_ISL_654714	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2034/2020	EPI_ISL_654715	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2035/2020	EPI_ISL_654716	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2036/2020	EPI_ISL_654717	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2037/2020	EPI_ISL_654718	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2038/2020	EPI_ISL_654719	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2039/2020	EPI_ISL_654720	2020-11-03	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/England/QEUH-B67CBD/2020	EPI_ISL_655079	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68CCB/2020	EPI_ISL_655095	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-B5499E/2020	EPI_ISL_658203	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B549E9/2020	EPI_ISL_658206	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5461F/2020	EPI_ISL_658212	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B5A831/2020	EPI_ISL_658223	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-B5A79E/2020	EPI_ISL_658248	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A4D3/2020	EPI_ISL_658255	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-B54952/2020	EPI_ISL_658270	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B55BE2/2020	EPI_ISL_658273	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B519DD/2020	EPI_ISL_658317	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32D8B/2020	EPI_ISL_659507	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B350F8/2020	EPI_ISL_659509	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B34509/2020	EPI_ISL_659531	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3467F/2020	EPI_ISL_659543	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B34606/2020	EPI_ISL_659565	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B32CBB/2020	EPI_ISL_659580	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B349EF/2020	EPI_ISL_659614	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-B32CAC/2020	EPI_ISL_659649	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Taiwan/CGMH-CGU-31/2020	EPI_ISL_660543	2020-07-31	Asia / Taiwan / Taoyuan	Human	Vero E6	Throat Swab		Illumina MiSeq (assembled sequences)	SPAdes Version 3.14.1			B.1.1	GR
hCoV-19/England/QEUH-B7EF50/2020	EPI_ISL_661837	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7FDFB/2020	EPI_ISL_661841	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7F3CC/2020	EPI_ISL_661899	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B787D6/2020	EPI_ISL_661900	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7F03E/2020	EPI_ISL_661913	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7E9E9/2020	EPI_ISL_667966	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79984/2020	EPI_ISL_667971	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-11959/2020	EPI_ISL_671232	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	G
hCoV-19/Denmark/DCGC-11994/2020	EPI_ISL_671241	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20Z06465/2020	EPI_ISL_671372	2020-04-17	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/CA-CZB-13468/2020	EPI_ISL_672501	2020-10-22	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/MILK-B952C3/2020	EPI_ISL_673803	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B99EAD/2020	EPI_ISL_673816	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9AEAC/2020	EPI_ISL_673850	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8623E/2020	EPI_ISL_673895	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84E4B/2020	EPI_ISL_676010	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-B944FB/2020	EPI_ISL_676014	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B939DF/2020	EPI_ISL_676122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/WI-UW-2006/2020	EPI_ISL_677414	2020-09-10	North America / USA / Wisconsin / Milwaukee County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.1.453	GR
hCoV-19/USA/WI-UW-2082/2020	EPI_ISL_677487	2020-10-18	North America / USA / Wisconsin / Jefferson County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.1.453	GR
hCoV-19/England/204540971/2020	EPI_ISL_678658	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/NOTT-117366/2020	EPI_ISL_679925	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B2C08B/2020	EPI_ISL_680051	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/QEUH-B2C0F4/2020	EPI_ISL_680058	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/Wales/PHWC-48E7C5/2020	EPI_ISL_680912	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-BAA595/2020	EPI_ISL_681361	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/mink/Denmark/mDK-465/2020	EPI_ISL_683216	2020-10-23	Europe / Denmark	Neovison vison	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/mink/Denmark/mDK-466/2020	EPI_ISL_683217	2020-10-23	Europe / Denmark	Neovison vison	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/mink/Denmark/mDK-467/2020	EPI_ISL_683218	2020-10-23	Europe / Denmark	Neovison vison	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/France/ARA-40115/2020	EPI_ISL_683357	2020-05-23	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/England/ALDP-BB3195/2020	EPI_ISL_702637	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BCB929/2020	EPI_ISL_703973	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC3736/2020	EPI_ISL_703986	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A6206C/2020	EPI_ISL_704594	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/MILK-B3CA11/2020	EPI_ISL_706179	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3CB4B/2020	EPI_ISL_706186	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3CB78/2020	EPI_ISL_706188	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3CEBB/2020	EPI_ISL_706202	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3D5F1/2020	EPI_ISL_706230	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3D7BF/2020	EPI_ISL_706235	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3D7DD/2020	EPI_ISL_706237	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3DC1A/2020	EPI_ISL_706249	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3E11A/2020	EPI_ISL_706261	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-B3E226/2020	EPI_ISL_706266	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/NORT-1B70683/2020	EPI_ISL_706288	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B70744/2020	EPI_ISL_706290	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B70902/2020	EPI_ISL_706292	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B7093F/2020	EPI_ISL_706293	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B70A69/2020	EPI_ISL_706296	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B70EF4/2020	EPI_ISL_706299	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/QEUH-BEAFC8/2020	EPI_ISL_708906	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BE93BE/2020	EPI_ISL_708911	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-16201/2020	EPI_ISL_714633	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16207/2020	EPI_ISL_714638	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-16226/2020	EPI_ISL_714650	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16253/2020	EPI_ISL_714666	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16297/2020	EPI_ISL_714686	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16341/2020	EPI_ISL_714714	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-16373/2020	EPI_ISL_714731	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16405/2020	EPI_ISL_714747	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-16441/2020	EPI_ISL_714770	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/England/CAMC-C458A1/2020	EPI_ISL_719545	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-BB0BA9/2020	EPI_ISL_720522	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BBC5EB/2020	EPI_ISL_724159	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-496CBC/2020	EPI_ISL_726712	2020-11-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-496D5F/2020	EPI_ISL_726722	2020	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-496D7D/2020	EPI_ISL_726724	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-496D9B/2020	EPI_ISL_726726	2020-11-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-10CF125/2020	EPI_ISL_727928	2020-12-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D032B/2020	EPI_ISL_727938	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-C3C579/2020	EPI_ISL_731243	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/CO-NVRL-76IRL32312/2020	EPI_ISL_732464	2020-10-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LH-NVRL-20ILR11490/2020	EPI_ISL_732514	2020-11-24	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/England/ALDP-C58A1E/2020	EPI_ISL_736040	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C57C64/2020	EPI_ISL_736087	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C582CB/2020	EPI_ISL_736103	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-C5BD21/2020	EPI_ISL_736130	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/CA-CZB-13909/2020	EPI_ISL_738766	2020-08-07	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13833/2020	EPI_ISL_738783	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14134/2020	EPI_ISL_738788	2020-05-23	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14590/2020	EPI_ISL_739203	2020-10-08	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14117/2020	EPI_ISL_739207	2020-05-23	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13866/2020	EPI_ISL_739213	2020-08-12	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14387/2020	EPI_ISL_739236	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.277	GR
hCoV-19/Luxembourg/LNS2914409/2020	EPI_ISL_740217	2020-10-23	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/Wales/PHWC-49F5D6/2020	EPI_ISL_743239	2020-12-08	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-20129/2020	EPI_ISL_748001	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20147/2020	EPI_ISL_748013	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20167/2020	EPI_ISL_748022	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20220/2020	EPI_ISL_748058	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20319/2020	EPI_ISL_748112	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-20355/2020	EPI_ISL_748135	2020-09-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.2	GR
hCoV-19/USA/NY-CDC-2-3714160/2020	EPI_ISL_751658	2020-11-10	North America / USA / New York	Human	Original			Illumina	IRMA v0.9.5-beta			B.1.1.231	GR
hCoV-19/USA/LA-CDC-2-3714577/2020	EPI_ISL_751696	2020-12-02	North America / USA / Louisiana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	IRMA v0.9.5-beta			B.1.1.426	GR
hCoV-19/USA/CA-CHLA-PLM76481572/2020	EPI_ISL_753550	2020-11-30	North America / USA / California / Los Angeles	Human	Original			Illumina NextSeq	Novoalign v4.02.00 + LUBA consensus			B.1.1	GR
hCoV-19/USA/CA-IGI-0392/2020	EPI_ISL_754882	2020-07-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0411/2020	EPI_ISL_754892	2020-07-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0422/2020	EPI_ISL_754897	2020-07-06	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-SEARCH-5361/2020	EPI_ISL_755173	2020-12-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.174	GR
hCoV-19/USA/CA-SEARCH-5365/2020	EPI_ISL_755177	2020-12-14	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-SEARCH-5366/2020	EPI_ISL_755178	2020-12-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.174	GR
hCoV-19/England/ALDP-C88444/2020	EPI_ISL_756470	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C85034/2020	EPI_ISL_756525	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C8B6D2/2020	EPI_ISL_756556	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/QEUH-CADF39/2020	EPI_ISL_761095	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Algeria/G35155-8850/2020	EPI_ISL_766864	2020-07-15	Africa / Algeria / Bouira	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Wales/ALDP-C5979E/2020	EPI_ISL_767122	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-C597BC/2020	EPI_ISL_767127	2020-12-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-C3B8F9/2020	EPI_ISL_767229	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-C3BED9/2020	EPI_ISL_767288	2020-12-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Italy/CAM-TIGEM-235/2020	EPI_ISL_776913	2020-10-26	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1	GR
hCoV-19/Italy/CAM-TIGEM-254/2020	EPI_ISL_776923	2020-10-26	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			AD.2	GR
hCoV-19/Italy/CAM-TIGEM-267/2020	EPI_ISL_776959	2020-10-26	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			AD.2	GR
hCoV-19/Canada/ON-PHL-20-03650/2020	EPI_ISL_778846	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 1 nucleotide found at refpos 29581 (frameshift confirmed by the submitter).	info	AL.1	GR
hCoV-19/Canada/ON-PHL-20-03657/2020	EPI_ISL_778847	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 1 nucleotide found at refpos 29581 (frameshift confirmed by the submitter).	info	AL.1	GR
hCoV-19/Canada/ON-PHL-20-03673/2020	EPI_ISL_778848	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 1 nucleotide found at refpos 29581 (frameshift confirmed by the submitter).	info	AL.1	GR
hCoV-19/Canada/ON-PHL-20-03674/2020	EPI_ISL_778849	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 1 nucleotide found at refpos 29581 (frameshift confirmed by the submitter).	info	AL.1	GR
hCoV-19/Canada/ON-PHL-20-03778/2020	EPI_ISL_778853	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 1 nucleotide found at refpos 29581 (frameshift confirmed by the submitter).	info	AL.1	GR
hCoV-19/Japan/IC-0541/2020	EPI_ISL_779224	2020-10-20	Asia / Japan	Human	Original		COVID-19 positive case who entered from Turkey.	Illumina iSeq	A5-miseq v. 20140604	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Japan/IC-0560/2021	EPI_ISL_779243	2021-01-02	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.1.349	GR
hCoV-19/USA/TX-HMH-MCoV-9607/2020	EPI_ISL_780146	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-9577/2020	EPI_ISL_780165	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-9578/2020	EPI_ISL_780166	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9632/2020	EPI_ISL_780193	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9634/2020	EPI_ISL_780195	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-9678/2020	EPI_ISL_780220	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-MCoV-9706/2020	EPI_ISL_780235	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9725/2020	EPI_ISL_780244	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-9748/2020	EPI_ISL_780254	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9768/2020	EPI_ISL_780263	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-9830/2020	EPI_ISL_780296	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/England/QEUH-C32C9C/2020	EPI_ISL_782727	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C26B43/2020	EPI_ISL_782746	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-18667/2020	EPI_ISL_785015	2020-11-20	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-14790/2020	EPI_ISL_786275	2020-10-12	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14833/2020	EPI_ISL_786317	2020-10-13	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14897/2020	EPI_ISL_786381	2020-10-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-14909/2020	EPI_ISL_786393	2020-10-15	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-MCoV-14910/2020	EPI_ISL_786394	2020-10-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-14358/2020	EPI_ISL_787643	2020-10-05	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14376/2020	EPI_ISL_787661	2020-10-06	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/Denmark/DCGC-23016/2020	EPI_ISL_793474	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-23168/2020	EPI_ISL_793581	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/NY-MSHSPSP-PV12341/2020	EPI_ISL_802068	2020-05-04	North America / USA / New York / Brooklyn	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV12330/2020	EPI_ISL_802086	2020-05-04	North America / USA / New York / Nassau County	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NJ-MSHSPSP-PV15139/2020	EPI_ISL_802108	2020-07-01	North America / USA / New Jersey / Bergen County	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.1.402	GR
hCoV-19/USA/MI-MDHHS-SC22849/2020	EPI_ISL_804757	2020-11-19	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/USA/MI-MDHHS-SC22851/2020	EPI_ISL_804759	2020-11-18	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/USA/MI-MDHHS-SC22875/2020	EPI_ISL_804762	2020-11-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/USA/MI-MDHHS-SC22876/2020	EPI_ISL_804763	2020-11-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/Canada/AB-77505/2020	EPI_ISL_805290	2020-04-17	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-23011/2020	EPI_ISL_805955	2020-03-24	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-87897/2020	EPI_ISL_805966	2020-04-23	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-36547/2020	EPI_ISL_805971	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Wales/PHWC-4A9BF5/2020	EPI_ISL_815244	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Mozambique/Cento-30032996/2020	EPI_ISL_815255	2020-09-19	Africa / Mozambique	Human	Original	Oropharyngeal swab		Illumina NextSeq	Dragen 3.5.7			B.1.1	GR
hCoV-19/Germany/BY-Cento-36048188/2020	EPI_ISL_815347	2020-09-19	Europe / Germany / Bavaria / Munich	Human	Original	Oropharyngeal swab		Illumina NextSeq	Dragen 3.5.7			B.1.1	GR
hCoV-19/Romania/Cento-70116498/2020	EPI_ISL_815391	2020-07-24	Europe / Romania / Sanmihaiu Roman	Human	Original	Oropharyngeal swab		Illumina NextSeq	Dragen 3.5.7			B.1.1	GR
hCoV-19/England/SHEF-10D5B2E/2020	EPI_ISL_816597	2020-12-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D7852/2020	EPI_ISL_816635	2020-12-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/TFCI-26FA076/2020	EPI_ISL_816743	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001747/2020	EPI_ISL_823813	2020-12-11	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001744/2020	EPI_ISL_823816	2020-12-11	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001681/2020	EPI_ISL_823872	2020-12-08	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/Iceland/3589/2020	EPI_ISL_827281	2020-11-01	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	MPileup			B.1.1	GR
hCoV-19/Iceland/4989/2020	EPI_ISL_828677	2020-10-24	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/Iceland/6274/2020	EPI_ISL_829949	2020-10-28	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/England/OXON-F44BB5/2020	EPI_ISL_840309	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/LOND-1286BDF/2020	EPI_ISL_842831	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Denmark/DCGC-28930/2021	EPI_ISL_845233	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-28996/2021	EPI_ISL_845250	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/OH-ODH-SC51220/2020	EPI_ISL_847824	2020-07-04	North America / USA / Ohio	Human	Original			Illumina MiSeq				B.1.1.337	GR
hCoV-19/USA/NY-NYCPHL-002196/2021	EPI_ISL_857074	2021-01-05	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002220/2021	EPI_ISL_857083	2021-01-05	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002352/2021	EPI_ISL_857174	2021-01-11	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002354/2021	EPI_ISL_857176	2021-01-11	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002150/2021	EPI_ISL_857225	2021-01-04	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/United Arab Emirates/3663/2020	EPI_ISL_859803	2020-10-27	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/3692/2020	EPI_ISL_859810	2020-10-22	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3698/2020	EPI_ISL_859812	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3711/2020	EPI_ISL_859817	2020-10-22	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3726/2020	EPI_ISL_859825	2020-10-17	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3730/2020	EPI_ISL_859829	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3739/2020	EPI_ISL_859832	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3756/2020	EPI_ISL_859838	2020-10-19	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3757/2020	EPI_ISL_859839	2020-10-19	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NSP3_Q775stop results in 60.2% truncation of the protein sequence.	info	B.1.1.315	GR
hCoV-19/United Arab Emirates/3793/2020	EPI_ISL_859847	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3802/2020	EPI_ISL_859851	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3809/2020	EPI_ISL_859853	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3823/2020	EPI_ISL_859858	2020-11-21	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3877/2020	EPI_ISL_859886	2020-11-25	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/3880/2020	EPI_ISL_859887	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.315	GR
hCoV-19/Belarus/ChVir21878/2020	EPI_ISL_860813	2020-10-28	Europe / Belarus	Human	Original			Illumina MiSeq	bowtie2			B.1.1.294	GR
hCoV-19/England/MILK-FAF07D/2021	EPI_ISL_864301	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-FAFCD3/2021	EPI_ISL_864396	2021-01-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ireland/WH-NVRL-MPW60621/2020	EPI_ISL_869162	2020-04-15	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WH-NVRL-MPJ82649/2020	EPI_ISL_869164	2020-04-15	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Denmark/DCGC-33172/2021	EPI_ISL_870177	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-33191/2021	EPI_ISL_870196	2021-01-11	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 7 nucleotide(s) found at refpos 28219 (frameshift confirmed by the submitter). NS8 without BLAST coverage.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-33233/2021	EPI_ISL_870238	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-34510/2020	EPI_ISL_871521	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/USA/NC-UNC-LCCC0072/2020	EPI_ISL_877653	2020-07-13	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/USA/NC-UNC-LCCC0074/2020	EPI_ISL_877655	2020-07-31	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/USA/NC-UNC-LCCC0077/2020	EPI_ISL_877658	2020-07-31	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/USA/NC-UNC-LCCC0084/2020	EPI_ISL_877665	2020-08-01	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/USA/NC-UNC-LCCC0115/2020	EPI_ISL_877696	2020-08-23	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/England/CAMC-105EBB4/2021	EPI_ISL_878818	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002181/2020	EPI_ISL_883350	2020-12-31	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-Wadsworth-21008800-01/2021	EPI_ISL_883466	2021-01-05	North America / USA / New York / New York County	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/USA/NY-Wadsworth-21008860-01/2021	EPI_ISL_883484	2021-01-10	North America / USA / New York / Suffolk County	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1.467	GR
hCoV-19/Ghana/WACCBIP-GS03/2020	EPI_ISL_884828	2020-07-20	Africa / Ghana	Human	Original	Nasal swab		MinION	Artic v. 1.1.3			B.1.1.359	GR
hCoV-19/Ghana/WACCBIP-GS34/2020	EPI_ISL_884854	2020-08-03	Africa / Ghana	Human	Original	Nasal swab		MinION	Artic v. 1.1.3			B.1.1.359	GR
hCoV-19/USA/AZ-CDC-LC00000181/2020	EPI_ISL_888332	2020-12-26	North America / USA / Arizona	Human	Original	Nasal Swabs		PacBio	CLC Genomics			B.1.1.231	GR
hCoV-19/Congo/Q001C116AO_2101-TM-r1-030/2021	EPI_ISL_912379	2021-01-05	Africa / Republic of the Congo / Brazzaville	Human	Original	Oropharyngeal swab		Illumina MiSeq	nf-core / viralrecon	Gap of 11 nucleotides when compared to the reference sequence.	info	B.1.1.349	GR
hCoV-19/Denmark/DCGC-38098/2021	EPI_ISL_929239	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-39081/2020	EPI_ISL_930223	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-39169/2021	EPI_ISL_930311	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/IL-NM-0821/2020	EPI_ISL_936502	2020-05-18	North America / USA / Illinois / DuPage County	Human	Original			Illumina MiSeq	ARTIC			B.1.1	GR
hCoV-19/England/ALDP-1145223/2021	EPI_ISL_948518	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 21 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/OXON-F44BF1/2020	EPI_ISL_950797	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-11961DB/2021	EPI_ISL_959115	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Germany/HH-HPI-p2994/2020	EPI_ISL_960069	2020-08-15	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.1.294	O
hCoV-19/South Africa/NHLS-UCT-GS-2420/2020	EPI_ISL_960165	2020-06-06	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina Miseq				B.1.1.34	GR
hCoV-19/USA/OH-ODH-SC57769/2020	EPI_ISL_965030	2020-07-15	North America / USA / Ohio	Human	Original			Illumina MiSeq				B.1.1.337	GR
hCoV-19/Canada/ON-PHL-20-80854/2020	EPI_ISL_966229	2020-03	North America / Canada / Ontario	Human	Original			unknown	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-80848/2020	EPI_ISL_966232	2020-03	North America / Canada / Ontario	Human	Original			unknown	ncov2019-artic-nv (OICR v1.6)			B.1.1	GR
hCoV-19/Denmark/DCGC-40507/2021	EPI_ISL_972184	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/AZ-ASPHL-3637/2021	EPI_ISL_978377	2021-01-28	North America / USA / Arizona / Apache	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.231	GR
hCoV-19/Ireland/TA-NVRL-20Z13164/2020	EPI_ISL_981249	2020-05-08	Europe / Ireland / Tipperary	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-20Z14264/2020	EPI_ISL_981257	2020-05-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.399	GR
hCoV-19/England/EXET-144F20/2021	EPI_ISL_997331	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Switzerland/BE-ETHZ-470277/2021	EPI_ISL_1003586	2021-01-24	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/SO-ETHZ-431430/2020	EPI_ISL_1004846	2020-12-29	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-431270/2020	EPI_ISL_1004916	2020-12-28	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-431280/2020	EPI_ISL_1004930	2020-12-28	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-431224/2020	EPI_ISL_1004972	2020-12-27	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.294	GR
hCoV-19/Netherlands/ZH-RIVM-12199/2021	EPI_ISL_1014211	2021-02-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Ecuador/ZZL-7/2020	EPI_ISL_1014238	2020-10-30	South America / Ecuador / Quito	Human	Original			lllumina MiSeq				B.1.1.231	GR
hCoV-19/Belgium/AZKLINA121-030338/2021	EPI_ISL_1020139	2021-02-08	Europe / Belgium / Antwerp	Human	Original			Illumina MiSeq	Sophia DDM			B.1.1.522	GR
hCoV-19/Belgium/AZKLINA121-032935/2021	EPI_ISL_1020156	2021-02-11	Europe / Belgium / Antwerp	Human	Original			Illumina MiSeq	Sophia DDM			B.1.1.522	GR
hCoV-19/Belgium/AZKLINA121-034546/2021	EPI_ISL_1020159	2021-02-14	Europe / Belgium / Antwerp	Human	Original			Illumina MiSeq	Sophia DDM			B.1.1	GR
hCoV-19/Indonesia/BGR-LIPI036/2020	EPI_ISL_1020193	2020-10-16	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Indonesia/BGR-LIPI049/2021	EPI_ISL_1020199	2021-01-18	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.1.398	GR
hCoV-19/Mexico/CMX-INMEGEN-01-04-02/2021	EPI_ISL_1040564	2021-01-16	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Nanopore MinION	MEDAKA			B.1.1	GR
hCoV-19/USA/NY-NYULH172/2021	EPI_ISL_1050062	2021-01-15	North America / USA / New York / Brooklyn	Human	Original			Amplicon (Swift), Illumina Novaseq	BWA v0.7.17, bases below 1000x coverage masked			B.1.1	GR
hCoV-19/Denmark/DCGC-46353/2021	EPI_ISL_1065863	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-23362/2021	EPI_ISL_1077892	2021-01-12	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/NY-NYULH335/2021	EPI_ISL_1087344	2021-02-03	North America / USA / New York / Brooklyn	Human	Original			Amplicon (Swift), Illumina Novaseq	BWA v0.7.17, bases below 1000x coverage masked			B.1.1.231	GR
hCoV-19/Netherlands/NB-RIVM-13565/2021	EPI_ISL_1089995	2021-02-08	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Switzerland/BL-SNRCI-29950902/2020	EPI_ISL_414021	2020-02-27	Europe / Switzerland / Basel-Landschaft	Human	Original			unknown				B.1.1	GR
hCoV-19/Switzerland/GE-SNRCI-29949586/2020	EPI_ISL_414022	2020-02-27	Europe / Switzerland / Geneve	Human	Original			unknown				B.1.1	GR
hCoV-19/Hungary/mbl49/2020	EPI_ISL_416744	2020-03-20	Europe / Hungary / Baranya	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1.5	GR
hCoV-19/Portugal/PT0007/2020	EPI_ISL_417992	2020-03-07	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0010/2020	EPI_ISL_417995	2020-03-08	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/England/20132107304/2020	EPI_ISL_423844	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/NY-NYUMC172/2020	EPI_ISL_427469	2020-04-01	North America / USA / New York / Manhattan	Human	Original			Targeted capture, Illumina Novaseq	bwa/0.7.17, mapped to NC_045512v2, bases below 30x coverage masked			B.1.1	GR
hCoV-19/Scotland/CVR491/2020	EPI_ISL_433304	2020-03-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/France/OCC-1/2020	EPI_ISL_434616	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-2/2020	EPI_ISL_434617	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-3/2020	EPI_ISL_434618	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-4/2020	EPI_ISL_434619	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-5/2020	EPI_ISL_434620	2020-03	Europe / France / Occitanie	Human	Vero			MinION				B.1.1.254	GR
hCoV-19/France/OCC-11/2020	EPI_ISL_434626	2020-03-26	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-12/2020	EPI_ISL_434627	2020-03-26	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-13/2020	EPI_ISL_434628	2020-04-07	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-14/2020	EPI_ISL_434629	2020-04-07	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-15/2020	EPI_ISL_434630	2020-04-08	Europe / France / Occitanie	Human	Original			MinION				B.1	GR
hCoV-19/France/OCC-20/2020	EPI_ISL_434635	2020-04-11	Europe / France / Occitanie	Human	Original			MinION				B.1	G
hCoV-19/Austria/CeMM0287/2020	EPI_ISL_438112	2020-03-26	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/CAMB-7766C/2020	EPI_ISL_439368	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-772A4/2020	EPI_ISL_439428	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7768A/2020	EPI_ISL_439443	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-776C6/2020	EPI_ISL_439449	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7666D/2020	EPI_ISL_439491	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-73FFC/2020	EPI_ISL_440335	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-758A4/2020	EPI_ISL_440351	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7524C/2020	EPI_ISL_440375	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D903/2020	EPI_ISL_441668	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FA986/2020	EPI_ISL_441693	2020-04-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D52D/2020	EPI_ISL_441721	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80BF8/2020	EPI_ISL_442914	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-7EE21/2020	EPI_ISL_442956	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.220	GR
hCoV-19/USA/CA-CZB-1123/2020	EPI_ISL_445171	2020-03-27	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	O
hCoV-19/France/IDF-10007LJ/2020	EPI_ISL_447725	2020-03	Europe / France	Human	Original			Illumina	BWA-MEM v. 0.7.17			B.1.1	GR
hCoV-19/Colombia/NAR-GUR-0609/2020	EPI_ISL_447748	2020-03-29	South America / Colombia / Narino / Ipiales	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.231	GR
hCoV-19/England/CAMB-1ACFF9/2020	EPI_ISL_447955	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/NOTT-11127E/2020	EPI_ISL_453638	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11128D/2020	EPI_ISL_453639	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11129C/2020	EPI_ISL_453640	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1112AB/2020	EPI_ISL_453641	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1112BA/2020	EPI_ISL_453642	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C88A2/2020	EPI_ISL_453729	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.5	O
hCoV-19/England/SHEF-CDD17/2020	EPI_ISL_453755	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.5	GR
hCoV-19/England/EXET-135C0D/2020	EPI_ISL_457146	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135C76/2020	EPI_ISL_457150	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-136C0C/2020	EPI_ISL_457256	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D59CD/2020	EPI_ISL_457287	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BRIS-129FD6/2020	EPI_ISL_458449	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A209/2020	EPI_ISL_458456	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A1B1/2020	EPI_ISL_458457	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2891A0/2020	EPI_ISL_458601	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-289410/2020	EPI_ISL_458612	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-170C24/2020	EPI_ISL_459718	2020-03-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Netherlands/NA_588/2020	EPI_ISL_460752	2020	Europe / Netherlands	Human	Original			Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/VA-DCLS-0366/2020	EPI_ISL_463126	2020-04-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0371/2020	EPI_ISL_463127	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0372/2020	EPI_ISL_463128	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/VA-DCLS-0373/2020	EPI_ISL_463129	2020-05-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/England/201080064/2020	EPI_ISL_464452	2020-03-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100050/2020	EPI_ISL_466972	2020-03-11	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Saudi Arabia/42952/2020	EPI_ISL_469242	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/England/CAMB-1AA8B4/2020	EPI_ISL_470102	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-1AB6F5/2020	EPI_ISL_470132	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1ABB9C/2020	EPI_ISL_470148	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1AB798/2020	EPI_ISL_470214	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB1F4/2020	EPI_ISL_470265	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/OXON-B0755/2020	EPI_ISL_478905	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0A6B/2020	EPI_ISL_478931	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0BFF/2020	EPI_ISL_478945	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/HECH-2599FF5/2020	EPI_ISL_482118	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-103F0F/2020	EPI_ISL_482134	2020-04-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12EC70/2020	EPI_ISL_488284	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F28C/2020	EPI_ISL_488296	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F028/2020	EPI_ISL_488316	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-170F1C/2020	EPI_ISL_489602	2020-03-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-1659EF/2020	EPI_ISL_490751	2020-06-18	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-165ACE/2020	EPI_ISL_490763	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166D2E/2020	EPI_ISL_494106	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166D6A/2020	EPI_ISL_494109	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166DD3/2020	EPI_ISL_494115	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166E1C/2020	EPI_ISL_494118	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166E58/2020	EPI_ISL_494121	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166F0A/2020	EPI_ISL_494130	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166F64/2020	EPI_ISL_494133	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-167060/2020	EPI_ISL_494146	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1681A8/2020	EPI_ISL_494208	2020-05-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16831B/2020	EPI_ISL_494226	2020-04-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Portugal/PT0886/2020	EPI_ISL_511144	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0900/2020	EPI_ISL_511157	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0902/2020	EPI_ISL_511159	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Scotland/CVR3933/2020	EPI_ISL_512475	2020-06-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1695F6/2020	EPI_ISL_512485	2020-07-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-CZB-2159/2020	EPI_ISL_513709	2020-05-21	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2161/2020	EPI_ISL_513711	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2162/2020	EPI_ISL_513712	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2164/2020	EPI_ISL_513714	2020-05-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2184/2020	EPI_ISL_513734	2020-05-26	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2194/2020	EPI_ISL_513743	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2195/2020	EPI_ISL_513744	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2196/2020	EPI_ISL_513745	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2205/2020	EPI_ISL_513753	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2206/2020	EPI_ISL_513754	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2207/2020	EPI_ISL_513755	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2208/2020	EPI_ISL_513756	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2209/2020	EPI_ISL_513757	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2210/2020	EPI_ISL_513758	2020-05-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2212/2020	EPI_ISL_513760	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2213/2020	EPI_ISL_513761	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2218/2020	EPI_ISL_513766	2020-05-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-2339/2020	EPI_ISL_513789	2020-05-12	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2344/2020	EPI_ISL_513793	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2346/2020	EPI_ISL_513795	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2347/2020	EPI_ISL_513796	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2350/2020	EPI_ISL_513798	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2353/2020	EPI_ISL_513800	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2354/2020	EPI_ISL_513801	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2355/2020	EPI_ISL_513802	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2356/2020	EPI_ISL_513803	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2357/2020	EPI_ISL_513804	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2391/2020	EPI_ISL_513822	2020-05-18	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.132	GR
hCoV-19/Netherlands/FR-EMC-50/2020	EPI_ISL_523142	2020-05-28	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Switzerland/ZH-UZH-1000478320/2020	EPI_ISL_524478	2020-03-02	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT, 15% ambiguity threshold			B.1.1	GR
hCoV-19/Switzerland/ZH-UZH-1000478554/2020	EPI_ISL_524479	2020-03-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT, 15% ambiguity threshold			B.1.1	GR
hCoV-19/England/BRIS-133883/2020	EPI_ISL_524487	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/BRIS-133874/2020	EPI_ISL_524488	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/England/BRIS-133838/2020	EPI_ISL_524492	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/Scotland/GCVR-170DA9/2020	EPI_ISL_524494	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1AE759/2020	EPI_ISL_524591	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-99027F/2020	EPI_ISL_530375	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96F40A/2020	EPI_ISL_530459	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-962ECD/2020	EPI_ISL_531593	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-963907/2020	EPI_ISL_531598	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961FAD/2020	EPI_ISL_531599	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963354/2020	EPI_ISL_531617	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9626B6/2020	EPI_ISL_531619	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96280B/2020	EPI_ISL_531625	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961FDA/2020	EPI_ISL_531631	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96363D/2020	EPI_ISL_531638	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962276/2020	EPI_ISL_531639	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962C69/2020	EPI_ISL_531649	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-962A50/2020	EPI_ISL_531651	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-965AE4/2020	EPI_ISL_531660	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962FCA/2020	EPI_ISL_531672	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9631D2/2020	EPI_ISL_531678	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-962522/2020	EPI_ISL_531718	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96357C/2020	EPI_ISL_531743	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9636E2/2020	EPI_ISL_531754	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96372B/2020	EPI_ISL_531755	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9628FC/2020	EPI_ISL_531760	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-962A8D/2020	EPI_ISL_531798	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/PHWC-16A2EF/2020	EPI_ISL_535230	2020-09-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A3FB/2020	EPI_ISL_535246	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Italy/LOM-UniMI-L361/2020	EPI_ISL_542293	2020-03-05	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L395/2020	EPI_ISL_542317	2020-03-09	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L430/2020	EPI_ISL_542349	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L439/2020	EPI_ISL_542358	2020-03-28	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L444/2020	EPI_ISL_542363	2020-03-20	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L55/2020	EPI_ISL_542402	2020-03-02	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/USA/TX-HMH-4389/2020	EPI_ISL_543582	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4390/2020	EPI_ISL_543583	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-4463/2020	EPI_ISL_543640	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4479/2020	EPI_ISL_543654	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4518/2020	EPI_ISL_543687	2020-06-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4544/2020	EPI_ISL_543707	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-4547/2020	EPI_ISL_543710	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4587/2020	EPI_ISL_543737	2020-06-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5649/2020	EPI_ISL_544933	2020-06-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-6109/2020	EPI_ISL_547244	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-6115/2020	EPI_ISL_547251	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-6116/2020	EPI_ISL_547252	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-6181/2020	EPI_ISL_547295	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/England/QEUH-9B8C37/2020	EPI_ISL_549713	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B8FE3/2020	EPI_ISL_549717	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9F6A/2020	EPI_ISL_549728	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B8C0A/2020	EPI_ISL_549730	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B99A8/2020	EPI_ISL_549731	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B9D33/2020	EPI_ISL_549734	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9B9E8B/2020	EPI_ISL_549756	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8F10/2020	EPI_ISL_549764	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8FC5/2020	EPI_ISL_549802	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8CCE/2020	EPI_ISL_549803	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D45E/2020	EPI_ISL_549808	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99D48B/2020	EPI_ISL_549879	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CBE1/2020	EPI_ISL_549886	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D00F/2020	EPI_ISL_549896	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D8BC/2020	EPI_ISL_550705	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C5B6/2020	EPI_ISL_550711	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DF6C/2020	EPI_ISL_550716	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E38D/2020	EPI_ISL_550720	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99DA3E/2020	EPI_ISL_550727	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D7DD/2020	EPI_ISL_550737	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C905/2020	EPI_ISL_550738	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E39C/2020	EPI_ISL_550747	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E587/2020	EPI_ISL_550753	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA7A0/2020	EPI_ISL_550857	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA48B/2020	EPI_ISL_550862	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AAC38/2020	EPI_ISL_550886	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9AA430/2020	EPI_ISL_550894	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-9712B0/2020	EPI_ISL_553029	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9718BE/2020	EPI_ISL_553031	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9702DF/2020	EPI_ISL_553042	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-951070/2020	EPI_ISL_554227	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956B7A/2020	EPI_ISL_554237	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956CC2/2020	EPI_ISL_554247	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-956D65/2020	EPI_ISL_554262	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-95117D/2020	EPI_ISL_554263	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95108F/2020	EPI_ISL_554270	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95116E/2020	EPI_ISL_554279	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951007/2020	EPI_ISL_554280	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95109E/2020	EPI_ISL_554282	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956A13/2020	EPI_ISL_554284	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-956AB9/2020	EPI_ISL_554290	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956D56/2020	EPI_ISL_554291	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-9570B6/2020	EPI_ISL_554294	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95082E/2020	EPI_ISL_554323	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95367C/2020	EPI_ISL_554345	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953418/2020	EPI_ISL_554364	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950BF8/2020	EPI_ISL_554365	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954374/2020	EPI_ISL_554374	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950800/2020	EPI_ISL_554379	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953779/2020	EPI_ISL_554399	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C7D/2020	EPI_ISL_554405	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-955452/2020	EPI_ISL_554417	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953427/2020	EPI_ISL_554443	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9558DE/2020	EPI_ISL_554444	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95AFE3/2020	EPI_ISL_555572	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94DC55/2020	EPI_ISL_555576	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95AE22/2020	EPI_ISL_555592	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9524CE/2020	EPI_ISL_555622	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D921/2020	EPI_ISL_555627	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94492A/2020	EPI_ISL_555630	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-94D97C/2020	EPI_ISL_555672	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95AF4D/2020	EPI_ISL_555694	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94DC28/2020	EPI_ISL_555727	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9448F0/2020	EPI_ISL_555734	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-944896/2020	EPI_ISL_555740	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95AD9E/2020	EPI_ISL_555744	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94B686/2020	EPI_ISL_555771	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-942CAB/2020	EPI_ISL_556875	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-948917/2020	EPI_ISL_556932	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9452D3/2020	EPI_ISL_556933	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9478B1/2020	EPI_ISL_556945	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.421	GR
hCoV-19/England/CAMC-944F28/2020	EPI_ISL_556948	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-94572F/2020	EPI_ISL_556950	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9484AD/2020	EPI_ISL_556960	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-948328/2020	EPI_ISL_556968	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-4B8470/2020	EPI_ISL_559194	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4F4F3B/2020	EPI_ISL_559205	2020-06-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-500144/2020	EPI_ISL_559214	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-4B2519/2020	EPI_ISL_559263	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F40DE/2020	EPI_ISL_559288	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4FBE19/2020	EPI_ISL_559292	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/Wales/PHWC-16ABC6/2020	EPI_ISL_560167	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AC2D/2020	EPI_ISL_560173	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AE27/2020	EPI_ISL_560205	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AE72/2020	EPI_ISL_560210	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AF7F/2020	EPI_ISL_560226	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B0E4/2020	EPI_ISL_560244	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B14B/2020	EPI_ISL_560249	2020-09-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B22A/2020	EPI_ISL_560261	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9CD3EF/2020	EPI_ISL_566200	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDCF3/2020	EPI_ISL_566202	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD200/2020	EPI_ISL_566222	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD8D1/2020	EPI_ISL_566225	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDB8D/2020	EPI_ISL_566227	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDD69/2020	EPI_ISL_566244	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD9B0/2020	EPI_ISL_566247	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE85/2020	EPI_ISL_566260	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD0D9/2020	EPI_ISL_566269	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDA08/2020	EPI_ISL_566275	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCD6A/2020	EPI_ISL_566319	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDBAB/2020	EPI_ISL_566329	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CDA44/2020	EPI_ISL_566358	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDA53/2020	EPI_ISL_566382	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCF19/2020	EPI_ISL_566405	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD112/2020	EPI_ISL_566407	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CDDB4/2020	EPI_ISL_566412	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE67/2020	EPI_ISL_566414	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE58/2020	EPI_ISL_566419	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C54B7/2020	EPI_ISL_567538	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5D9E/2020	EPI_ISL_567539	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5BFE/2020	EPI_ISL_567547	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C52F9/2020	EPI_ISL_567550	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5A88/2020	EPI_ISL_567567	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5684/2020	EPI_ISL_567596	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5C0A/2020	EPI_ISL_567599	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4C65/2020	EPI_ISL_567624	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E50/2020	EPI_ISL_567629	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5D8F/2020	EPI_ISL_567650	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4D26/2020	EPI_ISL_567666	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/ALDP-9C54F3/2020	EPI_ISL_567676	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4D80/2020	EPI_ISL_567687	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5A79/2020	EPI_ISL_567711	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C59F4/2020	EPI_ISL_567712	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5CDD/2020	EPI_ISL_567717	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5AA6/2020	EPI_ISL_567749	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/VA-DCLS-1409/2020	EPI_ISL_572244	2020-07-11	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1308/2020	EPI_ISL_572248	2020-07-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/VA-DCLS-1311/2020	EPI_ISL_572253	2020-07-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1328/2020	EPI_ISL_572259	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1346/2020	EPI_ISL_572265	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1350/2020	EPI_ISL_572266	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1217/2020	EPI_ISL_572284	2020-06-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/QEUH-9AEB28/2020	EPI_ISL_573479	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB37/2020	EPI_ISL_573480	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB46/2020	EPI_ISL_573481	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB64/2020	EPI_ISL_573482	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB73/2020	EPI_ISL_573483	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEBEC/2020	EPI_ISL_573486	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEC07/2020	EPI_ISL_573488	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEC70/2020	EPI_ISL_573490	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AECE9/2020	EPI_ISL_573495	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AECF8/2020	EPI_ISL_573496	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED04/2020	EPI_ISL_573497	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED22/2020	EPI_ISL_573498	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED40/2020	EPI_ISL_573499	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED9B/2020	EPI_ISL_573502	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDAA/2020	EPI_ISL_573503	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDB9/2020	EPI_ISL_573504	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDC8/2020	EPI_ISL_573505	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDD7/2020	EPI_ISL_573506	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE01/2020	EPI_ISL_573507	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE10/2020	EPI_ISL_573508	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE2F/2020	EPI_ISL_573509	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE3E/2020	EPI_ISL_573510	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE4D/2020	EPI_ISL_573511	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF68/2020	EPI_ISL_573517	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF77/2020	EPI_ISL_573518	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF95/2020	EPI_ISL_573520	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEFB3/2020	EPI_ISL_573521	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEFD1/2020	EPI_ISL_573523	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3ABA/2020	EPI_ISL_573527	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3AD8/2020	EPI_ISL_573528	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9B3B4E/2020	EPI_ISL_573534	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3B99/2020	EPI_ISL_573536	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3C2D/2020	EPI_ISL_573542	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3C4B/2020	EPI_ISL_573543	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3D57/2020	EPI_ISL_573548	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3EAF/2020	EPI_ISL_573556	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3F06/2020	EPI_ISL_573558	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B4002/2020	EPI_ISL_573563	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/QEUH-9B9F5B/2020	EPI_ISL_573567	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9B9FD3/2020	EPI_ISL_573569	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA048/2020	EPI_ISL_573572	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BA066/2020	EPI_ISL_573573	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BA109/2020	EPI_ISL_573579	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA172/2020	EPI_ISL_573583	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA2F7/2020	EPI_ISL_573587	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA37C/2020	EPI_ISL_573588	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA479/2020	EPI_ISL_573590	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA576/2020	EPI_ISL_573594	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Switzerland/BE-UNIBE-197-5085/2020	EPI_ISL_574835	2020-03-24	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1.1	GR
hCoV-19/Switzerland/BE-UNIBE-200-5795/2020	EPI_ISL_574838	2020-03-26	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-100343/2020	EPI_ISL_574894	2020-03-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/MILK-9919D3/2020	EPI_ISL_577011	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-9919E2/2020	EPI_ISL_577012	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-991B28/2020	EPI_ISL_577023	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991BEC/2020	EPI_ISL_577030	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991C07/2020	EPI_ISL_577032	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991C16/2020	EPI_ISL_577033	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9E1716/2020	EPI_ISL_577083	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/WI-WSLH-200113/2020	EPI_ISL_578344	2020-04-06	North America / USA / Wisconsin / Dane County	Human	Original			Nanopore MinION	ARTIC Pipeline			B.1.1	GR
hCoV-19/England/ALDP-9E6FEC/2020	EPI_ISL_580504	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E73EF/2020	EPI_ISL_580521	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E691B/2020	EPI_ISL_580523	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6E49/2020	EPI_ISL_580543	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/CAMC-9EC57B/2020	EPI_ISL_580557	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC55D/2020	EPI_ISL_580569	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E65F9/2020	EPI_ISL_580580	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9E625C/2020	EPI_ISL_580591	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC2ED/2020	EPI_ISL_580593	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6F64/2020	EPI_ISL_580608	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC405/2020	EPI_ISL_580610	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9E674E/2020	EPI_ISL_580615	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6D2E/2020	EPI_ISL_580616	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC308/2020	EPI_ISL_580618	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6EEF/2020	EPI_ISL_580622	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-9EDE06/2020	EPI_ISL_580651	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-9E9A42/2020	EPI_ISL_584282	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B6378/2020	EPI_ISL_584285	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9E386C/2020	EPI_ISL_585519	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A00DB4/2020	EPI_ISL_585573	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A00DC3/2020	EPI_ISL_585574	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/ALDP-A2D8B0/2020	EPI_ISL_586840	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A2D944/2020	EPI_ISL_586859	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E61F/2020	EPI_ISL_586864	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D829/2020	EPI_ISL_586885	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8BA7/2020	EPI_ISL_589008	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7E27/2020	EPI_ISL_589069	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F961E/2020	EPI_ISL_589076	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F268E/2020	EPI_ISL_589091	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F235A/2020	EPI_ISL_589097	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CEB31/2020	EPI_ISL_590044	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF3ED/2020	EPI_ISL_590048	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF59C/2020	EPI_ISL_590055	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF963/2020	EPI_ISL_590060	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF65D/2020	EPI_ISL_590082	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CED95/2020	EPI_ISL_590090	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF4EA/2020	EPI_ISL_590094	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE1E4/2020	EPI_ISL_590097	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE8D0/2020	EPI_ISL_590098	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE7E2/2020	EPI_ISL_590099	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/ON-S753/2020	EPI_ISL_591216	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S806/2020	EPI_ISL_591235	2020-04	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S850/2020	EPI_ISL_591247	2020-04-11	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S883/2020	EPI_ISL_591254	2020-04-12	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S894/2020	EPI_ISL_591256	2020-04-12	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S910/2020	EPI_ISL_591259	2020-04-13	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Japan/IC-0029/2020	EPI_ISL_591373	2020-05-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Canada.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0037/2020	EPI_ISL_591379	2020-05-05	Asia / Japan	Human	Original		COVID-19 positive case who entered from United States.	Illumina iSeq	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0039/2020	EPI_ISL_591381	2020-05-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina iSeq	SKESA v. 2.3.0			B.1.1.370	GR
hCoV-19/England/204221523/2020	EPI_ISL_593844	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/France/OCC-62/2020	EPI_ISL_593877	2020-07-29	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-69/2020	EPI_ISL_593883	2020-07-22	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-70/2020	EPI_ISL_593884	2020-08-02	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-71/2020	EPI_ISL_593885	2020-08-01	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/France/OCC-72/2020	EPI_ISL_593886	2020-08-01	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.1	GR
hCoV-19/England/204221423/2020	EPI_ISL_593984	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-A4CF7A/2020	EPI_ISL_596072	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A639BB/2020	EPI_ISL_596174	2020-10-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/SHEF-C2495/2020	EPI_ISL_596192	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C5BD9/2020	EPI_ISL_596198	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CD4C7/2020	EPI_ISL_596213	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D09FF/2020	EPI_ISL_596222	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Russia/SPE-RII-32307S/2020	EPI_ISL_596230	2020-08-31	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH1007S/2020	EPI_ISL_596250	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/Russia/SPE-RII-MH1008S/2020	EPI_ISL_596251	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SVE-RII-MH1430S/2020	EPI_ISL_596272	2020-09-11	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/Russia/SVE-RII-MH1436S/2020	EPI_ISL_596274	2020-09-12	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1438S/2020	EPI_ISL_596275	2020-09-06	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/Russia/SVE-RII-MH1441S/2020	EPI_ISL_596276	2020-09-06	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SVE-RII-MH1444S/2020	EPI_ISL_596278	2020-09-08	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH1504S/2020	EPI_ISL_596283	2020-09-08	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/Russia/SPE-RII-MH1509S/2020	EPI_ISL_596284	2020-09-10	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/Russia/SPE-RII-MH1568S/2020	EPI_ISL_596293	2020-09-10	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH1616S/2020	EPI_ISL_596297	2020-09-07	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1618S/2020	EPI_ISL_596298	2020-09-07	Europe / Russia / Sverdlovsk / Nizhniy Tagil	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/Russia/SVE-RII-MH1626S/2020	EPI_ISL_596299	2020-09-08	Europe / Russia / Sverdlovsk / Verkhny Tagil	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/England/CAMC-A5747D/2020	EPI_ISL_597451	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57413/2020	EPI_ISL_597477	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A510D9/2020	EPI_ISL_597532	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50AFA/2020	EPI_ISL_597536	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A4FCBC/2020	EPI_ISL_597545	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50131/2020	EPI_ISL_597547	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A4FCDA/2020	EPI_ISL_597548	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FCAD/2020	EPI_ISL_597550	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FFB3/2020	EPI_ISL_597553	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FD04/2020	EPI_ISL_597556	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A501C8/2020	EPI_ISL_597568	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50D88/2020	EPI_ISL_597569	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50ABE/2020	EPI_ISL_597576	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A500E9/2020	EPI_ISL_597581	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50D97/2020	EPI_ISL_597585	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A466D5/2020	EPI_ISL_598792	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44B14/2020	EPI_ISL_598800	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45EFC/2020	EPI_ISL_598802	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A468B1/2020	EPI_ISL_598806	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A456E5/2020	EPI_ISL_598809	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2EF23/2020	EPI_ISL_598827	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2EEDB/2020	EPI_ISL_598829	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2FECB/2020	EPI_ISL_598830	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A1E050/2020	EPI_ISL_598847	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9DC408/2020	EPI_ISL_601161	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DC347/2020	EPI_ISL_601184	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DE6B5/2020	EPI_ISL_601197	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEDFC/2020	EPI_ISL_601227	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0B2A/2020	EPI_ISL_601234	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DBE65/2020	EPI_ISL_601236	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Russia/DA-RII-MH2741S/2020	EPI_ISL_602419	2020-09-26	Europe / Russia / Dagestan / Derbent	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/KK-RII-MH2759S/2020	EPI_ISL_602432	2020-09-25	Europe / Russia / Khakassia / Abakan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/STA-RII-MH2777S/2020	EPI_ISL_602445	2020-09-21	Europe / Russia / Stavropol / Stavropol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/STA-RII-MH2784S/2020	EPI_ISL_602449	2020-09-19	Europe / Russia / Stavropol / Stavropol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/England/ALDP-A87D2E/2020	EPI_ISL_606015	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86FED/2020	EPI_ISL_606039	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87B8E/2020	EPI_ISL_606060	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A862B7/2020	EPI_ISL_606091	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F21E/2020	EPI_ISL_607236	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6CA91/2020	EPI_ISL_607252	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C9BF/2020	EPI_ISL_607309	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BF63/2020	EPI_ISL_607328	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B938/2020	EPI_ISL_607359	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BFFA/2020	EPI_ISL_607372	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B90B/2020	EPI_ISL_607385	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BD1E/2020	EPI_ISL_607411	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A65A7A/2020	EPI_ISL_608545	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A68488/2020	EPI_ISL_608595	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64BC3/2020	EPI_ISL_608602	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65324/2020	EPI_ISL_608607	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A68549/2020	EPI_ISL_608625	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A65940/2020	EPI_ISL_608642	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64ED9/2020	EPI_ISL_608666	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A67EF4/2020	EPI_ISL_608677	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A658AD/2020	EPI_ISL_608683	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6892F/2020	EPI_ISL_608694	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A6B230/2020	EPI_ISL_608697	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A6B1CA/2020	EPI_ISL_608708	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/204191267/2020	EPI_ISL_609860	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/CAMC-A81E21/2020	EPI_ISL_610896	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A81B93/2020	EPI_ISL_610903	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-A829F2/2020	EPI_ISL_610920	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92E5A/2020	EPI_ISL_610990	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4817C2/2020	EPI_ISL_613110	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48181A/2020	EPI_ISL_613115	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481980/2020	EPI_ISL_613129	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481C1E/2020	EPI_ISL_613156	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481C78/2020	EPI_ISL_613161	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481DC0/2020	EPI_ISL_613170	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-967/2020	EPI_ISL_614559	2020-03-09	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-4310/2020	EPI_ISL_615747	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4314/2020	EPI_ISL_615751	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4315/2020	EPI_ISL_615752	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3995/2020	EPI_ISL_615765	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6319/2020	EPI_ISL_615773	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4003/2020	EPI_ISL_615774	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-4013/2020	EPI_ISL_615785	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4024/2020	EPI_ISL_615796	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4027/2020	EPI_ISL_615799	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4047/2020	EPI_ISL_615821	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3925/2020	EPI_ISL_615836	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3933/2020	EPI_ISL_615844	2020-09-14	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3934/2020	EPI_ISL_615845	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7253/2020	EPI_ISL_619230	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7257/2020	EPI_ISL_619234	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7264/2020	EPI_ISL_619238	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7267/2020	EPI_ISL_619240	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7302/2020	EPI_ISL_619300	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7434/2020	EPI_ISL_619324	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7455/2020	EPI_ISL_619369	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7476/2020	EPI_ISL_619377	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5938/2020	EPI_ISL_620203	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6033/2020	EPI_ISL_620227	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6034/2020	EPI_ISL_620228	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6042/2020	EPI_ISL_620236	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6484/2020	EPI_ISL_620384	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-4852/2020	EPI_ISL_621538	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5062/2020	EPI_ISL_621600	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5070/2020	EPI_ISL_621608	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-5071/2020	EPI_ISL_621609	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5104/2020	EPI_ISL_621642	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5116/2020	EPI_ISL_621654	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5120/2020	EPI_ISL_621658	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5129/2020	EPI_ISL_621667	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5136/2020	EPI_ISL_621674	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5182/2020	EPI_ISL_621720	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/New Zealand/20CV0474/2020	EPI_ISL_622812	2020-10-22	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0496/2020	EPI_ISL_622824	2020-11-01	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0499/2020	EPI_ISL_622827	2020-10-25	Oceania / New Zealand / South Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0503/2020	EPI_ISL_622829	2020-10-31	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0504/2020	EPI_ISL_622830	2020-10-28	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/England/ALDP-AA5425/2020	EPI_ISL_625102	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA572C/2020	EPI_ISL_625127	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA5443/2020	EPI_ISL_625138	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA32B4/2020	EPI_ISL_625162	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA380D/2020	EPI_ISL_625173	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2200/2020	EPI_ISL_625187	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0A91/2020	EPI_ISL_625196	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-AA0BE9/2020	EPI_ISL_625198	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA22A6/2020	EPI_ISL_625206	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1623/2020	EPI_ISL_625258	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2C99/2020	EPI_ISL_625264	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/ALDP-A85643/2020	EPI_ISL_625277	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4833AE/2020	EPI_ISL_627811	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4834F6/2020	EPI_ISL_627828	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-48370C/2020	EPI_ISL_627851	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-483881/2020	EPI_ISL_627865	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-ABB83F/2020	EPI_ISL_631010	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-AC5D7F/2020	EPI_ISL_631027	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/MILK-ABBC51/2020	EPI_ISL_631051	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AC5DCA/2020	EPI_ISL_631056	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/ALDP-AC1256/2020	EPI_ISL_631060	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE21E9/2020	EPI_ISL_633513	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE23E3/2020	EPI_ISL_633545	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE25ED/2020	EPI_ISL_633605	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AE2EC4/2020	EPI_ISL_633627	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE1B91/2020	EPI_ISL_633636	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE2714/2020	EPI_ISL_633671	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE2B45/2020	EPI_ISL_633675	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/CAMC-AAFBAE/2020	EPI_ISL_634803	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/France/ARA-SC160/2020	EPI_ISL_634825	2020-04-08	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/USA/MN-MDH-1987/2020	EPI_ISL_634861	2020-10-27	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-1988/2020	EPI_ISL_634862	2020-10-27	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-1989/2020	EPI_ISL_634863	2020-10-27	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-1999/2020	EPI_ISL_634873	2020-10-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2000/2020	EPI_ISL_634874	2020-10-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2001/2020	EPI_ISL_634875	2020-10-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/England/CAMC-9DF57B/2020	EPI_ISL_638412	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9DF71B/2020	EPI_ISL_638419	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMC-9DF827/2020	EPI_ISL_638425	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF845/2020	EPI_ISL_638427	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9DF924/2020	EPI_ISL_638436	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-A23A96/2020	EPI_ISL_638457	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A7E0A9/2020	EPI_ISL_638483	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORT-2862DD/2020	EPI_ISL_638560	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2863F8/2020	EPI_ISL_638562	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2865C5/2020	EPI_ISL_638564	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2867DE/2020	EPI_ISL_638569	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286AD5/2020	EPI_ISL_638573	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286AF3/2020	EPI_ISL_638574	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Australia/QLD1174/2020	EPI_ISL_639765	2020-03-25	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.1	GR
hCoV-19/England/MILK-B02601/2020	EPI_ISL_643010	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B01D58/2020	EPI_ISL_643036	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02829/2020	EPI_ISL_643038	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B8ED/2020	EPI_ISL_643047	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8B5D7/2020	EPI_ISL_643058	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C71C/2020	EPI_ISL_643072	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C785/2020	EPI_ISL_643074	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C433/2020	EPI_ISL_643086	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/D-NVRL-AIIDV0264v1/2020	EPI_ISL_644294	2020-04-25	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0264v2/2020	EPI_ISL_644297	2020-04-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0425v1/2020	EPI_ISL_644300	2020-04-09	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0346v1/2020	EPI_ISL_644307	2020-05-06	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0071v1/2020	EPI_ISL_644316	2020-04-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/England/ALDP-B1AF56/2020	EPI_ISL_645624	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1AFFC/2020	EPI_ISL_645629	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1BF19/2020	EPI_ISL_645675	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24609/2020	EPI_ISL_646800	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24B19/2020	EPI_ISL_646815	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B2493D/2020	EPI_ISL_646835	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B2485E/2020	EPI_ISL_646951	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/ITM_C5189_200701416/2020	EPI_ISL_649154	2020-06-30	Europe / Belgium / Brussels	Human	Original	Oropharyngeal swab		Nanopore MinION	BWA-MEM			B.1.1.254	GR
hCoV-19/England/ALDP-B49352/2020	EPI_ISL_649213	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B48DBF/2020	EPI_ISL_649233	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B48EAD/2020	EPI_ISL_649275	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5FF8/2020	EPI_ISL_651418	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF60A9/2020	EPI_ISL_651419	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AAECCA/2020	EPI_ISL_651481	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-B39ABA/2020	EPI_ISL_651527	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AA00AE/2020	EPI_ISL_652706	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-AA0114/2020	EPI_ISL_652708	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-AAA8AC/2020	EPI_ISL_652716	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAC73/2020	EPI_ISL_652737	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAE13/2020	EPI_ISL_652746	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAF4D/2020	EPI_ISL_652756	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAB01C/2020	EPI_ISL_652766	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAB45C/2020	EPI_ISL_652791	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC6EC/2020	EPI_ISL_652867	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC6FB/2020	EPI_ISL_652868	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC85F/2020	EPI_ISL_652877	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC88C/2020	EPI_ISL_652879	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC92F/2020	EPI_ISL_652883	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-AAC9F2/2020	EPI_ISL_652884	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B6887C/2020	EPI_ISL_655001	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6C92A/2020	EPI_ISL_655008	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B9B2/2020	EPI_ISL_655015	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69EA6/2020	EPI_ISL_655020	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69C60/2020	EPI_ISL_655026	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B684C3/2020	EPI_ISL_655042	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69556/2020	EPI_ISL_655047	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69E5B/2020	EPI_ISL_655062	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6889A/2020	EPI_ISL_655088	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B45E19/2020	EPI_ISL_656311	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B5308B/2020	EPI_ISL_657679	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B53355/2020	EPI_ISL_657686	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B3868A/2020	EPI_ISL_658801	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38769/2020	EPI_ISL_658828	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B392FE/2020	EPI_ISL_658920	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-B3955F/2020	EPI_ISL_658935	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B37E38/2020	EPI_ISL_658948	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B381C5/2020	EPI_ISL_658959	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/England/CAMC-B37EB0/2020	EPI_ISL_658963	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B39461/2020	EPI_ISL_658984	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B68636/2020	EPI_ISL_662090	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-B75056/2020	EPI_ISL_662141	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B75645/2020	EPI_ISL_662183	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B746DD/2020	EPI_ISL_662200	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B75575/2020	EPI_ISL_662229	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B691F8/2020	EPI_ISL_662230	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68A1C/2020	EPI_ISL_662232	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B1CBF6/2020	EPI_ISL_664848	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B1D07E/2020	EPI_ISL_664852	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B73C81/2020	EPI_ISL_664879	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7C31A/2020	EPI_ISL_668240	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7FD37/2020	EPI_ISL_668241	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B77D3F/2020	EPI_ISL_668251	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7C15C/2020	EPI_ISL_668259	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B82144/2020	EPI_ISL_668260	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7C110/2020	EPI_ISL_668287	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7E8A0/2020	EPI_ISL_668330	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-11068/2020	EPI_ISL_669599	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-11957/2020	EPI_ISL_670650	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11960/2020	EPI_ISL_670651	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11961/2020	EPI_ISL_670652	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11963/2020	EPI_ISL_670653	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	G
hCoV-19/Denmark/DCGC-11968/2020	EPI_ISL_670654	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11969/2020	EPI_ISL_670655	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11970/2020	EPI_ISL_670656	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11971/2020	EPI_ISL_670657	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/Denmark/DCGC-11974/2020	EPI_ISL_670659	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11975/2020	EPI_ISL_670660	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11977/2020	EPI_ISL_670661	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11978/2020	EPI_ISL_670662	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11980/2020	EPI_ISL_670663	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11983/2020	EPI_ISL_670664	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-11985/2020	EPI_ISL_670665	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Ireland/LS-NVRL-75IRL70478/2020	EPI_ISL_671921	2020-10-12	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ecuador/UEES-4040/2020	EPI_ISL_671988	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-7462/2020	EPI_ISL_671995	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-4107/2020	EPI_ISL_671999	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/England/MILK-B8D307/2020	EPI_ISL_674011	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B85DB6/2020	EPI_ISL_674023	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D343/2020	EPI_ISL_674024	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D2BF/2020	EPI_ISL_674044	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B85DA7/2020	EPI_ISL_674111	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D3DA/2020	EPI_ISL_674122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D2CE/2020	EPI_ISL_674141	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8525D/2020	EPI_ISL_674174	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B84A0B/2020	EPI_ISL_674193	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B840BE/2020	EPI_ISL_674195	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B84B44/2020	EPI_ISL_674204	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B85AA0/2020	EPI_ISL_675336	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8427C/2020	EPI_ISL_675343	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B83723/2020	EPI_ISL_675344	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EEC9/2020	EPI_ISL_675364	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B851BA/2020	EPI_ISL_675383	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8432E/2020	EPI_ISL_675400	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B82AEF/2020	EPI_ISL_675502	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B89DEF/2020	EPI_ISL_675556	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/BIRM-6A268/2020	EPI_ISL_679033	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6A2FF/2020	EPI_ISL_679039	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9D6B1/2020	EPI_ISL_680019	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9D6EE/2020	EPI_ISL_680020	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B2C759/2020	EPI_ISL_680078	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B2C7A4/2020	EPI_ISL_680080	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-48FC6B/2020	EPI_ISL_681208	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48FCC5/2020	EPI_ISL_681214	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-12349/2020	EPI_ISL_682530	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-12351/2020	EPI_ISL_682532	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-12365/2020	EPI_ISL_682546	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001226/2020	EPI_ISL_683890	2020-11-05	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001295/2020	EPI_ISL_683905	2020-11-09	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001329/2020	EPI_ISL_683923	2020-11-12	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001194/2020	EPI_ISL_683938	2020-10-30	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001232/2020	EPI_ISL_683940	2020-11-05	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001272/2020	EPI_ISL_683953	2020-11-09	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001376/2020	EPI_ISL_683987	2020-11-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/Taiwan/NTU34/2020	EPI_ISL_693305	2020-11-20	Asia / Taiwan / Taipei	Human	Vero	Throat swab		Sanger				AD.2	GR
hCoV-19/USA/AZ-TG640908/2020	EPI_ISL_695812	2020-04-13	North America / USA / Arizona	Human	Original			Illumina				B.1.1	G
hCoV-19/Canada/ON-UHTC_0381/2020	EPI_ISL_698103	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			AL.1	GR
hCoV-19/United Arab Emirates/1031/2020	EPI_ISL_698106	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1045/2020	EPI_ISL_698120	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0100/2020	EPI_ISL_698184	2020-05-19	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-G400	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0491/2020	EPI_ISL_698185	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0506/2020	EPI_ISL_698186	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0513/2020	EPI_ISL_698187	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0527/2020	EPI_ISL_698188	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0736/2020	EPI_ISL_698189	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0802/2020	EPI_ISL_698190	2020-05-19	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/United Arab Emirates/0971/2020	EPI_ISL_698191	2020-06-29	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.366	GR
hCoV-19/Thailand/Bangkok_PT386/2020	EPI_ISL_699484	2020	Asia / Thailand / Bangkok	Human	Vero1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.1	GR
hCoV-19/dog/USA/TX-TAMU-077/2020	EPI_ISL_699508	2020-07-28	North America / USA / Texas / Brazos County	Canis lupus familiaris	Original	Respiratory swab		IonTorrent	IRMA v. 0.6.7; SeqMan NGen v. 14			B.1.1	GR
hCoV-19/England/ALDP-BBB50A/2020	EPI_ISL_702010	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BCA26B/2020	EPI_ISL_703341	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCCB31/2020	EPI_ISL_704655	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BCBA44/2020	EPI_ISL_704673	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCD4BD/2020	EPI_ISL_704678	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC0B97/2020	EPI_ISL_704700	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/LIVE-DC46AF/2020	EPI_ISL_705902	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/LIVE-DC46CD/2020	EPI_ISL_705903	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A9185D/2020	EPI_ISL_705992	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Turkey/DEN-PAU12/2020	EPI_ISL_708190	2020-07-30	Europe / Turkey / Denizli	Human	Original			Illumina NextSeq				B.1.1	GR
hCoV-19/Turkey/DEN-PAU14/2020	EPI_ISL_708195	2020-08-26	Europe / Turkey / Denizli	Human	Original			Illumina NextSeq				B.1.1	GR
hCoV-19/USA/MI-MDHHS-SC22515/2020	EPI_ISL_708218	2020-11-16	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.337	GR
hCoV-19/England/QEUH-C15FC3/2020	EPI_ISL_709490	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C1453B/2020	EPI_ISL_709541	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/USA/TX-DSHS-1754/2020	EPI_ISL_710402	2020-06-23	North America / USA / Texas / Harris County	Human	Original	Nasopharyngeal swab		Illumina Miseq	bwa v1.2.2/ivar 0.7.17			B.1.1.258	GR
hCoV-19/USA/TX-DSHS-1755/2020	EPI_ISL_710403	2020-06-23	North America / USA / Texas / Harris County	Human	Original	Nasopharyngeal swab		Illumina Miseq	bwa v1.2.2/ivar 0.7.17			B.1.1.258	GR
hCoV-19/USA/TX-DSHS-1773/2020	EPI_ISL_710413	2020-06-20	North America / USA / Texas / Harris County	Human	Original	Nasopharyngeal swab		Illumina Miseq	bwa v1.2.2/ivar 0.7.17			B.1.1.258	GR
hCoV-19/Croatia/Zagreb-23/2020	EPI_ISL_710564	2020-09-19	Europe / Croatia / Zagreb	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Croatia/Zagreb-11/2020	EPI_ISL_710569	2020-09-30	Europe / Croatia / Zagreb	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Croatia/Zagreb-22/2020	EPI_ISL_710570	2020-10-01	Europe / Croatia / Zagreb	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Croatia/Zagreb-1/2020	EPI_ISL_710574	2020-10-05	Europe / Croatia / Zagreb	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-14338/2020	EPI_ISL_711702	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	G
hCoV-19/Denmark/DCGC-15753/2020	EPI_ISL_714000	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-15794/2020	EPI_ISL_714024	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-15807/2020	EPI_ISL_714032	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-15826/2020	EPI_ISL_714043	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-15840/2020	EPI_ISL_714054	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-15890/2020	EPI_ISL_714087	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15908/2020	EPI_ISL_714097	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13385510/2020	EPI_ISL_717973	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/MOS-CRIE-13386579/2020	EPI_ISL_717974	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.349	GR
hCoV-19/England/QEUH-B9F575/2020	EPI_ISL_721123	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9E057/2020	EPI_ISL_721137	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F557/2020	EPI_ISL_721140	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9E0FD/2020	EPI_ISL_721153	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9FD7D/2020	EPI_ISL_721155	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA4276/2020	EPI_ISL_721181	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-BC6609/2020	EPI_ISL_721199	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B75F95/2020	EPI_ISL_723718	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B75FFF/2020	EPI_ISL_723723	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/ALDP-B761DA/2020	EPI_ISL_723744	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B762F5/2020	EPI_ISL_723753	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B768E4/2020	EPI_ISL_723782	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B7690F/2020	EPI_ISL_723784	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B7695A/2020	EPI_ISL_723787	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-493D9E/2020	EPI_ISL_726023	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/Wales/PHWC-49986A/2020	EPI_ISL_727367	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Nigeria/NI-CV237/2020	EPI_ISL_729923	2020-06-01	Africa / Nigeria / Niger State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1.484	GR
hCoV-19/Nigeria/NA-CV239/2020	EPI_ISL_729925	2020-06-11	Africa / Nigeria / Nasarawa State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1.484	GR
hCoV-19/Nigeria/NA-CV240/2020	EPI_ISL_729926	2020-05-31	Africa / Nigeria / Nasarawa State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1.484	GR
hCoV-19/Nigeria/KN-CV252/2020	EPI_ISL_729937	2020-04-25	Africa / Nigeria / Kano State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1.487	GR
hCoV-19/Nigeria/LA-CV259/2020	EPI_ISL_729943	2020-04-25	Africa / Nigeria / Lagos State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1	GR
hCoV-19/Nigeria/OS-CV288/2020	EPI_ISL_729969	2020-06-30	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.1	GR
hCoV-19/England/ALDP-C3B808/2020	EPI_ISL_730931	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Russia/SE-RII-MH3355S/2020	EPI_ISL_733102	2020-10-07	Europe / Russia / North Ossetia-Alania / Vladikavkaz	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.163	GR
hCoV-19/Russia/SE-RII-MH3356S/2020	EPI_ISL_733103	2020-10-07	Europe / Russia / North Ossetia-Alania / Vladikavkaz	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/ROS-RII-MH3377S/2020	EPI_ISL_733117	2020-10-07	Europe / Russia / Rostov / Zernograd	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/MOS-RII-MH3393S/2020	EPI_ISL_733126	2020-10-07	Europe / Russia / Moscow Region / Sergiyev Posad	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH3401S/2020	EPI_ISL_733132	2020-10-07	Europe / Russia / Moscow / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/STA-RII-MH3407S/2020	EPI_ISL_733135	2020-10-07	Europe / Russia / Stavropol / Stavropol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/MOS-RII-MH3424S/2020	EPI_ISL_733145	2020-10-07	Europe / Russia / Moscow Region / Zvenigorod	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Crimea/RII-MH3437S/2020	EPI_ISL_733151	2020-10-07	Europe / Crimea / Simpheropol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.274	GR
hCoV-19/Russia/MO-RII-MH3571S/2020	EPI_ISL_733154	2020-10-13	Europe / Russia / Mordovia / Saransk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/AST-RII-MH4151S/2020	EPI_ISL_733175	2020-08-18	Europe / Russia / Astrakhan / Volodarskiy	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/SVE-RII-MH4700S/2020	EPI_ISL_733240	2020-10-19	Europe / Russia / Sverdlovsk / Yekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.449	GR
hCoV-19/Russia/KDA-RII-MH4727S/2020	EPI_ISL_733247	2020-10-11	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/KDA-RII-MH4730S/2020	EPI_ISL_733248	2020-10-14	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/KDA-RII-MH4747S/2020	EPI_ISL_733256	2020-10-21	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/KDA-RII-MH4887S/2020	EPI_ISL_733280	2020-10-25	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/KDA-RII-MH4917S/2020	EPI_ISL_733284	2020-10-17	Europe / Russia / Krasnodar / Armavir	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/KDA-RII-MH4936S/2020	EPI_ISL_733289	2020-10-14	Europe / Russia / Krasnodar / Armavir	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.336	GR
hCoV-19/Russia/KDA-RII-MH4938S/2020	EPI_ISL_733290	2020-10-14	Europe / Russia / Krasnodar / Armavir	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Belgium/rega-0409565/2020	EPI_ISL_734555	2020-04-09	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0409566/2020	EPI_ISL_734556	2020-04-09	Europe / Belgium / Lubbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0409567/2020	EPI_ISL_734557	2020-04-09	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0409568/2020	EPI_ISL_734558	2020-04-09	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0410573/2020	EPI_ISL_734563	2020-04-10	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0410574/2020	EPI_ISL_734564	2020-04-10	Europe / Belgium / Glabbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0413577/2020	EPI_ISL_734569	2020-04-13	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0414495/2020	EPI_ISL_734578	2020-04-14	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0414584/2020	EPI_ISL_734582	2020-04-14	Europe / Belgium / Houthalen-Helchteren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/England/ALDP-C58BFD/2020	EPI_ISL_735899	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Taiwan/NTU38/2020	EPI_ISL_738065	2020-11-26	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.1.398	GR
hCoV-19/USA/CA-CZB-14135/2020	EPI_ISL_739286	2020-05-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14106/2020	EPI_ISL_739306	2020-05-22	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14360/2020	EPI_ISL_739349	2020-07-14	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-15139/2020	EPI_ISL_739382	2020-11-23	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13870/2020	EPI_ISL_739387	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14402/2020	EPI_ISL_739395	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/Belgium/rega-12141317/2020	EPI_ISL_745222	2020-12-14	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13384497/2020	EPI_ISL_745234	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	ambiguous nucleotide at reference position 15,960, coverage of T - 1928 (11 %), coverage of C - 16083 (79 %)	info	B.1.1.336	GR
hCoV-19/Russia/MOS-CRIE-13372214/2020	EPI_ISL_745235	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	ambiguous nucleotide at reference position 15,141, coverage of C - 3451 (79 %), coverage of T – 926 (21 %)	info	B.1.1.163	GR
hCoV-19/Russia/MOS-CRIE-13676494/2020	EPI_ISL_745246	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	ambiguous nucleotide at reference position 15,975, coverage of T - 4909 (21 %), coverage of C - 18670 (79 %), ambiguous nucleotide at reference position 21,575, coverage ofC - 634 (22 %), coverage of T - 2190 (78 %)	info	B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13680794/2020	EPI_ISL_745247	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.336	GR
hCoV-19/Chile/AR-192900/2020	EPI_ISL_746502	2020-09-29	South America / Chile / La Araucania / Angol	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Denmark/DCGC-19773/2020	EPI_ISL_747778	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.44	GR
hCoV-19/Denmark/DCGC-19833/2020	EPI_ISL_747819	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19871/2020	EPI_ISL_747842	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19874/2020	EPI_ISL_747844	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19952/2020	EPI_ISL_747888	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17553/2020	EPI_ISL_751064	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/CA-CHLA-PLM07768214/2020	EPI_ISL_753531	2020-11-28	North America / USA / California / Los Angeles	Human	Original			Illumina NextSeq	Novoalign v4.02.00 + LUBA consensus			B.1.1	GR
hCoV-19/USA/CA-CHLA-PLM25788503/2020	EPI_ISL_753532	2020-11-28	North America / USA / California / Los Angeles	Human	Original			Illumina NextSeq	Novoalign v4.02.00 + LUBA consensus			B.1.1	O
hCoV-19/Denmark/DCGC-21909/2020	EPI_ISL_758449	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22119/2020	EPI_ISL_758564	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Finland/24ES21A11/2020	EPI_ISL_759811	2020-08-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.1	GR
hCoV-19/Finland/24MS5A4/2020	EPI_ISL_759814	2020-03-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.1	GR
hCoV-19/England/CAMB-1BCB10/2020	EPI_ISL_764294	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/MA-MGH-02765/2020	EPI_ISL_765623	2020-09-23	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.1	GR
hCoV-19/USA/DE-DHSS-F986914/2020	EPI_ISL_766993	2020-11-23	North America / USA / Delaware / Sussex	Human	Original		Not screened by S dropout	Illumina MiSeq	DRAGEN			B.1.1.337	GR
hCoV-19/USA/WY-WPHL-20063393/2020	EPI_ISL_770077	2020-08-19	North America / USA / Wyoming	Human	Original	Nasopharyngeal swab		Illumina MiSeq	StaphB Monroe; trimmomatic 0.39, bbtools 38.76, ivar1.2.1-SC2			B.1.1.453	GR
hCoV-19/USA/WY-WPHL-20063394/2020	EPI_ISL_770078	2020-08-19	North America / USA / Wyoming	Human	Original	Nasopharyngeal swab		Illumina MiSeq	StaphB Monroe; trimmomatic 0.39, bbtools 38.76, ivar1.2.1-SC2			B.1.1.453	GR
hCoV-19/Germany/HH-hpi-p1952/2020	EPI_ISL_776279	2020-03-24	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p1957/2020	EPI_ISL_776282	2020-03-25	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p1959/2020	EPI_ISL_776284	2020-03-25	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.5	GR
hCoV-19/Germany/HH-hpi-p2071/2020	EPI_ISL_776347	2020-03-20	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMC-C9849C/2020	EPI_ISL_777609	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/USA/MD-MDH-0492/2020	EPI_ISL_778873	2020-12-01	North America / USA / Maryland	Human	Original	Throat swab		Illumina MiSeq	p			B.1.1.467	GR
hCoV-19/England/CAMC-B78A64/2020	EPI_ISL_783449	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B786F7/2020	EPI_ISL_783483	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B784B1/2020	EPI_ISL_783522	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/USA/TX-HMH-MCoV-15610/2020	EPI_ISL_787094	2020-10-26	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.596	G
hCoV-19/USA/TX-HMH-MCoV-10601/2020	EPI_ISL_789554	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-10607/2020	EPI_ISL_789558	2020-07-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	O
hCoV-19/USA/TX-HMH-MCoV-10650/2020	EPI_ISL_789576	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-10654/2020	EPI_ISL_789579	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-10685/2020	EPI_ISL_789588	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-10716/2020	EPI_ISL_789600	2020-07-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-10734/2020	EPI_ISL_789608	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-10757/2020	EPI_ISL_789615	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-10772/2020	EPI_ISL_789619	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	O
hCoV-19/USA/TX-HMH-MCoV-10803/2020	EPI_ISL_789633	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-10814/2020	EPI_ISL_789639	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-10815/2020	EPI_ISL_789640	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-10912/2020	EPI_ISL_789681	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-10958/2020	EPI_ISL_789696	2020-07-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-11064/2020	EPI_ISL_789699	2020-09-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	G
hCoV-19/USA/TX-HMH-MCoV-12815/2020	EPI_ISL_790545	2020-08-19	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-12828/2020	EPI_ISL_790552	2020-08-19	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/Netherlands/GE-RIVM-20585/2020	EPI_ISL_790669	2020-12-11	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Slovakia/UKBA-605/2020	EPI_ISL_791990	2020-11-23	Europe / Slovakia / Doľany	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 2000bp; frameshift confirmed by manual examination of reads	Insertion of 2 nucleotides found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.1.163	GR
hCoV-19/USA/NY-Wadsworth-21000068-01/2020	EPI_ISL_794158	2020-12-27	North America / USA / New York / Suffolk County	Human	Original			Illumna NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-293276-01/2020	EPI_ISL_794194	2020-12-28	North America / USA / New York / Ontario County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/Denmark/DCGC-24370/2020	EPI_ISL_795501	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Norway/7202/2020	EPI_ISL_796704	2020-12-22	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1.274	GR
hCoV-19/Portugal/PT2163/2020	EPI_ISL_796763	2020-11-10	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-D50796/2020	EPI_ISL_799081	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-C182C7/2020	EPI_ISL_800594	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Chile/Santiago-PUC_MVL_0183/2020	EPI_ISL_801708	2020-04-16	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0216/2020	EPI_ISL_801726	2020-04-25	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0237/2020	EPI_ISL_801739	2020-04-27	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0265/2020	EPI_ISL_801749	2020-05-04	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0327/2020	EPI_ISL_801772	2020-05-10	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0358/2020	EPI_ISL_801785	2020-05-11	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/Chile/Santiago-PUC_MVL_0391/2020	EPI_ISL_801803	2020-05-12	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/MD-MDH-0549/2020	EPI_ISL_804026	2020-12-29	North America / USA / Maryland	Human	Original	Throat swab		Illumina MiSeq				B.1.1.337	GR
hCoV-19/Germany/BE-ChVir-3177-a-4339/2020	EPI_ISL_806531	2020-04-02	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/USA/CA-SC20002/2020	EPI_ISL_806543	2020-08-31	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.174	GR
hCoV-19/USA/CA-SC20006/2020	EPI_ISL_806545	2020-08-26	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.174	GR
hCoV-19/Turkey/HSGM-1192/2020	EPI_ISL_811143	2020-12-30	Europe / Turkey / Kahramanmaras	Human	Original	Oropharyngeal swab		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.1	GR
hCoV-19/England/OXON-F41A9D/2020	EPI_ISL_819840	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/NM-DOH-2020648915/2020	EPI_ISL_824545	2020-12-29	North America / USA / New Mexico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188/ivar v. 1.2.2			B.1.1.231	GR
hCoV-19/Canada/Qc-HCLM-0081268037/2020	EPI_ISL_825765	2020-08-21	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-CHUM-2015703462A/2020	EPI_ISL_825823	2020-06-05	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Iceland/5709/2020	EPI_ISL_829391	2020-12-22	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/England/MILK-ED4FBF/2021	EPI_ISL_836415	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Mexico/CMX-INER-0092/2020	EPI_ISL_837690	2020-05-09	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0094/2020	EPI_ISL_837692	2020-05-11	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0095/2020	EPI_ISL_837693	2020-05-11	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0159/2020	EPI_ISL_837755	2020-07-05	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/England/SHEF-10C70F3/2020	EPI_ISL_842214	2020-12-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Czech Republic/NRL_12341/2020	EPI_ISL_850670	2020-12-10	Europe / Czech Republic / Ústí nad Labem Region	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1	GR
hCoV-19/Italy/CAM-AMC-13-5287/2020	EPI_ISL_856869	2020-03-27	Europe / Italy / Campania	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Italy/LAZ-AMC-7-2253/2020	EPI_ISL_856877	2020-03-12	Europe / Italy / Lazio	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Poland/NIPH-NIH-07/2020	EPI_ISL_856910	2020-12-17	Europe / Poland / Mazowieckie / Warsaw	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/United Arab Emirates/4221/2020	EPI_ISL_860000	2020-05-04	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.263	GR
hCoV-19/United Arab Emirates/4231/2020	EPI_ISL_860010	2020-05-04	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/4240/2020	EPI_ISL_860018	2020-05-04	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/4286/2020	EPI_ISL_860054	2020-12-28	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/4310/2020	EPI_ISL_860070	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/United Arab Emirates/4314/2020	EPI_ISL_860074	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21005034-01/2020	EPI_ISL_861320	2020-12-27	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NMDOH-2021017349/2021	EPI_ISL_862695	2021-01-11	North America / USA / New Mexico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188/ivar v. 1.2.2			B.1.1.231	GR
hCoV-19/England/TFCI-26FEACF/2020	EPI_ISL_868802	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/TFCI-26FED11/2020	EPI_ISL_868828	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/TFCI-26FED8A/2020	EPI_ISL_868834	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Poland/312601021_diag1_gx1/2020	EPI_ISL_875980	2020-12-22	Europe / Poland / dolnoslaskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/USA/CA-QDX-3766/2021	EPI_ISL_877040	2021-01-15	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2	NS8_K68stop results in 44.6% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/IN-CDC-LC0003999/2021	EPI_ISL_886791	2021-01-02	North America / USA / Indiana	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.294	GR
hCoV-19/USA/WA-CDC-LC00000770/2020	EPI_ISL_887972	2020-12-24	North America / USA / Washington	Human	Original	Nasal Swabs		PacBio	CLC Genomics			B.1.1.337	GR
hCoV-19/Canada/QC-JUS-V6010582/2020	EPI_ISL_890010	2020-03-30	North America / Canada / Quebec	Human	Original			Illumina_NexteraFlex				B.1.1	GR
hCoV-19/Romania/RO_IOCN15/2020	EPI_ISL_891223	2020-07-17	Europe / Romania / Suceava	Human	Original			Ion Torrent		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Singapore/110/2021	EPI_ISL_891251	2021-01-22	Asia / Singapore	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Switzerland/VS-ETHZ-451805/2021	EPI_ISL_899920	2021-01-13	Europe / Switzerland / Valais	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-431085/2020	EPI_ISL_899957	2020-12-29	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-431115/2020	EPI_ISL_899967	2020-12-29	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-431116/2020	EPI_ISL_899968	2020-12-29	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-431117/2020	EPI_ISL_899969	2020-12-29	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/USA/MN-CDC-2-4122317/2020	EPI_ISL_903691	2020-12-18	North America / USA / Minnesota	Human	Original	Nasal secretions		Illumina	IRMA v0.9.5-beta			B.1.1.453	GR
hCoV-19/USA/MT-CDC-2-4068591/2020	EPI_ISL_903853	2020-12-26	North America / USA / Montana	Human	Original	Nasopharyngeal aspirate		Illumina	IRMA v0.9.5-beta			B.1.1	GR
hCoV-19/Czech Republic/Tilia-10/2020	EPI_ISL_906062	2020-12-29	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Ion Torrent		NS8_E19stop results in 85.1% truncation of the protein sequence. Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	O
hCoV-19/England/ALDP-BC9BAD/2020	EPI_ISL_915638	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC8F75/2020	EPI_ISL_915663	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BCAED0/2020	EPI_ISL_915810	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Poland/1692597229_diag1_gx1/2020	EPI_ISL_925035	2020-12-25	Europe / Poland / Zachodniopomorskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/4300570422_diag1_gx1/2020	EPI_ISL_925037	2020-12-22	Europe / Poland / Dolnośląskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/573607221_diag1_gx1/2020	EPI_ISL_925038	2020-12-22	Europe / Poland / Warmińsko-mazurskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/7254615422_diag1_gx1/2020	EPI_ISL_925040	2020-12-22	Europe / Poland / Pomorskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/8616597429_diag1_gx1/2020	EPI_ISL_925042	2020-12-25	Europe / Poland / Zachodniopomorskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/8709597429_diag1_gx1/2020	EPI_ISL_925044	2020-12-25	Europe / Poland / Zachodniopomorskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Poland/8791615423_diag1_gx1/2020	EPI_ISL_925045	2020-12-22	Europe / Poland / Pomorskie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3			B.1.1	GR
hCoV-19/Denmark/DCGC-35207/2021	EPI_ISL_926347	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-37821/2021	EPI_ISL_928962	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Mexico/CMX-INMEGEN-11-05/2020	EPI_ISL_933515	2020-11-27	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Canada/ON-SC0052/2020	EPI_ISL_933612	2020-03-25	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/USA/MI-QDX-4516/2020	EPI_ISL_937071	2020-10-08	North America / USA / Michigan	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; iVar 1.2.2			B.1.1.337	GR
hCoV-19/USA/NY-NYCPHL-002572/2021	EPI_ISL_937146	2021-01-19	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-002590/2021	EPI_ISL_937163	2021-01-20	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.1	GR
hCoV-19/USA/CA-LACPHL-AF00321/2021	EPI_ISL_939615	2021-01-22	North America / USA / California / Los Angeles County	Human	Original			Illumina MiSeq	Monroe v1.0.0			B.1.1.231	GR
hCoV-19/Indonesia/JK-NIHRDMI2100330/2021	EPI_ISL_949192	2021-01-09	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Taiwan/CGMH-CGU-39/2020	EPI_ISL_956320	2020-11-01	Asia / Taiwan / Taoyuan	Human	Vero E6	Saliva		Illumina MiSeq	SPAdes Version 3.14.1			AD.2	GR
hCoV-19/Taiwan/CGMH-CGU-40/2020	EPI_ISL_956321	2020-11-10	Asia / Taiwan / Taoyuan	Human	Vero E6	Saliva		Illumina MiSeq	SPAdes Version 3.14.1			B.1.1	GR
hCoV-19/USA/IL-IDPH-I-000561/2020	EPI_ISL_962095	2020-12-11	North America / USA / Illinois / Cook County, IL	Human	Original			Nanopore MinION	Medaka			B.1.1	GR
hCoV-19/USA/NC-UNC-LCCC0193/2020	EPI_ISL_968149	2020-07-18	North America / USA / North Carolina	Human	Original			Ion Torrent				B.1.1.231	GR
hCoV-19/Denmark/DCGC-40224/2021	EPI_ISL_971901	2021-01-25	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21008483-01/2021	EPI_ISL_982436	2021-01-07	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21008484-01/2021	EPI_ISL_982437	2021-01-03	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21008559-01/2021	EPI_ISL_982469	2021-01-02	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/England/MILK-11EB939/2021	EPI_ISL_986055	2021-02-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-10AF05B/2021	EPI_ISL_993294	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Finland/HEL-12-94/2021	EPI_ISL_995935	2021-01-16	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-450592/2021	EPI_ISL_1002195	2021-01-08	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-480846/2021	EPI_ISL_1002397	2021-01-05	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-470048/2021	EPI_ISL_1003372	2021-01-20	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			M.2	GR
hCoV-19/Switzerland/ZH-ETHZ-440549/2021	EPI_ISL_1004615	2021-01-02	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-440559/2021	EPI_ISL_1004623	2021-01-02	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-440453/2021	EPI_ISL_1004683	2021-01-01	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Austria/CeMM3224/2021	EPI_ISL_1008222	2021-01-22	Europe / Austria / Upper Austria	Human	Original	Swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-11857/2021	EPI_ISL_1014034	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.163	GR
hCoV-19/Netherlands/UT-RIVM-12306/2021	EPI_ISL_1014142	2021-01-31	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/ZH-RIVM-12167/2021	EPI_ISL_1014190	2021-02-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/USA/NM-UNM-01837/2021	EPI_ISL_1015351	2021-01-16	North America / USA / New Mexico	Human	Original			Nanopore GridION	ARTIC_v3_nanopolish			B.1.1.337	GR
hCoV-19/Canada/ON-SLB3266/2021	EPI_ISL_1015366	2021-01-04	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			AL.1	GR
hCoV-19/Denmark/DCGC-43434/2021	EPI_ISL_1023778	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-43509/2021	EPI_ISL_1023887	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-44633/2021	EPI_ISL_1025011	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/CA-CZB-23029/2020	EPI_ISL_1027470	2020-11-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.294	GR
hCoV-19/Kosovo/ChVir23106/2021	EPI_ISL_1027657	2021-01-04	Europe / Kosovo	Human	Original			GridION	Bowtie2			AD.2	GR
hCoV-19/Belgium/MBLG03417/2020	EPI_ISL_1029957	2020-04-23	Europe / Belgium / Brussels	Human	Original	Oropharyngeal swab		Illumina iSeq	Smartgene 2.2.0_COV_v0.2			B.1.1.5	GR
hCoV-19/USA/CA-LACPHL-AF00446/2021	EPI_ISL_1040426	2021-01-26	North America / USA / California / Los Angeles County	Human	Original			Illumina MiSeq	Monroe v1.0.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/NY-PRL-2021_02_15_02D03/2021	EPI_ISL_1041631	2021-02-12	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq / NextSeq	BWA mem			B.1.1.231	GR
hCoV-19/Mexico/TAM-InDRE_279/2020	EPI_ISL_1054955	2020-08-11	North America / Mexico / Tamaulipas	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Serbia/M16276/2020	EPI_ISL_1057102	2020-10-02	Europe / Serbia	Human	Original			Ion Torrent				B.1.1.398	GR
hCoV-19/Switzerland/ZH-ETHZ-461507/2021	EPI_ISL_1059810	2021-01-20	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-481396/2021	EPI_ISL_1059823	2021-01-04	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Denmark/DCGC-46090/2021	EPI_ISL_1065600	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/TX-HMH-MCoV-20563/2021	EPI_ISL_1075005	2021-01-04	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-23082/2021	EPI_ISL_1077612	2021-01-11	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/Belgium/QKJ-03015/2020	EPI_ISL_415158	2020-03-01	Europe / Belgium / Brussels	Human	Original	Oropharyngeal swab		Nanopore MinION	CLC Genomics Workbench 20, Nanopolish	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Switzerland/GE-HUG-0199/2020	EPI_ISL_415455	2020-02-28	Europe / Switzerland / Geneve	Human	Original			unknown				B.1.1	GR
hCoV-19/Switzerland/BE-HUG-6651/2020	EPI_ISL_415456	2020-02-29	Europe / Switzerland / Bern	Human	Original			unknown				B.1.1	GR
hCoV-19/Belgium/DBD-03024/2020	EPI_ISL_416471	2020-03-02	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	CLC Genomics Workbench 20, Nanopolish	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/UMF-03025/2020	EPI_ISL_416472	2020-03-02	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	CLC Genomics Wornbench 20, Nanopolish	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Spain/VC-FISABIO-7/2020	EPI_ISL_416486	2020-03-02	Europe / Spain / Comunitat Valenciana / Valencia	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic pipeline			B.1.1	GR
hCoV-19/Singapore/38/2020	EPI_ISL_422431	2020-03-31	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Singapore/39/2020	EPI_ISL_422432	2020-03-31	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Netherlands/Friesland_7/2020	EPI_ISL_422572	2020-03-28	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/20144073804/2020	EPI_ISL_423561	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132003204/2020	EPI_ISL_423712	2020-03-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20132026904/2020	EPI_ISL_423761	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Australia/VIC881/2020	EPI_ISL_427135	2020-04-06	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Scotland/EDB734/2020	EPI_ISL_433233	2020-04-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/USA/NY-NYUMC440/2020	EPI_ISL_435507	2020-04-15	North America / USA / New York / Manhattan	Human	Original			Illumina NovaSeq (Ribo-depleted)	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/England/BRIS-121FB0/2020	EPI_ISL_440102	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-734FD/2020	EPI_ISL_440258	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-73475/2020	EPI_ISL_440290	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FB448/2020	EPI_ISL_441424	2020-03-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BRIS-1239FC/2020	EPI_ISL_442729	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1234DD/2020	EPI_ISL_442759	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1239CF/2020	EPI_ISL_442771	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123A62/2020	EPI_ISL_442797	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101E8C/2020	EPI_ISL_453471	2020-03-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-2899D5/2020	EPI_ISL_453509	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-E9331/2020	EPI_ISL_453592	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Italy/TUS-UniSI-1/2020	EPI_ISL_454733	2020-03-01	Europe / Italy / Tuscany / Siena	Human	unknown	Nasopharyngeal		Nanopore	Medaka v. MAY-2020			B.1.1	GR
hCoV-19/Netherlands/ZuidHolland_10005/2020	EPI_ISL_454754	2020-02-28	Europe / Netherlands / Utrecht	Human	Original			Illumina NextSeq				B.1.1	GR
hCoV-19/Belgium/Rega-0329233/2020	EPI_ISL_458203	2020-03-29	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/Rega-0330249/2020	EPI_ISL_458219	2020-03-30	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/Rega-0319259/2020	EPI_ISL_458229	2020-03-19	Europe / Belgium / Scherpenheuvel-Zichem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/Rega-0316260/2020	EPI_ISL_458230	2020-03-16	Europe / Belgium / Overijse	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/Rega-0331264/2020	EPI_ISL_458234	2020-03-31	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/USA/CA-SR0410/2020	EPI_ISL_458280	2020-04-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1.1	GR
hCoV-19/England/CAMB-1B1DCA/2020	EPI_ISL_458552	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Canada/ON_QGLO-012/2020	EPI_ISL_459872	2020-03-26	North America / Canada / Ontario	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Netherlands/Friesland_38/2020	EPI_ISL_460853	2020-04-14	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/NORW-E8DDA/2020	EPI_ISL_461810	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Belgium/MI-0407274/2020	EPI_ISL_464068	2020-04-07	Europe / Belgium / Blanden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/rega-0408284/2020	EPI_ISL_464078	2020-04-08	Europe / Belgium / Heppen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/VJ-0409291/2020	EPI_ISL_464085	2020-04-09	Europe / Belgium / Houthalen-Helchteren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/LEV-0409294/2020	EPI_ISL_464088	2020-04-09	Europe / Belgium / Zolder	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/England/CAMB-1AB21F/2020	EPI_ISL_470241	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Wales/PHWC-15E59A/2020	EPI_ISL_472821	2020-05-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-15FCD0/2020	EPI_ISL_472845	2020-05-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/EDB5437/2020	EPI_ISL_473819	2020-04-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/Scotland/EDB5661/2020	EPI_ISL_473825	2020-05-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Sweden/20-50362/2020	EPI_ISL_475095	2020-03-16	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Hungary/UD-7039/2020	EPI_ISL_476072	2020-04-09	Europe / Hungary / Borsod-Abauj-Zemplen County	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Hungary/UD-7373/2020	EPI_ISL_476074	2020-04-08	Europe / Hungary / Heves county	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Hungary/UD-7417/2020	EPI_ISL_476075	2020-04-08	Europe / Hungary / Heves county	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Hungary/UD-7729/2020	EPI_ISL_476076	2020-04-12	Europe / Hungary / Borsod-Abauj-Zemplen County	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Hungary/UD-8157/2020	EPI_ISL_476077	2020-04-14	Europe / Hungary / Heves county	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-140047/2020	EPI_ISL_476098	2020-05-28	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/OXON-B04A9/2020	EPI_ISL_478883	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/HECH-2599E52/2020	EPI_ISL_482084	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A097/2020	EPI_ISL_482093	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/CA-ALSR-0642-SAN/2020	EPI_ISL_483275	2020-04-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.132	GR
hCoV-19/England/SHEF-CFFA6/2020	EPI_ISL_484508	2020-06-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D0458/2020	EPI_ISL_484511	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/VA-DCLS-0556/2020	EPI_ISL_485857	2020-03-18	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/England/NORT-2976DD/2020	EPI_ISL_488021	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29743D/2020	EPI_ISL_488028	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E2D2/2020	EPI_ISL_488065	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29800B/2020	EPI_ISL_488075	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29EE38/2020	EPI_ISL_488113	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297075/2020	EPI_ISL_488123	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F1DA/2020	EPI_ISL_488226	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FD1A9/2020	EPI_ISL_489352	2020-04-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-10010C/2020	EPI_ISL_489373	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5AC/2020	EPI_ISL_489431	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5E8/2020	EPI_ISL_489432	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC58E/2020	EPI_ISL_489444	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ACE29/2020	EPI_ISL_489457	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1AD4F9/2020	EPI_ISL_489468	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1ACBAA/2020	EPI_ISL_489554	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC612/2020	EPI_ISL_489559	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD49F/2020	EPI_ISL_489565	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/LIVE-A2431/2020	EPI_ISL_490382	2020-05-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/202881379/2020	EPI_ISL_491714	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Latvia/061/2020	EPI_ISL_492996	2020-07-07	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.1.1.294	GR
hCoV-19/Wales/PHWC-1668E1/2020	EPI_ISL_494057	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1668F0/2020	EPI_ISL_494058	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16690C/2020	EPI_ISL_494059	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166A72/2020	EPI_ISL_494075	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166ABE/2020	EPI_ISL_494077	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-079/2020	EPI_ISL_497846	2020-03-20	Asia / Hong Kong	Human	Original	Nasopharyngeal and throat swab		Nanopore MinION				B.1.1	GR
hCoV-19/Spain/PV-IBV-004258/2020	EPI_ISL_500322	2020-04-06	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004259/2020	EPI_ISL_500323	2020-04-06	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/BRIS-130FAF/2020	EPI_ISL_501609	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260F18A/2020	EPI_ISL_501616	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260EF63/2020	EPI_ISL_501626	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/NOTT-112E5B/2020	EPI_ISL_512381	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112E79/2020	EPI_ISL_512382	2020-07-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Czech Republic/NRL_4037/2020	EPI_ISL_513512	2020-03-17	Europe / Czech Republic / Zlin / Uhersky Brod	Human	Original	Oropharyngeal swab		Nanopore MinION	RAMPART			B.1.1	GR
hCoV-19/England/LIVE-AA0BD/2020	EPI_ISL_517399	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BRIS-133892/2020	EPI_ISL_524490	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.349	GR
hCoV-19/USA/NY-Wadsworth-33281-01/2020	EPI_ISL_525639	2020-03-30	North America / USA / New York	Human	Original	Upper respiratory swab		Ion Torrent	Ion AmpliSeq(tm) SARS-CoV-2 Research Panel with Ion SARS-CoV-2 Research Plug in package IRMAreport / Geneious 9.1.8			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1032/2020	EPI_ISL_526917	2020-06-03	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Italy/ABR-IZSGC-TE28268/2020	EPI_ISL_529020	2020-04-29	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE30364/2020	EPI_ISL_529021	2020-04-29	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/England/QEUH-96B43B/2020	EPI_ISL_531338	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BE1F/2020	EPI_ISL_531341	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96AC16/2020	EPI_ISL_531343	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BC15/2020	EPI_ISL_531346	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96B1CB/2020	EPI_ISL_531458	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A40F/2020	EPI_ISL_531468	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-96A751/2020	EPI_ISL_531480	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-962874/2020	EPI_ISL_531482	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96313C/2020	EPI_ISL_531483	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963DFC/2020	EPI_ISL_531484	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A548/2020	EPI_ISL_531504	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-962847/2020	EPI_ISL_531512	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Scotland/QEUH-963E08/2020	EPI_ISL_531524	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96314B/2020	EPI_ISL_531546	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96315A/2020	EPI_ISL_531548	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963C3B/2020	EPI_ISL_531550	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A4B4/2020	EPI_ISL_531551	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-963B3E/2020	EPI_ISL_531554	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Scotland/QEUH-9639BC/2020	EPI_ISL_531557	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9628CF/2020	EPI_ISL_531560	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Scotland/QEUH-963BE3/2020	EPI_ISL_531564	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A663/2020	EPI_ISL_531565	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A672/2020	EPI_ISL_531570	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96303F/2020	EPI_ISL_531575	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962FE8/2020	EPI_ISL_531607	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963002/2020	EPI_ISL_531690	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-881BC2/2020	EPI_ISL_532675	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-8A6BD6/2020	EPI_ISL_532677	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-89C0D4/2020	EPI_ISL_532811	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-89EBA4/2020	EPI_ISL_532816	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-7EF273/2020	EPI_ISL_532927	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/SHEF-CAC3B/2020	EPI_ISL_535071	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CC96F/2020	EPI_ISL_535077	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/SHEF-CF79F/2020	EPI_ISL_535089	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D1B25/2020	EPI_ISL_535095	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/CVR4062/2020	EPI_ISL_535154	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4075/2020	EPI_ISL_535166	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4083/2020	EPI_ISL_535173	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-16A012/2020	EPI_ISL_535188	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A05E/2020	EPI_ISL_535192	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LEED-2AA4BF/2020	EPI_ISL_538832	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A9B15/2020	EPI_ISL_538922	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA75C/2020	EPI_ISL_538958	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A828A/2020	EPI_ISL_538990	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Italy/LOM-UniMI-L150/2020	EPI_ISL_542145	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L223/2020	EPI_ISL_542210	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/USA/TX-HMH-4042/2020	EPI_ISL_543320	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-4208/2020	EPI_ISL_543439	2020-06-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-4209/2020	EPI_ISL_543440	2020-06-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-4294/2020	EPI_ISL_543504	2020-06-18	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5304/2020	EPI_ISL_544665	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5435/2020	EPI_ISL_544773	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-5508/2020	EPI_ISL_544831	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5545/2020	EPI_ISL_544852	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-5592/2020	EPI_ISL_544886	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-5831/2020	EPI_ISL_547047	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5896/2020	EPI_ISL_547092	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5962/2020	EPI_ISL_547126	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/CA-CZB-3353/2020	EPI_ISL_548309	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3354/2020	EPI_ISL_548315	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3646/2020	EPI_ISL_548364	2020-04-01	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/England/NOTT-113616/2020	EPI_ISL_549518	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113661/2020	EPI_ISL_549519	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/NOTT-11369E/2020	EPI_ISL_549520	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1136AD/2020	EPI_ISL_549521	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9963D0/2020	EPI_ISL_549530	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9968A4/2020	EPI_ISL_549538	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B8FF2/2020	EPI_ISL_549611	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8AF1/2020	EPI_ISL_549616	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9B48/2020	EPI_ISL_549625	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9331/2020	EPI_ISL_549628	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8E22/2020	EPI_ISL_549647	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B83D8/2020	EPI_ISL_549658	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-9B8F7A/2020	EPI_ISL_549662	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9AC3/2020	EPI_ISL_549665	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9BC0/2020	EPI_ISL_549674	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B87EB/2020	EPI_ISL_549689	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8C91/2020	EPI_ISL_549694	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B837E/2020	EPI_ISL_549786	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B85A5/2020	EPI_ISL_549791	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9F00/2020	EPI_ISL_549792	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97787C/2020	EPI_ISL_550507	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-97877E/2020	EPI_ISL_550508	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-978644/2020	EPI_ISL_550509	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99DA10/2020	EPI_ISL_550600	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-99D209/2020	EPI_ISL_550602	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C89F/2020	EPI_ISL_550604	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DB0E/2020	EPI_ISL_550612	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DFF3/2020	EPI_ISL_550613	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C53E/2020	EPI_ISL_550614	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E44E/2020	EPI_ISL_550617	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CB4B/2020	EPI_ISL_550618	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E068/2020	EPI_ISL_550634	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DC92/2020	EPI_ISL_550636	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DC83/2020	EPI_ISL_550645	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E4F3/2020	EPI_ISL_550653	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-99E2CC/2020	EPI_ISL_550658	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99E350/2020	EPI_ISL_550659	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DBFF/2020	EPI_ISL_550661	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C71A/2020	EPI_ISL_550663	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/MILK-99DE8D/2020	EPI_ISL_550675	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99DA6B/2020	EPI_ISL_550682	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E323/2020	EPI_ISL_550685	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C57A/2020	EPI_ISL_550763	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Wales/MILK-99CA7B/2020	EPI_ISL_550767	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C64A/2020	EPI_ISL_550774	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E0FF/2020	EPI_ISL_550784	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CB0F/2020	EPI_ISL_550785	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-6A65F8/2020	EPI_ISL_551809	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.421	GR
hCoV-19/England/MILK-6ABF04/2020	EPI_ISL_551817	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-69ECA3/2020	EPI_ISL_551829	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99341C/2020	EPI_ISL_551923	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9937C8/2020	EPI_ISL_551945	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-991F1D/2020	EPI_ISL_551947	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-992CF7/2020	EPI_ISL_551949	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992ED3/2020	EPI_ISL_551954	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D7C/2020	EPI_ISL_551957	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992A39/2020	EPI_ISL_551960	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993300/2020	EPI_ISL_551962	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9936BC/2020	EPI_ISL_551974	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992750/2020	EPI_ISL_551979	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9564F7/2020	EPI_ISL_554050	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9578BE/2020	EPI_ISL_554054	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-95614B/2020	EPI_ISL_554061	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9594D6/2020	EPI_ISL_554065	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95659A/2020	EPI_ISL_554086	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9562A2/2020	EPI_ISL_554095	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9573DB/2020	EPI_ISL_554099	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956A22/2020	EPI_ISL_554144	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-9510AD/2020	EPI_ISL_554174	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9511AA/2020	EPI_ISL_554188	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-956A31/2020	EPI_ISL_554191	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-957B3D/2020	EPI_ISL_554200	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951034/2020	EPI_ISL_554202	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9519C0/2020	EPI_ISL_555313	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-955BF3/2020	EPI_ISL_555417	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954884/2020	EPI_ISL_555427	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954839/2020	EPI_ISL_555458	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94DFF2/2020	EPI_ISL_555463	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-955C1E/2020	EPI_ISL_555482	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9559CC/2020	EPI_ISL_555492	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-954866/2020	EPI_ISL_555494	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-951A90/2020	EPI_ISL_555504	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-95ADBC/2020	EPI_ISL_555516	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-95ACDD/2020	EPI_ISL_555520	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-95AB49/2020	EPI_ISL_555523	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95B00D/2020	EPI_ISL_555533	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9457B6/2020	EPI_ISL_556749	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94B57A/2020	EPI_ISL_556755	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/CAMC-945B23/2020	EPI_ISL_556763	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-9456B9/2020	EPI_ISL_556812	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMC-948BF3/2020	EPI_ISL_556823	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-941D4F/2020	EPI_ISL_556832	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.421	GR
hCoV-19/England/CAMC-94169F/2020	EPI_ISL_556834	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-61AB75/2020	EPI_ISL_557956	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-639CF5/2020	EPI_ISL_557972	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-6AEDF8/2020	EPI_ISL_557973	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-522917/2020	EPI_ISL_559003	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-519D17/2020	EPI_ISL_559014	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5249BB/2020	EPI_ISL_559020	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-51D44B/2020	EPI_ISL_559029	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-52C230/2020	EPI_ISL_559035	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-521893/2020	EPI_ISL_559036	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-525A11/2020	EPI_ISL_559044	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-526209/2020	EPI_ISL_559051	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-51D4E1/2020	EPI_ISL_559054	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-52A636/2020	EPI_ISL_559070	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-526B0E/2020	EPI_ISL_559072	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-5262DC/2020	EPI_ISL_559073	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-51D6FA/2020	EPI_ISL_559079	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4F7035/2020	EPI_ISL_559110	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-509196/2020	EPI_ISL_559130	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4BBD54/2020	EPI_ISL_559132	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4F3F2D/2020	EPI_ISL_559135	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-502F48/2020	EPI_ISL_559153	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-99BF5F/2020	EPI_ISL_560000	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-99BF6E/2020	EPI_ISL_560001	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-99C370/2020	EPI_ISL_560003	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.44	GR
hCoV-19/Scotland/QEUH-9ACF2E/2020	EPI_ISL_560010	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9ACF97/2020	EPI_ISL_560012	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9AD075/2020	EPI_ISL_560018	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9AF0EC/2020	EPI_ISL_560026	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9B4521/2020	EPI_ISL_560077	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A67A/2020	EPI_ISL_560084	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A698/2020	EPI_ISL_560086	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A6D4/2020	EPI_ISL_560090	2020-09-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A7C2/2020	EPI_ISL_560105	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A926/2020	EPI_ISL_560126	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16ABA8/2020	EPI_ISL_560165	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Gambia/NPHL-287/2020	EPI_ISL_561300	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-290/2020	EPI_ISL_561303	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2909/2020	EPI_ISL_561304	2020-07-26	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-295/2020	EPI_ISL_561305	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-297/2020	EPI_ISL_561306	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2984/2020	EPI_ISL_561307	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-299/2020	EPI_ISL_561308	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-3206/2020	EPI_ISL_561313	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-748/2020	EPI_ISL_561324	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-760/2020	EPI_ISL_561327	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/England/202660056/2020	EPI_ISL_566057	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/England/203180881/2020	EPI_ISL_566064	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.115	GR
hCoV-19/Russia/MOW-RII-MH251S/2020	EPI_ISL_566079	2020-06-19	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH252S/2020	EPI_ISL_566080	2020-06-25	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH256S/2020	EPI_ISL_566083	2020-06-18	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/England/ALDP-9CD6AA/2020	EPI_ISL_566151	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CD69B/2020	EPI_ISL_566156	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDA26/2020	EPI_ISL_566159	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9CD77A/2020	EPI_ISL_566163	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD68C/2020	EPI_ISL_566170	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CD8C2/2020	EPI_ISL_566180	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD9DE/2020	EPI_ISL_566190	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD437/2020	EPI_ISL_566197	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C96DB/2020	EPI_ISL_567363	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA8A7/2020	EPI_ISL_567370	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9C15/2020	EPI_ISL_567378	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA94A/2020	EPI_ISL_567394	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9E00/2020	EPI_ISL_567397	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C984E/2020	EPI_ISL_567407	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C986C/2020	EPI_ISL_567410	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA0FA/2020	EPI_ISL_567412	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9CA0AF/2020	EPI_ISL_567413	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C93E3/2020	EPI_ISL_567414	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C933E/2020	EPI_ISL_567418	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C97F6/2020	EPI_ISL_567455	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C9E88/2020	EPI_ISL_567479	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9574/2020	EPI_ISL_567483	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9CA573/2020	EPI_ISL_567484	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA713/2020	EPI_ISL_567485	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C991E/2020	EPI_ISL_567489	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9C98B7/2020	EPI_ISL_567493	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CA063/2020	EPI_ISL_567500	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA33D/2020	EPI_ISL_567506	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA2F4/2020	EPI_ISL_567512	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5086/2020	EPI_ISL_567619	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9C5B94/2020	EPI_ISL_567621	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/FL-BPHL-1520/2020	EPI_ISL_568618	2020-07-28	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0174/2020	EPI_ISL_569949	2020-05-23	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0186/2020	EPI_ISL_569955	2020-05-26	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/USA/CA-QDX-1444/2020	EPI_ISL_572095	2020-03-17	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/England/MILK-9C736D/2020	EPI_ISL_573300	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C738B/2020	EPI_ISL_573302	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C739A/2020	EPI_ISL_573303	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C745B/2020	EPI_ISL_573306	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C746A/2020	EPI_ISL_573307	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-286149/2020	EPI_ISL_573312	2020-07-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-286167/2020	EPI_ISL_573313	2020-07-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286185/2020	EPI_ISL_573315	2020-08-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2861A3/2020	EPI_ISL_573316	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286219/2020	EPI_ISL_573320	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-28CBDC/2020	EPI_ISL_573323	2020-08-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-29C3E0/2020	EPI_ISL_573357	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A4804/2020	EPI_ISL_573382	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A485F/2020	EPI_ISL_573385	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A49E3/2020	EPI_ISL_573392	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4B92/2020	EPI_ISL_573399	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D14/2020	EPI_ISL_573403	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D41/2020	EPI_ISL_573404	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D9C/2020	EPI_ISL_573405	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4DC9/2020	EPI_ISL_573407	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4E5D/2020	EPI_ISL_573410	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4E7B/2020	EPI_ISL_573411	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4EA8/2020	EPI_ISL_573413	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11385C/2020	EPI_ISL_573437	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11386B/2020	EPI_ISL_573438	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113898/2020	EPI_ISL_573439	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138A7/2020	EPI_ISL_573440	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138B6/2020	EPI_ISL_573441	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138F2/2020	EPI_ISL_573443	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11390E/2020	EPI_ISL_573444	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11391D/2020	EPI_ISL_573445	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11392C/2020	EPI_ISL_573446	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113986/2020	EPI_ISL_573448	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1139FF/2020	EPI_ISL_573449	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/MILK-9762D9/2020	EPI_ISL_575901	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-976682/2020	EPI_ISL_575910	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-97312A/2020	EPI_ISL_575942	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97353D/2020	EPI_ISL_575958	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9735D3/2020	EPI_ISL_575981	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/MILK-9C3817/2020	EPI_ISL_575990	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/New Zealand/20VR2955/2020	EPI_ISL_579374	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1.89	GR
hCoV-19/New Zealand/20VR3060/2020	EPI_ISL_579403	2020-05-02	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3088/2020	EPI_ISL_579415	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3154/2020	EPI_ISL_579444	2020-03-23	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/England/ALDP-9E725B/2020	EPI_ISL_580331	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E6720/2020	EPI_ISL_580355	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC793/2020	EPI_ISL_580364	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9EC0B6/2020	EPI_ISL_580367	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E60E9/2020	EPI_ISL_580381	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E72E2/2020	EPI_ISL_580406	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6CB8/2020	EPI_ISL_580412	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC1FF/2020	EPI_ISL_580421	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6948/2020	EPI_ISL_580423	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC4F6/2020	EPI_ISL_580435	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9E707F/2020	EPI_ISL_580445	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC1D1/2020	EPI_ISL_580471	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6BAC/2020	EPI_ISL_580490	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC58A/2020	EPI_ISL_580499	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/BS-42233903/2020	EPI_ISL_581708	2020-04-16	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/VD-42205435/2020	EPI_ISL_581784	2020-03-24	Europe / Switzerland / Vaud	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/BS-42350110/2020	EPI_ISL_581901	2020-07-13	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.421	GR
hCoV-19/USA/CA-CZB-6994/2020	EPI_ISL_582921	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6995/2020	EPI_ISL_582922	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6996/2020	EPI_ISL_582923	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6997/2020	EPI_ISL_582924	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6999/2020	EPI_ISL_582925	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-7000/2020	EPI_ISL_582926	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-7003/2020	EPI_ISL_582928	2020-09-05	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-7199/2020	EPI_ISL_582937	2020-09-06	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/20422148504/2020	EPI_ISL_584068	2020-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Scotland/CVR4442/2020	EPI_ISL_585311	2020-09-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4451/2020	EPI_ISL_585318	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4470/2020	EPI_ISL_585334	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4473/2020	EPI_ISL_585337	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4474/2020	EPI_ISL_585338	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4475/2020	EPI_ISL_585339	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4477/2020	EPI_ISL_585341	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4488/2020	EPI_ISL_585352	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4490/2020	EPI_ISL_585353	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4494/2020	EPI_ISL_585357	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4499/2020	EPI_ISL_585362	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4500/2020	EPI_ISL_585363	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4508/2020	EPI_ISL_585370	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4512/2020	EPI_ISL_585373	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4515/2020	EPI_ISL_585376	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4516/2020	EPI_ISL_585377	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4525/2020	EPI_ISL_585385	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4527/2020	EPI_ISL_585387	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4529/2020	EPI_ISL_585389	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4531/2020	EPI_ISL_585391	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4534/2020	EPI_ISL_585394	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4541/2020	EPI_ISL_585400	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4552/2020	EPI_ISL_585411	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4561/2020	EPI_ISL_585419	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4732/2020	EPI_ISL_585425	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-A2D13D/2020	EPI_ISL_586609	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D768/2020	EPI_ISL_586618	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D908/2020	EPI_ISL_586622	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2DF60/2020	EPI_ISL_586671	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D6A7/2020	EPI_ISL_586695	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2E1D2/2020	EPI_ISL_586703	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D3EC/2020	EPI_ISL_586705	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D4AD/2020	EPI_ISL_586713	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E80A/2020	EPI_ISL_586720	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D22B/2020	EPI_ISL_586737	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-A2DA7E/2020	EPI_ISL_586759	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D3A0/2020	EPI_ISL_586763	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D689/2020	EPI_ISL_586784	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FDE9A/2020	EPI_ISL_587941	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCF2F/2020	EPI_ISL_587990	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCAB5/2020	EPI_ISL_587992	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/ON-S754/2020	EPI_ISL_591159	2020-04-10	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Canada/ON-S803/2020	EPI_ISL_591162	2020-04	North America / Canada / Ontario / Toronto	Human	Original			Illumina HiSeq				B.1.1	GR
hCoV-19/Australia/NSW1039/2020	EPI_ISL_593691	2020-06-30	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.254	GR
hCoV-19/England/204221398/2020	EPI_ISL_593793	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Wales/MILK-9EF165/2020	EPI_ISL_594904	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/MILK-9EFAB5/2020	EPI_ISL_594976	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-A585C4/2020	EPI_ISL_597183	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57BF0/2020	EPI_ISL_597283	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A57404/2020	EPI_ISL_597305	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57B2D/2020	EPI_ISL_597310	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57422/2020	EPI_ISL_597327	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5DE88/2020	EPI_ISL_597333	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5DD8B/2020	EPI_ISL_597338	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5738F/2020	EPI_ISL_597343	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A59C28/2020	EPI_ISL_597358	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A574C8/2020	EPI_ISL_597381	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5E35B/2020	EPI_ISL_597384	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5DEF1/2020	EPI_ISL_597386	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A5DEC4/2020	EPI_ISL_597430	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A458D0/2020	EPI_ISL_598659	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A463CF/2020	EPI_ISL_598662	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46444/2020	EPI_ISL_598712	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45F26/2020	EPI_ISL_598729	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44B23/2020	EPI_ISL_598737	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A4615C/2020	EPI_ISL_598742	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45ABC/2020	EPI_ISL_598752	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A05A4F/2020	EPI_ISL_599905	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05D55/2020	EPI_ISL_599917	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A06686/2020	EPI_ISL_599949	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-A06853/2020	EPI_ISL_599961	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05C67/2020	EPI_ISL_599969	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A05BC4/2020	EPI_ISL_599981	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E435B/2020	EPI_ISL_601042	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E54EE/2020	EPI_ISL_601078	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/FL-BMMG/2020	EPI_ISL_602320	2020-08-31	North America / USA / Florida / Miami-Dade County	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH1014S/2020	EPI_ISL_602329	2020-09-05	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH1057S/2020	EPI_ISL_602330	2020-09-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SVE-RII-MH1697S/2020	EPI_ISL_602343	2020-09-20	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1713S/2020	EPI_ISL_602350	2020-09-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SVE-RII-MH1720S/2020	EPI_ISL_602355	2020-09-19	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1725S/2020	EPI_ISL_602359	2020-09-18	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/Russia/SVE-RII-MH1932S/2020	EPI_ISL_602372	2020-09-16	Europe / Russia / Sverdlovsk / Nizhny Tagil	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/Russia/SVE-RII-MH2024S/2020	EPI_ISL_602382	2020-09-18	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/LEN-RII-MH2053S/2020	EPI_ISL_602390	2020-09-28	Europe / Russia / Leningrad / Kirovsk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH2061S/2020	EPI_ISL_602396	2020-09-25	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH2069S/2020	EPI_ISL_602402	2020-09-21	Europe / Russia / Sverdlovsk / Nizhny Tagil	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/Russia/CE-RII-MH2649S/2020	EPI_ISL_602414	2020-09-11	Europe / Russia / Chechen / Grozny	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.31	GR
hCoV-19/Russia/CE-RII-MH2709S/2020	EPI_ISL_602415	2020-09-11	Europe / Russia / Chechen / Grozny	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/USA/CA-QDX-2645/2020	EPI_ISL_604907	2020-03-15	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NV-QDX-2627/2020	EPI_ISL_604950	2020-03-15	North America / USA / Nevada	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/UT-QDX-2572/2020	EPI_ISL_604962	2020-03-13	North America / USA / Utah	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.231	GR
hCoV-19/England/ALDP-A6FABC/2020	EPI_ISL_607101	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6EC02/2020	EPI_ISL_607106	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E6B9/2020	EPI_ISL_607150	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6EB9C/2020	EPI_ISL_607175	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E604/2020	EPI_ISL_607185	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6FD59/2020	EPI_ISL_607229	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68BA1/2020	EPI_ISL_608418	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A684F1/2020	EPI_ISL_608422	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64DAF/2020	EPI_ISL_608428	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68E3F/2020	EPI_ISL_608443	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A651C0/2020	EPI_ISL_608459	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6851C/2020	EPI_ISL_608462	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64D36/2020	EPI_ISL_608490	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6852B/2020	EPI_ISL_608500	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82B0B/2020	EPI_ISL_610754	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82CEA/2020	EPI_ISL_610761	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81E6D/2020	EPI_ISL_610770	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82989/2020	EPI_ISL_610782	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-A8241F/2020	EPI_ISL_610788	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82BFC/2020	EPI_ISL_610799	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A829B6/2020	EPI_ISL_610811	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82AB3/2020	EPI_ISL_610815	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81119/2020	EPI_ISL_610823	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A8102B/2020	EPI_ISL_610831	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4810B8/2020	EPI_ISL_613033	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4813DD/2020	EPI_ISL_613065	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48156E/2020	EPI_ISL_613085	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Italy/SAR-ASSL-07/2020	EPI_ISL_614396	2020-04-23	Europe / Italy / Sardinia	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.1	GR
hCoV-19/Italy/SAR-ASSL-06/2020	EPI_ISL_614397	2020-04-28	Europe / Italy / Sardinia	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.1	GR
hCoV-19/Denmark/DCGC-6311/2020	EPI_ISL_615514	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4319/2020	EPI_ISL_615519	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4320/2020	EPI_ISL_615520	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4321/2020	EPI_ISL_615521	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4355/2020	EPI_ISL_615557	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4356/2020	EPI_ISL_615558	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4471/2020	EPI_ISL_615656	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4473/2020	EPI_ISL_615658	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4474/2020	EPI_ISL_615659	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4478/2020	EPI_ISL_615663	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4481/2020	EPI_ISL_615666	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4485/2020	EPI_ISL_615670	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4486/2020	EPI_ISL_615671	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4487/2020	EPI_ISL_615672	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4271/2020	EPI_ISL_615708	2020-09-07	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3242/2020	EPI_ISL_616822	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3068/2020	EPI_ISL_616848	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3072/2020	EPI_ISL_616852	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3244/2020	EPI_ISL_616876	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3219/2020	EPI_ISL_616879	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3225/2020	EPI_ISL_616885	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3226/2020	EPI_ISL_616886	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7345/2020	EPI_ISL_619090	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7347/2020	EPI_ISL_619091	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7071/2020	EPI_ISL_619122	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7199/2020	EPI_ISL_619196	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7200/2020	EPI_ISL_619197	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7297/2020	EPI_ISL_619257	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7299/2020	EPI_ISL_619259	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6178/2020	EPI_ISL_620081	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6179/2020	EPI_ISL_620082	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6187/2020	EPI_ISL_620090	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6204/2020	EPI_ISL_620107	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6209/2020	EPI_ISL_620112	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6211/2020	EPI_ISL_620114	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6217/2020	EPI_ISL_620120	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5933/2020	EPI_ISL_620198	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6043/2020	EPI_ISL_620237	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6044/2020	EPI_ISL_620238	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6045/2020	EPI_ISL_620239	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-4816/2020	EPI_ISL_621426	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4818/2020	EPI_ISL_621428	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4829/2020	EPI_ISL_621439	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4941/2020	EPI_ISL_621479	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4951/2020	EPI_ISL_621489	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4885/2020	EPI_ISL_621571	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4887/2020	EPI_ISL_621573	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-4892/2020	EPI_ISL_621578	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		NSP11 without BLAST coverage.	warn	B.1.1.224	GR
hCoV-19/Denmark/DCGC-5051/2020	EPI_ISL_621589	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5056/2020	EPI_ISL_621594	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5057/2020	EPI_ISL_621595	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3793/2020	EPI_ISL_622719	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3856/2020	EPI_ISL_622737	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4984/2020	EPI_ISL_622757	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/New Zealand/20CV0404/2020	EPI_ISL_622805	2020-09-13	Oceania / New Zealand / Bay of Plenty	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0405/2020	EPI_ISL_622806	2020-09-13	Oceania / New Zealand / Bay of Plenty	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/New Zealand/20CV0458/2020	EPI_ISL_622809	2020-10-19	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Wales/ALDP-AA0949/2020	EPI_ISL_625000	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0C04/2020	EPI_ISL_625021	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA49AF/2020	EPI_ISL_625065	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA457E/2020	EPI_ISL_625067	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-AA21F4/2020	EPI_ISL_625075	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1887/2020	EPI_ISL_625082	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/NIRE-1089C0/2020	EPI_ISL_627520	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/Northern Ireland/NIRE-1089EE/2020	EPI_ISL_627522	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F14F7/2020	EPI_ISL_627599	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F1503/2020	EPI_ISL_627600	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F1512/2020	EPI_ISL_627601	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F15A9/2020	EPI_ISL_627606	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F20B6/2020	EPI_ISL_627654	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/UT-UPHL-201110826/2020	EPI_ISL_628935	2020-09-23	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2.2			B.1.1.453	GR
hCoV-19/England/QEUH-AE232F/2020	EPI_ISL_633427	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE236B/2020	EPI_ISL_633482	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE21AD/2020	EPI_ISL_633593	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1639/2020	EPI_ISL_634711	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1F89/2020	EPI_ISL_634725	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0FB7/2020	EPI_ISL_634730	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AD3A59/2020	EPI_ISL_634753	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA1C30/2020	EPI_ISL_634759	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA1C6D/2020	EPI_ISL_634764	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/UGent-155/2020	EPI_ISL_634878	2020-06-03	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/ALDP-9E816C/2020	EPI_ISL_638240	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E818A/2020	EPI_ISL_638242	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8199/2020	EPI_ISL_638243	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8515/2020	EPI_ISL_638252	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E8858/2020	EPI_ISL_638259	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8C7A/2020	EPI_ISL_638286	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9E94EA/2020	EPI_ISL_638287	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B77B7/2020	EPI_ISL_638334	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-489487/2020	EPI_ISL_639579	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4894D2/2020	EPI_ISL_639583	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/QEUH-9AE00B/2020	EPI_ISL_639624	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/QEUH-9AE065/2020	EPI_ISL_639625	2020-09-02	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Latvia/193/2020	EPI_ISL_639690	2020-10-08	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.294	GR
hCoV-19/England/QEUH-B0F77A/2020	EPI_ISL_641824	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10776/2020	EPI_ISL_641829	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B142DB/2020	EPI_ISL_641838	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0F9B0/2020	EPI_ISL_641920	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8C3/2020	EPI_ISL_641926	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E571/2020	EPI_ISL_641942	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F376/2020	EPI_ISL_641967	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8A5/2020	EPI_ISL_641968	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F2E2/2020	EPI_ISL_641975	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E966/2020	EPI_ISL_641996	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-ACEE37/2020	EPI_ISL_644084	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2A80/2020	EPI_ISL_644103	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DA3/2020	EPI_ISL_644113	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/D-NVRL-AIIDV0023v1/2020	EPI_ISL_644267	2020-04-24	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/England/CAMC-B363B2/2020	EPI_ISL_645371	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3D290/2020	EPI_ISL_645393	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B375BB/2020	EPI_ISL_645470	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1B2F2/2020	EPI_ISL_645532	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1A080/2020	EPI_ISL_645538	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1BB9D/2020	EPI_ISL_645568	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1B025/2020	EPI_ISL_645587	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2B927/2020	EPI_ISL_646700	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-B24DF5/2020	EPI_ISL_646718	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-B24F68/2020	EPI_ISL_646738	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2B4BD/2020	EPI_ISL_646748	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2C9BD/2020	EPI_ISL_646765	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23822/2020	EPI_ISL_646862	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC76/2020	EPI_ISL_646872	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9D165/2020	EPI_ISL_652659	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/QEUH-A9F9A7/2020	EPI_ISL_652689	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/204400610/2020	EPI_ISL_653960	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/ALDP-B46759/2020	EPI_ISL_656031	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B45A60/2020	EPI_ISL_656062	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46E90/2020	EPI_ISL_656075	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46F33/2020	EPI_ISL_656082	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46012/2020	EPI_ISL_656167	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46E09/2020	EPI_ISL_656215	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46BC6/2020	EPI_ISL_656218	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46D48/2020	EPI_ISL_656229	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46F06/2020	EPI_ISL_656253	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B56149/2020	EPI_ISL_657443	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B52B30/2020	EPI_ISL_657445	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-B5645F/2020	EPI_ISL_657512	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B52A7F/2020	EPI_ISL_657516	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B53030/2020	EPI_ISL_657566	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B55775/2020	EPI_ISL_657581	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3FD33/2020	EPI_ISL_658685	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B41B16/2020	EPI_ISL_658695	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B418F1/2020	EPI_ISL_658721	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B416D9/2020	EPI_ISL_658738	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-B39179/2020	EPI_ISL_658757	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38D76/2020	EPI_ISL_658786	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38444/2020	EPI_ISL_658842	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38699/2020	EPI_ISL_658887	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B394BC/2020	EPI_ISL_658895	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68153/2020	EPI_ISL_662005	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/EXET-1391CE/2020	EPI_ISL_664603	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/NORT-28CD12/2020	EPI_ISL_665868	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CD6D/2020	EPI_ISL_665869	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A490A7/2020	EPI_ISL_665959	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A9FC26/2020	EPI_ISL_665993	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-B7F20B/2020	EPI_ISL_668001	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B7981E/2020	EPI_ISL_668002	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B78ED1/2020	EPI_ISL_668068	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B790CB/2020	EPI_ISL_668069	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79A54/2020	EPI_ISL_668072	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79966/2020	EPI_ISL_668122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7C295/2020	EPI_ISL_668186	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B7C07D/2020	EPI_ISL_668203	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-10031/2020	EPI_ISL_669348	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10036/2020	EPI_ISL_669351	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10071/2020	EPI_ISL_669377	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10100/2020	EPI_ISL_669393	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10172/2020	EPI_ISL_669435	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-11168/2020	EPI_ISL_670432	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-11197/2020	EPI_ISL_670450	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Ireland/CO-NVRL-75IRL73629/2020	EPI_ISL_671878	2020-10-11	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/CO-NVRL-75IRL73676/2020	EPI_ISL_671879	2020-10-11	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/England/CAMC-B096A0/2020	EPI_ISL_672975	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08DBB/2020	EPI_ISL_672991	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F3AB/2020	EPI_ISL_675212	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B842C7/2020	EPI_ISL_675235	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B85897/2020	EPI_ISL_675299	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F217/2020	EPI_ISL_675301	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Sweden/20-53067/2020	EPI_ISL_676534	2020-10-02	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/France/ARA-24352/2020	EPI_ISL_676545	2020-04-13	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/France/ARA-27101/2020	EPI_ISL_676566	2020-04-18	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/USA/CA-IGI-0618/2020	EPI_ISL_677848	2020-07-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0672/2020	EPI_ISL_677865	2020-08-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0723/2020	EPI_ISL_677878	2020-07-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1	GR
hCoV-19/USA/CA-IGI-0730/2020	EPI_ISL_677880	2020-08-03	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1	GR
hCoV-19/USA/CA-IGI-0765/2020	EPI_ISL_677886	2020-07-31	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1	GR
hCoV-19/USA/CA-IGI-0813/2020	EPI_ISL_677898	2020-07-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0826/2020	EPI_ISL_677904	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1	GR
hCoV-19/USA/CA-IGI-0830/2020	EPI_ISL_677905	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH1292/2020	EPI_ISL_677923	2020-06-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.1	GR
hCoV-19/Denmark/DCGC-12242/2020	EPI_ISL_682423	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12255/2020	EPI_ISL_682436	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12277/2020	EPI_ISL_682458	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/England/CAMC-BD20DF/2020	EPI_ISL_702107	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BD12CB/2020	EPI_ISL_702139	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-BD46DB/2020	EPI_ISL_702150	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BD186F/2020	EPI_ISL_702240	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BD20EE/2020	EPI_ISL_702267	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BD2084/2020	EPI_ISL_702279	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BD48C6/2020	EPI_ISL_702294	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC4762/2020	EPI_ISL_703515	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BCA2F2/2020	EPI_ISL_703552	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BCAA18/2020	EPI_ISL_703592	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC03BD/2020	EPI_ISL_704721	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-BC2306/2020	EPI_ISL_704798	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC03DB/2020	EPI_ISL_704805	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BC05C6/2020	EPI_ISL_704814	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-BC0F9B/2020	EPI_ISL_704863	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/ULG-10967/2020	EPI_ISL_708453	2020-09-08	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel	Gap of 2 nucleotide(s) found at refpos 28252 (FRAMESHIFT confirmed by submitter). Gap of 20 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.	info	B.1.1	GR
hCoV-19/USA/MN-MDH-2122/2020	EPI_ISL_708460	2020-10-30	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2126/2020	EPI_ISL_708464	2020-11-04	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2127/2020	EPI_ISL_708465	2020-11-04	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2128/2020	EPI_ISL_708466	2020-11-04	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2131/2020	EPI_ISL_708469	2020-11-05	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/England/MILK-BDC3AF/2020	EPI_ISL_709713	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-BDB917/2020	EPI_ISL_709731	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/ALDP-C06842/2020	EPI_ISL_710694	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC64D2/2020	EPI_ISL_721306	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC74FF/2020	EPI_ISL_721308	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC7C15/2020	EPI_ISL_721348	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC7978/2020	EPI_ISL_721374	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B7AC5D/2020	EPI_ISL_723952	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-B7B102/2020	EPI_ISL_723982	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-494331/2020	EPI_ISL_726102	2020-11-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4945D1/2020	EPI_ISL_726140	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49A711/2020	EPI_ISL_727587	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49A75D/2020	EPI_ISL_727591	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49A76C/2020	EPI_ISL_727592	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-49A77B/2020	EPI_ISL_727593	2020-12-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Portugal/PT1776/2020	EPI_ISL_732007	2020-11-11	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			AD.2	GR
hCoV-19/Portugal/PT1779/2020	EPI_ISL_732008	2020-11-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			AD.2	GR
hCoV-19/Russia/KDA-RII-MH4836S/2020	EPI_ISL_733269	2020-10-08	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/MUR-RII-MH6034S/2020	EPI_ISL_733334	2020-11-11	Europe / Russia / Murmansk / Murmansk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/LEN-RII-MH6062S/2020	EPI_ISL_733337	2020-11-11	Europe / Russia / Leningrad / Gatchina	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/NGR-RII-MH6127S/2020	EPI_ISL_733350	2020-11-06	Europe / Russia / Novgorod / Veliky Novgorod	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/MUR-RII-MH6168S/2020	EPI_ISL_733355	2020-11-13	Europe / Russia / Murmansk / Severomorsk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.336	GR
hCoV-19/Russia/SVE-RII-MH9000S/2020	EPI_ISL_733406	2020-10-01	Europe / Russia / Sverdlovsk / Dvurechensk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.163	GR
hCoV-19/Belgium/rega-0417503/2020	EPI_ISL_734596	2020-04-17	Europe / Belgium / Mouscron	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0417505/2020	EPI_ISL_734598	2020-04-17	Europe / Belgium / Mouscron	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0417511/2020	EPI_ISL_734603	2020-04-17	Europe / Belgium / Bertem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0417515/2020	EPI_ISL_734607	2020-04-17	Europe / Belgium / Lubbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0417524/2020	EPI_ISL_734615	2020-04-17	Europe / Belgium / Mouscron	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0417525/2020	EPI_ISL_734616	2020-04-17	Europe / Belgium / Mouscron	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0419531/2020	EPI_ISL_734624	2020-04-19	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0419533/2020	EPI_ISL_734626	2020-04-19	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0419536/2020	EPI_ISL_734629	2020-04-19	Europe / Belgium / Lubbeek	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0419585/2020	EPI_ISL_734630	2020-04-19	Europe / Belgium / Geetbets	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0422590/2020	EPI_ISL_734636	2020-04-22	Europe / Belgium / Rochefort	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0422591/2020	EPI_ISL_734637	2020-04-22	Europe / Belgium / Averbode	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0423598/2020	EPI_ISL_734645	2020-04-23	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0427607/2020	EPI_ISL_734658	2020-04-27	Europe / Belgium / Tessenderlo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0429627/2020	EPI_ISL_734680	2020-04-29	Europe / Belgium / Blandain	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0430630/2020	EPI_ISL_734687	2020-04-30	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0502639/2020	EPI_ISL_734697	2020-05-02	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0503642/2020	EPI_ISL_734702	2020-05-03	Europe / Belgium / Zoutleeuw	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0513655/2020	EPI_ISL_734729	2020-05-13	Europe / Belgium / Brussel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0513668/2020	EPI_ISL_734730	2020-05-13	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0514551/2020	EPI_ISL_734731	2020-05-14	Europe / Belgium / Bekkevoort	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0514669/2020	EPI_ISL_734732	2020-05-14	Europe / Belgium / Leuven	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0514670/2020	EPI_ISL_734733	2020-05-14	Europe / Belgium / Heverlee	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0517553/2020	EPI_ISL_734737	2020-05-17	Europe / Belgium / Zaventem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0521558/2020	EPI_ISL_734742	2020-05-21	Europe / Belgium / Zaventem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/England/QEUH-C5BCF7/2020	EPI_ISL_735909	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Portugal/PT2086/2020	EPI_ISL_738118	2020-11-08	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT2087/2020	EPI_ISL_738119	2020-11-08	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/USA/TX-DSHS-1803/2020	EPI_ISL_738174	2020-06-13	North America / USA / Texas / Harris	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/USA/TX-DSHS-1820/2020	EPI_ISL_738187	2020-06-22	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/Belgium/rega-03071156/2020	EPI_ISL_738204	2020-03-07	Europe / Belgium / Grimbergen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0414676/2020	EPI_ISL_738211	2020-04-14	Europe / Belgium / Diest	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0508674/2020	EPI_ISL_738215	2020-05-08	Europe / Belgium / Tessenderlo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-09151142/2020	EPI_ISL_738223	2020-09-15	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/USA/CA-CZB-14351/2020	EPI_ISL_739422	2020-07-14	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14410/2020	EPI_ISL_739434	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.277	GR
hCoV-19/USA/CA-CZB-13806/2020	EPI_ISL_739448	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-15159/2020	EPI_ISL_739458	2020-11-23	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14409/2020	EPI_ISL_739463	2020-06-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.277	GR
hCoV-19/USA/CA-CZB-13843/2020	EPI_ISL_739515	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14313/2020	EPI_ISL_739541	2020-08-22	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13945/2020	EPI_ISL_739544	2020-06-22	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14130/2020	EPI_ISL_739576	2020-05-23	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13669/2020	EPI_ISL_739580	2020-11-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/Luxembourg/LNS4519371/2020	EPI_ISL_740488	2020-09-09	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/England/QEUH-AAE3F2/2020	EPI_ISL_741775	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B7C909/2020	EPI_ISL_741800	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7C936/2020	EPI_ISL_741801	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7D07C/2020	EPI_ISL_741843	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7D337/2020	EPI_ISL_741851	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7D355/2020	EPI_ISL_741852	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-B7D470/2020	EPI_ISL_741864	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-B7D513/2020	EPI_ISL_741870	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7D5E6/2020	EPI_ISL_741876	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-B7D768/2020	EPI_ISL_741878	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina		NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B7DAE7/2020	EPI_ISL_741895	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Russia/MOS-CRIE-13381296/2020	EPI_ISL_745241	2020-11-06	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	ambiguous nucleotide at reference position 19,145, coverage of T - 275 (22 %), coverage of C - 1004 (78 %), ambiguous nucleotide at reference position 23,475, coverage of C - 667 (26 %), coverage of T - 1851 (73 %)	info	B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13678204/2020	EPI_ISL_745245	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/MOS-CRIE-13681164/2020	EPI_ISL_745249	2020-11-09	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	ambiguous nucleotide at reference position 21,411, coverage of T - 94 (32 %), coverage of C - 197 (68 %), ambiguous nucleotide at reference position 21,622, coverage of T - 180 (37 %), coverage of C - 312 (63 %)	info	B.1.1.349	GR
hCoV-19/USA/TX-DSHS-1851/2020	EPI_ISL_745289	2020-06-23	North America / USA / Texas / Harris	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1.177	GR
hCoV-19/Chile/RM-156567/2020	EPI_ISL_746668	2020-08-20	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-157770/2020	EPI_ISL_746680	2020-08-21	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-157771/2020	EPI_ISL_746681	2020-08-21	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Denmark/DCGC-20004/2020	EPI_ISL_747922	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20015/2020	EPI_ISL_747930	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20087/2020	EPI_ISL_747973	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20111/2020	EPI_ISL_747989	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20127/2020	EPI_ISL_747999	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17711/2020	EPI_ISL_751161	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17717/2020	EPI_ISL_751162	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Germany/BE-ChVir-W1389-4345/2020	EPI_ISL_753825	2020-05-20	Europe / Germany / Berlin	Human	Original			Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/HE-ChVir-W1553-8207/2020	EPI_ISL_753835	2020-06-17	Europe / Germany / Hesse	Human	Original			Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BB-ChVir-W1413-8296/2020	EPI_ISL_753853	2020-06-19	Europe / Germany / Brandenburg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BB-ChVir-W1419-8228/2020	EPI_ISL_753854	2020-06-18	Europe / Germany / Brandenburg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BB-ChVir-W1423-8226/2020	EPI_ISL_753855	2020-06-19	Europe / Germany / Brandenburg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BB-ChVir-W1426-8229/2020	EPI_ISL_753856	2020-06-19	Europe / Germany / Brandenburg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BB-ChVir-W1442-8234/2020	EPI_ISL_753857	2020-06-19	Europe / Germany / Brandenburg	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-D1911-8207/2020	EPI_ISL_753860	2020-09-29	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-D1914-8251/2020	EPI_ISL_753862	2020-10-05	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Denmark/DCGC-22093/2020	EPI_ISL_758549	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.315	GR
hCoV-19/Denmark/DCGC-22283/2020	EPI_ISL_758655	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22312/2020	EPI_ISL_758671	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/CAMC-C11A3F/2020	EPI_ISL_760969	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-CABDB9/2020	EPI_ISL_760970	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/NIRE-2352A0/2020	EPI_ISL_764425	2020-10-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/Northern Ireland/NIRE-235343/2020	EPI_ISL_764428	2020-10-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/MA-MGH-03149/2020	EPI_ISL_765720	2020-09-08	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.1	GR
hCoV-19/USA/MA-MGH-03150/2020	EPI_ISL_765721	2020-09-08	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.1	GR
hCoV-19/USA/MA-MGH-03177/2020	EPI_ISL_765734	2020-09-24	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.1	GR
hCoV-19/USA/MA-MGH-03375/2020	EPI_ISL_765810	2020-11-09	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.1	GR
hCoV-19/England/QEUH-C5BB45/2020	EPI_ISL_769367	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Germany/HH-hpi-p2307/2020	EPI_ISL_776438	2020-03-12	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.271	GR
hCoV-19/Germany/HH-hpi-p2379/2020	EPI_ISL_776457	2020-06-02	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2380/2020	EPI_ISL_776458	2020-06-04	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2451/2020	EPI_ISL_776513	2020-05-30	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2452/2020	EPI_ISL_776514	2020-05-30	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2454/2020	EPI_ISL_776516	2020-06-03	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2455/2020	EPI_ISL_776517	2020-06-02	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2457/2020	EPI_ISL_776518	2020-05-31	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2458/2020	EPI_ISL_776519	2020-05-30	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2464/2020	EPI_ISL_776523	2020-06-03	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2465/2020	EPI_ISL_776524	2020-06-03	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2466/2020	EPI_ISL_776525	2020-06-03	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2495/2020	EPI_ISL_776545	2020-06-19	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2496/2020	EPI_ISL_776546	2020-06-26	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2497/2020	EPI_ISL_776547	2020-06-26	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/SH-hpi-p2017/2020	EPI_ISL_776557	2020-03-21	Europe / Germany / Schleswig-Holstein	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p2317/2020	EPI_ISL_776563	2020-03-24	Europe / Germany / Hamburg	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-9295/2020	EPI_ISL_781044	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9330/2020	EPI_ISL_781064	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9393/2020	EPI_ISL_781093	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-MCoV-9400/2020	EPI_ISL_781098	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/England/QEUH-CDF860/2020	EPI_ISL_782374	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-CD0FB5/2020	EPI_ISL_782399	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-13821/2020	EPI_ISL_787114	2020-08-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13829/2020	EPI_ISL_787122	2020-08-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-13863/2020	EPI_ISL_787156	2020-08-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13908/2020	EPI_ISL_787200	2020-08-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13914/2020	EPI_ISL_787206	2020-08-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13262/2020	EPI_ISL_788411	2020-08-24	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-MCoV-13316/2020	EPI_ISL_788464	2020-08-25	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13393/2020	EPI_ISL_788536	2020-08-23	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/NY-Wadsworth-21000328-01/2020	EPI_ISL_794227	2020-12-27	North America / USA / New York / Dutchess County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/Denmark/DCGC-24435/2020	EPI_ISL_795542	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/ALDP-D9F0BE/2020	EPI_ISL_796920	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-C1829A/2020	EPI_ISL_800646	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Chile/Santiago-PUC_MVL_0487/2020	EPI_ISL_801831	2020-05-14	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2, Pilon			B.1.1	GR
hCoV-19/USA/NY-MSHSPSP-PV21114/2020	EPI_ISL_801943	2020-09-30	North America / USA / New York / Brooklyn	Human	Original			Illumina MiSeq	Minimap2, Pilon	NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.1.231	GR
hCoV-19/England/204140907/2020	EPI_ISL_804264	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Canada/AB-69131/2020	EPI_ISL_805418	2020-05-09	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-47840/2020	EPI_ISL_805570	2020-04-27	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-15239/2020	EPI_ISL_805571	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001817/2020	EPI_ISL_812743	2020-12-15	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/USA/NY-NYCPHL-001822/2020	EPI_ISL_812748	2020-12-16	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/Denmark/DCGC-28152/2020	EPI_ISL_816133	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-26131/2021	EPI_ISL_818686	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21001873-01/2021	EPI_ISL_830310	2021-01-06	North America / USA / New York / Montgomery County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/Iceland/6662/2020	EPI_ISL_830412	2020-12-12	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1.294	GR
hCoV-19/Denmark/DCGC-31244/2021	EPI_ISL_855624	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/CA-CZB-9850/2020	EPI_ISL_856984	2020-05-21	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/Norway/7216/2020	EPI_ISL_860220	2020-12-26	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Norway/0380/2021	EPI_ISL_860264	2021-01-04	Europe / Norway / Vestfold og Telemark	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1.451	GR
hCoV-19/Norway/0492/2021	EPI_ISL_860280	2021-01-11	Europe / Norway / Nordland	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1	GR
hCoV-19/Scotland/EDB13461/2021	EPI_ISL_865150	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB13462/2021	EPI_ISL_865151	2021-01-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/TFCI-26FF457/2020	EPI_ISL_868930	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/TFCI-26FF475/2020	EPI_ISL_868932	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-102E607/2021	EPI_ISL_873462	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/TX-QDX-3487/2020	EPI_ISL_877124	2020-09-11	North America / USA / Texas	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2	Insertion of 2 nucleotide(s) found at refpos 27906 (FRAMESHIFT confirmed by submitter).	info	B.1.1	GR
hCoV-19/USA/TX-QDX-3498/2020	EPI_ISL_877125	2020-09-13	North America / USA / Texas	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2	Insertion of 2 nucleotide(s) found at refpos 27906 (FRAMESHIFT confirmed by submitter).	info	B.1.1	GR
hCoV-19/Israel/CVL-918ngs/2020	EPI_ISL_889264	2020-12-30	Asia / Israel / Haifa / Tirat Carmel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Indonesia/YO-UGM-120782/2020	EPI_ISL_890185	2020-12-01	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.1.398	GR
hCoV-19/Belgium/rega-1560/2020	EPI_ISL_890239	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1561/2020	EPI_ISL_890240	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1566/2020	EPI_ISL_890244	2020-12-20	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/USA/LA-CDC-2-4044350/2020	EPI_ISL_903765	2020-11-20	North America / USA / Louisiana	Human	Original	Nasopharyngeal aspirate		Illumina	IRMA v0.9.5-beta			B.1.1.337	GR
hCoV-19/England/QEUH-10EF347/2021	EPI_ISL_907451	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/MI-UM-10037007972/2020	EPI_ISL_913242	2020-11-18	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.1.337	GR
hCoV-19/England/ALDP-BC6D04/2020	EPI_ISL_915779	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC8072/2020	EPI_ISL_915883	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-BC7107/2020	EPI_ISL_915929	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-BC72B9/2020	EPI_ISL_915969	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/NORT-28E5DC/2020	EPI_ISL_921716	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 18 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/NORT-28E7C7/2020	EPI_ISL_921732	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 2 nucleotide(s) found at refpos 11082 (Frameshift confirmed by the submitter). NSP6 without BLAST coverage.	info	AD.2	GR
hCoV-19/England/NORT-28E8F1/2020	EPI_ISL_921745	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 2 nucleotide(s) found at refpos 11082 (Frameshift confirmed by the submitter). Gap of 20 nucleotides when compared to the reference sequence. NSP6 without BLAST coverage.	info	AD.2	GR
hCoV-19/England/NORT-28EA55/2020	EPI_ISL_921757	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 2 nucleotide(s) found at refpos 11082 (Frameshift confirmed by the submitter). Gap of 20 nucleotides when compared to the reference sequence. NSP6 without BLAST coverage.	info	AD.2	GR
hCoV-19/Denmark/DCGC-35606/2021	EPI_ISL_926747	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-36699/2020	EPI_ISL_927840	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-36714/2020	EPI_ISL_927855	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-36731/2020	EPI_ISL_927872	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-36735/2021	EPI_ISL_927876	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Switzerland/BS-UHB-42502258/2020	EPI_ISL_931134	2020-10-24	Europe / Switzerland / Basel-Land / Allschwil	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.221	GR
hCoV-19/Australia/WA610/2021	EPI_ISL_933792	2021-01-22	Oceania / Australia / Western Australia	Human	Original			Illumina iSeq				B.1.1.163	GR
hCoV-19/Australia/WA611/2021	EPI_ISL_933793	2021-01-24	Oceania / Australia / Western Australia	Human	Original			Illumina iSeq				B.1.1.163	GR
hCoV-19/Australia/WA615/2021	EPI_ISL_933798	2021-01-28	Oceania / Australia / Western Australia	Human	Original			Illumina iSeq				B.1.1.163	GR
hCoV-19/USA/TX-QDX-4470/2020	EPI_ISL_937110	2020-08-25	North America / USA / Texas	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/PR-CDC-S31/2020	EPI_ISL_940904	2020-06-11	North America / USA / Puerto Rico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Genome Detective Virus Tool			B.1.1	GR
hCoV-19/USA/PR-CDC-S34/2020	EPI_ISL_940907	2020-06-11	North America / USA / Puerto Rico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Genome Detective Virus Tool			B.1.1	GR
hCoV-19/Netherlands/GR-RIVM-10888/2021	EPI_ISL_943120	2021-01-20	Europe / Netherlands / Groningen	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Israel/CVL-1037/2021	EPI_ISL_944421	2021-01-03	Asia / Israel / Haifa	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-1049/2021	EPI_ISL_944422	2021-01-03	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-1911/2021	EPI_ISL_944423	2021-01-11	Asia / Israel / Central District	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-1949/2021	EPI_ISL_944424	2021-01-11	Asia / Israel / Central District	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-1989/2021	EPI_ISL_944425	2021-01-12	Asia / Israel / Central District	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-2007/2021	EPI_ISL_944426	2021-01-12	Asia / Israel / Haifa	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Israel/CVL-2012/2021	EPI_ISL_944427	2021-01-12	Asia / Israel / Central District	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-2577/2021	EPI_ISL_944428	2021-01-14	Asia / Israel / Central District	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Israel/CVL-62/2020	EPI_ISL_944429	2020-12-24	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Israel/CVL-38/2020	EPI_ISL_944441	2020-12-24	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Israel/CVL-1044/2021	EPI_ISL_944461	2021-01-03	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/Israel/CVL-2565/2021	EPI_ISL_944569	2021-01-15	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/Israel/CVL-2566/2021	EPI_ISL_944570	2021-01-15	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/Belgium/MBLG41527/2020	EPI_ISL_949249	2020-03-16	Europe / Belgium / Brussels	Human	Original	Oropharyngeal swab		Illumina iSeq	Smartgene 2.2.0_COV_v0.2			B.1.1.5	GR
hCoV-19/England/NORT-1B7B776/2021	EPI_ISL_950258	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-1032503/2021	EPI_ISL_952867	2021-01-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Mexico/CMX-IBT-IMSS-21/2020	EPI_ISL_955239	2020-04-16	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NexSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/GRO-IBT-IMSS-08/2020	EPI_ISL_955244	2020-04-08	North America / Mexico / Guerrero	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NexSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-IBT-IMSS-05/2020	EPI_ISL_955248	2020-04-08	North America / Mexico / Mexico City	Human	Original	Pharyngeal swab		Illumina NexSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/USA/CA-CDC-STM-000002946/2021	EPI_ISL_967211	2021-01-17	North America / USA / California	Human	Original	Nasal swab		Illumina	COVIDSEQ	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/NM-CDC-STM-000002428/2021	EPI_ISL_967275	2021-01-13	North America / USA / New Mexico	Human	Original	Nasal swab		Illumina	COVIDSEQ			B.1.1.231	GR
hCoV-19/England/ALDP-11BE5FF/2021	EPI_ISL_969558	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-40143/2021	EPI_ISL_971820	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-41412/2021	EPI_ISL_973089	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/MA-Broad_UMMS-00185/2020	EPI_ISL_976930	2020-09-14	North America / USA / Massachusetts	Human	Original			Illumina NovaSeq 6000	Broad viral-ngs v. v2.1.19			B.1.1.337	GR
hCoV-19/England/CAMC-1173AD9/2021	EPI_ISL_987392	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Switzerland/SO-ETHZ-431584/2020	EPI_ISL_1004731	2020-12-31	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-431523/2020	EPI_ISL_1004759	2020-12-30	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Ecuador/ZZL-6/2020	EPI_ISL_1014102	2020-10-30	South America / Ecuador / Quito	Human	Original			Illumina Miseq				B.1.1.203	GR
hCoV-19/Netherlands/UT-RIVM-12303/2021	EPI_ISL_1014139	2021-01-31	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Ecuador/UEES-A1-GV/2021	EPI_ISL_1015463	2021	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics	NS8_E59stop results in 52.1% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ecuador/UEES-A2-BC/2021	EPI_ISL_1015464	2021	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics	NS8_E59stop results in 52.1% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21008973-01/2021	EPI_ISL_1016454	2021-01-12	North America / USA / New York / Monroe County	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1	GR
hCoV-19/Denmark/DCGC-44518/2021	EPI_ISL_1024896	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	G
hCoV-19/Denmark/DCGC-44552/2021	EPI_ISL_1024930	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Hong Kong/HKU-201216-281/2020	EPI_ISL_1034598	2020-10-01	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				AD.2	GR
hCoV-19/USA/SC-USAFSAM-S0280/2021	EPI_ISL_1036885	2021-01-11	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0285/2021	EPI_ISL_1036886	2021-01-12	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0271/2021	EPI_ISL_1036896	2021-01-06	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0281/2021	EPI_ISL_1036900	2021-01-11	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0282/2021	EPI_ISL_1036901	2021-01-11	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0283/2021	EPI_ISL_1036902	2021-01-11	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0290/2021	EPI_ISL_1036905	2021-01-12	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0295/2021	EPI_ISL_1036906	2021-01-13	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/USA/SC-USAFSAM-S0304/2021	EPI_ISL_1036910	2021-01-19	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1	G
hCoV-19/USA/SC-USAFSAM-S0320/2021	EPI_ISL_1036921	2021-01-25	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina NextSeq High	BBMap v. 38.86			B.1.1.337	GR
hCoV-19/Russia/BEL-RII-MH12817S/2020	EPI_ISL_1039101	2020-11-30	Europe / Russia / Belgorod / Stary Oskol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/BEL-RII-MH12858S/2020	EPI_ISL_1039123	2020-11-30	Europe / Russia / Belgorod / Belgorod	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH13422S/2020	EPI_ISL_1039133	2020-12-24	Europe / Russia / Saint Petersburg / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/SPE-RII-MH13427S/2020	EPI_ISL_1039135	2020-12-24	Europe / Russia / Saint Petersburg / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH13433S/2020	EPI_ISL_1039137	2020-12-24	Europe / Russia / Saint Petersburg / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Norway/7341/2020	EPI_ISL_1040156	2020-12-20	Europe / Norway / Trondelag	Human	Original			Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1	GR
hCoV-19/Norway/3371/2021	EPI_ISL_1040166	2021-02-04	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-481397/2021	EPI_ISL_1059861	2021-01-04	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Denmark/DCGC-45930/2021	EPI_ISL_1065440	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Turkey/HSGM-4031/2021	EPI_ISL_1073803	2021-02-11	Europe / Turkey	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-22937/2021	EPI_ISL_1077467	2021-01-11	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/NJ-CDC-QDX21489182/2021	EPI_ISL_1087071	2021-01-27	North America / USA / New Jersey	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12			B.1.1.467	GR
hCoV-19/USA/CA-CDC-QDX21612709/2021	EPI_ISL_1088430	2021-01-31	North America / USA / California	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12			B.1.1	GR
hCoV-19/Netherlands/ZuidHolland_13/2020	EPI_ISL_414470	2020-03-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Peru/LIM-010/2020	EPI_ISL_415787	2020-03-10	South America / Peru / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/Iceland/188/2020	EPI_ISL_417816	2020-03-16	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1.5	GR
hCoV-19/Portugal/PT0016/2020	EPI_ISL_418001	2020-03-10	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0028/2020	EPI_ISL_418013	2020-03-07	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Belgium/AKM-030670/2020	EPI_ISL_420326	2020-03-06	Europe / Belgium / Winksele	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/MCW-030574/2020	EPI_ISL_420330	2020-03-05	Europe / Belgium / Neerpelt	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/LY-030575/2020	EPI_ISL_420331	2020-03-05	Europe / Belgium / Bree	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/DD-030593/2020	EPI_ISL_420349	2020-03-05	Europe / Belgium / Haulchin	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/RR-030699/2020	EPI_ISL_420355	2020-03-06	Europe / Belgium / Ronse	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/SEM-0324120/2020	EPI_ISL_420377	2020-03-24	Europe / Belgium / Beringen	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.5	GR
hCoV-19/Australia/NSW159/2020	EPI_ISL_427781	2020-03-24	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Thailand/TNIC-1889/2020	EPI_ISL_430837	2020-03-03	Asia / Thailand / Nonthaburi	Human	Original	Oropharyngeal	Patient came from Italy	Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/Sweden/20-08171/2020	EPI_ISL_430854	2020-03-12	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50360/2020	EPI_ISL_430864	2020-03-16	Europe / Sweden / Gavleborgs lan	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Wales/PHWC-2780B/2020	EPI_ISL_432322	2020-04-01	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-283CD/2020	EPI_ISL_432352	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/England/CAMB-73C31/2020	EPI_ISL_433678	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/USA/TX-HMH0361/2020	EPI_ISL_434954	2020-03-29	North America / USA / Texas	Human	Original			Oxford Nanopore	ARTIC V1			B.1.1	GR
hCoV-19/England/CAMB-75FBE/2020	EPI_ISL_438414	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-75D2D/2020	EPI_ISL_438423	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-76023/2020	EPI_ISL_438442	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-766C7/2020	EPI_ISL_438466	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-9945B/2020	EPI_ISL_439725	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BRIS-123B6F/2020	EPI_ISL_442802	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7D04A/2020	EPI_ISL_442811	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80976/2020	EPI_ISL_442867	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80B43/2020	EPI_ISL_442878	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1AB701/2020	EPI_ISL_444328	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Northern Ireland/NIRE-FAFDF/2020	EPI_ISL_448939	2020-03-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FB6CA/2020	EPI_ISL_448965	2020-03-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8596/2020	EPI_ISL_449162	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Australia/NSW225/2020	EPI_ISL_451491	2020-03-28	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Sweden/20-50089/2020	EPI_ISL_454872	2020-03-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50090/2020	EPI_ISL_454873	2020-03-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-50099/2020	EPI_ISL_454878	2020-03-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/New Zealand/20VR1618/2020	EPI_ISL_456228	2020-03-23	Oceania / New Zealand / Southern	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.254	GR
hCoV-19/England/BRIS-12AED8/2020	EPI_ISL_458319	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-129194/2020	EPI_ISL_458885	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126768/2020	EPI_ISL_458949	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Turkey/IMU-SP-01/2020	EPI_ISL_460618	2020-04-15	Europe / Turkey	Human	Original	Broncoalveolar		Illumina	SpaDES v. May 2012			B.1.1	GR
hCoV-19/Turkey/IMU-SP-04/2020	EPI_ISL_460619	2020-04-16	Europe / Turkey	Human	Original	Broncoalveolar		Illumina	SpaDES v. May 2012			B.1.1	GR
hCoV-19/Russia/CRIE162784/2020	EPI_ISL_462150	2020-03-31	Europe / Russia / Moscow	Human	Original			Illumina MiSeq	Spades3.13			B.1.1.294	GR
hCoV-19/Belgium/LAM-0325339/2020	EPI_ISL_462193	2020-03-25	Europe / Belgium / Blankenberge	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/AM-0328342/2020	EPI_ISL_462196	2020-03-28	Europe / Belgium / Genk	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/NA-0328342/2020	EPI_ISL_462197	2020-03-28	Europe / Belgium / Maaseik	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/MR-0327344/2020	EPI_ISL_462198	2020-03-27	Europe / Belgium / Eisden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/CF-0327345/2020	EPI_ISL_462199	2020-03-27	Europe / Belgium / Beverst	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/USA/WA-S965/2020	EPI_ISL_463455	2020-05-01	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/Italy/APU-UniMI-857/2020	EPI_ISL_469023	2020-03-20	Europe / Italy / Apulia / Brindisi	Human	Original	Oropharyngeal swab		Illumina				B.1.1	GR
hCoV-19/Sweden/20-51758/2020	EPI_ISL_469071	2020-05-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Wales/PHWC-1636CC/2020	EPI_ISL_473981	2020-04-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C9470/2020	EPI_ISL_475420	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/OXON-AFF42/2020	EPI_ISL_478837	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Belgium/UGent-128/2020	EPI_ISL_481224	2020-05-15	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/UGent-136/2020	EPI_ISL_481229	2020-04-16	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.1.5	GR
hCoV-19/Japan/NGS-CD-010/2020	EPI_ISL_481255	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1	GR
hCoV-19/Japan/NGS-CD-024/2020	EPI_ISL_481257	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1	GR
hCoV-19/Japan/NGS-CD-107/2020	EPI_ISL_481258	2020-04-23	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-235/2020	EPI_ISL_481259	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-292/2020	EPI_ISL_481260	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-361/2020	EPI_ISL_481261	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench			B.1.1.465	GR
hCoV-19/Japan/NGS-CD-365/2020	EPI_ISL_481263	2020-04-24	Asia / Japan / Nagasaki	Human	Vero			Illumina MiSeq	CLC Genomics Workbench	NS7a_E92stop results in 24.8% truncation of the protein sequence.	info	B.1.1.465	GR
hCoV-19/Northern Ireland/NIRE-103EB7/2020	EPI_ISL_482056	2020-04-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A079/2020	EPI_ISL_482071	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Hangzhou/HZCDCp145/2020	EPI_ISL_482582	2020-03-21	Asia / China / Zhejiang / Hangzhou	Human	Original	Nasal, oropharyngeal swab	Infected in Switzerland	Nanopore MinION	artic-ncov2019 and Geneious 11.1.5			B.1.1	GR
hCoV-19/England/BIRM-60781/2020	EPI_ISL_483887	2020-06-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B51D9/2020	EPI_ISL_483914	2020-06-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/Wales/PHWC-165615/2020	EPI_ISL_484689	2020-06-28	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-165633/2020	EPI_ISL_484691	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Belgium/ULG-10209/2020	EPI_ISL_484698	2020-05-14	Europe / Belgium	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/USA/CA-CZB-1881/2020	EPI_ISL_486180	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1882/2020	EPI_ISL_486181	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/England/NORT-29D886/2020	EPI_ISL_488158	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E24B/2020	EPI_ISL_488162	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29C9DF/2020	EPI_ISL_488166	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E22D/2020	EPI_ISL_488171	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29E8A3/2020	EPI_ISL_488172	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297145/2020	EPI_ISL_488174	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC5CA/2020	EPI_ISL_489481	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ACF62/2020	EPI_ISL_489485	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD417/2020	EPI_ISL_489487	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD383/2020	EPI_ISL_489488	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-1ACE0B/2020	EPI_ISL_489493	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-1AC560/2020	EPI_ISL_489498	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29EAE9/2020	EPI_ISL_490473	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-166474/2020	EPI_ISL_494001	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1664FC/2020	EPI_ISL_494008	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166517/2020	EPI_ISL_494010	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1665CC/2020	EPI_ISL_494020	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16666F/2020	EPI_ISL_494026	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16668D/2020	EPI_ISL_494028	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16676C/2020	EPI_ISL_494036	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1667F3/2020	EPI_ISL_494043	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16680F/2020	EPI_ISL_494044	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16683C/2020	EPI_ISL_494047	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166869/2020	EPI_ISL_494050	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166896/2020	EPI_ISL_494053	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16691B/2020	EPI_ISL_494060	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166957/2020	EPI_ISL_494062	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166ACD/2020	EPI_ISL_494078	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166AEB/2020	EPI_ISL_494080	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166B8E/2020	EPI_ISL_494088	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166BCA/2020	EPI_ISL_494091	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C03/2020	EPI_ISL_494094	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C30/2020	EPI_ISL_494096	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-166C8B/2020	EPI_ISL_494099	2020-06-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-ALSR-1379/2020	EPI_ISL_494570	2020-06-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence. NSP11 without BLAST coverage.	warn	B.1.1.132	GR
hCoV-19/South Africa/KRISP-0563/2020	EPI_ISL_498102	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/Belgium/ULG-10221/2020	EPI_ISL_498127	2020-05-14	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Wales/PHWC-1695AB/2020	EPI_ISL_499459	2020-06-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Spain/PV-IBV-004230/2020	EPI_ISL_500294	2020-04-05	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/BRIS-130EC0/2020	EPI_ISL_501597	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/South Africa/KRISP-K001049/2020	EPI_ISL_509308	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001057/2020	EPI_ISL_509314	2020-07-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K001109/2020	EPI_ISL_509356	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001123/2020	EPI_ISL_509366	2020-07-15	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/Portugal/PT1176/2020	EPI_ISL_511722	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/South Korea/KCDC2448/2020	EPI_ISL_514851	2020-06-07	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-230018/2020	EPI_ISL_516561	2020-08-02	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/LIVE-A818F/2020	EPI_ISL_517123	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/FL-BPHL-0911/2020	EPI_ISL_517801	2020-06-30	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.180	GR
hCoV-19/United Arab Emirates/L3290361549/2020	EPI_ISL_520708	2020-05-30	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/L3300061195/2020	EPI_ISL_520713	2020-06-07	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/L920632111/2020	EPI_ISL_520720	2020-03-29	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/L920633851/2020	EPI_ISL_520726	2020-03-31	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.366	GR
hCoV-19/United Arab Emirates/L920634181/2020	EPI_ISL_520727	2020-03-31	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/VA-DCLS-0722/2020	EPI_ISL_526845	2020-07-06	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0723/2020	EPI_ISL_526846	2020-07-06	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0724/2020	EPI_ISL_526847	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0725/2020	EPI_ISL_526848	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0726/2020	EPI_ISL_526849	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0727/2020	EPI_ISL_526850	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0728/2020	EPI_ISL_526851	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0729/2020	EPI_ISL_526852	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0731/2020	EPI_ISL_526853	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0732/2020	EPI_ISL_526854	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0733/2020	EPI_ISL_526855	2020-07-16	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0734/2020	EPI_ISL_526856	2020-07-16	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0760/2020	EPI_ISL_526876	2020-06-24	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0761/2020	EPI_ISL_526877	2020-06-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0762/2020	EPI_ISL_526878	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0763/2020	EPI_ISL_526879	2020-06-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0764/2020	EPI_ISL_526880	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0765/2020	EPI_ISL_526881	2020-06-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Spain/MD-HLP-81/2020	EPI_ISL_530078	2020-05-06	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Spain/MD-HLP-R56/2020	EPI_ISL_530104	2020-04-20	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Spain/MD-HLP-R63/2020	EPI_ISL_530109	2020-03-17	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Spain/MD-HLP-R84/2020	EPI_ISL_530116	2020-05-11	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Scotland/QEUH-96C0BE/2020	EPI_ISL_530826	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-96B723/2020	EPI_ISL_531350	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BE6A/2020	EPI_ISL_531353	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96B2B9/2020	EPI_ISL_531385	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-96BA84/2020	EPI_ISL_531413	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96BA93/2020	EPI_ISL_531429	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/QEUH-96BF94/2020	EPI_ISL_531433	2020-08-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96BEA6/2020	EPI_ISL_531447	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-884804/2020	EPI_ISL_532737	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-79A20E/2020	EPI_ISL_533034	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-7A8FF7/2020	EPI_ISL_533042	2020-07-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-790709/2020	EPI_ISL_533044	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-78CC4D/2020	EPI_ISL_533076	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Russia/CRIE4924360/2020	EPI_ISL_534337	2020-07-15	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE5027243/2020	EPI_ISL_534340	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina MiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Russia/CRIE166582/2020	EPI_ISL_534349	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.294	GR
hCoV-19/Scotland/QEUH-963A7D/2020	EPI_ISL_534366	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963FAB/2020	EPI_ISL_534368	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963A6E/2020	EPI_ISL_534369	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964344/2020	EPI_ISL_534371	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963A8C/2020	EPI_ISL_534384	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964195/2020	EPI_ISL_534385	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969FF0/2020	EPI_ISL_534390	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-963F50/2020	EPI_ISL_534391	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9640C5/2020	EPI_ISL_534392	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964308/2020	EPI_ISL_534398	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A28D/2020	EPI_ISL_534399	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/BL-ETHZ-250090/2020	EPI_ISL_535608	2020-08-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00241862/2020	EPI_ISL_536291	2020-03-28	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/England/QEUH-96A205/2020	EPI_ISL_536958	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95E3A7/2020	EPI_ISL_536963	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-95DF0E/2020	EPI_ISL_536970	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/LEED-2AA2F1/2020	EPI_ISL_538890	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9A465E/2020	EPI_ISL_540178	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A44FA/2020	EPI_ISL_540188	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A41E4/2020	EPI_ISL_540193	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A3FDC/2020	EPI_ISL_540211	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A4612/2020	EPI_ISL_540224	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A44EB/2020	EPI_ISL_540231	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96FCC6/2020	EPI_ISL_540253	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/USA/TX-HMH-1737/2020	EPI_ISL_542804	2020-05-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-1898/2020	EPI_ISL_542894	2020-05-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-4128/2020	EPI_ISL_543394	2020-06-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.367	GR
hCoV-19/USA/TX-HMH-4135/2020	EPI_ISL_543399	2020-06-18	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-4203/2020	EPI_ISL_543434	2020-06-19	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5324/2020	EPI_ISL_544681	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5339/2020	EPI_ISL_544695	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-5363/2020	EPI_ISL_544717	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5364/2020	EPI_ISL_544718	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-5382/2020	EPI_ISL_544734	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.258	GR
hCoV-19/Switzerland/GE-SNRCI-8099/2020	EPI_ISL_548215	2020-03	Europe / Switzerland / Geneve	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/CA-CZB-3351/2020	EPI_ISL_548273	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3332/2020	EPI_ISL_548276	2020-07-10	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3352/2020	EPI_ISL_548285	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-3350/2020	EPI_ISL_548298	2020-07-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/Canada/ON-PHL-20-01319/2020	EPI_ISL_548922	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/United Arab Emirates/DU-A-S2-3_S2/2020	EPI_ISL_548967	2020-04-23	Asia / United Arab Emirates / Dubai	Human	Original	Oropharyngeal swab		Illumina MiSeq	Abiomix Amplicon analysis			B.1.1.366	O
hCoV-19/Singapore/982/2020	EPI_ISL_548990	2020-03-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/QEUH-997BB9/2020	EPI_ISL_549544	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B9137/2020	EPI_ISL_549573	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9058/2020	EPI_ISL_549579	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-99D89E/2020	EPI_ISL_550523	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99DDCC/2020	EPI_ISL_550525	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E2BD/2020	EPI_ISL_550528	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99E077/2020	EPI_ISL_550531	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C54D/2020	EPI_ISL_550535	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E10B/2020	EPI_ISL_550540	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DCCF/2020	EPI_ISL_550548	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C52F/2020	EPI_ISL_550552	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E341/2020	EPI_ISL_550553	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DAA7/2020	EPI_ISL_550568	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E53C/2020	EPI_ISL_550570	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C6B3/2020	EPI_ISL_550571	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DA2F/2020	EPI_ISL_550580	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C7ED/2020	EPI_ISL_550598	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9911AE/2020	EPI_ISL_551870	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-991575/2020	EPI_ISL_552151	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992CBB/2020	EPI_ISL_552154	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-992820/2020	EPI_ISL_552164	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9949B2/2020	EPI_ISL_552195	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-99476D/2020	EPI_ISL_552205	2020-08-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994AA0/2020	EPI_ISL_552224	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994E95/2020	EPI_ISL_552231	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9938D4/2020	EPI_ISL_552245	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-994484/2020	EPI_ISL_552261	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994F74/2020	EPI_ISL_552267	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-94D4B7/2020	EPI_ISL_553522	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB56/2020	EPI_ISL_553523	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9550E5/2020	EPI_ISL_553526	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95D241/2020	EPI_ISL_553531	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-954E64/2020	EPI_ISL_553540	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95C9D4/2020	EPI_ISL_553551	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-95CB38/2020	EPI_ISL_553552	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB92/2020	EPI_ISL_553570	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CB65/2020	EPI_ISL_553580	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95CBA1/2020	EPI_ISL_553592	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9551E2/2020	EPI_ISL_553594	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9560D5/2020	EPI_ISL_554016	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95276B/2020	EPI_ISL_554023	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9560A8/2020	EPI_ISL_554029	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-956169/2020	EPI_ISL_554031	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955B11/2020	EPI_ISL_554036	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-952507/2020	EPI_ISL_554041	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955FF7/2020	EPI_ISL_554047	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-955C3C/2020	EPI_ISL_555363	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94E638/2020	EPI_ISL_555372	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9519B1/2020	EPI_ISL_555374	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94E61A/2020	EPI_ISL_555379	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94E4D4/2020	EPI_ISL_555405	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-954945/2020	EPI_ISL_555407	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-94B71A/2020	EPI_ISL_556646	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/CAMC-9460BA/2020	EPI_ISL_556673	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-9464EB/2020	EPI_ISL_556696	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/CAMC-945BBA/2020	EPI_ISL_556709	2020-07-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94C175/2020	EPI_ISL_556715	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-9496F1/2020	EPI_ISL_556730	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-945B7E/2020	EPI_ISL_556731	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-948B8A/2020	EPI_ISL_556737	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-948A8D/2020	EPI_ISL_556739	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-8B7F9A/2020	EPI_ISL_557018	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8D5549/2020	EPI_ISL_557020	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8DDFBC/2020	EPI_ISL_557022	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8B41B5/2020	EPI_ISL_557025	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-8B9F4D/2020	EPI_ISL_557041	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-90FCE6/2020	EPI_ISL_557050	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-8E2567/2020	EPI_ISL_557053	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-620D49/2020	EPI_ISL_557965	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Wales/MILK-60FED4/2020	EPI_ISL_557977	2020-07-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-559C3C/2020	EPI_ISL_558301	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-566838/2020	EPI_ISL_558327	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-565D2B/2020	EPI_ISL_558337	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-568D37/2020	EPI_ISL_558342	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/MILK-56C4E3/2020	EPI_ISL_558353	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-59AD69/2020	EPI_ISL_558355	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-599474/2020	EPI_ISL_558357	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-559CF0/2020	EPI_ISL_558358	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-56710F/2020	EPI_ISL_558360	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-56B89D/2020	EPI_ISL_558380	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4822C0/2020	EPI_ISL_559674	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Gambia/GC19-3659/2020	EPI_ISL_561202	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	G
hCoV-19/Gambia/NPHL-038/2020	EPI_ISL_561205	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1645/2020	EPI_ISL_561236	2020-08-04	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/NPHL-1711/2020	EPI_ISL_561237	2020-08-04	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-1746/2020	EPI_ISL_561238	2020-07-20	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1921/2020	EPI_ISL_561239	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-1968/2020	EPI_ISL_561240	2020-07-16	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2037/2020	EPI_ISL_561241	2020-07-15	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-244/2020	EPI_ISL_561247	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-245/2020	EPI_ISL_561251	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-247/2020	EPI_ISL_561257	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-253/2020	EPI_ISL_561270	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-255/2020	EPI_ISL_561273	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-256/2020	EPI_ISL_561277	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2588/2020	EPI_ISL_561282	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2615/2020	EPI_ISL_561283	2020-08-18	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2626/2020	EPI_ISL_561284	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	G
hCoV-19/Gambia/NPHL-2729/2020	EPI_ISL_561290	2020-07-23	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2767/2020	EPI_ISL_561294	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2768/2020	EPI_ISL_561295	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/Gambia/NPHL-2790/2020	EPI_ISL_561298	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.466	GR
hCoV-19/England/MILK-9C3F6D/2020	EPI_ISL_566831	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3ED9/2020	EPI_ISL_566839	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C41A2/2020	EPI_ISL_566848	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9C35F2/2020	EPI_ISL_566862	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3DEB/2020	EPI_ISL_566865	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C30C4/2020	EPI_ISL_566871	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C4342/2020	EPI_ISL_566891	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9C312B/2020	EPI_ISL_566895	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3404/2020	EPI_ISL_566899	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9CA3D3/2020	EPI_ISL_567307	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9705/2020	EPI_ISL_567308	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA986/2020	EPI_ISL_567309	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9C98D5/2020	EPI_ISL_567310	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9B27/2020	EPI_ISL_567311	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9310/2020	EPI_ISL_567317	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA722/2020	EPI_ISL_567335	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C934D/2020	EPI_ISL_567339	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA93B/2020	EPI_ISL_567341	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9C9468/2020	EPI_ISL_567349	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/ON-UHTC-0202/2020	EPI_ISL_569972	2020-06-10	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0197/2020	EPI_ISL_569978	2020-05-29	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0241/2020	EPI_ISL_570009	2020-06-08	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0238/2020	EPI_ISL_570019	2020-06-07	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/England/CAMC-9C1970/2020	EPI_ISL_573210	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/CAMC-9C19E9/2020	EPI_ISL_573213	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1A04/2020	EPI_ISL_573214	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1AD7/2020	EPI_ISL_573219	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1CE0/2020	EPI_ISL_573229	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1CFF/2020	EPI_ISL_573230	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1D29/2020	EPI_ISL_573231	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1DDE/2020	EPI_ISL_573235	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/LIVE-1D20E8/2020	EPI_ISL_573243	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-9C4685/2020	EPI_ISL_573253	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9C7084/2020	EPI_ISL_573276	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C70EE/2020	EPI_ISL_573281	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C727F/2020	EPI_ISL_573292	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C735E/2020	EPI_ISL_573299	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.294	GR
hCoV-19/Wales/PHWC-16B9CB/2020	EPI_ISL_573926	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B9E9/2020	EPI_ISL_573927	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16BE35/2020	EPI_ISL_573979	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16BFD8/2020	EPI_ISL_573999	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Singapore/1015/2020	EPI_ISL_574500	2020-03-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/1025/2020	EPI_ISL_574510	2020-03-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/1035/2020	EPI_ISL_574520	2020-03-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/1048/2020	EPI_ISL_574533	2020-03-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/1055/2020	EPI_ISL_574540	2020-03-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/MILK-976637/2020	EPI_ISL_575826	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-973175/2020	EPI_ISL_575842	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-973157/2020	EPI_ISL_575867	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-976655/2020	EPI_ISL_575891	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-976664/2020	EPI_ISL_575897	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Ukraine/Ivano-Frankivsk-706/2020	EPI_ISL_576147	2020-07-28	Europe / Ukraine / Ivano-Frankivsk	Human	Original	Oropharyngeal swab		Illumina iSeq100	Dragen			B.1.1	GR
hCoV-19/USA/WI-CDC-6231/2020	EPI_ISL_576180	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/USA/WI-CDC-6232/2020	EPI_ISL_576181	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/USA/WI-CDC-6236/2020	EPI_ISL_576185	2020-03-25	North America / USA / Wisconsin	Human	Original	Nasopharyngeal swab		Nanopore	minimap 2.17			B.1.1	GR
hCoV-19/Wales/PHWC-16D756/2020	EPI_ISL_577441	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16DB2D/2020	EPI_ISL_577493	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16DDEB/2020	EPI_ISL_577537	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/New Zealand/20VR2719/2020	EPI_ISL_579337	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/USA/CA-CZB-6988/2020	EPI_ISL_582915	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6989/2020	EPI_ISL_582916	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6990/2020	EPI_ISL_582917	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6991/2020	EPI_ISL_582918	2020-09-03	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-6992/2020	EPI_ISL_582919	2020-09-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-7204/2020	EPI_ISL_582940	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-7205/2020	EPI_ISL_582941	2020-08-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11008/2020	EPI_ISL_582950	2020-08-20	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11010/2020	EPI_ISL_582952	2020-09-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11015/2020	EPI_ISL_582955	2020-08-20	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11017/2020	EPI_ISL_582957	2020-08-24	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/NORT-29CDF1/2020	EPI_ISL_584681	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-108289/2020	EPI_ISL_585180	2020-04-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR4398/2020	EPI_ISL_585272	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-16F077/2020	EPI_ISL_585906	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16F129/2020	EPI_ISL_585916	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9FCB0D/2020	EPI_ISL_587807	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD850/2020	EPI_ISL_587810	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCD8F/2020	EPI_ISL_587827	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FD498/2020	EPI_ISL_587838	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD0A3/2020	EPI_ISL_587841	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD340/2020	EPI_ISL_587851	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCAD3/2020	EPI_ISL_587861	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9FCA88/2020	EPI_ISL_587888	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB281/2020	EPI_ISL_588119	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB209/2020	EPI_ISL_588121	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA422/2020	EPI_ISL_588150	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAE8E/2020	EPI_ISL_588155	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FA835/2020	EPI_ISL_588170	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ED6C2/2020	EPI_ISL_589422	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9E5976/2020	EPI_ISL_589431	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9ED440/2020	EPI_ISL_589446	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9ED45F/2020	EPI_ISL_589468	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E59EF/2020	EPI_ISL_589482	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ED64A/2020	EPI_ISL_589485	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-9E56D9/2020	EPI_ISL_589494	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9ED6B3/2020	EPI_ISL_589502	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED46E/2020	EPI_ISL_589512	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9ECD19/2020	EPI_ISL_589517	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-9E5712/2020	EPI_ISL_589530	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5845/2020	EPI_ISL_590405	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B48A0/2020	EPI_ISL_590414	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B49F8/2020	EPI_ISL_590417	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B59BB/2020	EPI_ISL_590422	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4E62/2020	EPI_ISL_590430	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9B49BC/2020	EPI_ISL_590432	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5405/2020	EPI_ISL_590436	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-9B46D3/2020	EPI_ISL_590443	2020-09-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B49AD/2020	EPI_ISL_590454	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B562D/2020	EPI_ISL_590456	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9B4AAA/2020	EPI_ISL_590458	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B7685/2020	EPI_ISL_590464	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B81A1/2020	EPI_ISL_590466	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7B59/2020	EPI_ISL_590470	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7D08/2020	EPI_ISL_590473	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7B77/2020	EPI_ISL_590474	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B701E/2020	EPI_ISL_590478	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B789E/2020	EPI_ISL_590485	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7430/2020	EPI_ISL_590492	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B78DA/2020	EPI_ISL_590510	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EF5F0/2020	EPI_ISL_594923	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/MILK-9EF684/2020	EPI_ISL_594929	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/MILK-9EF790/2020	EPI_ISL_594939	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Wales/PHWC-47DFA3/2020	EPI_ISL_595389	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-A58AE3/2020	EPI_ISL_597163	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A594F3/2020	EPI_ISL_597175	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57F21/2020	EPI_ISL_597178	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585B5/2020	EPI_ISL_597208	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A586FE/2020	EPI_ISL_597210	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A581C0/2020	EPI_ISL_597211	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A58148/2020	EPI_ISL_597220	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57B96/2020	EPI_ISL_597255	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5281C/2020	EPI_ISL_597900	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51297/2020	EPI_ISL_597910	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51F27/2020	EPI_ISL_597914	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5118B/2020	EPI_ISL_597950	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A520C9/2020	EPI_ISL_597960	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A51534/2020	EPI_ISL_597973	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A520AB/2020	EPI_ISL_597988	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A470A9/2020	EPI_ISL_598495	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-A48002/2020	EPI_ISL_598516	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A464AE/2020	EPI_ISL_598529	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44D69/2020	EPI_ISL_598566	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44A62/2020	EPI_ISL_598570	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A468C0/2020	EPI_ISL_598573	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDC5A/2020	EPI_ISL_599802	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DCD0D/2020	EPI_ISL_599815	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A067FC/2020	EPI_ISL_599819	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/MILK-A0671A/2020	EPI_ISL_599889	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9FFBDD/2020	EPI_ISL_600319	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF5B1/2020	EPI_ISL_600323	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00130/2020	EPI_ISL_600324	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00006/2020	EPI_ISL_600363	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A000CA/2020	EPI_ISL_600379	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00464/2020	EPI_ISL_600390	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4F87/2020	EPI_ISL_601647	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4EF3/2020	EPI_ISL_601651	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-9D2129/2020	EPI_ISL_601664	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-9D402A/2020	EPI_ISL_601695	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K003724/2020	EPI_ISL_602902	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003730/2020	EPI_ISL_602908	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003733/2020	EPI_ISL_602911	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/England/MILK-A7C366/2020	EPI_ISL_606467	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7DF34/2020	EPI_ISL_606504	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7ADB5/2020	EPI_ISL_606506	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D5E7/2020	EPI_ISL_606561	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6D553/2020	EPI_ISL_607004	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CC31/2020	EPI_ISL_607026	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E59E/2020	EPI_ISL_607048	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6FB31/2020	EPI_ISL_607060	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CC40/2020	EPI_ISL_607088	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6FDA4/2020	EPI_ISL_607091	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A6E4CE/2020	EPI_ISL_607807	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F68B/2020	EPI_ISL_607814	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E561/2020	EPI_ISL_607830	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DB24/2020	EPI_ISL_607852	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A705B7/2020	EPI_ISL_607856	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F4BE/2020	EPI_ISL_607861	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DB51/2020	EPI_ISL_607871	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6ED69/2020	EPI_ISL_607877	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DEEF/2020	EPI_ISL_607889	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DFBF/2020	EPI_ISL_607892	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A6546D/2020	EPI_ISL_608354	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65333/2020	EPI_ISL_608381	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A684E2/2020	EPI_ISL_608386	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65579/2020	EPI_ISL_608393	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E8F8/2020	EPI_ISL_609610	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E97D/2020	EPI_ISL_609613	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F350/2020	EPI_ISL_609621	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F8E8/2020	EPI_ISL_609635	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-A3E4F4/2020	EPI_ISL_609637	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3F411/2020	EPI_ISL_609645	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3F4E4/2020	EPI_ISL_609648	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E728/2020	EPI_ISL_609649	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E4E5/2020	EPI_ISL_609668	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3F499/2020	EPI_ISL_609670	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A3E8E9/2020	EPI_ISL_609710	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E3F7/2020	EPI_ISL_609719	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85A47/2020	EPI_ISL_610608	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85F2A/2020	EPI_ISL_610610	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A859FF/2020	EPI_ISL_610619	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85801/2020	EPI_ISL_610628	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81304/2020	EPI_ISL_610635	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81C63/2020	EPI_ISL_610653	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82CF9/2020	EPI_ISL_610683	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A943D1/2020	EPI_ISL_611013	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92670/2020	EPI_ISL_611020	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A94896/2020	EPI_ISL_611073	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A93D10/2020	EPI_ISL_611076	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A93FA1/2020	EPI_ISL_611097	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/EDB8490/2020	EPI_ISL_612372	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-13803B/2020	EPI_ISL_612376	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138068/2020	EPI_ISL_612379	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Denmark/DCGC-3870/2020	EPI_ISL_615588	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3881/2020	EPI_ISL_615599	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-8007/2020	EPI_ISL_617122	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-8156/2020	EPI_ISL_617223	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7591/2020	EPI_ISL_618460	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7597/2020	EPI_ISL_618461	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Denmark/DCGC-7574/2020	EPI_ISL_618477	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7550/2020	EPI_ISL_618482	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7545/2020	EPI_ISL_618490	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7647/2020	EPI_ISL_618539	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7221/2020	EPI_ISL_619005	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7223/2020	EPI_ISL_619006	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7251/2020	EPI_ISL_619011	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7320/2020	EPI_ISL_619019	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7321/2020	EPI_ISL_619021	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7367/2020	EPI_ISL_619030	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7435/2020	EPI_ISL_619037	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-7087/2020	EPI_ISL_619083	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7089/2020	EPI_ISL_619084	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7185/2020	EPI_ISL_619086	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7186/2020	EPI_ISL_619087	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7222/2020	EPI_ISL_619088	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-7311/2020	EPI_ISL_619089	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-6959/2020	EPI_ISL_619805	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6960/2020	EPI_ISL_619806	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-7026/2020	EPI_ISL_619873	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-6240/2020	EPI_ISL_620000	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6241/2020	EPI_ISL_620001	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6243/2020	EPI_ISL_620003	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6244/2020	EPI_ISL_620004	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6260/2020	EPI_ISL_620020	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6262/2020	EPI_ISL_620022	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6263/2020	EPI_ISL_620023	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-6264/2020	EPI_ISL_620024	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6265/2020	EPI_ISL_620025	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6266/2020	EPI_ISL_620026	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5440/2020	EPI_ISL_620765	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5441/2020	EPI_ISL_620766	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5443/2020	EPI_ISL_620768	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5444/2020	EPI_ISL_620769	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5446/2020	EPI_ISL_620771	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5447/2020	EPI_ISL_620772	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5452/2020	EPI_ISL_620777	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5453/2020	EPI_ISL_620778	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5460/2020	EPI_ISL_620785	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5469/2020	EPI_ISL_620794	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5486/2020	EPI_ISL_620811	2020-09-28	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5492/2020	EPI_ISL_620817	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5494/2020	EPI_ISL_620819	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5495/2020	EPI_ISL_620820	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5498/2020	EPI_ISL_620823	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5501/2020	EPI_ISL_620826	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5524/2020	EPI_ISL_620849	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4763/2020	EPI_ISL_621373	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4764/2020	EPI_ISL_621374	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4765/2020	EPI_ISL_621375	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4766/2020	EPI_ISL_621376	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4768/2020	EPI_ISL_621378	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-3758/2020	EPI_ISL_622645	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/QEUH-AADD31/2020	EPI_ISL_623907	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAD37B/2020	EPI_ISL_623908	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2D4B/2020	EPI_ISL_623915	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA34FA/2020	EPI_ISL_623945	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2DF0/2020	EPI_ISL_623969	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAEF67/2020	EPI_ISL_623976	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0E2C/2020	EPI_ISL_623985	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAD399/2020	EPI_ISL_623991	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3DE0/2020	EPI_ISL_624320	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-AA2051/2020	EPI_ISL_624339	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3E0B/2020	EPI_ISL_624365	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3A70/2020	EPI_ISL_624375	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA39EC/2020	EPI_ISL_624387	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1F0A/2020	EPI_ISL_624388	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-CZB-11870/2020	EPI_ISL_625622	2020-09-08	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11958/2020	EPI_ISL_625662	2020-10-07	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11956/2020	EPI_ISL_625664	2020-10-07	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/Belgium/ULG-10604/2020	EPI_ISL_626249	2020-09-04	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/MILK-AC85FC/2020	EPI_ISL_629116	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE893/2020	EPI_ISL_629123	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ACE972/2020	EPI_ISL_629143	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE356/2020	EPI_ISL_629166	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE5131/2020	EPI_ISL_633317	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-AEA7C1/2020	EPI_ISL_633324	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AE4994/2020	EPI_ISL_633335	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4FCF/2020	EPI_ISL_633364	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AEACD1/2020	EPI_ISL_633373	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-AD1E6E/2020	EPI_ISL_634606	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD5B09/2020	EPI_ISL_634612	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD1ED7/2020	EPI_ISL_634618	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD5A1B/2020	EPI_ISL_634629	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19F4/2020	EPI_ISL_634634	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD578D/2020	EPI_ISL_634640	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0FE4/2020	EPI_ISL_634645	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19D6/2020	EPI_ISL_634664	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD5B45/2020	EPI_ISL_634669	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD42D8/2020	EPI_ISL_634670	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD5C60/2020	EPI_ISL_634684	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD442D/2020	EPI_ISL_634697	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K004037/2020	EPI_ISL_635018	2020-10-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/England/ALDP-9E766E/2020	EPI_ISL_638208	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E767D/2020	EPI_ISL_638209	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E77A7/2020	EPI_ISL_638219	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8AAD/2020	EPI_ISL_638279	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9F4F09/2020	EPI_ISL_638915	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B13E05/2020	EPI_ISL_641843	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B1344F/2020	EPI_ISL_641873	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13C0B/2020	EPI_ISL_641898	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-B0F3C1/2020	EPI_ISL_642104	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EC9A/2020	EPI_ISL_642112	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B0E69C/2020	EPI_ISL_642113	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E33B/2020	EPI_ISL_642124	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0C8D4/2020	EPI_ISL_643402	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0AE01/2020	EPI_ISL_643422	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B5FC/2020	EPI_ISL_643447	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0CAB0/2020	EPI_ISL_643455	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0CBEA/2020	EPI_ISL_643460	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B080A3/2020	EPI_ISL_643462	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2C917/2020	EPI_ISL_646608	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2CAF6/2020	EPI_ISL_646624	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24D22/2020	EPI_ISL_646665	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B24D9B/2020	EPI_ISL_646693	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B2D9DA/2020	EPI_ISL_647014	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23743/2020	EPI_ISL_647015	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D776/2020	EPI_ISL_647050	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2DD47/2020	EPI_ISL_647061	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AD4320/2020	EPI_ISL_647925	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B12589/2020	EPI_ISL_649622	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B125B6/2020	EPI_ISL_649624	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE28B7/2020	EPI_ISL_649651	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE26AE/2020	EPI_ISL_649652	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE4A0A/2020	EPI_ISL_649667	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AD5B27/2020	EPI_ISL_649675	2020-10-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/EDB8058/2020	EPI_ISL_651957	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.315	G
hCoV-19/Wales/PHWC-48A152/2020	EPI_ISL_652527	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Italy/APU-IZSPB_171PT/2020	EPI_ISL_653823	2020-08-17	Europe / Italy / Apulia / Foggia / Manfredonia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/India/DL-NIBG-MN7/2020	EPI_ISL_653836	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/England/CAMC-B53F8E/2020	EPI_ISL_656712	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B538B0/2020	EPI_ISL_656715	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5359B/2020	EPI_ISL_656726	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B56B1E/2020	EPI_ISL_656733	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B542C0/2020	EPI_ISL_656767	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B540F3/2020	EPI_ISL_656773	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B408A7/2020	EPI_ISL_657308	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B423D1/2020	EPI_ISL_657311	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B423C2/2020	EPI_ISL_657317	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B4027C/2020	EPI_ISL_657345	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B4240B/2020	EPI_ISL_657349	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-B41721/2020	EPI_ISL_658604	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4118D/2020	EPI_ISL_658637	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F489/2020	EPI_ISL_658644	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B3F683/2020	EPI_ISL_658649	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B38AE8/2020	EPI_ISL_659024	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38471/2020	EPI_ISL_659047	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B38D49/2020	EPI_ISL_659078	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-B37E56/2020	EPI_ISL_659083	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B2EDDD/2020	EPI_ISL_659930	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EEBC/2020	EPI_ISL_659936	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EEAD/2020	EPI_ISL_659938	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D336/2020	EPI_ISL_659939	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3034F/2020	EPI_ISL_659949	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2DFAB/2020	EPI_ISL_659956	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B30312/2020	EPI_ISL_659984	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D3FA/2020	EPI_ISL_659988	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EB2E/2020	EPI_ISL_659993	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D248/2020	EPI_ISL_659998	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC2B/2020	EPI_ISL_660029	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30BB0/2020	EPI_ISL_660033	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D2C0/2020	EPI_ISL_660046	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30B47/2020	EPI_ISL_660047	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30C08/2020	EPI_ISL_660058	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ecuador/ZZL-3/2020	EPI_ISL_660069	2020-07-20	South America / Ecuador / Quito	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.203	O
hCoV-19/USA/WI-GMF-27069/2020	EPI_ISL_660968	2020-10-21	North America / USA / Wisconsin / Adams County	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/USA/WI-GMF-27242/2020	EPI_ISL_660974	2020-10-23	North America / USA / Wisconsin / Adams County	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/India/WB-IICB-036/2020	EPI_ISL_661309	2020-10-27	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.1.409	O
hCoV-19/England/QEUH-B698B7/2020	EPI_ISL_661322	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6993C/2020	EPI_ISL_661343	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B677BC/2020	EPI_ISL_661398	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A1F7/2020	EPI_ISL_662620	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3875A/2020	EPI_ISL_662643	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF28B4/2020	EPI_ISL_662663	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF46D6/2020	EPI_ISL_662691	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5365/2020	EPI_ISL_663112	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5A7F/2020	EPI_ISL_663113	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4C3E/2020	EPI_ISL_663126	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4B9B/2020	EPI_ISL_663135	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF566C/2020	EPI_ISL_663143	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4CE3/2020	EPI_ISL_663195	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/NORT-28D063/2020	EPI_ISL_665787	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-A563F9/2020	EPI_ISL_665850	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORT-28CD8B/2020	EPI_ISL_665870	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CD9A/2020	EPI_ISL_665871	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D081/2020	EPI_ISL_665875	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/WA-OHSU-2911/2020	EPI_ISL_667410	2020-09-05	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.453	GR
hCoV-19/England/QEUH-B7EA31/2020	EPI_ISL_668096	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B09619/2020	EPI_ISL_672917	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B09057/2020	EPI_ISL_672922	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/CAMC-B090FD/2020	EPI_ISL_672945	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0A117/2020	EPI_ISL_672969	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B990E3/2020	EPI_ISL_673337	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/CAMC-B99FC8/2020	EPI_ISL_673353	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B9A264/2020	EPI_ISL_673385	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8F8D9/2020	EPI_ISL_674611	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EC1A/2020	EPI_ISL_674640	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B7CE19/2020	EPI_ISL_674667	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EA4D/2020	EPI_ISL_674673	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8E0B4/2020	EPI_ISL_674679	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-B8EC0B/2020	EPI_ISL_674693	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B959A0/2020	EPI_ISL_675121	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8388A/2020	EPI_ISL_675143	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B83714/2020	EPI_ISL_675182	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B856F7/2020	EPI_ISL_675184	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84722/2020	EPI_ISL_675187	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88C5C/2020	EPI_ISL_675914	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B31BCE/2020	EPI_ISL_676416	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-IGI-0564/2020	EPI_ISL_677832	2020-07-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/USA/CA-IGI-0585/2020	EPI_ISL_677837	2020-08-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.174	GR
hCoV-19/Ecuador/ZZ-SARS-2/2020	EPI_ISL_681703	2020-04-30	South America / Ecuador / Quito	Human	Original			Illumina MiSeq				B.1.1.231	O
hCoV-19/Denmark/DCGC-12200/2020	EPI_ISL_682381	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/England/204681084/2020	EPI_ISL_686583	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Switzerland/BL-ETHZ-350011/2020	EPI_ISL_693785	2020-11-03	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe			B.1.1	GR
hCoV-19/United Arab Emirates/0388/2020	EPI_ISL_698563	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0431/2020	EPI_ISL_698605	2020-05-16	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0488/2020	EPI_ISL_698656	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	O
hCoV-19/United Arab Emirates/1019/2020	EPI_ISL_699151	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1021/2020	EPI_ISL_699153	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1024/2020	EPI_ISL_699156	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1025/2020	EPI_ISL_699157	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1026/2020	EPI_ISL_699158	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1027/2020	EPI_ISL_699159	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original	Nasopharyngeal swab		MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/1029/2020	EPI_ISL_699161	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/England/204961150/2020	EPI_ISL_700698	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/ALDP-BBA79C/2020	EPI_ISL_701927	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-BB512A/2020	EPI_ISL_701945	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BBB4B2/2020	EPI_ISL_701970	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BBB0AF/2020	EPI_ISL_701995	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BD435C/2020	EPI_ISL_702356	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC4BC0/2020	EPI_ISL_704114	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BC3A2E/2020	EPI_ISL_704121	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCB9FC/2020	EPI_ISL_704136	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCB9B0/2020	EPI_ISL_704191	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC07EE/2020	EPI_ISL_704917	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/England/CAMC-BC0292/2020	EPI_ISL_704951	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BC07DF/2020	EPI_ISL_704984	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/USA/MN-MDH-2132/2020	EPI_ISL_708470	2020-11-05	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2133/2020	EPI_ISL_708471	2020-11-05	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2134/2020	EPI_ISL_708472	2020-11-04	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2135/2020	EPI_ISL_708473	2020-11-05	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2137/2020	EPI_ISL_708475	2020-11-06	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2139/2020	EPI_ISL_708477	2020-11-08	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MN-MDH-2140/2020	EPI_ISL_708478	2020-11-08	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/England/CAMC-BFB87E/2020	EPI_ISL_709008	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMC-BFB753/2020	EPI_ISL_709072	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Wales/ALDP-BCAACD/2020	EPI_ISL_710745	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-14009/2020	EPI_ISL_711388	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.359	GR
hCoV-19/Denmark/DCGC-14116/2020	EPI_ISL_711389	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.359	GR
hCoV-19/Denmark/DCGC-13196/2020	EPI_ISL_712644	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13842/2020	EPI_ISL_713056	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15647/2020	EPI_ISL_713938	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15659/2020	EPI_ISL_713945	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15662/2020	EPI_ISL_713947	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-15695/2020	EPI_ISL_713968	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/MILK-BB04EA/2020	EPI_ISL_720158	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-BC7626/2020	EPI_ISL_721439	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC7BBE/2020	EPI_ISL_721461	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-495330/2020	EPI_ISL_726330	2020-11-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-495400/2020	EPI_ISL_726343	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-495497/2020	EPI_ISL_726351	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4954A6/2020	EPI_ISL_726352	2020-11-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Germany/ChVir8135/2020	EPI_ISL_729415	2020	Europe / Germany	Human	Original			MiSeq	bowtie2	NSP16_Q3stop results in 99.3% truncation of the protein sequence.	info	B.1.1.135	GR
hCoV-19/England/ALDP-C3D174/2020	EPI_ISL_731741	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-C33BDA/2020	EPI_ISL_734022	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C3393A/2020	EPI_ISL_734025	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Belgium/rega-0506644/2020	EPI_ISL_734705	2020-05-06	Europe / Belgium / Geetbets	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1.5	GR
hCoV-19/Belgium/rega-0506645/2020	EPI_ISL_734706	2020-05-06	Europe / Belgium / Linter	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Belgium/rega-0615916/2020	EPI_ISL_734756	2020-06-15	Europe / Belgium / Tervuren	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.1	GR
hCoV-19/Turkey/IST-GLAB-299/2020	EPI_ISL_735339	2020-05-23	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM			B.1.1	G
hCoV-19/Turkey/IST-GLAB-341/2020	EPI_ISL_735356	2020-06-24	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM			B.1.1	GR
hCoV-19/England/MILK-C5064F/2020	EPI_ISL_736637	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-C4898D/2020	EPI_ISL_736654	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				AD.2	GR
hCoV-19/England/MILK-C5059D/2020	EPI_ISL_736675	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				AD.2	GR
hCoV-19/USA/CA-CZB-13744/2020	EPI_ISL_739623	2020-09-11	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14050/2020	EPI_ISL_739638	2020-07-10	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/CAMC-B7A552/2020	EPI_ISL_741122	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-B7B515/2020	EPI_ISL_741176	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-B7B5CA/2020	EPI_ISL_741184	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7DC5A/2020	EPI_ISL_741909	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B7DF06/2020	EPI_ISL_741927	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-10C9F12/2020	EPI_ISL_741967	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10CA4A9/2020	EPI_ISL_741969	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-49BA17/2020	EPI_ISL_742416	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A1999/2020	EPI_ISL_743754	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Luxembourg/LNS4969344/2020	EPI_ISL_744165	2020-09-23	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-001524/2020	EPI_ISL_745439	2020-11-30	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1	GR
hCoV-19/Chile/RM-171015/2020	EPI_ISL_746726	2020-09-07	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-183871/2020	EPI_ISL_746731	2020-09-21	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-185039/2020	EPI_ISL_746733	2020-09-21	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-189170/2020	EPI_ISL_746740	2020-09-24	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-191185/2020	EPI_ISL_746745	2020-09-26	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-191308/2020	EPI_ISL_746747	2020-09-26	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-191972/2020	EPI_ISL_746751	2020-09-28	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-192950/2020	EPI_ISL_746752	2020-09-28	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Chile/RM-83539/2020	EPI_ISL_746795	2020-05-30	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Oropharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/South Korea/KDCA0100/2020	EPI_ISL_747336	2020-09-11	Asia / South Korea	Human	Original		Imported case from Uzbekistan	Illumina MiSeq		NS8_K44stop results in 64.5% truncation of the protein sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-18910/2020	EPI_ISL_748635	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17325/2020	EPI_ISL_750908	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-17333/2020	EPI_ISL_750915	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Germany/BE-ChVir-D2021-4462/2020	EPI_ISL_753904	2020-10-10	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1336-5617/2020	EPI_ISL_753954	2020-05-05	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1418-8203/2020	EPI_ISL_753960	2020-06-30	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1429-8283/2020	EPI_ISL_753962	2020-06-27	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1431-8290/2020	EPI_ISL_753963	2020-06-19	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1432-4374/2020	EPI_ISL_753964	2020-06-26	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1433-8258/2020	EPI_ISL_753965	2020-06-17	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1436-4360/2020	EPI_ISL_753966	2020-06-16	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1451-8252/2020	EPI_ISL_753972	2020-06-29	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/BE-ChVir-W1637-6714/2020	EPI_ISL_753974	2020-08-02	Europe / Germany / Berlin	Human	Original			llumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/USA/WA-UW-46871/2020	EPI_ISL_756197	2020-12-11	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/England/ALDP-CB36FF/2020	EPI_ISL_761684	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-4A3B64/2020	EPI_ISL_764601	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-10C6DEE/2020	EPI_ISL_765154	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/205140900/2020	EPI_ISL_766402	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/205160985/2020	EPI_ISL_766426	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Ireland/D-NVRL-MPW25565/2020	EPI_ISL_767755	2020-04-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-MPU79359/2020	EPI_ISL_767758	2020-04-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-MPS11026/2020	EPI_ISL_767784	2020-04-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Switzerland/SO-ETHZ-420732/2020	EPI_ISL_768178	2020-12-24	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Luxembourg/LNS8539717/2020	EPI_ISL_771007	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/Luxembourg/LNS3153052/2020	EPI_ISL_771009	2020-12-02	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/Italy/CAM-INTPas-20/2020	EPI_ISL_775259	2020-04-03	Europe / Italy / Campania	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/England/QEUH-C93877/2020	EPI_ISL_777105	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-8729/2020	EPI_ISL_780723	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8806/2020	EPI_ISL_780768	2020-07-01	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9466/2020	EPI_ISL_781139	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-9474/2020	EPI_ISL_781144	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-9504/2020	EPI_ISL_781155	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-9508/2020	EPI_ISL_781156	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-9522/2020	EPI_ISL_781163	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.426	GR
hCoV-19/USA/TX-HMH-MCoV-9529/2020	EPI_ISL_781167	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/England/ALDP-CEBAF2/2020	EPI_ISL_782474	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-8140/2020	EPI_ISL_784227	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-8203/2020	EPI_ISL_784262	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-8207/2020	EPI_ISL_784266	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-8237/2020	EPI_ISL_784282	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-8287/2020	EPI_ISL_784310	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-15886/2020	EPI_ISL_785570	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-15912/2020	EPI_ISL_785596	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	G
hCoV-19/USA/TX-HMH-MCoV-15951/2020	EPI_ISL_785635	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-15413/2020	EPI_ISL_786897	2020-10-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-15489/2020	EPI_ISL_786973	2020-10-24	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-13925/2020	EPI_ISL_787217	2020-08-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13926/2020	EPI_ISL_787218	2020-08-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-13967/2020	EPI_ISL_787258	2020-08-15	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-13998/2020	EPI_ISL_787289	2020-08-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-14008/2020	EPI_ISL_787299	2020-07-05	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-13439/2020	EPI_ISL_788574	2020-08-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.426	GR
hCoV-19/USA/TX-HMH-MCoV-10945/2020	EPI_ISL_789191	2020-07-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Spike_G416stop results in 67.4% truncation of the protein sequence.	info	B.1.1.367	GR
hCoV-19/USA/TX-HMH-MCoV-10834/2020	EPI_ISL_789196	2020-07-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	NS8_W45stop results in 63.6% truncation of the protein sequence.	info	B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-10497/2020	EPI_ISL_789197	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-11918/2020	EPI_ISL_790132	2020-09-17	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-12013/2020	EPI_ISL_790167	2020-09-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/Denmark/DCGC-22674/2020	EPI_ISL_794447	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22711/2020	EPI_ISL_794472	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-22738/2020	EPI_ISL_794487	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-24761/2020	EPI_ISL_795720	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-D507A5/2020	EPI_ISL_799222	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-C1826D/2020	EPI_ISL_800739	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B801BF/2020	EPI_ISL_801320	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7FAE5/2020	EPI_ISL_801326	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/QEUH-B7FB1F/2020	EPI_ISL_801349	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Japan/IC-0617/2020	EPI_ISL_803940	2020-12-11	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.1.398	GR
hCoV-19/Canada/AB-31420/2020	EPI_ISL_805613	2020-04-26	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-74914/2020	EPI_ISL_805626	2020-04-29	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/England/CAMC-9C02B2/2020	EPI_ISL_813356	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Denmark/DCGC-27824/2020	EPI_ISL_815918	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-27925/2020	EPI_ISL_815985	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/SHEF-10C6BB7/2020	EPI_ISL_816249	2020-12-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10C6F15/2020	EPI_ISL_816256	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10C7C2C/2020	EPI_ISL_816273	2020-12-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/USA/NY-AECOM_110/2020	EPI_ISL_826655	2020-08-01	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.231	GR
hCoV-19/USA/NY-AECOM_113/2020	EPI_ISL_826657	2020-08-04	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/USA/NY-AECOM_117/2020	EPI_ISL_826660	2020-09-01	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Iceland/4258/2021	EPI_ISL_827951	2021-01-05	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/Iceland/4563/2021	EPI_ISL_828255	2021-01-04	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/Iceland/5865/2020	EPI_ISL_829545	2020-12-29	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/USA/OR-OHSU-3377/2020	EPI_ISL_832467	2020-10-12	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/Italy/CAM-TIGEM-1047/2020	EPI_ISL_837316	2020-09-16	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1	GR
hCoV-19/Canada/ON-PPS-00109/2020	EPI_ISL_852845	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00437/2020	EPI_ISL_852846	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00361/2020	EPI_ISL_852847	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00355/2020	EPI_ISL_852848	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00371/2020	EPI_ISL_852850	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00107/2020	EPI_ISL_852856	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00053/2020	EPI_ISL_852862	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Canada/ON-PPS-00056/2020	EPI_ISL_852865	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 1 nucleotide(s) found at refpos 29581 (frameshift confirmed by the submitter). NSP11 without BLAST coverage.	info	AL.1	GR
hCoV-19/Wales/ALDP-CB6656/2020	EPI_ISL_859353	2020-12-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-CB5A00/2020	EPI_ISL_859414	2020-12-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/SHEF-10C857B/2020	EPI_ISL_868411	2020-12-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Denmark/DCGC-32747/2021	EPI_ISL_869751	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-34008/2021	EPI_ISL_871018	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-34035/2021	EPI_ISL_871045	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/AL-Cullman-JDSU/2020	EPI_ISL_872396	2020-10-03	North America / USA / Alabama / Cullman County	Human	Original	Nasal swab		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			AD.2	GR
hCoV-19/USA/AL-Limestone-JDSX/2020	EPI_ISL_872398	2020-10-03	North America / USA / Alabama / Limestone County	Human	Original	Nasopharyngeal		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			AD.2	GR
hCoV-19/Italy/APU-IZSPB-74PT/2020	EPI_ISL_876813	2020-04-11	Europe / Italy / Apulia / Brindisi	Human	Original	Nasopharyngeal Swab		Illumina Miseq	SPAdes			B.1.1	GR
hCoV-19/USA/TX-QDX-3503/2020	EPI_ISL_876820	2020-09-13	North America / USA / Texas	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/USA/CA-QDX-3444/2020	EPI_ISL_876828	2020-08-06	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/TX-QDX-3415/2020	EPI_ISL_876847	2020-11-04	North America / USA / Texas	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.258	GR
hCoV-19/England/ALDP-1068953/2021	EPI_ISL_879114	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-106907B/2021	EPI_ISL_879154	2021-01-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Italy/CAM-CRGS-160/2020	EPI_ISL_882712	2020-10-05	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/USA/AL-Montgomery-JFHN/2020	EPI_ISL_883094	2020-11-28	North America / USA / Alabama / Montgomery County	Human	Original	Nasal		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			B.1.1	GR
hCoV-19/USA/CA-QDX-3338/2020	EPI_ISL_884308	2020-09-17	North America / USA / California	Human	Original	Patient specimen		Illumina	Bwa v. 0.7.17-r1188; iVar v. 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/England/ALDP-10B5D79/2021	EPI_ISL_885705	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Israel/CVL-970ngs/2020	EPI_ISL_889283	2020-12-31	Asia / Israel / Central District / Petach Tikva	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 14 nucleotides when compared to the reference sequence.	info	M.1	GR
hCoV-19/Belgium/rega-1577/2020	EPI_ISL_890254	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1583/2020	EPI_ISL_890259	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1589/2020	EPI_ISL_890265	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1594/2020	EPI_ISL_890269	2020-12-21	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1595/2020	EPI_ISL_890270	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1600/2020	EPI_ISL_890274	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/Belgium/rega-1601/2020	EPI_ISL_890275	2020-12-18	Europe / Belgium / Mol	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21010011-01/2020	EPI_ISL_896346	2020-12-18	North America / USA / New York / Kings County	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/Romania/RO_DJ37480/2020	EPI_ISL_896373	2020-10-20	Europe / Romania / Suceava	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21006617-01/2021	EPI_ISL_896396	2021-01-11	North America / USA / New York / Chemung County	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/Switzerland/GE-32970256/2021	EPI_ISL_897697	2021-01-14	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	G
hCoV-19/Sweden/21-50082/2020	EPI_ISL_913325	2020-05-11	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/NORT-1B736EA/2020	EPI_ISL_921158	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-10339E8/2021	EPI_ISL_924008	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Denmark/DCGC-35510/2021	EPI_ISL_926651	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-36154/2020	EPI_ISL_927295	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Austria/CeMM2038/2020	EPI_ISL_934429	2020-12-22	Europe / Austria / Carinthia / Hermagor	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/USA/PR-CDC-S61/2020	EPI_ISL_940934	2020-08-01	North America / USA / Puerto Rico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Genome Detective Virus Tool			B.1.1	GR
hCoV-19/England/ALDP-114E47F/2021	EPI_ISL_947731	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/BIRM-6B49E/2020	EPI_ISL_949347	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A4B3CA/2020	EPI_ISL_952949	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-11B5D4B/2021	EPI_ISL_957821	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Portugal/IGC_g159/2020	EPI_ISL_960753	2020-12-23	Europe / Portugal / Lisboa	Human	Original			Illumina NextSeq				B.1.1.37	GR
hCoV-19/Denmark/DCGC-39756/2021	EPI_ISL_971418	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/CA-CZB-16752/2020	EPI_ISL_978990	2020-12-09	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/KS-KHEL-0123/2021	EPI_ISL_983494	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0124/2021	EPI_ISL_983495	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0125/2021	EPI_ISL_983496	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0126/2021	EPI_ISL_983497	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0127/2021	EPI_ISL_983498	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0128/2021	EPI_ISL_983499	2021-01-26	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/Turkey/13-Ankara-GUMV-48663/2020	EPI_ISL_984736	2020-11-14	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-AA175D/2021	EPI_ISL_996762	2021-02-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Switzerland/ZH-ETHZ-461070/2021	EPI_ISL_1003211	2021-01-18	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/USA/NY-UB-00284/2020	EPI_ISL_1009445	2020-12-03	North America / USA / New York / Erie County	Human	Original			Illumina MiSeq	BWA 0.7.17-r1188, ivar 1.2.4 , bcftools 1.10.157	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/NY-UB-00285/2020	EPI_ISL_1009446	2020-12-03	North America / USA / New York / Erie County	Human	Original			Illumina MiSeq	BWA 0.7.17-r1188, ivar 1.2.4 , bcftools 1.10.158	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/NY-Yale-1109/2020	EPI_ISL_1017536	2020-12-21	North America / USA / New York	Human	Original	Nasopharyngeal swab		Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.231	GR
hCoV-19/Denmark/DCGC-43379/2021	EPI_ISL_1023715	2021-02-01	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Singapore/200/2021	EPI_ISL_1034268	2021-02-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.315	GR
hCoV-19/Poland/Pomorskie_MWB_78/2021	EPI_ISL_1034274	2021-02-02	Europe / Poland / Pomorskie	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC_V1200	NS7b_L22stop results in 51.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Norway/0714/2021	EPI_ISL_1034332	2021-01-07	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/0712-2/2021	EPI_ISL_1034334	2021-01-08	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/England/TFCI-27066CF/2020	EPI_ISL_1054842	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/TFCI-27066FC/2020	EPI_ISL_1054845	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Belgium/rega-2994/2021	EPI_ISL_1057020	2021-02-06	Europe / Belgium / Beerse	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.1	GR
hCoV-19/USA/KS-KHEL-0190/2021	EPI_ISL_1058067	2021-02-02	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/Switzerland/BS-ETHZ-481376/2021	EPI_ISL_1059553	2021-01-04	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-461594/2021	EPI_ISL_1059617	2021-01-21	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.349	GR
hCoV-19/Switzerland/BE-ETHZ-461574/2021	EPI_ISL_1059630	2021-01-20	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.349	GR
hCoV-19/USA/CA-SC210156/2021	EPI_ISL_1060555	2021-01-28	North America / USA / California / Santa Clara County	Human	Original	Nasopharygeal swab		Illumina Miseq				B.1.1	GR
hCoV-19/USA/NY-NYULH267/2020	EPI_ISL_1060663	2020-11-10	North America / USA / New York / Brooklyn	Human	Original			Targeted capture, Illumina NovaSeq	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/Denmark/DCGC-45750/2021	EPI_ISL_1065260	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-47049/2020	EPI_ISL_1066560	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 14 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-20469/2021	EPI_ISL_1074911	2021-01-04	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-24018/2021	EPI_ISL_1078548	2021-01-15	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-24311/2021	EPI_ISL_1078865	2021-01-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-24325/2021	EPI_ISL_1078879	2021-01-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-24337/2021	EPI_ISL_1078891	2021-01-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0245/2021	EPI_ISL_1079890	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0246/2021	EPI_ISL_1079891	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0247/2021	EPI_ISL_1079893	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/USA/KS-KHEL-0248/2021	EPI_ISL_1079894	2021-01-21	North America / USA / Kansas	Human	Original			ClearLabs	ClearLabs	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/Poland/Mazowieckie_MWB_189/2021	EPI_ISL_1084637	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_190/2021	EPI_ISL_1084638	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1.336	GR
hCoV-19/Poland/Mazowieckie_MWB_191/2021	EPI_ISL_1084639	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1.336	GR
hCoV-19/Poland/Mazowieckie_MWB_198/2021	EPI_ISL_1084641	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_203/2021	EPI_ISL_1084644	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_204/2021	EPI_ISL_1084645	2021-01-21	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_210/2021	EPI_ISL_1084647	2021-01-22	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1.10	GR
hCoV-19/Poland/Mazowieckie_MWB_213/2021	EPI_ISL_1084649	2021-01-22	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_214/2021	EPI_ISL_1084650	2021-01-22	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_216/2021	EPI_ISL_1084651	2021-01-22	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_227/2021	EPI_ISL_1084656	2021-01-25	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_246/2021	EPI_ISL_1084661	2021-01-26	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_251/2021	EPI_ISL_1084666	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_253/2021	EPI_ISL_1084667	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Poland/Mazowieckie_MWB_260/2021	EPI_ISL_1084668	2021-01-27	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1.447	GR
hCoV-19/Poland/Mazowieckie_MWB_76/2021	EPI_ISL_1084672	2021-02-08	Europe / Poland / Mazowieckie	Human	Original			Nanopore MinION	ARTIC / Geneious Prime			B.1.1	GR
hCoV-19/Switzerland/BS-HUG-0914/2020	EPI_ISL_415701	2020-03-02	Europe / Switzerland / Basel-Stadt	Human	Original			unknown				B.1.1	GR
hCoV-19/Switzerland/TI-HUG-2045/2020	EPI_ISL_415703	2020-03-01	Europe / Switzerland / Ticino	Human	Original			unknown				B.1.1	GR
hCoV-19/Belgium/PC-0325147/2020	EPI_ISL_420404	2020-03-25	Europe / Belgium / Quaregnon	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/LJ-0325148/2020	EPI_ISL_420405	2020-03-25	Europe / Belgium / Sint-Truiden	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.5	GR
hCoV-19/Belgium/VPMV-0325153/2020	EPI_ISL_420410	2020-03-25	Europe / Belgium / Huldenberg	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.5	GR
hCoV-19/Belgium/NIM-0324161/2020	EPI_ISL_420418	2020-03-24	Europe / Belgium / Nieuwerkerken	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.5	GR
hCoV-19/Belgium/ML-0324164/2020	EPI_ISL_420421	2020-03-24	Europe / Belgium / Zoutleeuw	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.5	GR
hCoV-19/Belgium/DNS-0324176/2020	EPI_ISL_420433	2020-03-24	Europe / Belgium / Fontaine-l'Eveque	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/PC-0325182/2020	EPI_ISL_420439	2020-03-25	Europe / Belgium / Quaregnon	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/RA-030664/2020	EPI_ISL_420441	2020-03-06	Europe / Belgium / Sint-Genesius-Rode	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Portugal/PT0059/2020	EPI_ISL_421462	2020-03-20	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/England/201360289/2020	EPI_ISL_421773	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380030/2020	EPI_ISL_421797	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/CAMB-74386/2020	EPI_ISL_425283	2020-03-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Wales/PHWC-24859/2020	EPI_ISL_432405	2020-03	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-24886/2020	EPI_ISL_432406	2020-03	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2B1B1/2020	EPI_ISL_432418	2020-04-07	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/CAMB-73DB6/2020	EPI_ISL_433697	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78452/2020	EPI_ISL_433734	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78461/2020	EPI_ISL_433735	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7862F/2020	EPI_ISL_433757	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78883/2020	EPI_ISL_433783	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78917/2020	EPI_ISL_433791	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-75B7E/2020	EPI_ISL_438278	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76DE0/2020	EPI_ISL_438524	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-8109E/2020	EPI_ISL_438563	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.274	GR
hCoV-19/England/CAMB-811AA/2020	EPI_ISL_438577	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-72670/2020	EPI_ISL_439570	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72115/2020	EPI_ISL_439576	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-99BED/2020	EPI_ISL_439807	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99D14/2020	EPI_ISL_439815	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-7A827/2020	EPI_ISL_440584	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/CAMB-77C2E/2020	EPI_ISL_440814	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/LIVE-9A29C/2020	EPI_ISL_440853	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1109B6/2020	EPI_ISL_441881	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-815CC/2020	EPI_ISL_443033	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-81BE8/2020	EPI_ISL_443051	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-81C30/2020	EPI_ISL_443060	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7E920/2020	EPI_ISL_443072	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BIRM-5E30A/2020	EPI_ISL_444285	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5E391/2020	EPI_ISL_444291	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AC005/2020	EPI_ISL_444359	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AC06F/2020	EPI_ISL_444365	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.274	GR
hCoV-19/England/CAMB-1AC21E/2020	EPI_ISL_444384	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80EB3/2020	EPI_ISL_444441	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80F1A/2020	EPI_ISL_444447	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80F29/2020	EPI_ISL_444448	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-2B62B/2020	EPI_ISL_445737	2020-04-10	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2B6D0/2020	EPI_ISL_445748	2020-04	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/USA/CA-UCSF-UC46/2020	EPI_ISL_450238	2020-03-17	North America / USA / California / San Francisco County	Human	Original			Illumina NovaSeq with MSSPE	BBMap v38.81			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII7340V/2020	EPI_ISL_450251	2020-04-20	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII7555S/2020	EPI_ISL_450259	2020-04-21	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII8275S/2020	EPI_ISL_450268	2020-04-21	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Australia/NSW318/2020	EPI_ISL_451581	2020-04-01	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.89	GR
hCoV-19/USA/VA-DCLS-0271/2020	EPI_ISL_452840	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0274/2020	EPI_ISL_452843	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0275/2020	EPI_ISL_452844	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0276/2020	EPI_ISL_452845	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0277/2020	EPI_ISL_452846	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0278/2020	EPI_ISL_452847	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0280/2020	EPI_ISL_452849	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/CAMB-1AEDA2/2020	EPI_ISL_452862	2020-05-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AFD1A/2020	EPI_ISL_452876	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0138/2020	EPI_ISL_452880	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0147/2020	EPI_ISL_452881	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B052D/2020	EPI_ISL_452888	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B054B/2020	EPI_ISL_452890	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B055A/2020	EPI_ISL_452891	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0569/2020	EPI_ISL_452892	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0578/2020	EPI_ISL_452893	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0596/2020	EPI_ISL_452894	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B05A5/2020	EPI_ISL_452895	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B05B4/2020	EPI_ISL_452896	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/New Zealand/20VR2475/2020	EPI_ISL_456379	2020-04-15	Oceania / New Zealand / Auckland	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Estonia/ChVir4286/2020	EPI_ISL_457725	2020-03	Europe / Estonia	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Estonia/ChVir4299/2020	EPI_ISL_457735	2020-03	Europe / Estonia	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/Estonia/ChVir4301/2020	EPI_ISL_457737	2020-03	Europe / Estonia	Human	Original			Illumina NextSeq	bowtie2			B.1.1	GR
hCoV-19/USA/MD-HP00093/2020	EPI_ISL_457758	2020-03-31	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC v1.0.0_20cab1a			B.1.1	GR
hCoV-19/Belgium/VAJ-0328370/2020	EPI_ISL_462224	2020-03-28	Europe / Belgium / Bevere	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/VGM-0402374/2020	EPI_ISL_462228	2020-04-02	Europe / Belgium / Vlamertinge	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/DLM-0330385/2020	EPI_ISL_462239	2020-03-30	Europe / Belgium / Lovendegem	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/LHL-0329389/2020	EPI_ISL_462243	2020-03-29	Europe / Belgium / Lommel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/Belgium/GM-0407395/2020	EPI_ISL_462249	2020-04-07	Europe / Belgium / Kermt	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/Belgium/HNF-0507417/2020	EPI_ISL_462271	2020-05-07	Europe / Belgium / Vorselaar	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1.5	GR
hCoV-19/England/20109007104/2020	EPI_ISL_464525	2020-03-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140002304/2020	EPI_ISL_465867	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140004104/2020	EPI_ISL_465871	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.89	GR
hCoV-19/England/20140005404/2020	EPI_ISL_465873	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Spain/AN-IBV-001919/2020	EPI_ISL_467080	2020-03-17	Europe / Spain / Andalusia / Rio San Pedro	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/AN-IBV-001917/2020	EPI_ISL_467081	2020-03-17	Europe / Spain / Andalusia / Cadiz	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/BRIS-12758B/2020	EPI_ISL_469577	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1273AF/2020	EPI_ISL_469579	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127390/2020	EPI_ISL_469586	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1273BE/2020	EPI_ISL_469692	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-128098/2020	EPI_ISL_469711	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DF10/2020	EPI_ISL_470380	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/PORT-2CFEB6/2020	EPI_ISL_475244	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D0C8B/2020	EPI_ISL_475269	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Sweden/20-50237/2020	EPI_ISL_475560	2020-03-10	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/OXON-B199A/2020	EPI_ISL_479058	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1A88/2020	EPI_ISL_479069	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1CFB/2020	EPI_ISL_479088	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1DF8/2020	EPI_ISL_479094	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/GSTT-265D527/2020	EPI_ISL_483973	2020-03-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/USA/CA-CZB-1970/2020	EPI_ISL_486242	2020-05-06	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1984/2020	EPI_ISL_486251	2020-05-07	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.132	GR
hCoV-19/USA/CA-CZB-1985/2020	EPI_ISL_486252	2020-04-29	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-1986/2020	EPI_ISL_486253	2020-04-29	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2011/2020	EPI_ISL_486266	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/USA/CA-CZB-2013/2020	EPI_ISL_486267	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.132	GR
hCoV-19/England/LOND-D6513/2020	EPI_ISL_487525	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D663E/2020	EPI_ISL_487584	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295E04/2020	EPI_ISL_488521	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283BD5/2020	EPI_ISL_488532	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2952AE/2020	EPI_ISL_488545	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294E50/2020	EPI_ISL_488552	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2819DD/2020	EPI_ISL_488815	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/HECH-259A273/2020	EPI_ISL_488844	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A2A0/2020	EPI_ISL_488857	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A1B2/2020	EPI_ISL_488862	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A264/2020	EPI_ISL_488865	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A255/2020	EPI_ISL_488867	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/HECH-259A194/2020	EPI_ISL_488873	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2797/2020	EPI_ISL_488887	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB3033/2020	EPI_ISL_488889	2020-04-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Wales/PHWC-165FFC/2020	EPI_ISL_490825	2020-06-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/IL-QDX-200/2020	EPI_ISL_494517	2020-04-30	North America / USA / Illinois	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/South Africa/KRISP-0550/2020	EPI_ISL_498089	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/Vietnam/HCMC-35008/2020	EPI_ISL_498184	2020-03-19	Asia / Vietnam / Ho Chi Minh City	Human	unknown	Nasal and Throat Swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1.1	GR
hCoV-19/Vietnam/HCMC-35010/2020	EPI_ISL_498186	2020-03-18	Asia / Vietnam / Ho Chi Minh City	Human	unknown	Nasal and Throat Swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1.1	GR
hCoV-19/Senegal/45436/2020	EPI_ISL_498238	2020-05-27	Africa / Senegal / Dakar	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106C50/2020	EPI_ISL_500954	2020-05-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/OR-OHSU-1121/2020	EPI_ISL_509144	2020-07-10	North America / USA / Oregon / Marion County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.258	GR
hCoV-19/South Africa/KRISP-K000597/2020	EPI_ISL_509250	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K000641/2020	EPI_ISL_509290	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/Portugal/PT1467/2020	EPI_ISL_511426	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1468/2020	EPI_ISL_511427	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0940/2020	EPI_ISL_511490	2020-04-08	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1024/2020	EPI_ISL_511571	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH1030/2020	EPI_ISL_512899	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.1	GR
hCoV-19/Netherlands/un-EMC-728/2020	EPI_ISL_523483	2020-04-20	Europe / Netherlands	Human	Original			Nanopore				B.1.1.5	GR
hCoV-19/England/LOND-126169D/2020	EPI_ISL_524706	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B5C14/2020	EPI_ISL_529657	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMB-1B5C23/2020	EPI_ISL_529658	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMB-1B5C32/2020	EPI_ISL_529659	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/Wales/PHWC-169EBF/2020	EPI_ISL_529709	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-169F52/2020	EPI_ISL_529713	2020-08-28	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-169F70/2020	EPI_ISL_529715	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/South Africa/KRISP-K002717/2020	EPI_ISL_529720	2020-08-14	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002732/2020	EPI_ISL_529730	2020-08-15	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002735/2020	EPI_ISL_529733	2020-08-16	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002739/2020	EPI_ISL_529737	2020-08-13	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002759/2020	EPI_ISL_529755	2020-08-15	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002795/2020	EPI_ISL_529789	2020-08-23	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002802/2020	EPI_ISL_529796	2020-08-20	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002805/2020	EPI_ISL_529799	2020-08-24	Africa / South Africa / KwaZulu-Natal / uThukela	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/Scotland/QEUH-96CE2D/2020	EPI_ISL_530760	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-96C212/2020	EPI_ISL_530836	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96C2E5/2020	EPI_ISL_530858	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-969C71/2020	EPI_ISL_530859	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-96C203/2020	EPI_ISL_530871	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96A0ED/2020	EPI_ISL_530876	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96C40D/2020	EPI_ISL_530878	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-96121D/2020	EPI_ISL_531973	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960C10/2020	EPI_ISL_531979	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Sweden/20-52388/2020	EPI_ISL_534243	2020-07-06	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/South Africa/KRISP-K002545/2020	EPI_ISL_535415	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002600/2020	EPI_ISL_535464	2020-07-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002639/2020	EPI_ISL_535509	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002641/2020	EPI_ISL_535511	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002646/2020	EPI_ISL_535516	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002649/2020	EPI_ISL_535519	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002673/2020	EPI_ISL_535539	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002678/2020	EPI_ISL_535542	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002681/2020	EPI_ISL_535545	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002684/2020	EPI_ISL_535547	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/England/QEUH-9644F6/2020	EPI_ISL_536819	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-963AC8/2020	EPI_ISL_536825	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96457B/2020	EPI_ISL_536833	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96456C/2020	EPI_ISL_536848	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A214/2020	EPI_ISL_536863	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96A320/2020	EPI_ISL_536866	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-96A2E7/2020	EPI_ISL_536872	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9645C6/2020	EPI_ISL_536879	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/QEUH-96446F/2020	EPI_ISL_536885	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/LEED-2A90CB/2020	EPI_ISL_539091	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/LEED-2A88F1/2020	EPI_ISL_539110	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-998893/2020	EPI_ISL_540055	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998AE8/2020	EPI_ISL_540057	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998972/2020	EPI_ISL_540102	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-990136/2020	EPI_ISL_540121	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F589/2020	EPI_ISL_540125	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A406F/2020	EPI_ISL_540159	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-1750/2020	EPI_ISL_542813	2020-05-12	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-1763/2020	EPI_ISL_542822	2020-05-14	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-1813/2020	EPI_ISL_542857	2020-05-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6638/2020	EPI_ISL_546136	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6639/2020	EPI_ISL_546137	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6751/2020	EPI_ISL_546216	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-6753/2020	EPI_ISL_546218	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-6786/2020	EPI_ISL_546242	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6837/2020	EPI_ISL_546277	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6860/2020	EPI_ISL_546296	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-6863/2020	EPI_ISL_546299	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-10148/2020	EPI_ISL_547539	2020-06-09	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Netherlands/ZH-RIVM-10117/2020	EPI_ISL_547564	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01282/2020	EPI_ISL_548887	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01284/2020	EPI_ISL_548889	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01291/2020	EPI_ISL_548895	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/England/MILK-993133/2020	EPI_ISL_552032	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D8B/2020	EPI_ISL_552033	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-992C51/2020	EPI_ISL_552045	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D12/2020	EPI_ISL_552055	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9928A8/2020	EPI_ISL_552056	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9928D5/2020	EPI_ISL_552066	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993124/2020	EPI_ISL_552069	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993106/2020	EPI_ISL_552096	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99368F/2020	EPI_ISL_552117	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D21/2020	EPI_ISL_552123	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9931BB/2020	EPI_ISL_552144	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D5E/2020	EPI_ISL_552146	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-971335/2020	EPI_ISL_553263	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-970ECC/2020	EPI_ISL_553267	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-922193/2020	EPI_ISL_553273	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92239D/2020	EPI_ISL_553278	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9221DF/2020	EPI_ISL_553281	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-92248B/2020	EPI_ISL_553288	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A5B4/2020	EPI_ISL_553379	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94D499/2020	EPI_ISL_553380	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9550D6/2020	EPI_ISL_553388	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A87F/2020	EPI_ISL_553390	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95A806/2020	EPI_ISL_553394	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9557E0/2020	EPI_ISL_553400	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-954AD9/2020	EPI_ISL_553418	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.115	GR
hCoV-19/England/ALDP-954B7C/2020	EPI_ISL_553469	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9508B5/2020	EPI_ISL_554575	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954286/2020	EPI_ISL_554589	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-950879/2020	EPI_ISL_554592	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9554AD/2020	EPI_ISL_554595	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955944/2020	EPI_ISL_554604	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-9540AA/2020	EPI_ISL_554610	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944623/2020	EPI_ISL_554696	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94426B/2020	EPI_ISL_554708	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944298/2020	EPI_ISL_554727	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9442F2/2020	EPI_ISL_554735	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-959940/2020	EPI_ISL_554740	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/ALDP-9442C5/2020	EPI_ISL_554757	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9443A4/2020	EPI_ISL_554759	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9586A4/2020	EPI_ISL_554768	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-95998C/2020	EPI_ISL_554769	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-9586E0/2020	EPI_ISL_554784	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9586B3/2020	EPI_ISL_554790	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-944650/2020	EPI_ISL_554794	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-943F38/2020	EPI_ISL_554795	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-944641/2020	EPI_ISL_554804	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94423E/2020	EPI_ISL_554808	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94424D/2020	EPI_ISL_554809	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9441AA/2020	EPI_ISL_554812	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9583BC/2020	EPI_ISL_554821	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-943F47/2020	EPI_ISL_554830	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94427A/2020	EPI_ISL_554841	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CB2C/2020	EPI_ISL_555937	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CB59/2020	EPI_ISL_555938	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-64D827/2020	EPI_ISL_558100	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-64B3EC/2020	EPI_ISL_558116	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-64A30B/2020	EPI_ISL_558124	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-652045/2020	EPI_ISL_558212	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68A484/2020	EPI_ISL_558216	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-673B98/2020	EPI_ISL_558223	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-66C822/2020	EPI_ISL_558233	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-559ABA/2020	EPI_ISL_558243	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559DA2/2020	EPI_ISL_558245	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559EFA/2020	EPI_ISL_558253	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-576F4F/2020	EPI_ISL_558266	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-56514D/2020	EPI_ISL_558295	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/MILK-559E27/2020	EPI_ISL_558298	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559F15/2020	EPI_ISL_558391	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559DB1/2020	EPI_ISL_558393	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/Switzerland/ZH-ETHZ-280174/2020	EPI_ISL_560549	2020-09-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/MILK-9C26E1/2020	EPI_ISL_566675	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2C76/2020	EPI_ISL_566678	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C31EF/2020	EPI_ISL_566679	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Wales/MILK-9C3AB7/2020	EPI_ISL_566683	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C33F8/2020	EPI_ISL_566714	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C3B96/2020	EPI_ISL_566735	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C32A0/2020	EPI_ISL_566754	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C3E8E/2020	EPI_ISL_566765	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9C3EAC/2020	EPI_ISL_566780	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3AA8/2020	EPI_ISL_566819	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5C37/2020	EPI_ISL_567878	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5860/2020	EPI_ISL_567881	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE800/2020	EPI_ISL_567924	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9BDACF/2020	EPI_ISL_567929	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BE2E4/2020	EPI_ISL_567930	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/SHEF-C5562/2020	EPI_ISL_573702	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C5CC7/2020	EPI_ISL_573705	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C8972/2020	EPI_ISL_573715	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CE87F/2020	EPI_ISL_573738	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF0A3/2020	EPI_ISL_573743	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF1FB/2020	EPI_ISL_573744	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF3AA/2020	EPI_ISL_573745	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/QEUH-9BA45B/2020	EPI_ISL_573814	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9BA5EF/2020	EPI_ISL_573818	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9BADD8/2020	EPI_ISL_573841	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B73A/2020	EPI_ISL_573894	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AE51B/2020	EPI_ISL_577224	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE539/2020	EPI_ISL_577225	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE5FD/2020	EPI_ISL_577227	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE7AC/2020	EPI_ISL_577239	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE9B5/2020	EPI_ISL_577260	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA2B/2020	EPI_ISL_577266	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA3A/2020	EPI_ISL_577267	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA85/2020	EPI_ISL_577271	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEAA3/2020	EPI_ISL_577272	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/ALDP-9D8BF8/2020	EPI_ISL_577383	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/MILK-9D52BA/2020	EPI_ISL_577387	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/MILK-9E153A/2020	EPI_ISL_577406	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9E4BAE/2020	EPI_ISL_579858	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E5475/2020	EPI_ISL_579861	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4E69/2020	EPI_ISL_579864	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9E4616/2020	EPI_ISL_579867	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4E5A/2020	EPI_ISL_579871	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E478C/2020	EPI_ISL_579890	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E477D/2020	EPI_ISL_579899	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4B44/2020	EPI_ISL_579901	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA3DD/2020	EPI_ISL_579983	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EA1C4/2020	EPI_ISL_579990	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E9CA6/2020	EPI_ISL_579992	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9DC67B/2020	EPI_ISL_580862	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DAACC/2020	EPI_ISL_580869	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DCAAC/2020	EPI_ISL_580874	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E1181/2020	EPI_ISL_580877	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC620/2020	EPI_ISL_580878	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAE66/2020	EPI_ISL_580964	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD337/2020	EPI_ISL_580975	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DAD2D/2020	EPI_ISL_580997	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-16EA10/2020	EPI_ISL_585806	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9FD6A1/2020	EPI_ISL_588000	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD1BF/2020	EPI_ISL_588003	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FDE30/2020	EPI_ISL_588013	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCCA0/2020	EPI_ISL_588016	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD89C/2020	EPI_ISL_588023	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCEC8/2020	EPI_ISL_588025	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FDA0F/2020	EPI_ISL_588041	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9FDEF4/2020	EPI_ISL_588045	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA4F5/2020	EPI_ISL_588060	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA4B9/2020	EPI_ISL_588064	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAE33/2020	EPI_ISL_588072	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FAA3F/2020	EPI_ISL_588082	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB227/2020	EPI_ISL_588083	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FADBE/2020	EPI_ISL_588094	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9FA792/2020	EPI_ISL_588097	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F75F5/2020	EPI_ISL_589207	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9A8B/2020	EPI_ISL_589210	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2062/2020	EPI_ISL_589227	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9F2A55/2020	EPI_ISL_589233	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	AD.2	GR
hCoV-19/England/MILK-9F2958/2020	EPI_ISL_589237	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7D84/2020	EPI_ISL_589238	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7865/2020	EPI_ISL_589245	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2730/2020	EPI_ISL_589247	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7AAB/2020	EPI_ISL_589254	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7C5A/2020	EPI_ISL_589263	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E59B2/2020	EPI_ISL_589294	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EE39D/2020	EPI_ISL_589346	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9ECC3A/2020	EPI_ISL_589377	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED4B9/2020	EPI_ISL_589383	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED352/2020	EPI_ISL_589405	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9B5C58/2020	EPI_ISL_590214	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5757/2020	EPI_ISL_590225	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B4F50/2020	EPI_ISL_590233	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B48BF/2020	EPI_ISL_590243	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4AB9/2020	EPI_ISL_590248	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4F41/2020	EPI_ISL_590249	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5A7C/2020	EPI_ISL_590257	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5BD3/2020	EPI_ISL_590260	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5B00/2020	EPI_ISL_590265	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B564B/2020	EPI_ISL_590270	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B5915/2020	EPI_ISL_590284	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9B4891/2020	EPI_ISL_590293	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4828/2020	EPI_ISL_590298	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5362/2020	EPI_ISL_590299	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5414/2020	EPI_ISL_590303	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9B5793/2020	EPI_ISL_590309	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4E17/2020	EPI_ISL_590338	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9B49CB/2020	EPI_ISL_590339	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4D74/2020	EPI_ISL_590343	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4916/2020	EPI_ISL_590356	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B50E3/2020	EPI_ISL_590360	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4FF6/2020	EPI_ISL_590374	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4864/2020	EPI_ISL_590376	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B50C5/2020	EPI_ISL_590377	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4943/2020	EPI_ISL_590382	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B5B5B/2020	EPI_ISL_590383	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B49DA/2020	EPI_ISL_590385	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Japan/IC-0013/2020	EPI_ISL_591535	2020-03-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Great Britain (United Kingdom).	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 1 nucleotide(s) found at refpos 6862 (FRAMESHIFT). Submitter Note: Submitter confirmed sequence contains frameshift.	info	B.1.1	GR
hCoV-19/England/NOTT-115F64/2020	EPI_ISL_595296	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-A50B51/2020	EPI_ISL_597707	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A4FBFB/2020	EPI_ISL_597709	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50B33/2020	EPI_ISL_597807	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A50B24/2020	EPI_ISL_597842	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A4FC52/2020	EPI_ISL_597844	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A501E6/2020	EPI_ISL_597849	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4F9D3/2020	EPI_ISL_597850	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51FCD/2020	EPI_ISL_597892	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5173E/2020	EPI_ISL_597898	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A527B5/2020	EPI_ISL_597957	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A522C3/2020	EPI_ISL_597970	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A514CE/2020	EPI_ISL_597972	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0007F/2020	EPI_ISL_600149	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00103/2020	EPI_ISL_600173	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFC07/2020	EPI_ISL_600177	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9FFF1D/2020	EPI_ISL_600213	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFC9E/2020	EPI_ISL_600217	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFF95/2020	EPI_ISL_600236	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFF59/2020	EPI_ISL_600243	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0009D/2020	EPI_ISL_600247	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFA2B/2020	EPI_ISL_600248	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF1EA/2020	EPI_ISL_600278	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0031C/2020	EPI_ISL_600288	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF654/2020	EPI_ISL_600294	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9FFED4/2020	EPI_ISL_600296	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF2AB/2020	EPI_ISL_600305	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A000BB/2020	EPI_ISL_600343	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E097B/2020	EPI_ISL_601449	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0498/2020	EPI_ISL_601452	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E0999/2020	EPI_ISL_601456	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DBFAE/2020	EPI_ISL_601461	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DBE29/2020	EPI_ISL_601471	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9E087E/2020	EPI_ISL_601475	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D2174/2020	EPI_ISL_601493	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Wales/MILK-9D3F6A/2020	EPI_ISL_601509	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D4CEA/2020	EPI_ISL_601527	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3DBB/2020	EPI_ISL_601537	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4F1E/2020	EPI_ISL_601543	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D1DBD/2020	EPI_ISL_601550	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9D46DD/2020	EPI_ISL_601556	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4549/2020	EPI_ISL_601592	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D1EF6/2020	EPI_ISL_601606	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3D33/2020	EPI_ISL_601612	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D4CBD/2020	EPI_ISL_601620	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D46CE/2020	EPI_ISL_601677	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D3FB5/2020	EPI_ISL_601684	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3FD3/2020	EPI_ISL_601689	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K003402/2020	EPI_ISL_602790	2020-09-12	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003689/2020	EPI_ISL_602871	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003696/2020	EPI_ISL_602876	2020-10-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003715/2020	EPI_ISL_602895	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/England/ALDP-A87052/2020	EPI_ISL_606268	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C0D8/2020	EPI_ISL_606303	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7DABB/2020	EPI_ISL_606345	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D23B/2020	EPI_ISL_606385	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C612/2020	EPI_ISL_606396	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D347/2020	EPI_ISL_606399	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7CB7D/2020	EPI_ISL_606409	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7AD6A/2020	EPI_ISL_606413	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7DECE/2020	EPI_ISL_606455	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6EFDC/2020	EPI_ISL_607630	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E482/2020	EPI_ISL_607631	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E1D6/2020	EPI_ISL_607678	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6DFDD/2020	EPI_ISL_607783	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A647FC/2020	EPI_ISL_608912	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A69029/2020	EPI_ISL_608941	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A691EA/2020	EPI_ISL_608948	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64C66/2020	EPI_ISL_608960	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-A64817/2020	EPI_ISL_608965	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67FA6/2020	EPI_ISL_608979	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6941E/2020	EPI_ISL_608980	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-A64A5D/2020	EPI_ISL_608996	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A18D31/2020	EPI_ISL_612121	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/BIRM-65DF3/2020	EPI_ISL_612230	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B6ABF/2020	EPI_ISL_612271	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B6B43/2020	EPI_ISL_612273	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Turkey/KOC-IST-OD5/2020	EPI_ISL_613460	2020-06-21	Europe / Turkey	Human	Original	Nasal swab		Illumina	SPAdes v. 3.14.1			B.1.1	GR
hCoV-19/USA/MN-MDH-1903/2020	EPI_ISL_613523	2020-10-19	North America / USA / Minnesota	Human	Original	Nares		Illumina	StaPH-B Toolkit - Monroe v. 1.1.1			B.1.1.453	GR
hCoV-19/USA/MN-MDH-1901/2020	EPI_ISL_613525	2020-10-18	North America / USA / Minnesota	Human	Original	Nares		Illumina	StaPH-B Toolkit - Monroe v. 1.1.1			B.1.1.453	GR
hCoV-19/England/204261316/2020	EPI_ISL_613587	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.177.17	GR
hCoV-19/Denmark/DCGC-2081/2020	EPI_ISL_618337	2020-07-27	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2082/2020	EPI_ISL_618338	2020-07-27	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2104/2020	EPI_ISL_618346	2020-08-03	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2471/2020	EPI_ISL_618363	2020-08-03	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-8488/2020	EPI_ISL_618382	2020-07-27	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-2139/2020	EPI_ISL_618402	2020-07-20	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7553/2020	EPI_ISL_618437	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6573/2020	EPI_ISL_619621	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6619/2020	EPI_ISL_619668	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/England/ALDP-AA2E57/2020	EPI_ISL_624102	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA40F5/2020	EPI_ISL_624134	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA357F/2020	EPI_ISL_624169	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2D96/2020	EPI_ISL_624198	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA3DC2/2020	EPI_ISL_624205	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA284A/2020	EPI_ISL_624216	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1E85/2020	EPI_ISL_624222	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-AA3BD7/2020	EPI_ISL_624238	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2789/2020	EPI_ISL_624270	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3AAD/2020	EPI_ISL_624288	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA281D/2020	EPI_ISL_624305	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A6AC60/2020	EPI_ISL_625417	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-CZB-11677/2020	EPI_ISL_625489	2020-08-16	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11115/2020	EPI_ISL_625508	2020-05-28	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11122/2020	EPI_ISL_625514	2020-05-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-11131/2020	EPI_ISL_625520	2020-05-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/MILK-ACBC7C/2020	EPI_ISL_629171	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/MILK-ACC0F7/2020	EPI_ISL_629174	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1833/2020	EPI_ISL_630003	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-ACDCD4/2020	EPI_ISL_630023	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD0F6/2020	EPI_ISL_630077	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE13E/2020	EPI_ISL_630092	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACDCB6/2020	EPI_ISL_630096	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Germany/NW-HHU-304/2020	EPI_ISL_631307	2020-10-05	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/NW-HHU-307/2020	EPI_ISL_631310	2020-10-05	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Germany/NW-HHU-313/2020	EPI_ISL_631316	2020-10-06	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/NW-HHU-256/2020	EPI_ISL_631344	2020-09-21	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Germany/NW-HHU-263/2020	EPI_ISL_631351	2020-09-21	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			AD.2	GR
hCoV-19/England/QEUH-AD0A5C/2020	EPI_ISL_633881	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD387D/2020	EPI_ISL_633902	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1271/2020	EPI_ISL_633946	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD08E9/2020	EPI_ISL_633947	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-AD11DE/2020	EPI_ISL_633967	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD388C/2020	EPI_ISL_633986	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD15D2/2020	EPI_ISL_633997	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD35FE/2020	EPI_ISL_633998	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A3707F/2020	EPI_ISL_638724	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A370BB/2020	EPI_ISL_638726	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A370D9/2020	EPI_ISL_638727	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A77BDC/2020	EPI_ISL_638739	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A77BFA/2020	EPI_ISL_638740	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A78D4E/2020	EPI_ISL_638780	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A794DF/2020	EPI_ISL_638806	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A89CC5/2020	EPI_ISL_638821	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8A8EE/2020	EPI_ISL_638858	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A8A981/2020	EPI_ISL_638864	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8A9FA/2020	EPI_ISL_638867	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8AA9D/2020	EPI_ISL_638870	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8AABB/2020	EPI_ISL_638871	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9ADF5A/2020	EPI_ISL_638897	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9ADF87/2020	EPI_ISL_638898	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A4B4C7/2020	EPI_ISL_638940	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/QEUH-B0E131/2020	EPI_ISL_642016	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8D2/2020	EPI_ISL_642019	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E201/2020	EPI_ISL_642023	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E061/2020	EPI_ISL_642025	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0E939/2020	EPI_ISL_642032	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E25C/2020	EPI_ISL_642037	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EC7C/2020	EPI_ISL_642041	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E23E/2020	EPI_ISL_642042	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8F0/2020	EPI_ISL_642059	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0DFCF/2020	EPI_ISL_642061	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0DC8C/2020	EPI_ISL_642062	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EB15/2020	EPI_ISL_642067	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0DF83/2020	EPI_ISL_642069	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E92A/2020	EPI_ISL_642141	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B0EA72/2020	EPI_ISL_642158	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E298/2020	EPI_ISL_642160	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-B0E22F/2020	EPI_ISL_642163	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E869/2020	EPI_ISL_642174	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B0EAFA/2020	EPI_ISL_642186	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E368/2020	EPI_ISL_642190	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EB9D/2020	EPI_ISL_642197	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8BAAB/2020	EPI_ISL_643209	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0AD7D/2020	EPI_ISL_643345	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B07E5F/2020	EPI_ISL_643382	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B07E8C/2020	EPI_ISL_643478	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0AD6E/2020	EPI_ISL_643496	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/France/OCC-SC463/2020	EPI_ISL_644681	2020-02-26	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	BWA, samtools, custom			B.1.1	GR
hCoV-19/England/ALDP-B1D533/2020	EPI_ISL_645912	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22410/2020	EPI_ISL_645917	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2239B/2020	EPI_ISL_645925	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21D07/2020	EPI_ISL_645949	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B223D7/2020	EPI_ISL_645958	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Sweden/20-53092/2020	EPI_ISL_648134	2020-07-11	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-53089/2020	EPI_ISL_648139	2020-07-15	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52813/2020	EPI_ISL_648144	2020-06-29	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-53094/2020	EPI_ISL_648145	2020-07-10	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52391/2020	EPI_ISL_648173	2020-07-01	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/ALDP-B47E9F/2020	EPI_ISL_649400	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B48775/2020	EPI_ISL_649402	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B4864B/2020	EPI_ISL_649443	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47EAE/2020	EPI_ISL_649444	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47F41/2020	EPI_ISL_649453	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B48757/2020	EPI_ISL_649456	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B4872A/2020	EPI_ISL_649469	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B12FA9/2020	EPI_ISL_649510	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B024E9/2020	EPI_ISL_649555	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C855/2020	EPI_ISL_649558	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B118DC/2020	EPI_ISL_649573	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B13263/2020	EPI_ISL_649574	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B23136/2020	EPI_ISL_651719	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5394/2020	EPI_ISL_651796	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5398/2020	EPI_ISL_651798	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5405/2020	EPI_ISL_651803	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.315	GR
hCoV-19/England/ALDP-B62CC1/2020	EPI_ISL_655315	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B8A9/2020	EPI_ISL_655321	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62AD6/2020	EPI_ISL_655355	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B5B1/2020	EPI_ISL_655361	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5AF3C/2020	EPI_ISL_655368	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B4A5/2020	EPI_ISL_655383	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63088/2020	EPI_ISL_655384	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62CA3/2020	EPI_ISL_655391	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B584/2020	EPI_ISL_655474	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62942/2020	EPI_ISL_656602	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B620E3/2020	EPI_ISL_656653	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B62520/2020	EPI_ISL_656663	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B625C6/2020	EPI_ISL_656667	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62353/2020	EPI_ISL_656675	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B543FA/2020	EPI_ISL_656784	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54FAB/2020	EPI_ISL_657850	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-B51C10/2020	EPI_ISL_657907	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-B54BE3/2020	EPI_ISL_657915	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B51E47/2020	EPI_ISL_657924	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54AB9/2020	EPI_ISL_657954	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B55344/2020	EPI_ISL_657973	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/204821174/2020	EPI_ISL_661175	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.294	GR
hCoV-19/Sweden/20-52819/2020	EPI_ISL_661283	2020-06-25	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/England/QEUH-B66410/2020	EPI_ISL_662417	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B735A4/2020	EPI_ISL_662452	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B675B2/2020	EPI_ISL_662454	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B09F/2020	EPI_ISL_662481	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B6E8/2020	EPI_ISL_662517	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6752B/2020	EPI_ISL_662546	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A115/2020	EPI_ISL_662560	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6751C/2020	EPI_ISL_662567	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B67567/2020	EPI_ISL_662569	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6AE1E/2020	EPI_ISL_662573	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A555/2020	EPI_ISL_662585	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B7360B/2020	EPI_ISL_662588	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/EDB9324/2020	EPI_ISL_666075	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A61416/2020	EPI_ISL_666086	2020-10-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/USA/OR-OHSU-2840/2020	EPI_ISL_667345	2020-09-02	North America / USA / Oregon / Columbia County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-2861/2020	EPI_ISL_667364	2020-09-03	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.174	GR
hCoV-19/USA/WA-OHSU-2897/2020	EPI_ISL_667397	2020-09-04	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-2975/2020	EPI_ISL_667440	2020-09-09	North America / USA / Oregon / Clackamas County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.174	GR
hCoV-19/Denmark/DCGC-9292/2020	EPI_ISL_668636	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-10343/2020	EPI_ISL_669913	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10344/2020	EPI_ISL_669914	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10382/2020	EPI_ISL_669933	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10411/2020	EPI_ISL_669952	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10431/2020	EPI_ISL_669965	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10437/2020	EPI_ISL_669969	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-10458/2020	EPI_ISL_669987	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/England/CAMC-B0935E/2020	EPI_ISL_673109	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B0A047/2020	EPI_ISL_673136	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B09A0E/2020	EPI_ISL_673138	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B098F5/2020	EPI_ISL_673155	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B0A171/2020	EPI_ISL_673173	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08DAC/2020	EPI_ISL_673212	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B83D30/2020	EPI_ISL_674404	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B85536/2020	EPI_ISL_674408	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B84036/2020	EPI_ISL_674445	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8C502/2020	EPI_ISL_674453	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B839F0/2020	EPI_ISL_674462	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7D71D/2020	EPI_ISL_674498	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7F4C9/2020	EPI_ISL_674545	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F8E8/2020	EPI_ISL_674554	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8C64B/2020	EPI_ISL_675762	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88CA7/2020	EPI_ISL_675790	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88C98/2020	EPI_ISL_675805	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8CB5B/2020	EPI_ISL_675866	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8CA7C/2020	EPI_ISL_675886	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/EXET-139C90/2020	EPI_ISL_679332	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Northern Ireland/NIRE-2341D1/2020	EPI_ISL_680352	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-BA9CFB/2020	EPI_ISL_681590	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-BAB51C/2020	EPI_ISL_681602	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BA9B0D/2020	EPI_ISL_681618	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/LK-UHL12/2020	EPI_ISL_681721	2020-03-31	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL144/2020	EPI_ISL_681734	2020-04-08	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL15/2020	EPI_ISL_681736	2020-04-06	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL18/2020	EPI_ISL_681737	2020-04-06	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.5	GR
hCoV-19/Ireland/LK-UHL28/2020	EPI_ISL_681739	2020-04-05	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL294/2020	EPI_ISL_681742	2020-04-27	Europe / Ireland / Limerick / Limerick County	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL30/2020	EPI_ISL_681744	2020-04-07	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL31/2020	EPI_ISL_681749	2020-04-10	Europe / Ireland / Limerick / Limerick County	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL6/2020	EPI_ISL_681757	2020-04-02	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/LK-UHL8/2020	EPI_ISL_681760	2020-04-01	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Denmark/DCGC-12620/2020	EPI_ISL_682801	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12622/2020	EPI_ISL_682803	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12767/2020	EPI_ISL_682948	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-12781/2020	EPI_ISL_682962	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12791/2020	EPI_ISL_682972	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Japan/PG-1479/2020	EPI_ISL_685086	2020-04-14	Asia / Japan / Saitama	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Portugal/PT1586/2020	EPI_ISL_693542	2020-07-01	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.421	GR
hCoV-19/Portugal/PT1546/2020	EPI_ISL_693559	2020-06-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1550/2020	EPI_ISL_693563	2020-06-21	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1566/2020	EPI_ISL_693576	2020-06-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1573/2020	EPI_ISL_693581	2020-06-29	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1577/2020	EPI_ISL_693585	2020-06-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1578/2020	EPI_ISL_693586	2020-06-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1597/2020	EPI_ISL_693601	2020-07-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1	GR
hCoV-19/Portugal/PT1605/2020	EPI_ISL_693608	2020-07-07	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1610/2020	EPI_ISL_693612	2020-07-07	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1611/2020	EPI_ISL_693613	2020-07-07	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1614/2020	EPI_ISL_693616	2020-07-08	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1620/2020	EPI_ISL_693621	2020-07-09	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.421	GR
hCoV-19/Portugal/PT1701/2020	EPI_ISL_693630	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1702/2020	EPI_ISL_693631	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1703/2020	EPI_ISL_693632	2020-08-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1704/2020	EPI_ISL_693633	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1705/2020	EPI_ISL_693634	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1706/2020	EPI_ISL_693635	2020-08-31	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1708/2020	EPI_ISL_693636	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1710/2020	EPI_ISL_693637	2020-08-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1711/2020	EPI_ISL_693638	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1712/2020	EPI_ISL_693639	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1713/2020	EPI_ISL_693640	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1714/2020	EPI_ISL_693641	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1715/2020	EPI_ISL_693642	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1716/2020	EPI_ISL_693643	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1717/2020	EPI_ISL_693644	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1718/2020	EPI_ISL_693645	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1719/2020	EPI_ISL_693646	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1720/2020	EPI_ISL_693647	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1721/2020	EPI_ISL_693648	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1722/2020	EPI_ISL_693649	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1724/2020	EPI_ISL_693650	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1725/2020	EPI_ISL_693651	2020-08-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1726/2020	EPI_ISL_693652	2020-08-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1727/2020	EPI_ISL_693653	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1728/2020	EPI_ISL_693654	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1731/2020	EPI_ISL_693655	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1733/2020	EPI_ISL_693656	2020-08-24	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Portugal/PT1736/2020	EPI_ISL_693657	2020-08-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.394	GR
hCoV-19/Czech Republic/NRL-10733/2020	EPI_ISL_693675	2020-11-03	Europe / Czech Republic	Human	Original	Organ - trachea		Nanopore MinION	ARTIC-Medaka			B.1.1.294	GR
hCoV-19/USA/AZ-TG408166/2020	EPI_ISL_694917	2020-06-16	North America / USA / Arizona	Human	Original			Illumina				B.1.1	GR
hCoV-19/United Arab Emirates/0223/2020	EPI_ISL_698408	2020-05-17	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.274	GR
hCoV-19/United Arab Emirates/0241/2020	EPI_ISL_698423	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0278/2020	EPI_ISL_698458	2020-05-17	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0310/2020	EPI_ISL_698487	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0335/2020	EPI_ISL_698511	2020-05-19	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.208	GR
hCoV-19/United Arab Emirates/0377/2020	EPI_ISL_698552	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0424/2020	EPI_ISL_698598	2020-05-16	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/India/MH-ACTREC-214/2020	EPI_ISL_699868	2020-06-29	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.1.174	GR
hCoV-19/India/MH-ACTREC-215/2020	EPI_ISL_699869	2020-06-29	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.1.174	GR
hCoV-19/England/ALDP-BB2AF5/2020	EPI_ISL_703009	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-BB2AC8/2020	EPI_ISL_703086	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCE258/2020	EPI_ISL_704249	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCD73C/2020	EPI_ISL_704253	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCBB23/2020	EPI_ISL_704287	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCCF80/2020	EPI_ISL_704310	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCBBE7/2020	EPI_ISL_704323	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCBC11/2020	EPI_ISL_704343	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCCFCC/2020	EPI_ISL_704386	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1B91F3/2020	EPI_ISL_705546	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B924B/2020	EPI_ISL_705550	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-BBB90E/2020	EPI_ISL_705565	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-BBBF48/2020	EPI_ISL_705577	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/PORT-2F50C0/2020	EPI_ISL_706883	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A364A1/2020	EPI_ISL_706909	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61A05/2020	EPI_ISL_706934	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61A50/2020	EPI_ISL_706936	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61E36/2020	EPI_ISL_706939	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61EEB/2020	EPI_ISL_706942	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A6210F/2020	EPI_ISL_706959	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A6214B/2020	EPI_ISL_706960	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-A624F7/2020	EPI_ISL_706966	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-BFBA0F/2020	EPI_ISL_709232	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-BFBAB4/2020	EPI_ISL_709238	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-14085/2020	EPI_ISL_711556	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-14119/2020	EPI_ISL_711580	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-14130/2020	EPI_ISL_711587	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13367/2020	EPI_ISL_712753	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13371/2020	EPI_ISL_712757	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13442/2020	EPI_ISL_712803	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13530/2020	EPI_ISL_712858	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-13573/2020	EPI_ISL_712884	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/England/ALDP-C4996E/2020	EPI_ISL_718871	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Netherlands/NH-RIVM-20344/2020	EPI_ISL_723465	2020-12-05	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/England/LOND-DB350/2020	EPI_ISL_724759	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B87710/2020	EPI_ISL_724794	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/NORT-1B726CD/2020	EPI_ISL_724895	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Germany/TH-IIMK-CaSe-9/2020	EPI_ISL_728303	2020-05-24	Europe / Germany / Thuringia	Human	Original			Nanopore MinION	ARTIC			B.1.1	GR
hCoV-19/Morocco/FMP-21/2020	EPI_ISL_728342	2020-12	Africa / Morocco / Temara	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Morocco/FMP-22/2020	EPI_ISL_728344	2020-12	Africa / Morocco / Rabat	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Morocco/FMP-25/2020	EPI_ISL_728352	2020-12	Africa / Morocco / Temara	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Germany/SH-ChVir8177/2020	EPI_ISL_729562	2020-06-30	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/SH-ChVir8179/2020	EPI_ISL_729563	2020-07-01	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/SH-ChVir8326/2020	EPI_ISL_729581	2020-07-28	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.1	GR
hCoV-19/Germany/SH-ChVir20299/2020	EPI_ISL_729637	2020-11-13	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2			B.1.1	GR
hCoV-19/Turkey/Ankara_GUMV_25210/2020	EPI_ISL_730568	2020-09-01	Europe / Turkey / Ankara	Human	Original			Illumina ISeq 100				B.1.1	GR
hCoV-19/Turkey/Ankara_GUMV_28458/2020	EPI_ISL_730573	2020-09-07	Europe / Turkey / Ankara	Human	Original			Illumina ISeq 100				B.1.1	GR
hCoV-19/Turkey/Ankara_GUMV_18121/2020	EPI_ISL_730574	2020-08-11	Europe / Turkey / Ankara	Human	Original			Illumina ISeq 100				B.1.1	GR
hCoV-19/England/QEUH-C30D40/2020	EPI_ISL_730676	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C3B871/2020	EPI_ISL_731802	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Portugal/PT1836/2020	EPI_ISL_731938	2020-11-09	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/Portugal/PT1668/2020	EPI_ISL_731967	2020-11-12	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			AD.2	GR
hCoV-19/England/QEUH-C33ADD/2020	EPI_ISL_734110	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/USA/CA-CZB-14118/2020	EPI_ISL_739003	2020-05-24	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14593/2020	EPI_ISL_739004	2020-10-15	North America / USA / California / Marin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13852/2020	EPI_ISL_739023	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14107/2020	EPI_ISL_739029	2020-05-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13861/2020	EPI_ISL_739046	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13943/2020	EPI_ISL_739056	2020-06-23	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14305/2020	EPI_ISL_739082	2020-08-24	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.277	GR
hCoV-19/Luxembourg/LNS2068754/2020	EPI_ISL_740053	2020-10-31	Europe / Luxembourg	Human	Original	Nasopharyngeal swab		Illumina MiniSeq, (2x150bp, Amplicon, LNS primer scheme)	Bowtie2, Ivar			B.1.1	GR
hCoV-19/England/MILK-B3D44F/2020	EPI_ISL_741372	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-49C1A8/2020	EPI_ISL_742519	2020-12-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A234F/2020	EPI_ISL_743875	2020-12-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A235E/2020	EPI_ISL_743876	2020-12-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A237C/2020	EPI_ISL_743878	2020-12-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/South Korea/KDCA0183/2020	EPI_ISL_747416	2020-07-04	Asia / South Korea	Human	Original		Imported case from Philippines	Illumina MiSeq				B.1.1	GR
hCoV-19/England/204940073/2020	EPI_ISL_747496	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Denmark/DCGC-19051/2020	EPI_ISL_748722	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19155/2020	EPI_ISL_748784	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/NY-Wadsworth-280814-01/2020	EPI_ISL_754508	2020-11-30	North America / USA / New York / Hamilton County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-233496-01/2020	EPI_ISL_754527	2020-10-01	North America / USA / New York / Warren County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/USA/NY-Wadsworth-269500-01/2020	EPI_ISL_754575	2020-11-10	North America / USA / New York / Columbia County	Human	Original			Illumna MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/Canada/ON-S1592/2020	EPI_ISL_755933	2020-09-04	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-20836/2020	EPI_ISL_759394	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-20878/2020	EPI_ISL_759423	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/ALDP-CBDFAF/2020	EPI_ISL_760471	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-CB511A/2020	EPI_ISL_761776	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/LH-NVRL-MPZ41611/2020	EPI_ISL_767807	2020-04-15	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1.399	GR
hCoV-19/Ireland/LS-NVRL-MPS29388/2020	EPI_ISL_767815	2020-04-09	Europe / Ireland / Laois	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/MH-NVRL-MPK48258/2020	EPI_ISL_767816	2020-05-20	Europe / Ireland / Meath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1.399	GR
hCoV-19/Ireland/WW-NVRL-MPJ92577/2020	EPI_ISL_767836	2020-03-13	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-MPN63349/2020	EPI_ISL_767838	2020-04-04	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Germany/HH-hpi-p1525/2020	EPI_ISL_776025	2020-03-15	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.271	GR
hCoV-19/England/ALDP-C8EA3D/2020	EPI_ISL_777270	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-C8C167/2020	EPI_ISL_777276	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-C98D28/2020	EPI_ISL_777332	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Italy/CAM-TIGEM-614/2020	EPI_ISL_778656	2020-04-09	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1	GR
hCoV-19/Italy/CAM-TIGEM-628/2020	EPI_ISL_778682	2020-04-24	Europe / Italy / Campania	Human	Original	Oropharyngeal swab		MGI DNBSEQ-G400	SARS-CoV-2_Multi-PCR_v1.0			B.1.1	GR
hCoV-19/France/ARA-SC737/2020	EPI_ISL_779831	2020-11-17	Europe / France / Auvergne-Rhone-Alpes / Grenoble	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-8902/2020	EPI_ISL_780820	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8958/2020	EPI_ISL_780858	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	O
hCoV-19/USA/TX-HMH-MCoV-8962/2020	EPI_ISL_780862	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-8991/2020	EPI_ISL_780877	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-8998/2020	EPI_ISL_780883	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-9008/2020	EPI_ISL_780892	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9041/2020	EPI_ISL_780914	2020-07-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9042/2020	EPI_ISL_780915	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-9185/2020	EPI_ISL_780988	2020-07-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/England/MILK-C2F6EF/2020	EPI_ISL_783060	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA0EF/2020	EPI_ISL_783073	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-BAA45C/2020	EPI_ISL_783075	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA0FE/2020	EPI_ISL_783092	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-BAB716/2020	EPI_ISL_783107	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-BAADE8/2020	EPI_ISL_783128	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAAC72/2020	EPI_ISL_783140	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAF93A/2020	EPI_ISL_783154	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAAED6/2020	EPI_ISL_783172	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-8317/2020	EPI_ISL_784327	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-8343/2020	EPI_ISL_784343	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-8364/2020	EPI_ISL_784354	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8376/2020	EPI_ISL_784358	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-8398/2020	EPI_ISL_784371	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-8400/2020	EPI_ISL_784373	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-15939/2020	EPI_ISL_785623	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-15975/2020	EPI_ISL_785659	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-16012/2020	EPI_ISL_785696	2020-07-10	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-10085/2020	EPI_ISL_789263	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-10057/2020	EPI_ISL_789308	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-MCoV-10169/2020	EPI_ISL_789350	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-12119/2020	EPI_ISL_790207	2020-09-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	GR
hCoV-19/USA/TX-HMH-MCoV-12133/2020	EPI_ISL_790214	2020-09-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.337	GR
hCoV-19/USA/TX-HMH-MCoV-12183/2020	EPI_ISL_790237	2020-09-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	O
hCoV-19/USA/TX-HMH-MCoV-12195/2020	EPI_ISL_790241	2020-09-21	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-12207/2020	EPI_ISL_790247	2020-09-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.294	GR
hCoV-19/USA/TX-HMH-MCoV-12223/2020	EPI_ISL_790254	2020-09-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12318/2020	EPI_ISL_790298	2020-09-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.411	GR
hCoV-19/USA/TX-HMH-MCoV-12364/2020	EPI_ISL_790313	2020-09-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-12372/2020	EPI_ISL_790316	2020-09-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12378/2020	EPI_ISL_790319	2020-09-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12399/2020	EPI_ISL_790327	2020-09-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-12422/2020	EPI_ISL_790338	2020-09-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/Denmark/DCGC-24040/2020	EPI_ISL_792907	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-24150/2020	EPI_ISL_792966	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-24175/2020	EPI_ISL_792978	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Switzerland/SO-ETHZ-430631/2020	EPI_ISL_796480	2020-12-30	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1	O
hCoV-19/England/QEUH-D199EE/2020	EPI_ISL_800124	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/Canada/AB-31113/2020	EPI_ISL_806194	2020-04-06	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-97052/2020	EPI_ISL_806202	2020-05-07	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-95581/2020	EPI_ISL_806222	2020-04-15	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-67102/2020	EPI_ISL_806229	2020-05-15	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-40872/2020	EPI_ISL_806286	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-32164/2020	EPI_ISL_806354	2020-04-06	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-30465/2020	EPI_ISL_806377	2020-04-13	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/England/NORT-1B7E807/2020	EPI_ISL_819434	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/NORT-1B7E04B/2020	EPI_ISL_819453	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B7E7FB/2020	EPI_ISL_819568	2020-12-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-DE5550/2020	EPI_ISL_821867	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Netherlands/LI-RIVM-21311/2020	EPI_ISL_824231	2020-12-28	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Japan/IC-0695/2021	EPI_ISL_825395	2021-01-11	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0	Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/204380227/2020	EPI_ISL_825588	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Ecuador/EC-M-48779/2020	EPI_ISL_826822	2020-05-25	South America / Ecuador / Manabi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Ecuador/EC-E-124322/2020	EPI_ISL_826832	2020-09-08	South America / Ecuador / Esmeraldas	Human	Original	Nasopharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1.231	GR
hCoV-19/Ecuador/EC-M-127111/2020	EPI_ISL_826836	2020-09-11	South America / Ecuador / Manabi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Iceland/5410/2020	EPI_ISL_829094	2020-12-22	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.1	GR
hCoV-19/USA/OR-OHSU-3551/2020	EPI_ISL_832508	2020-10-21	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3553/2020	EPI_ISL_832509	2020-10-21	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3565/2020	EPI_ISL_832512	2020-10-21	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3607/2020	EPI_ISL_832528	2020-10-22	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3647/2020	EPI_ISL_832539	2020-10-20	North America / USA / Oregon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3675/2020	EPI_ISL_832546	2020-10-20	North America / USA / Oregon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-3731/2020	EPI_ISL_832561	2020-10-20	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/England/MILK-EC5CBA/2021	EPI_ISL_836221	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/Denmark/DCGC-29208/2021	EPI_ISL_843255	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-29249/2021	EPI_ISL_843296	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/SHEF-10D12B4/2021	EPI_ISL_868555	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D5DDD/2021	EPI_ISL_868640	2021-01-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Denmark/DCGC-33793/2021	EPI_ISL_870803	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-33958/2021	EPI_ISL_870968	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-33975/2021	EPI_ISL_870985	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Russia/LEN-RII-MH13317S/2020	EPI_ISL_873006	2020-12-24	Europe / Russia / Leningrad / Vsevolozhsk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.336	GR
hCoV-19/Italy/CAM-CRGS-1/2020	EPI_ISL_875674	2020-03-14	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/USA/FL-QDX-3431/2020	EPI_ISL_876960	2020-07-08	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.231	GR
hCoV-19/Italy/CAM-CRGS-73/2020	EPI_ISL_876972	2020-03-30	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1.1	GR
hCoV-19/England/ALDP-1092343/2021	EPI_ISL_878032	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-ALSR-6178/2021	EPI_ISL_880218	2021-01-07	North America / USA / California / Riverside	Human	Original	Nasal swab		Illumina	iVar 1.2.2	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/CA-ALSR-6211/2021	EPI_ISL_880284	2021-01-07	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.2.2	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Poland/NIPH-NIH-05/2020	EPI_ISL_882960	2020-10-29	Europe / Poland / Mazowieckie / Warsaw	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Poland/NIPH-NIH-08/2020	EPI_ISL_882962	2020-12-17	Europe / Poland / Mazowieckie / Warsaw	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Wales/ALDP-1004EC3/2021	EPI_ISL_892160	2021-01-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA430B/2020	EPI_ISL_892221	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9CF471/2020	EPI_ISL_892229	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/SG-ETHZ-450199/2021	EPI_ISL_899609	2021-01-13	Europe / Switzerland / St Gallen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/SH-ETHZ-431025/2020	EPI_ISL_899625	2020-12-28	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.294	GR
hCoV-19/USA/MT-BHDH-1450/2020	EPI_ISL_903339	2020-05-27	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-1508/2020	EPI_ISL_903340	2020-05-28	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter). %UniqueMutations 0.06%.	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-1865/2020	EPI_ISL_903341	2020-06-04	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-2045/2020	EPI_ISL_903342	2020-06-08	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-2346/2020	EPI_ISL_903343	2020-06-14	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-2973/2020	EPI_ISL_903344	2020-06-23	North America / USA / Montana	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-3695/2020	EPI_ISL_903345	2020-07-07	North America / USA / Montana / Big Sky	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/USA/MT-BHDH-5077/2020	EPI_ISL_903346	2020-07-30	North America / USA / Montana / Bozeman	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC	Gap of 115 nucleotide(s) found at refpos 27547 (frameshift confirmed by the submitter).	info	B.1.1.231	GR
hCoV-19/Spain/CT-IrsiCaixaLMUKZ1/2021	EPI_ISL_904650	2021-01-05	Europe / Spain / Cataluna / Mataró	Human	Original	Oropharyngeal swab		Illumina MiSeq	Viralrecon/bcftools	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Netherlands/NB-RIVM-10708/2021	EPI_ISL_904829	2021-01-14	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/USA/OR-OHSU-8305/2020	EPI_ISL_905847	2020-12-19	North America / USA / Oregon / Clackamas County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp				B.1.1.337	GR
hCoV-19/England/ALDP-10132B6/2021	EPI_ISL_916670	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/NORT-1B84DB4/2020	EPI_ISL_921325	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-1032E53/2021	EPI_ISL_923881	2021-01-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Denmark/DCGC-34862/2020	EPI_ISL_926002	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-34875/2020	EPI_ISL_926015	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-34910/2020	EPI_ISL_926050	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-38758/2020	EPI_ISL_929900	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Austria/CeMM2603/2020	EPI_ISL_934542	2020-11-19	Europe / Austria / Tyrol / Innsbruck-Stadt	Human	Original			Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM2604/2020	EPI_ISL_934543	2020-11-11	Europe / Austria / Tyrol / Innsbruck-Stadt	Human	Original			Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/OXON-F4A0B0/2021	EPI_ISL_951091	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Switzerland/GE-33053723/2021	EPI_ISL_953632	2021-01-23	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/GE-33058305/2021	EPI_ISL_953633	2021-01-24	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/un-33063201/2021	EPI_ISL_953634	2021-01-25	Europe / Switzerland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/GE-33091077/2021	EPI_ISL_953635	2021-01-27	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/GE-33090665/2021	EPI_ISL_953658	2021-01-27	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.384	GR
hCoV-19/USA/CO-CDPHE-V40909434/2021	EPI_ISL_954929	2021-01-10	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1	GR
hCoV-19/USA/OH-PLMI-J6JJ7-5152/2020	EPI_ISL_956002	2020-03	North America / USA / Ohio	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Megahit	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/OH-PLMI-J6HBW-2171/2020	EPI_ISL_956007	2020-04	North America / USA / Ohio	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Megahit	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/D-NVRL-83IRL90431/2021	EPI_ISL_959839	2021-01-17	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Germany/HH-HPI-p2886/2020	EPI_ISL_959924	2020-09-30	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.1	O
hCoV-19/Germany/HH-HPI-p2957/2020	EPI_ISL_959997	2020-09-18	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.1.294	O
hCoV-19/Denmark/DCGC-39731/2020	EPI_ISL_971345	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/MILK-11C1CF4/2021	EPI_ISL_971397	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-41161/2021	EPI_ISL_972838	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/USA/NC-SLPH_0024/2020	EPI_ISL_977514	2020-11-27	North America / USA / North Carolina	Human	Original			Illumina MiSeq	EDGE-covid19: bwa 0.7.12-r1039			B.1.1.231	GR
hCoV-19/USA/MN-MDH-2581/2021	EPI_ISL_982356	2021-01-02	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/Russia/ARK-CRIE-7602088531/2020	EPI_ISL_984634	2020-12-28	Europe / Russia / Arkhangelsk	Human	Original	Oropharyngeal swab		Illumina MiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools	From submitter: ambiguous nucleotide at reference position 1885, coverage of T - 84 (13 %), coverage of C - 546 (87 %), ambiguous nucleotide at reference position 10263, coverage of C - 1151 (17 %), coverage of T - 5743 (83 %)	info	B.1.1.336	GR
hCoV-19/Russia/ARK-CRIE-7602074634/2020	EPI_ISL_984649	2020-12-26	Europe / Russia / Arkhangelsk	Human	Original	Oropharyngeal swab		Illumina MiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/England/QEUH-109D630/2021	EPI_ISL_994079	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Switzerland/BE-ETHZ-460938/2021	EPI_ISL_1003098	2021-01-17	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Switzerland/ZH-ETHZ-441108/2021	EPI_ISL_1004303	2021-01-07	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/USA/CA-LACPHL-AF00395/2021	EPI_ISL_1005503	2021-02-01	North America / USA / California / Los Angeles County	Human	Original			Illumina MiSeq	Monroe v1.0.0			B.1.1	GR
hCoV-19/Mexico/CMX-INMEGEN-01-01-12/2020	EPI_ISL_1005662	2020-12-30	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Nanopore MinION	MEDAKA			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21010229-01/2021	EPI_ISL_1016388	2021-01-07	North America / USA / New York / Queens	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.1.231	GR
hCoV-19/USA/NY-Yale-1107/2020	EPI_ISL_1017502	2020-12-30	North America / USA / New York	Human	Original	Nasopharyngeal swab		Illumina NovaSeq				B.1.1.231	GR
hCoV-19/USA/NY-Yale-1123/2020	EPI_ISL_1017525	2020-12-28	North America / USA / New York	Human	Original	Nasopharyngeal swab		Illumina NovaSeq				B.1.1.231	GR
hCoV-19/Serbia/Belgrade-2972550801/2021	EPI_ISL_1017696	2021-01-08	Europe / Serbia / Belgrade	Human	Original	Nasopharyngeal swab		Nanopore MinION	Medaka v. v. 1.0.1; ARTIC nCoV-2019 v. V3			B.1.1.294	GR
hCoV-19/USA/CA-CDC-LC0006384/2021	EPI_ISL_1022120	2021-01-16	North America / USA / California	Human	Original	Nasal swab		PacBio	CLC Genomics	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/MA-CDC-LC0006106/2021	EPI_ISL_1022152	2021-01-16	North America / USA / Massachusetts	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.1.231	GR
hCoV-19/Denmark/DCGC-43063/2021	EPI_ISL_1023341	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-43169/2021	EPI_ISL_1023447	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-43237/2021	EPI_ISL_1023529	2021-02-08	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-44389/2021	EPI_ISL_1024767	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-44407/2021	EPI_ISL_1024785	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-44415/2021	EPI_ISL_1024793	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-44448/2021	EPI_ISL_1024826	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Netherlands/UT-RIVM-13151/2021	EPI_ISL_1035344	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.163	GR
hCoV-19/Netherlands/UT-RIVM-13142/2021	EPI_ISL_1035353	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-13113/2021	EPI_ISL_1035382	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-12696/2021	EPI_ISL_1035478	2021-01-29	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.163	GR
hCoV-19/Russia/KAM-RII-MH12371S/2020	EPI_ISL_1039054	2020-12-14	Europe / Russia / Kamchatka / Petropavlovsk-Kamchatsky	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/BEL-RII-MH12724S/2020	EPI_ISL_1039069	2020-11-26	Europe / Russia / Belgorod / Stary Oskol	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/BEL-RII-MH12759S/2020	EPI_ISL_1039083	2020-11-27	Europe / Russia / Belgorod / Belgorod	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA, samtools, ivar, lofreq			B.1.1.274	GR
hCoV-19/USA/CA-IGI-1013/2020	EPI_ISL_1041194	2020-07-29	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.3.1 reference aligned	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.1.174	GR
hCoV-19/USA/NY-PRL-2021_02_08_05D10/2021	EPI_ISL_1041378	2021-02-06	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq / NextSeq	BWA mem			B.1.1	GR
hCoV-19/USA/NY-PRL-2021_02_08_05E02/2021	EPI_ISL_1041379	2021-02-06	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq / NextSeq	BWA mem			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-490803/2021	EPI_ISL_1059450	2021-02-09	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-481430/2021	EPI_ISL_1059460	2021-01-04	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Poland/2142413209_gx1/2021	EPI_ISL_1062936	2021-01-20	Europe / Poland / Wielkopolska / Plewiska	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	ARTICv3	Gap of 2 nucleotide(s) found at refpos 27792 (FRAMESHIFT confirmed by the submitter). NS7b without BLAST coverage.	info	B.1.1	GR
hCoV-19/Denmark/DCGC-45653/2021	EPI_ISL_1065163	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-45668/2021	EPI_ISL_1065178	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-45789/2021	EPI_ISL_1065299	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/TX-HMH-MCoV-20525/2021	EPI_ISL_1074967	2021-01-04	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.337	GR
hCoV-19/Switzerland/ZH-UZH-1000477377/2020	EPI_ISL_413020	2020-02-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT			B.1.1	GR
hCoV-19/Switzerland/ZH-UZH-1000477806/2020	EPI_ISL_413024	2020-02-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	SMALT, 15% ambiguity threshold			B.1.1	GR
hCoV-19/Belgium/UGent-6/2020	EPI_ISL_419265	2020-03-24	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/SHEF-C03F4/2020	EPI_ISL_420190	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.5	GR
hCoV-19/England/SHEF-C03B8/2020	EPI_ISL_420197	2020-03-28	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.5	GR
hCoV-19/Portugal/PT0065/2020	EPI_ISL_421468	2020-03-21	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0066/2020	EPI_ISL_421469	2020-03-21	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0068/2020	EPI_ISL_421471	2020-03-21	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0082/2020	EPI_ISL_421485	2020-03-22	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0085/2020	EPI_ISL_421488	2020-03-22	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0087/2020	EPI_ISL_421490	2020-03-22	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/USA/NY-WCMP10B11P/2020	EPI_ISL_427560	2020-03-15	North America / USA / New York / Manhattan	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	Metagenomic read filtering by kraken2, alignment by bwa-mem, variant and consensus calling by ivar. Also validated by SPAdes and IRMA assemblies.			B.1.1.231	GR
hCoV-19/Singapore/45/2020	EPI_ISL_428824	2020-03-16	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Russia/Moscow-25I/2020	EPI_ISL_428851	2020-04-02	Europe / Russia / Moscow	Human	Vero P1	Oropharyngeal swab		Illumina Hiseq				B.1.1	GR
hCoV-19/Scotland/CVR694/2020	EPI_ISL_433326	2020-03-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/CVR849/2020	EPI_ISL_433350	2020-03-25	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1.89	GR
hCoV-19/England/CAMB-7E313/2020	EPI_ISL_433470	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.208	GR
hCoV-19/England/CAMB-7FB74/2020	EPI_ISL_433483	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FB83/2020	EPI_ISL_433484	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FB92/2020	EPI_ISL_433485	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FC08/2020	EPI_ISL_433491	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FC44/2020	EPI_ISL_433495	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Thailand/NIH-1889/2020	EPI_ISL_434697	2020-03-03	Asia / Thailand / Nonthaburi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12, Geneious 10.2.4			B.1.1	GR
hCoV-19/England/CAMB-75D1E/2020	EPI_ISL_438355	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-75FCD/2020	EPI_ISL_438360	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76348/2020	EPI_ISL_438384	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76982/2020	EPI_ISL_438390	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-77B30/2020	EPI_ISL_439510	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76ECF/2020	EPI_ISL_439521	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72133/2020	EPI_ISL_439640	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-721D9/2020	EPI_ISL_439653	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-71B54/2020	EPI_ISL_439664	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-98FD3/2020	EPI_ISL_439681	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9901B/2020	EPI_ISL_439684	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BRIS-12267E/2020	EPI_ISL_440679	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D41C6/2020	EPI_ISL_444098	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D41F3/2020	EPI_ISL_444101	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D4287/2020	EPI_ISL_444108	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D45AC/2020	EPI_ISL_444137	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/England/LOND-D49EC/2020	EPI_ISL_444166	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD17A/2020	EPI_ISL_447972	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD2E0/2020	EPI_ISL_447989	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-E7315/2020	EPI_ISL_449023	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E738E/2020	EPI_ISL_449029	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7737/2020	EPI_ISL_449066	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Greece/HPI-6465/2020	EPI_ISL_451311	2020-03-29	Europe / Greece / Athens	Human	Original	Rhino-pharyngeal swab		Illumina NextSeq				B.1.1	GR
hCoV-19/Portugal/PT0185/2020	EPI_ISL_453901	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0210/2020	EPI_ISL_453924	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/USA/NY-NYUMC839/2020	EPI_ISL_456111	2020-04-24	North America / USA / New York / Brooklyn	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/England/NORW-EACBD/2020	EPI_ISL_457368	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB038/2020	EPI_ISL_457408	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.274	GR
hCoV-19/England/NORW-EB5EE/2020	EPI_ISL_457447	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EBA85/2020	EPI_ISL_457471	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.274	GR
hCoV-19/England/NORW-EBBA0/2020	EPI_ISL_457485	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-2894D4/2020	EPI_ISL_458662	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-288FC5/2020	EPI_ISL_458668	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2898BA/2020	EPI_ISL_458675	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28910A/2020	EPI_ISL_458686	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-128C58/2020	EPI_ISL_458746	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1287FD/2020	EPI_ISL_458755	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12913A/2020	EPI_ISL_458783	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Morocco/6895/2020	EPI_ISL_459973	2020-03-20	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6899/2020	EPI_ISL_459977	2020-04-21	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6900/2020	EPI_ISL_459978	2020-04-20	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/Morocco/6905/2020	EPI_ISL_459983	2020-04-21	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/England/SHEF-C0EF3/2020	EPI_ISL_462000	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C2459/2020	EPI_ISL_462005	2020-05-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/20142006104/2020	EPI_ISL_465906	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142015404/2020	EPI_ISL_465922	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142025204/2020	EPI_ISL_465936	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144009404/2020	EPI_ISL_465975	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.221	GR
hCoV-19/England/20144023004/2020	EPI_ISL_465993	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Romania/Bucuresti-4105/2020	EPI_ISL_468134	2020-03-21	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Bucuresti-6451/2020	EPI_ISL_468145	2020-03-28	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Bucuresti-12546/2020	EPI_ISL_468149	2020-04-12	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Mioveni-24095/2020	EPI_ISL_468156	2020-05-08	Europe / Romania / Mioveni	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/England/CAMB-1AB9DE/2020	EPI_ISL_470319	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-1ABD5A/2020	EPI_ISL_470320	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/CAMB-1AA81E/2020	EPI_ISL_470336	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80448/2020	EPI_ISL_470366	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80642/2020	EPI_ISL_470417	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-805EB/2020	EPI_ISL_470438	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-16029E/2020	EPI_ISL_472914	2020-05-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-16096C/2020	EPI_ISL_472998	2020-05-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/PORT-2D0EFE/2020	EPI_ISL_475303	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-184/2020	EPI_ISL_483631	2020-06-20	Asia / Bangladesh / Rajshahi / Pabna	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-218/2020	EPI_ISL_483705	2020-06-24	Asia / Bangladesh / Sylhet / Habiganj	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/England/NORT-282D85/2020	EPI_ISL_488617	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2839BD/2020	EPI_ISL_488643	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-1689A0/2020	EPI_ISL_494312	2020-04-20	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Portugal/PT1419/2020	EPI_ISL_511378	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Ukraine/203100337/2020	EPI_ISL_512616	2020-07-10	Europe / Ukraine	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Ukraine/203100355/2020	EPI_ISL_512634	2020-05-28	Europe / Ukraine	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Belgium/ULG-10256/2020	EPI_ISL_515063	2020-07-17	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10267/2020	EPI_ISL_515074	2020-07-07	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10268/2020	EPI_ISL_515075	2020-07-19	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10269/2020	EPI_ISL_515076	2020-07-20	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/PORT-2D373C/2020	EPI_ISL_517537	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C0D05/2020	EPI_ISL_517543	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C0D41/2020	EPI_ISL_517544	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C33B5/2020	EPI_ISL_517546	2020-07-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C527A/2020	EPI_ISL_517550	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C585A/2020	EPI_ISL_517552	2020-07-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C71F3/2020	EPI_ISL_517556	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-C9D57/2020	EPI_ISL_517560	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-C9D66/2020	EPI_ISL_517561	2020-08-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CF9E4/2020	EPI_ISL_517570	2020-08-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-CFBC0/2020	EPI_ISL_517572	2020-08-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D116F/2020	EPI_ISL_517575	2020-08-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D16F7/2020	EPI_ISL_517576	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Scotland/EDB7181/2020	EPI_ISL_517589	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Netherlands/NB-EMC-234/2020	EPI_ISL_523357	2020-05-09	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/LOND-126168E/2020	EPI_ISL_524648	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/OR-OHSU-1603/2020	EPI_ISL_525987	2020-07-21	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)	Gap of 6 nucleotides found at refpos 27786.	info	B.1.1.258	GR
hCoV-19/Australia/NSW2474/2020	EPI_ISL_527020	2020-07-01	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.254	GR
hCoV-19/Australia/NSW2495/2020	EPI_ISL_527024	2020-06-30	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.254	GR
hCoV-19/Switzerland/BS-UHB-42195425/2020	EPI_ISL_528176	2020-03-17	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/BS-UHB-42198593/2020	EPI_ISL_528222	2020-03-19	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/BS-UHB-42199036/2020	EPI_ISL_528235	2020-03-19	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/BS-UHB-42203282/2020	EPI_ISL_528348	2020-03-23	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/England/ALDP-97F1C4/2020	EPI_ISL_529530	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-97F20D/2020	EPI_ISL_529531	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-97F2B2/2020	EPI_ISL_529532	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/ALDP-9805C4/2020	EPI_ISL_529540	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-980B77/2020	EPI_ISL_529543	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-981FA7/2020	EPI_ISL_529549	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846AF/2020	EPI_ISL_529561	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846BE/2020	EPI_ISL_529562	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846CD/2020	EPI_ISL_529563	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846DC/2020	EPI_ISL_529564	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846EB/2020	EPI_ISL_529565	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-9846FA/2020	EPI_ISL_529566	2020-07-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-984D04/2020	EPI_ISL_529568	2020-08-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-985BDC/2020	EPI_ISL_529572	2020-08-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/ALDP-987651/2020	EPI_ISL_529578	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMB-1B5C41/2020	EPI_ISL_529660	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/NOTT-112FA3/2020	EPI_ISL_529667	2020-08-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-96E9A2/2020	EPI_ISL_530503	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96F3A3/2020	EPI_ISL_530521	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96DF47/2020	EPI_ISL_530590	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96D19C/2020	EPI_ISL_530629	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-96D4C0/2020	EPI_ISL_530673	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9631E1/2020	EPI_ISL_531801	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962BA8/2020	EPI_ISL_531805	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962C0F/2020	EPI_ISL_531815	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/Scotland/QEUH-962EDC/2020	EPI_ISL_531821	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963381/2020	EPI_ISL_531822	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962328/2020	EPI_ISL_531824	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963345/2020	EPI_ISL_531832	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962B20/2020	EPI_ISL_531842	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961F9E/2020	EPI_ISL_531856	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963530/2020	EPI_ISL_531862	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96355E/2020	EPI_ISL_531863	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FE0F/2020	EPI_ISL_531865	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9600F6/2020	EPI_ISL_531873	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960445/2020	EPI_ISL_531877	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/Scotland/QEUH-960014/2020	EPI_ISL_531880	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FFFD/2020	EPI_ISL_531881	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FCF6/2020	EPI_ISL_531889	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FF39/2020	EPI_ISL_531890	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FE78/2020	EPI_ISL_531892	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960032/2020	EPI_ISL_531905	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960023/2020	EPI_ISL_531912	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FCD8/2020	EPI_ISL_531913	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FDB7/2020	EPI_ISL_531918	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FF66/2020	EPI_ISL_531919	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FFEE/2020	EPI_ISL_531925	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FE1E/2020	EPI_ISL_531929	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960041/2020	EPI_ISL_531932	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961189/2020	EPI_ISL_531933	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9610B9/2020	EPI_ISL_531945	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9602D2/2020	EPI_ISL_531949	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9610AA/2020	EPI_ISL_531951	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9605CA/2020	EPI_ISL_531961	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/Scotland/QEUH-96131A/2020	EPI_ISL_531963	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9603FD/2020	EPI_ISL_531965	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.421	GR
hCoV-19/England/QEUH-9612A4/2020	EPI_ISL_531967	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-9606E5/2020	EPI_ISL_531982	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960560/2020	EPI_ISL_531990	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960C2F/2020	EPI_ISL_531995	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/LEED-2A908F/2020	EPI_ISL_539024	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-998B12/2020	EPI_ISL_540037	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-990190/2020	EPI_ISL_540039	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/FL-BPHL-1203/2020	EPI_ISL_541176	2020-07-22	North America / USA / Florida	Human	Original			Illumina	Bwa v. 0.7.17; ivar v. 1.2.2			B.1.1.231	GR
hCoV-19/USA/TX-HMH-2834/2020	EPI_ISL_543807	2020-06-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2847/2020	EPI_ISL_543818	2020-06-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2848/2020	EPI_ISL_543819	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-2862/2020	EPI_ISL_543832	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-2944/2020	EPI_ISL_543880	2020-06-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2963/2020	EPI_ISL_543897	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2964/2020	EPI_ISL_543898	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-2987/2020	EPI_ISL_543914	2020-05-31	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3021/2020	EPI_ISL_543939	2020-05-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-3076/2020	EPI_ISL_543979	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-3108/2020	EPI_ISL_543997	2020-05-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-6452/2020	EPI_ISL_546005	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-6456/2020	EPI_ISL_546009	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6499/2020	EPI_ISL_546039	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6500/2020	EPI_ISL_546040	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-6511/2020	EPI_ISL_546048	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6513/2020	EPI_ISL_546049	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-6558/2020	EPI_ISL_546083	2020-06-23	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6573/2020	EPI_ISL_546096	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-6686/2020	EPI_ISL_546173	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-6720/2020	EPI_ISL_546192	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-6724/2020	EPI_ISL_546194	2020-06-24	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6294/2020	EPI_ISL_547369	2020-07-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.402	GR
hCoV-19/USA/TX-HMH-6322/2020	EPI_ISL_547390	2020-06-27	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/CA-CZB-4047/2020	EPI_ISL_548659	2020-08-18	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/MILK-99CD27/2020	EPI_ISL_549910	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CDCD/2020	EPI_ISL_549915	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D342/2020	EPI_ISL_549942	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A53DE/2020	EPI_ISL_549956	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A51D4/2020	EPI_ISL_549963	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6953/2020	EPI_ISL_549967	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6926/2020	EPI_ISL_549973	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A6A05/2020	EPI_ISL_549974	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AADCC/2020	EPI_ISL_550901	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9914/2020	EPI_ISL_550926	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA3F7/2020	EPI_ISL_550928	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA272/2020	EPI_ISL_550937	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AA6B2/2020	EPI_ISL_550945	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAA98/2020	EPI_ISL_550959	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA45E/2020	EPI_ISL_550964	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AAD62/2020	EPI_ISL_550987	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-970406/2020	EPI_ISL_553119	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9712ED/2020	EPI_ISL_553125	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-97020C/2020	EPI_ISL_553127	2020-08-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-971010/2020	EPI_ISL_553131	2020-08-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9704AC/2020	EPI_ISL_553132	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-97055E/2020	EPI_ISL_553139	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-970EEA/2020	EPI_ISL_553164	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-970B89/2020	EPI_ISL_553166	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-971001/2020	EPI_ISL_553195	2020-08-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-970B6B/2020	EPI_ISL_553219	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9712DE/2020	EPI_ISL_553223	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-907264/2020	EPI_ISL_553301	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-922CFC/2020	EPI_ISL_553307	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-922500/2020	EPI_ISL_553343	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95D26F/2020	EPI_ISL_553346	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-9511B9/2020	EPI_ISL_554451	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-953FDB/2020	EPI_ISL_554454	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-95124D/2020	EPI_ISL_554467	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-95086A/2020	EPI_ISL_554469	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-953788/2020	EPI_ISL_554474	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9534DC/2020	EPI_ISL_554503	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9507E5/2020	EPI_ISL_554504	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-954277/2020	EPI_ISL_554508	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C31/2020	EPI_ISL_554514	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C40/2020	EPI_ISL_554521	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950BBC/2020	EPI_ISL_554527	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.89	GR
hCoV-19/England/ALDP-953ABC/2020	EPI_ISL_554531	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955443/2020	EPI_ISL_554533	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9533FD/2020	EPI_ISL_554534	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-950C22/2020	EPI_ISL_554535	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-955786/2020	EPI_ISL_554542	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-9533EE/2020	EPI_ISL_554544	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-943FA1/2020	EPI_ISL_554626	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-958194/2020	EPI_ISL_554629	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/Wales/MILK-958862/2020	EPI_ISL_554633	2020-06-13	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9588AE/2020	EPI_ISL_554639	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957E16/2020	EPI_ISL_554673	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94F7BC/2020	EPI_ISL_555779	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94B871/2020	EPI_ISL_555780	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94BBB4/2020	EPI_ISL_555784	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94B96F/2020	EPI_ISL_555788	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94A63C/2020	EPI_ISL_555795	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94F7DA/2020	EPI_ISL_555808	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94BB4B/2020	EPI_ISL_555821	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94C843/2020	EPI_ISL_555832	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C8DA/2020	EPI_ISL_555839	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-94F233/2020	EPI_ISL_555842	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CC0B/2020	EPI_ISL_555858	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C685/2020	EPI_ISL_555867	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94C5C4/2020	EPI_ISL_555874	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C421/2020	EPI_ISL_555885	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.123	GR
hCoV-19/England/ALDP-94F093/2020	EPI_ISL_555892	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C834/2020	EPI_ISL_555897	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94C8BC/2020	EPI_ISL_555925	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C9E6/2020	EPI_ISL_555942	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CDF9/2020	EPI_ISL_555954	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94CFC6/2020	EPI_ISL_555974	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-94C825/2020	EPI_ISL_555996	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6461AB/2020	EPI_ISL_558012	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66C840/2020	EPI_ISL_558036	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-670050/2020	EPI_ISL_558040	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-6511BC/2020	EPI_ISL_558044	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-649D77/2020	EPI_ISL_558046	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-673BD4/2020	EPI_ISL_558053	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-68FE81/2020	EPI_ISL_558054	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-645F75/2020	EPI_ISL_558063	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-673C86/2020	EPI_ISL_558066	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-673B7A/2020	EPI_ISL_558075	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-691CFB/2020	EPI_ISL_558092	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-643F1D/2020	EPI_ISL_558148	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-4A19A8/2020	EPI_ISL_559300	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-4AF166/2020	EPI_ISL_559333	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4A723E/2020	EPI_ISL_559463	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Russia/SVE-RII-MH197S/2020	EPI_ISL_560311	2020-07-16	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH198S/2020	EPI_ISL_560312	2020-07-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH199S/2020	EPI_ISL_560313	2020-07-16	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH200S/2020	EPI_ISL_560314	2020-07-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Lithuania/C20-05-R15/2020	EPI_ISL_560394	2020-05-22	Europe / Lithuania / Vilnius	Human	Original	Oropharyngeal swab		Illumina MiSeq	Meraculous-2D v2.2.6, BLAST+ 2.10.0	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-280150/2020	EPI_ISL_560459	2020-09-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GE-ETHZ-280201/2020	EPI_ISL_560475	2020-09-10	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-280154/2020	EPI_ISL_560479	2020-09-08	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NS7a_L77stop results in 37.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9C239F/2020	EPI_ISL_566454	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C28DC/2020	EPI_ISL_566485	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1ADA/2020	EPI_ISL_566493	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2CB2/2020	EPI_ISL_566515	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B25C9/2020	EPI_ISL_566524	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1AE9/2020	EPI_ISL_566544	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2380/2020	EPI_ISL_566609	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1C3E/2020	EPI_ISL_566611	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B2839/2020	EPI_ISL_566625	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9C255D/2020	EPI_ISL_566626	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9C2335/2020	EPI_ISL_566645	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C1FF6/2020	EPI_ISL_566656	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C5CEC/2020	EPI_ISL_567757	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4EF6/2020	EPI_ISL_567760	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C6182/2020	EPI_ISL_567766	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C550F/2020	EPI_ISL_567777	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C61CE/2020	EPI_ISL_567784	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C6207/2020	EPI_ISL_567785	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C55A5/2020	EPI_ISL_567786	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5C91/2020	EPI_ISL_567788	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4D53/2020	EPI_ISL_567790	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/ALDP-9C4D71/2020	EPI_ISL_567806	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C501D/2020	EPI_ISL_567814	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C61BF/2020	EPI_ISL_567815	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5F7A/2020	EPI_ISL_567818	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5D16/2020	EPI_ISL_567819	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9C4E9C/2020	EPI_ISL_567827	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5587/2020	EPI_ISL_567846	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BDE4B/2020	EPI_ISL_567904	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BEAA0/2020	EPI_ISL_567905	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BEACE/2020	EPI_ISL_567908	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BDFFD/2020	EPI_ISL_567946	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9BDC14/2020	EPI_ISL_567977	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BEB25/2020	EPI_ISL_567988	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9BED3E/2020	EPI_ISL_567990	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-QDX-425/2020	EPI_ISL_571157	2020-03-16	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/England/QEUH-9BA770/2020	EPI_ISL_573601	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA79E/2020	EPI_ISL_573602	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA7AD/2020	EPI_ISL_573603	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA8B9/2020	EPI_ISL_573609	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BAB29/2020	EPI_ISL_573622	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BAC08/2020	EPI_ISL_573630	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BAC53/2020	EPI_ISL_573631	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/England/QEUH-9BB092/2020	EPI_ISL_573648	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BB0CF/2020	EPI_ISL_573650	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9D16B2/2020	EPI_ISL_573653	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1746/2020	EPI_ISL_573657	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1791/2020	EPI_ISL_573658	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D17EC/2020	EPI_ISL_573660	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1843/2020	EPI_ISL_573662	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1861/2020	EPI_ISL_573664	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D188F/2020	EPI_ISL_573666	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D18DA/2020	EPI_ISL_573668	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1904/2020	EPI_ISL_573670	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D19B9/2020	EPI_ISL_573672	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D19E6/2020	EPI_ISL_573674	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D19F5/2020	EPI_ISL_573675	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1A10/2020	EPI_ISL_573677	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9D1B77/2020	EPI_ISL_573682	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1C83/2020	EPI_ISL_573684	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.44	GR
hCoV-19/England/SHEF-C12F6/2020	EPI_ISL_573688	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Switzerland/BE-ETHZ-100378/2020	EPI_ISL_574929	2020-03-20	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-100156/2020	EPI_ISL_574944	2020-03-17	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/SZ-ETHZ-100303/2020	EPI_ISL_574952	2020-03-19	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/NOTT-113FA2/2020	EPI_ISL_577126	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D3128/2020	EPI_ISL_577310	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9E5633/2020	EPI_ISL_579770	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4977/2020	EPI_ISL_579788	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E426D/2020	EPI_ISL_579811	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E3EE2/2020	EPI_ISL_579834	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E47B9/2020	EPI_ISL_579847	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E493B/2020	EPI_ISL_579912	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4DB7/2020	EPI_ISL_579913	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9EA892/2020	EPI_ISL_579954	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA3A0/2020	EPI_ISL_579961	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/ALDP-9EA197/2020	EPI_ISL_579965	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E9C88/2020	EPI_ISL_579976	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EE63A/2020	EPI_ISL_580757	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EE55B/2020	EPI_ISL_580801	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9EE834/2020	EPI_ISL_580802	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EE8E9/2020	EPI_ISL_580820	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EE588/2020	EPI_ISL_580832	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EDB5A/2020	EPI_ISL_580835	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-9DC6A8/2020	EPI_ISL_580911	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC6D5/2020	EPI_ISL_580934	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DADD2/2020	EPI_ISL_580943	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DABBA/2020	EPI_ISL_580949	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DACF3/2020	EPI_ISL_580953	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC75A/2020	EPI_ISL_580957	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/CAMB-1B67D6/2020	EPI_ISL_584307	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMC-9D6E3D/2020	EPI_ISL_584326	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D70AF/2020	EPI_ISL_584344	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D7212/2020	EPI_ISL_584353	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9D731F/2020	EPI_ISL_584362	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9D73F1/2020	EPI_ISL_584368	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D7458/2020	EPI_ISL_584371	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CAMC-9D7467/2020	EPI_ISL_584372	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9EBCE0/2020	EPI_ISL_584413	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/CWAR-24FDB92/2020	EPI_ISL_584489	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.89	GR
hCoV-19/Wales/CAMC-9D70EB/2020	EPI_ISL_585625	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-16DE9D/2020	EPI_ISL_585634	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-16DF8B/2020	EPI_ISL_585646	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16E0D2/2020	EPI_ISL_585667	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A2D3FB/2020	EPI_ISL_586914	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F2DE/2020	EPI_ISL_586946	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A2F317/2020	EPI_ISL_586951	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2ED38/2020	EPI_ISL_586959	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2FC0D/2020	EPI_ISL_586991	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E6D3/2020	EPI_ISL_586994	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7E63/2020	EPI_ISL_589112	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1FC0/2020	EPI_ISL_589115	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9F9809/2020	EPI_ISL_589120	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F74DA/2020	EPI_ISL_589128	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7434/2020	EPI_ISL_589139	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F95E4/2020	EPI_ISL_589142	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F74E9/2020	EPI_ISL_589150	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F78A1/2020	EPI_ISL_589155	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F963C/2020	EPI_ISL_589156	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7522/2020	EPI_ISL_589180	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7A50/2020	EPI_ISL_589181	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7C3C/2020	EPI_ISL_589186	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F7E36/2020	EPI_ISL_589189	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF7C3/2020	EPI_ISL_590102	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF839/2020	EPI_ISL_590107	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE490/2020	EPI_ISL_590114	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE9FB/2020	EPI_ISL_590124	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CEE74/2020	EPI_ISL_590134	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF9BE/2020	EPI_ISL_590135	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9CE4CD/2020	EPI_ISL_590138	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE849/2020	EPI_ISL_590144	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE83A/2020	EPI_ISL_590146	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE8A3/2020	EPI_ISL_590153	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE876/2020	EPI_ISL_590155	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF031/2020	EPI_ISL_590168	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B54AB/2020	EPI_ISL_590184	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-9B5890/2020	EPI_ISL_590194	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B46F1/2020	EPI_ISL_590196	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Japan/IC-0116/2020	EPI_ISL_591457	2020-07-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from Philippines.	Illumina NextSeq2000	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/England/MILK-A17F87/2020	EPI_ISL_595003	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A1D6E6/2020	EPI_ISL_595077	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A1D710/2020	EPI_ISL_595079	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Russia/SVE-RII-MH1627S/2020	EPI_ISL_596300	2020-09-08	Europe / Russia / Sverdlovsk / Verkhny Tagil	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.274	GR
hCoV-19/Russia/KL-RII-MH1686S/2020	EPI_ISL_596317	2020-09-03	Europe / Russia / Kalmykia / Elista	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.184	GR
hCoV-19/Russia/MOW-RII-MH1979S/2020	EPI_ISL_596325	2020-05-28	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1992S/2020	EPI_ISL_596336	2020-06-05	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH1995S/2020	EPI_ISL_596339	2020-06-06	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/MOW-RII-MH1998S/2020	EPI_ISL_596342	2020-06-10	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/MOW-RII-MH2001S/2020	EPI_ISL_596344	2020-06-15	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH2003S/2020	EPI_ISL_596345	2020-06-19	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/MOW-RII-MH2010S/2020	EPI_ISL_596351	2020-06-05	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH958S/2020	EPI_ISL_596365	2020-09-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH960S/2020	EPI_ISL_596366	2020-09-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.294	GR
hCoV-19/Russia/SPE-RII-MH995S/2020	EPI_ISL_596375	2020-09-05	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.449	GR
hCoV-19/USA/WA-S2864/2020	EPI_ISL_596395	2020-09-19	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1.337	GR
hCoV-19/England/ALDP-A50D3D/2020	EPI_ISL_597649	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FBCE/2020	EPI_ISL_597653	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FAC1/2020	EPI_ISL_597685	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A500F8/2020	EPI_ISL_597747	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A504CF/2020	EPI_ISL_597781	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A1E09C/2020	EPI_ISL_598901	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/MILK-A06880/2020	EPI_ISL_600009	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A05A03/2020	EPI_ISL_600015	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A05D28/2020	EPI_ISL_600030	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A0565A/2020	EPI_ISL_600036	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A0670B/2020	EPI_ISL_600055	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A064D7/2020	EPI_ISL_600071	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A06194/2020	EPI_ISL_600105	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A060C4/2020	EPI_ISL_600114	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E096C/2020	EPI_ISL_601320	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E02CB/2020	EPI_ISL_601330	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E03D7/2020	EPI_ISL_601343	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0647/2020	EPI_ISL_601360	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC295/2020	EPI_ISL_601393	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-9DC013/2020	EPI_ISL_601403	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-9E07EA/2020	EPI_ISL_601417	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DA72F/2020	EPI_ISL_601446	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/South Africa/KRISP-K002816/2020	EPI_ISL_602637	2020-08-21	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002829/2020	EPI_ISL_602649	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002840/2020	EPI_ISL_602656	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002848/2020	EPI_ISL_602664	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002867/2020	EPI_ISL_602681	2020-08-29	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002903/2020	EPI_ISL_602714	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003322/2020	EPI_ISL_602715	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003330/2020	EPI_ISL_602723	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003335/2020	EPI_ISL_602727	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003360/2020	EPI_ISL_602751	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003391/2020	EPI_ISL_602779	2020-09-09	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/England/ALDP-A864C0/2020	EPI_ISL_606118	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A8792A/2020	EPI_ISL_606148	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87B7F/2020	EPI_ISL_606152	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87C03/2020	EPI_ISL_606163	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A86509/2020	EPI_ISL_606167	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A872B6/2020	EPI_ISL_606231	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86633/2020	EPI_ISL_606234	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A879C0/2020	EPI_ISL_606254	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A8624E/2020	EPI_ISL_606263	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D65D/2020	EPI_ISL_606296	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-A7B561/2020	EPI_ISL_607466	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BDF0/2020	EPI_ISL_607479	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B3D0/2020	EPI_ISL_607480	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BA26/2020	EPI_ISL_607481	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CC89/2020	EPI_ISL_607490	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C7E2/2020	EPI_ISL_607497	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C6C7/2020	EPI_ISL_607504	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.274	GR
hCoV-19/England/MILK-A7C6D6/2020	EPI_ISL_607529	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B525/2020	EPI_ISL_607551	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B570/2020	EPI_ISL_607555	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A6BAFC/2020	EPI_ISL_608771	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A69D31/2020	EPI_ISL_608772	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-A692AB/2020	EPI_ISL_608866	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6919F/2020	EPI_ISL_608880	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A769D3/2020	EPI_ISL_613341	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/Scotland/QEUH-A76A0D/2020	EPI_ISL_613344	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/QEUH-A78036/2020	EPI_ISL_613353	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C1AD0/2020	EPI_ISL_613359	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C5605/2020	EPI_ISL_613367	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6CA8/2020	EPI_ISL_613371	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-D094A/2020	EPI_ISL_613398	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/SHEF-D3419/2020	EPI_ISL_613408	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/Denmark/DCGC-5230/2020	EPI_ISL_615901	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5231/2020	EPI_ISL_615902	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5232/2020	EPI_ISL_615903	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5233/2020	EPI_ISL_615904	2020-09-14	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3110/2020	EPI_ISL_615927	2020-08-31	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-3153/2020	EPI_ISL_615973	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3154/2020	EPI_ISL_615974	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/Denmark/DCGC-3175/2020	EPI_ISL_615997	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2033/2020	EPI_ISL_618233	2020-07-27	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2024/2020	EPI_ISL_618239	2020-07-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2028/2020	EPI_ISL_618252	2020-07-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-2032/2020	EPI_ISL_618253	2020-07-27	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-6516/2020	EPI_ISL_619416	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-6552/2020	EPI_ISL_619452	2020-10-05	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6650/2020	EPI_ISL_619552	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-6652/2020	EPI_ISL_619554	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/Denmark/DCGC-5184/2020	EPI_ISL_621722	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5187/2020	EPI_ISL_621725	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5189/2020	EPI_ISL_621727	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5190/2020	EPI_ISL_621728	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.346	GR
hCoV-19/Denmark/DCGC-5192/2020	EPI_ISL_621730	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-5195/2020	EPI_ISL_621733	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5200/2020	EPI_ISL_621738	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5206/2020	EPI_ISL_621744	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5211/2020	EPI_ISL_621749	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5223/2020	EPI_ISL_621761	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-5026/2020	EPI_ISL_621803	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.288	GR
hCoV-19/Denmark/DCGC-4408/2020	EPI_ISL_621829	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4411/2020	EPI_ISL_621832	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4422/2020	EPI_ISL_621843	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4436/2020	EPI_ISL_621857	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4437/2020	EPI_ISL_621858	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4439/2020	EPI_ISL_621860	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4440/2020	EPI_ISL_621861	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4441/2020	EPI_ISL_621862	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4442/2020	EPI_ISL_621863	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4444/2020	EPI_ISL_621865	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.191	GR
hCoV-19/Denmark/DCGC-4648/2020	EPI_ISL_621880	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.224	GR
hCoV-19/England/ALDP-AA2F18/2020	EPI_ISL_624036	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAD36C/2020	EPI_ISL_624077	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1201/2020	EPI_ISL_624089	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A9EA3C/2020	EPI_ISL_625321	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/Scotland/QEUH-A9EBC0/2020	EPI_ISL_625325	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Wales/QEUH-AA0509/2020	EPI_ISL_625382	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A87D3D/2020	EPI_ISL_625396	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A8640C/2020	EPI_ISL_625398	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A862D5/2020	EPI_ISL_625399	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Czech Republic/NRL_9885/2020	EPI_ISL_626615	2020-10-11	Europe / Czech Republic / Central Bohemian Region / Bášť	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1.294	GR
hCoV-19/Wales/PHWC-483E8F/2020	EPI_ISL_627940	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.37	GR
hCoV-19/Wales/PHWC-4841EF/2020	EPI_ISL_627976	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-ABD23F/2020	EPI_ISL_631116	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABB8B7/2020	EPI_ISL_631145	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-ABB86C/2020	EPI_ISL_631161	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABC212/2020	EPI_ISL_631176	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-ABB8A8/2020	EPI_ISL_631182	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AC5D06/2020	EPI_ISL_631189	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AC11D1/2020	EPI_ISL_631190	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABC151/2020	EPI_ISL_631196	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/MILK-ABC4EF/2020	EPI_ISL_631207	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/ALDP-ABD299/2020	EPI_ISL_631228	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAF92C/2020	EPI_ISL_631245	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/MILK-ABBCAC/2020	EPI_ISL_631252	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABC124/2020	EPI_ISL_631264	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/ALDP-AC12A1/2020	EPI_ISL_631269	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAF564/2020	EPI_ISL_631272	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-AD1244/2020	EPI_ISL_633704	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0AD4/2020	EPI_ISL_633713	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0A98/2020	EPI_ISL_633738	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD15C3/2020	EPI_ISL_633772	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3989/2020	EPI_ISL_633808	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3127/2020	EPI_ISL_633812	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0852/2020	EPI_ISL_633836	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD15E1/2020	EPI_ISL_633841	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/QEUH-AD1314/2020	EPI_ISL_633855	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1183/2020	EPI_ISL_633869	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-AD396B/2020	EPI_ISL_633890	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9AE0A1/2020	EPI_ISL_638622	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE0B0/2020	EPI_ISL_638623	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE0CF/2020	EPI_ISL_638624	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE1DB/2020	EPI_ISL_638629	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE27E/2020	EPI_ISL_638631	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F4DC3/2020	EPI_ISL_638643	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F5032/2020	EPI_ISL_638649	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F513F/2020	EPI_ISL_638657	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F515D/2020	EPI_ISL_638658	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F520F/2020	EPI_ISL_638659	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-9F532A/2020	EPI_ISL_638664	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F5357/2020	EPI_ISL_638665	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A36C03/2020	EPI_ISL_638704	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A36D4C/2020	EPI_ISL_638712	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Russia/OMS-ORINFI-1564S/2020	EPI_ISL_639913	2020-06-30	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/OMS-ORINFI-1612S/2020	EPI_ISL_639914	2020-07-06	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-1068S/2020	EPI_ISL_639915	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-2114S/2020	EPI_ISL_639918	2020-07-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-3801S/2020	EPI_ISL_639924	2020-06-01	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3818S/2020	EPI_ISL_639926	2020-06-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5774S/2020	EPI_ISL_639932	2020-06-07	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-858S/2020	EPI_ISL_639941	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/MOS-RII-MH2804S/2020	EPI_ISL_639953	2020-09-27	Europe / Russia / Moscow / Sergiyev Posad	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/MOS-RII-MH2808S/2020	EPI_ISL_639957	2020-09-27	Europe / Russia / Moscow / Sergiyev Posad	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.294	GR
hCoV-19/Russia/RYA-RII-MH2823S/2020	EPI_ISL_639967	2020-09-24	Europe / Russia / Ryazan / Ryazan	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.349	GR
hCoV-19/Russia/SVE-RII-MH2824S/2020	EPI_ISL_639969	2020-09-18	Europe / Russia / Sverdlovsk / Asbest	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/England/QEUH-A8C48E/2020	EPI_ISL_643101	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5E5/2020	EPI_ISL_643104	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8CA13/2020	EPI_ISL_643107	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C62E/2020	EPI_ISL_643115	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8BD0C/2020	EPI_ISL_643126	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/England/QEUH-A8BF60/2020	EPI_ISL_643127	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8B382/2020	EPI_ISL_643134	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-A8C697/2020	EPI_ISL_643139	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C293/2020	EPI_ISL_643144	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C819/2020	EPI_ISL_643147	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-A8C4D9/2020	EPI_ISL_643150	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B285/2020	EPI_ISL_643152	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C451/2020	EPI_ISL_643183	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C372/2020	EPI_ISL_643189	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8BB20/2020	EPI_ISL_643192	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C406/2020	EPI_ISL_643195	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B3BF/2020	EPI_ISL_643196	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5F4/2020	EPI_ISL_643210	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C4E8/2020	EPI_ISL_643223	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C503/2020	EPI_ISL_643229	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C600/2020	EPI_ISL_643244	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C688/2020	EPI_ISL_643265	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5C7/2020	EPI_ISL_643272	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C64C/2020	EPI_ISL_643281	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C318/2020	EPI_ISL_643283	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C309/2020	EPI_ISL_643293	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/France/PAC-MEPHI-2413/2020	EPI_ISL_644561	2020-10-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/England/ALDP-B1B4CF/2020	EPI_ISL_645808	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				M.3	GR
hCoV-19/England/ALDP-B1B4A1/2020	EPI_ISL_645816	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2228F/2020	EPI_ISL_645866	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47FD8/2020	EPI_ISL_649378	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/BIRM-675EA/2020	EPI_ISL_651619	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/BIRM-6AA33/2020	EPI_ISL_651639	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B8A08/2020	EPI_ISL_651674	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/QEUH-AACD9C/2020	EPI_ISL_652915	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADB28/2020	EPI_ISL_652947	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADDC8/2020	EPI_ISL_652949	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADED4/2020	EPI_ISL_652959	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEA2A/2020	EPI_ISL_652978	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEA75/2020	EPI_ISL_652980	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-AAEAFD/2020	EPI_ISL_652983	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-AAEB36/2020	EPI_ISL_652986	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEC60/2020	EPI_ISL_652993	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEC7F/2020	EPI_ISL_652994	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAECAC/2020	EPI_ISL_652997	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-B6BE2C/2020	EPI_ISL_655120	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6AC50/2020	EPI_ISL_655160	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69F94/2020	EPI_ISL_655162	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69C24/2020	EPI_ISL_655182	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B69B90/2020	EPI_ISL_655188	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B6BE59/2020	EPI_ISL_655189	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C957/2020	EPI_ISL_655201	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66AA5/2020	EPI_ISL_655203	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C0AD/2020	EPI_ISL_655221	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C975/2020	EPI_ISL_655235	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66A5A/2020	EPI_ISL_655242	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66A1E/2020	EPI_ISL_655266	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5BBEC/2020	EPI_ISL_655282	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B629F7/2020	EPI_ISL_656406	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63B0F/2020	EPI_ISL_656530	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63B2D/2020	EPI_ISL_656550	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5505C/2020	EPI_ISL_657712	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B55380/2020	EPI_ISL_657770	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B551E0/2020	EPI_ISL_657785	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/CAMC-B514CD/2020	EPI_ISL_657787	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B51F53/2020	EPI_ISL_657860	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B7452B/2020	EPI_ISL_662272	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-B691DA/2020	EPI_ISL_662283	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A564/2020	EPI_ISL_662350	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B735B3/2020	EPI_ISL_662391	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B73717/2020	EPI_ISL_662393	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1BA189/2020	EPI_ISL_664973	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1BA4EA/2020	EPI_ISL_664987	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/OR-OHSU-2257/2020	EPI_ISL_667162	2020-08-08	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-2297/2020	EPI_ISL_667173	2020-08-10	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-2331/2020	EPI_ISL_667185	2020-08-11	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/OR-OHSU-2471/2020	EPI_ISL_667219	2020-08-15	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/Norway/4764/2020	EPI_ISL_668400	2020-10-22	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Denmark/DCGC-10267/2020	EPI_ISL_669735	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.294	GR
hCoV-19/Denmark/DCGC-10232/2020	EPI_ISL_669847	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10241/2020	EPI_ISL_669853	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-10279/2020	EPI_ISL_669873	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-11320/2020	EPI_ISL_670837	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/CAMC-B09479/2020	EPI_ISL_673016	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0A609/2020	EPI_ISL_673082	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B099A7/2020	EPI_ISL_673093	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B839D2/2020	EPI_ISL_674311	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8C2DE/2020	EPI_ISL_674358	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-B84F2A/2020	EPI_ISL_674396	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B85A73/2020	EPI_ISL_675636	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B83B45/2020	EPI_ISL_675650	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1B983A/2020	EPI_ISL_679143	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1BBA9C/2020	EPI_ISL_679186	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1BBB3F/2020	EPI_ISL_679196	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1BBC69/2020	EPI_ISL_679214	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-BA9B1C/2020	EPI_ISL_681400	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA401/2020	EPI_ISL_681417	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAB479/2020	EPI_ISL_681471	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BABC62/2020	EPI_ISL_681488	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAB260/2020	EPI_ISL_681496	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/MILK-BAC645/2020	EPI_ISL_681501	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA5C2/2020	EPI_ISL_681527	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-12542/2020	EPI_ISL_682723	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-12576/2020	EPI_ISL_682757	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-12588/2020	EPI_ISL_682769	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-12632/2020	EPI_ISL_682813	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-12639/2020	EPI_ISL_682820	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-12657/2020	EPI_ISL_682838	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.294	GR
hCoV-19/Denmark/DCGC-12695/2020	EPI_ISL_682876	2020-11-16	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/204740534/2020	EPI_ISL_693406	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/204661353/2020	EPI_ISL_693410	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.37	GR
hCoV-19/Portugal/PT1580/2020	EPI_ISL_693533	2020-07-01	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	NS8_L22stop results in 82.6% truncation of the protein sequence.	info	B.1.1.421	GR
hCoV-19/United Arab Emirates/0028/2020	EPI_ISL_698237	2020-05-17	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/United Arab Emirates/0116/2020	EPI_ISL_698306	2020-05-15	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-G400	nCoV_Finder			B.1.1.366	O
hCoV-19/United Arab Emirates/0190/2020	EPI_ISL_698376	2020-05-18	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.1.366	GR
hCoV-19/England/ALDP-BB33DB/2020	EPI_ISL_703191	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-BBAC9D/2020	EPI_ISL_703204	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BCA4A1/2020	EPI_ISL_703257	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCB77A/2020	EPI_ISL_704402	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BCBB6F/2020	EPI_ISL_704448	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCE522/2020	EPI_ISL_704480	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCBDF0/2020	EPI_ISL_704495	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCC515/2020	EPI_ISL_704501	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/QEUH-BCBA80/2020	EPI_ISL_704531	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BCCE56/2020	EPI_ISL_704533	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/LIVE-DC199A/2020	EPI_ISL_705812	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC1BEF/2020	EPI_ISL_705818	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/LIVE-DC1C64/2020	EPI_ISL_705820	2020-11-20	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC298A/2020	EPI_ISL_705830	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC2E4F/2020	EPI_ISL_705849	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.315	GR
hCoV-19/England/LIVE-DC2EC7/2020	EPI_ISL_705852	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC2F4C/2020	EPI_ISL_705854	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC2F5B/2020	EPI_ISL_705855	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-DC3057/2020	EPI_ISL_705858	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Norway/5092/2020	EPI_ISL_708037	2020-10-29	Europe / Norway / Innlandet	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			AD.2	GR
hCoV-19/Norway/5182/2020	EPI_ISL_708046	2020-10-26	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Norway/5393/2020	EPI_ISL_708074	2020-10-27	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/5399/2020	EPI_ISL_708078	2020-11-02	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/England/CAMC-BFB8E7/2020	EPI_ISL_709275	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C163D5/2020	EPI_ISL_709301	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.294	GR
hCoV-19/England/QEUH-C14577/2020	EPI_ISL_709332	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CO-CDPHE-2010280225/2020	EPI_ISL_710240	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280186/2020	EPI_ISL_710360	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280189/2020	EPI_ISL_710361	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280196/2020	EPI_ISL_710362	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280209/2020	EPI_ISL_710363	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280211/2020	EPI_ISL_710364	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280212/2020	EPI_ISL_710365	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280214/2020	EPI_ISL_710366	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280216/2020	EPI_ISL_710367	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/CO-CDPHE-2010280224/2020	EPI_ISL_710368	2020-10-26	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1.337	GR
hCoV-19/USA/TX-DSHS-1746/2020	EPI_ISL_710398	2020-06-13	North America / USA / Texas / Harris County	Human	Original	Nasopharyngeal swab		Illumina Miseq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/Denmark/DCGC-14107/2020	EPI_ISL_711573	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13612/2020	EPI_ISL_712911	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13634/2020	EPI_ISL_712928	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13669/2020	EPI_ISL_712947	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-13712/2020	EPI_ISL_712975	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-BA32D1/2020	EPI_ISL_721005	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F9C4/2020	EPI_ISL_721018	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F548/2020	EPI_ISL_721036	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F742/2020	EPI_ISL_721039	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B9F320/2020	EPI_ISL_721048	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA359C/2020	EPI_ISL_721099	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5E132/2020	EPI_ISL_723635	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B5E17E/2020	EPI_ISL_723636	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B758A9/2020	EPI_ISL_723677	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-B758E5/2020	EPI_ISL_723679	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORT-1B723C6/2020	EPI_ISL_724874	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.37	GR
hCoV-19/England/NORT-1B72566/2020	EPI_ISL_724887	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/Wales/PHWC-4985FB/2020	EPI_ISL_727100	2020-12-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-C30E10/2020	EPI_ISL_730765	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C319C3/2020	EPI_ISL_730803	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-C3226D/2020	EPI_ISL_730809	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-C3D8CA/2020	EPI_ISL_730819	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-C3D8E8/2020	EPI_ISL_730845	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Russia/SVE-RII-MH239S/2020	EPI_ISL_733002	2020-08-08	Europe / Russia / Sverdlovsk / Yekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/PRI-RII-MH760S/2020	EPI_ISL_733009	2020-08-10	Europe / Russia / Primorsky / Vladivostok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/PRI-RII-MH762S/2020	EPI_ISL_733010	2020-08-11	Europe / Russia / Primorsky / Vladivostok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/PRI-RII-MH768S/2020	EPI_ISL_733013	2020-08-11	Europe / Russia / Primorsky / Vladivostok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/PRI-RII-MH829S/2020	EPI_ISL_733018	2020-08-07	Europe / Russia / Primorsky / Ussuriysk	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.163	GR
hCoV-19/Russia/PRI-RII-MH892S/2020	EPI_ISL_733019	2020-08-02	Europe / Russia / Primorsky / Vladivostok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.294	GR
hCoV-19/Russia/PRI-RII-MH931S/2020	EPI_ISL_733022	2020-08-12	Europe / Russia / Primorsky / Vladivostok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.349	GR
hCoV-19/Russia/TAM-RII-MH2857S/2020	EPI_ISL_733039	2020-09-20	Europe / Russia / Tambov / Tambov	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.453	GR
hCoV-19/Russia/MOW-RII-MH2900S/2020	EPI_ISL_733061	2020-09-19	Europe / Russia / Moscow / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1.163	GR
hCoV-19/Russia/MOW-RII-MH2925S/2020	EPI_ISL_733073	2020-09-23	Europe / Russia / Moscow / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH2929S/2020	EPI_ISL_733074	2020-09-27	Europe / Russia / Moscow / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa, samtools, ivar, lofreq			B.1.1	GR
hCoV-19/South Africa/KRISP-MDSH920916/2020	EPI_ISL_736927	2020-12-07	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.507	G
hCoV-19/South Africa/KRISP-MDSH920913/2020	EPI_ISL_736995	2020-12-07	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/USA/CA-CZB-13834/2020	EPI_ISL_739109	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13807/2020	EPI_ISL_739115	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13973/2020	EPI_ISL_739135	2020-06-18	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13824/2020	EPI_ISL_739136	2020-08-17	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14119/2020	EPI_ISL_739161	2020-05-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-14133/2020	EPI_ISL_739196	2020-05-23	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/England/NORT-1B630D0/2020	EPI_ISL_741423	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-49D875/2020	EPI_ISL_742839	2020-12-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Indonesia/JB-WJHL-ITB-L18952/2020	EPI_ISL_745033	2020-10-04	Asia / Indonesia / West Java	Human	Original	Oropharyngeal swab, Nasopharyngeal swab		Illumina NextSeq 500	DRAGEN RNA Pathogen Ilumina			B.1.1.398	GR
hCoV-19/Israel/CVL-46019/2020	EPI_ISL_745062	2020-12-10	Asia / Israel / Tel Aviv	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.294	GR
hCoV-19/Denmark/DCGC-19371/2020	EPI_ISL_748910	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19439/2020	EPI_ISL_748947	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19467/2020	EPI_ISL_748966	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-19497/2020	EPI_ISL_748988	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/GA-EHC-064L/2020	EPI_ISL_754778	2020-03-04	North America / USA / Georgia	Human	Original	Oropharyngeal swab		Illumina NovaSeq	reference-based, viral-ngs v2.0.21			B.1.1	GR
hCoV-19/Scotland/QEUH-C5CB35/2020	EPI_ISL_757036	2020-12-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-21772/2020	EPI_ISL_758352	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-21834/2020	EPI_ISL_758393	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-21175/2020	EPI_ISL_759593	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/QEUH-CC387E/2020	EPI_ISL_760655	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-CC386F/2020	EPI_ISL_760696	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-CB4421/2020	EPI_ISL_761818	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-CB3774/2020	EPI_ISL_761894	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10C607C/2020	EPI_ISL_764103	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10C6443/2020	EPI_ISL_764104	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10C9E42/2020	EPI_ISL_764105	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10CB39C/2020	EPI_ISL_764106	2020-12-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10CFEC4/2020	EPI_ISL_764107	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D0C20/2020	EPI_ISL_764108	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D38FC/2020	EPI_ISL_764109	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D4512/2020	EPI_ISL_764110	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D510E/2020	EPI_ISL_764111	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/England/SHEF-10D6844/2020	EPI_ISL_764112	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.37	GR
hCoV-19/Sweden/20-53878/2020	EPI_ISL_766724	2020-12-22	Europe / Sweden / Vastra Gotalandsregionen	Human	Original			Ion Torrent Genexus System, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.1.294	GR
hCoV-19/USA/TX-DSHS-1981/2020	EPI_ISL_766767	2020-06-18	North America / USA / Texas / Hays	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/Latvia/220/2020	EPI_ISL_770055	2020-09-14	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2	NSP11 without BLAST coverage.	warn	B.1.1.294	GR
hCoV-19/USA/CO-CDPHE-2100037717/2020	EPI_ISL_771347	2020-11-25	North America / USA / Colorado	Human	Original			Illumina Miseq				B.1.1	GR
hCoV-19/Germany/HH-hpi-p1658/2020	EPI_ISL_776084	2020-03-18	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.271	GR
hCoV-19/Germany/HH-hpi-p1659/2020	EPI_ISL_776085	2020-03-18	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.271	GR
hCoV-19/Germany/HH-hpi-p1740/2020	EPI_ISL_776119	2020-03-12	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.271	GR
hCoV-19/Germany/HH-hpi-p1754/2020	EPI_ISL_776129	2020-03-19	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.5	GR
hCoV-19/Germany/HH-hpi-p1755/2020	EPI_ISL_776130	2020-03-19	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.5	GR
hCoV-19/Germany/HH-hpi-p1848/2020	EPI_ISL_776199	2020-03-22	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/England/MILK-BA9FF2/2020	EPI_ISL_783255	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA47A/2020	EPI_ISL_783342	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMC-B78A55/2020	EPI_ISL_783367	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B774D0/2020	EPI_ISL_783371	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B77A1A/2020	EPI_ISL_783372	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-MCoV-18213/2020	EPI_ISL_784561	2020-11-11	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-18214/2020	EPI_ISL_784562	2020-11-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-16242/2020	EPI_ISL_785926	2020-10-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-16272/2020	EPI_ISL_785956	2020-10-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-16307/2020	EPI_ISL_785991	2020-10-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12900/2020	EPI_ISL_788052	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12941/2020	EPI_ISL_788093	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-MCoV-12959/2020	EPI_ISL_788111	2020-08-28	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-MCoV-12990/2020	EPI_ISL_788141	2020-08-28	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-13031/2020	EPI_ISL_788182	2020-08-28	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-MCoV-10203/2020	EPI_ISL_789370	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	O
hCoV-19/USA/TX-HMH-MCoV-10224/2020	EPI_ISL_789377	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-10255/2020	EPI_ISL_789395	2020-07-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-10337/2020	EPI_ISL_789427	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-10351/2020	EPI_ISL_789432	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-10446/2020	EPI_ISL_789481	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.177	GR
hCoV-19/USA/TX-HMH-MCoV-10494/2020	EPI_ISL_789499	2020-07-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12476/2020	EPI_ISL_790358	2020-09-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.231	GR
hCoV-19/USA/TX-HMH-MCoV-12546/2020	EPI_ISL_790384	2020-09-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.258	GR
hCoV-19/USA/TX-HMH-MCoV-12694/2020	EPI_ISL_790468	2020-08-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.356	GR
hCoV-19/USA/TX-HMH-MCoV-12742/2020	EPI_ISL_790499	2020-08-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.1.231	GR
hCoV-19/Denmark/DCGC-23922/2020	EPI_ISL_794010	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Switzerland/ZH-ETHZ-430765/2020	EPI_ISL_796629	2020-12-31	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Norway/7201/2020	EPI_ISL_796670	2020-12-26	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.274	GR
hCoV-19/Canada/AB-37707/2020	EPI_ISL_805183	2020-04-23	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-96873/2020	EPI_ISL_806408	2020-03-25	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-17731/2020	EPI_ISL_806417	2020-03-31	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-17940/2020	EPI_ISL_806425	2020-04-15	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-94866/2020	EPI_ISL_806428	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-64929/2020	EPI_ISL_806446	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-27077/2020	EPI_ISL_806454	2020-03	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-36867/2020	EPI_ISL_806463	2020-03-30	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-60578/2020	EPI_ISL_806464	2020-04-04	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Canada/AB-49051/2020	EPI_ISL_806495	2020-04-15	North America / Canada / Alberta	Human	Original	Nasopharyngeal swab		Illumina NovaSeq 6000	ivar v1.2.3			B.1.1	GR
hCoV-19/Wales/PHWC-4A78B4/2020	EPI_ISL_814900	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A78C3/2020	EPI_ISL_814901	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4A7AEB/2020	EPI_ISL_814925	2020-12-15	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/TFCI-26FBC08/2020	EPI_ISL_817046	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/TFCI-26FC2E7/2020	EPI_ISL_817112	2020-12-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/Netherlands/UT-RIVM-10020/2021	EPI_ISL_824262	2021-01-06	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.294	GR
hCoV-19/USA/NY-NYCPHL-001785/2020	EPI_ISL_824328	2020-12-14	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.467	GR
hCoV-19/Canada/Qc-CHUM-2015201695A/2020	EPI_ISL_825642	2020-05-31	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Mexico/CMX-INER-0008/2020	EPI_ISL_837610	2020-03-20	North America / Mexico / Mexico City	Human	Original	Oropharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0021/2020	EPI_ISL_837623	2020-04-01	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0045/2020	EPI_ISL_837646	2020-04-11	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/Mexico/CMX-INER-0085/2020	EPI_ISL_837683	2020-04-30	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Illumina NextSeq	CLC Genomics Workbench 10			B.1.1	GR
hCoV-19/England/QEUH-A62424/2020	EPI_ISL_842133	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Ireland/CO-20G33763/2020	EPI_ISL_848163	2020-03-18	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21006718-01/2020	EPI_ISL_861230	2020-12-28	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1.467	GR
hCoV-19/USA/NY-Wadsworth-21004942-01/2020	EPI_ISL_861256	2020-12-28	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21004957-01/2020	EPI_ISL_861266	2020-12-26	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-21004989-01/2020	EPI_ISL_861290	2020-12-30	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.1	GR
hCoV-19/England/ALDP-1003FC1/2021	EPI_ISL_863876	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/TFCI-26FE898/2020	EPI_ISL_868775	2020-11-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 18 nucleotides when compared to the reference sequence.	info	B.1.1.37	GR
hCoV-19/USA/MN-MDH-2406/2021	EPI_ISL_873264	2021-01-11	North America / USA / Minnesota	Human	Original			MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/MO-CDC-LC00000324/2020	EPI_ISL_887740	2020-12-26	North America / USA / Missouri	Human	Original	Nasal Swabs		PacBio	CLC Genomics	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.337	GR
hCoV-19/Germany/BW-FR0382/2020	EPI_ISL_893744	2020-12-30	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0383/2021	EPI_ISL_893746	2021-01-03	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0384/2021	EPI_ISL_893748	2021-01-04	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0385/2021	EPI_ISL_893750	2021-01-05	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0388/2021	EPI_ISL_893752	2021-01-07	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0390/2021	EPI_ISL_893757	2021-01-07	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0391/2021	EPI_ISL_893759	2021-01-07	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0392/2021	EPI_ISL_893761	2021-01-07	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0394/2021	EPI_ISL_893766	2021-01-08	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0396/2020	EPI_ISL_893769	2020-12-20	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0398/2020	EPI_ISL_893771	2020-12-27	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Germany/BW-FR0399/2020	EPI_ISL_893773	2020-12-27	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.1.338	GR
hCoV-19/Switzerland/SO-ETHZ-451314/2021	EPI_ISL_899740	2021-01-09	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1	GR
hCoV-19/Switzerland/VD-ETHZ-451728/2021	EPI_ISL_899893	2021-01-13	Europe / Switzerland / Vaud	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.1.384	GR
hCoV-19/Japan/PG-9571/2020	EPI_ISL_902284	2020-08-01	Asia / Japan / Kanagawa	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/LA-CDC-2-4044426/2020	EPI_ISL_903613	2020-11-20	North America / USA / Louisiana	Human	Original	Nasal secretions		Illumina	IRMA v0.9.5-beta	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.1.426	GR
hCoV-19/England/ALDP-BC98F1/2020	EPI_ISL_915513	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC8D7B/2020	EPI_ISL_915518	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC9BE9/2020	EPI_ISL_915548	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-BC9DD4/2020	EPI_ISL_915557	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.37	GR
hCoV-19/England/ALDP-BC95FA/2020	EPI_ISL_915558	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-BC9606/2020	EPI_ISL_915595	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-34994/2020	EPI_ISL_926134	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-34997/2020	EPI_ISL_926137	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-35087/2021	EPI_ISL_926227	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-35116/2021	EPI_ISL_926256	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-36316/2021	EPI_ISL_927457	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-36428/2020	EPI_ISL_927569	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-37775/2020	EPI_ISL_928916	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-37783/2020	EPI_ISL_928924	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-37788/2021	EPI_ISL_928929	2021-01-18	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Switzerland/GE-33022121/2021	EPI_ISL_953711	2021-01-20	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq				B.1.1.384	GR
hCoV-19/Switzerland/GE-33022491/2021	EPI_ISL_953720	2021-01-20	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq				B.1.1.384	GR
hCoV-19/Switzerland/GE-33058535/2021	EPI_ISL_953839	2021-01-24	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-11A0226/2021	EPI_ISL_958694	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Denmark/DCGC-41199/2021	EPI_ISL_972876	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-41261/2021	EPI_ISL_972938	2021-02-01	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-41282/2021	EPI_ISL_972959	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/USA/MN-MDH-2646/2021	EPI_ISL_982412	2021-01-14	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/MN-MDH-2652/2021	EPI_ISL_982416	2021-01-14	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.453	GR
hCoV-19/USA/NY-PRL-2020_1229_01A12/2020	EPI_ISL_984847	2020-12-27	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq/NextSeq	bwa mem			B.1.1	GR
hCoV-19/USA/NY-PRL-2020_1229_01G11/2020	EPI_ISL_984868	2020-12-28	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq/NextSeq	bwa mem			B.1.1	GR
hCoV-19/USA/NY-PRL-2021_0202_00D02/2021	EPI_ISL_984934	2021-01-30	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq/NextSeq	bwa mem			B.1.1	GR
hCoV-19/USA/NY-PRL-2021_0201_03C12/2021	EPI_ISL_984937	2021-01-30	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina MiSeq/NextSeq	bwa mem			B.1.1.231	GR
hCoV-19/England/CAMC-11E3FB7/2021	EPI_ISL_988457	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Belgium/rega-2747/2021	EPI_ISL_995604	2021-02-02	Europe / Belgium / Sint-Truiden	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods			B.1.1.349	GR
